|
2025
Semi-Annual Report
(Unaudited) |
|
BlackRock
Energy and Resources Trust (BGR) |
|
BlackRock
Enhanced Equity Dividend Trust
(BDJ) |
|
BlackRock
Enhanced Global Dividend Trust
(BOE) |
|
BlackRock
Enhanced International Dividend Trust (BGY) |
|
BlackRock
Enhanced Large Cap Core Fund, Inc. (CII) |
|
BlackRock
Health Sciences Term Trust
(BMEZ) |
|
BlackRock
Health Sciences Trust (BME) |
|
BlackRock
Resources & Commodities Strategy Trust (BCX) |
|
BlackRock
Science and Technology Term Trust
(BSTZ) |
|
BlackRock
Science and Technology Trust (BST) |
|
BlackRock
Technology and Private Equity Term Trust
(BTX) |
|
BlackRock
Utilities, Infrastructure & Power Opportunities Trust
(BUI) |
|
Not
FDIC Insured • May Lose Value • No Bank
Guarantee |
|
|
|
Total
Cumulative Distributions
for the
Fiscal Period
|
%
Breakdown of the Total Cumulative
Distributions
for the Fiscal Period
| ||||||||
|
Trust
Name |
|
Net
Income |
Net
Realized
Capital
Gains
Short-Term |
Net
Realized
Capital
Gains
Long-Term |
Return
of
Capital
(a)
|
Total
Per
Common
Share |
Net
Income |
Net
Realized
Capital
Gains
Short-Term |
Net
Realized
Capital
Gains
Long-Term |
Return
of
Capital |
Total
Per
Common
Share |
|
BGR |
|
$ 0.170098 |
$ — |
$ — |
$ 0.413702 |
$ 0.583800 |
29
% |
—
% |
—
% |
71
% |
100
% |
|
BDJ |
|
0.260620 |
— |
0.110780 |
— |
0.371400 |
70 |
— |
30 |
— |
100 |
|
BOE |
|
0.094831 |
— |
0.108912 |
0.292457 |
0.496200 |
19 |
— |
22 |
59 |
100 |
|
BGY |
|
0.075115 |
— |
0.021509 |
0.158976 |
0.255600 |
29 |
— |
9 |
62 |
100 |
|
CII |
|
— |
— |
0.846000 |
— |
0.846000 |
— |
— |
100 |
— |
100 |
|
BMEZ |
|
— |
— |
— |
1.045990 |
1.045990 |
— |
— |
— |
100 |
100 |
|
BME |
|
0.046641 |
0.053013 |
1.350605 |
0.122341 |
1.572600 |
3 |
3 |
86 |
8 |
100 |
|
BCX |
|
0.172856 |
— |
— |
0.245344 |
0.418200 |
41 |
— |
— |
59 |
100 |
|
BSTZ |
|
— |
— |
1.323490 |
— |
1.323490 |
— |
— |
100 |
— |
100 |
|
BST |
|
— |
— |
1.500000 |
— |
1.500000 |
— |
— |
100 |
— |
100 |
|
BTX |
|
— |
— |
— |
0.507030 |
0.507030 |
— |
— |
— |
100 |
100 |
|
BUI |
|
0.140186 |
— |
0.675814 |
— |
0.816000 |
17 |
— |
83 |
— |
100 |
|
(a)
|
Each
Trust estimates that it has distributed more than its net income and net
realized capital gains; therefore, a portion of the distribution may be a
return of capital. A return of capital may
occur,
for example, when some or all of the shareholder’s investment in a Trust
is returned to the shareholder. A return of capital does not necessarily
reflect a Trust’s investment
performance
and should not be confused with “yield” or “income.” When distributions
exceed total return performance, the difference will reduce a Trust’s net
asset value per share. |
|
Trust
Name |
Amount
Per
Common
Share |
BGR |
$ 0.097300 |
|
BDJ |
0.061900 |
BOE |
0.082700 |
|
BGY |
0.042600 |
CII |
0.141000 |
|
BMEZ |
0.169020 |
BME |
0.262100 |
|
BCX |
0.069700 |
BSTZ |
0.217770 |
|
BST |
0.250000 |
BTX |
0.080690 |
|
BUI |
0.136000 |
|
Symbol
on New York Stock Exchange |
BGR |
|
Initial
Offering Date |
December
29, 2004 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($13.26)(a) |
8.81% |
|
Current
Monthly Distribution per Common Share(b) |
$0.097300 |
|
Current
Annualized Distribution per Common Share(b) |
$1.167600 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 13.26 |
$ 12.61 |
5.15
% |
$ 13.89 |
$ 11.27 |
|
Net
Asset Value |
13.86 |
13.77 |
0.65 |
14.71 |
12.27 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
5.21
% |
0.72
% |
18.53
% |
3.78
% |
|
Trust
at Market Price(a)(b) |
9.91 |
8.46 |
20.06 |
3.95 |
|
MSCI
World Energy Call Overwrite Index(c) |
3.56 |
(0.04
) |
17.94 |
N/A |
|
MSCI
World Energy Index (Net)(d) |
4.56 |
(0.84
) |
19.12 |
4.58 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI World
Energy Index with a 33% overwrite level. The benchmark commenced on
December 31, 2018 and therefore
the
benchmark does not have 10-year returns. |
|
(d)
|
An
index that is designed to capture the large- and mid-cap segments across
developed markets countries. All securities in the index are classified in
the energy sector as per the Global
Industry
Classification Standard. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Exxon
Mobil Corp. |
19.8
% |
|
Shell
PLC |
10.9 |
|
Chevron
Corp. |
9.9 |
|
TotalEnergies
SE |
7.1 |
|
Canadian
Natural Resources Ltd. |
4.2 |
|
Williams
Cos., Inc. |
4.1 |
|
Cheniere
Energy, Inc. |
4.1 |
|
EOG
Resources, Inc. |
3.9 |
|
Kinder
Morgan, Inc. |
3.8 |
|
TC
Energy Corp. |
3.8 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Oil,
Gas & Consumable Fuels |
98.0
% |
|
Energy
Equipment & Services |
2.0 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
Symbol
on New York Stock Exchange |
BDJ |
|
Initial
Offering Date |
August
31, 2005 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($8.89)(a) |
8.36% |
|
Current
Monthly Distribution per Common Share(b) |
$0.061900 |
|
Current
Annualized Distribution per Common Share(b) |
$0.742800 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ |
$ |
% |
$ |
$ |
|
Net
Asset Value |
|
|
|
|
|
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
8.63
% |
11.66
% |
12.80
% |
9.04
% |
|
Trust
at Market Price(a)(b) |
12.04 |
18.14 |
13.87 |
9.65 |
|
MSCI
USA Value Call Overwrite Index(c) |
5.00 |
12.13 |
12.56 |
N/A |
|
Russell
1000®
Value Index(d) |
6.00 |
13.70 |
13.93 |
9.19 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI USA Value
Index with a 55% overwrite level. The benchmark commenced on December 31,
2018 and therefore the
benchmark
does not have 10-year returns. |
|
(d)
|
An
index that measures the performance of the large-cap value segment of
the U.S. equity universe. It includes those Russell 1000 companies
with lower price-to-book ratios and lower
expected
growth values. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Citigroup,
Inc. |
3.6
% |
|
Wells
Fargo & Co. |
3.4 |
|
First
Citizens BancShares, Inc. |
3.0 |
|
SS&C
Technologies Holdings, Inc. |
2.8 |
|
Amazon.com,
Inc. |
2.5 |
|
CVS
Health Corp. |
2.5 |
|
Microsoft
Corp. |
2.2 |
|
Cardinal
Health, Inc. |
2.1 |
|
Baxter
International, Inc. |
2.0 |
|
Medtronic
PLC |
2.0 |
|
SECTOR
ALLOCATION | |
|
Sector(b)
|
Percent
of Total
Investments(a)
|
|
Financials |
23.7
% |
|
Health
Care |
15.1 |
|
Industrials |
12.3 |
|
Information
Technology |
12.0 |
|
Communication
Services |
7.4 |
|
Consumer
Staples |
6.2 |
|
Energy |
6.1 |
|
Consumer
Discretionary |
5.3 |
|
Utilities |
4.7 |
|
Materials |
4.4 |
|
Real
Estate |
2.8 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, sector sub-classifications may differ from those
utilized by the Trust for compliance
purposes. |
|
Symbol
on New York Stock Exchange |
BOE |
|
Initial
Offering Date |
May 31,
2005 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($11.35)(a) |
8.74% |
|
Current
Monthly Distribution per Common Share(b) |
$0.082700 |
|
Current
Annualized Distribution per Common Share(b) |
$0.992400 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 11.35 |
$ 10.77 |
5.39
% |
$ 11.42 |
$ 9.66 |
|
Net
Asset Value |
12.42 |
12.05 |
3.07 |
12.62 |
10.68 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
7.75
% |
10.83
% |
10.89
% |
6.56
% |
|
Trust
at Market Price(a)(b) |
10.17 |
15.89 |
11.69 |
6.90 |
|
MSCI
ACWI Call Overwrite Index(c) |
7.11 |
14.47 |
12.29 |
N/A |
|
MSCI
ACWI (Net)(d) |
10.05 |
16.17 |
13.65 |
9.99 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI ACWI Index
with a 45% overwrite level. The benchmark commenced on December 31, 2018
and therefore the
benchmark
does not have 10-year returns. |
|
(d)
|
An
index that captures large- and mid-cap representation across certain
developed and emerging
markets. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Microsoft
Corp. |
5.7
% |
|
Broadcom,
Inc. |
4.1 |
|
Taiwan
Semiconductor Manufacturing Co. Ltd. |
3.9 |
|
AstraZeneca
PLC |
3.2 |
|
CMS
Energy Corp. |
3.0 |
|
Coca-Cola
Co. |
3.0 |
|
Meta
Platforms, Inc. |
2.9 |
|
RELX
PLC |
2.6 |
|
Accenture
PLC |
2.6 |
|
Colgate-Palmolive
Co. |
2.5 |
|
GEOGRAPHIC
ALLOCATION | |
|
Country/Geographic
Region |
Percent
of Total
Investments |
|
United
States |
71.9
% |
|
United
Kingdom |
8.9 |
|
Taiwan |
5.3 |
|
Denmark |
2.2 |
|
Netherlands |
2.1 |
|
Spain |
2.1 |
|
France |
2.1 |
|
Canada |
2.0 |
|
Switzerland |
2.0 |
|
Japan |
1.4 |
|
India |
—
(b) |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
Rounds
to less than 0.1%. |
|
Symbol
on New York Stock Exchange |
BGY |
|
Initial
Offering Date |
May 30,
2007 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($5.79)(a) |
8.83% |
|
Current
Monthly Distribution per Common Share(b) |
$0.042600 |
|
Current
Annualized Distribution per Common Share(b) |
$0.511200 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 5.79 |
$ 5.31 |
9.04
% |
$ 5.90 |
$ 4.93 |
|
Net
Asset Value |
6.27 |
5.91 |
6.09 |
6.36 |
5.38 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
10.95
% |
8.41
% |
9.19
% |
5.68
% |
|
Trust
at Market Price(a)(b) |
14.04 |
12.68 |
10.36 |
5.55 |
|
MSCI
ACWI ex USA Call Overwrite Index(c) |
14.46 |
15.58 |
8.81 |
N/A |
|
MSCI
ACWI ex USA Index (Net)(d) |
17.90 |
17.72 |
10.13 |
6.12 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI ACWI ex
USA Index with a 45% overwrite level. The benchmark commenced on December
31, 2018 and therefore
the
benchmark does not have 10-year returns. |
|
(d)
|
An
index that captures large- and mid-cap representation across certain
developed markets countries (excluding the U.S.) and certain emerging
markets countries. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Taiwan
Semiconductor Manufacturing Co. Ltd. |
5.6
% |
|
Shell
PLC |
4.0 |
|
HDFC
Bank Ltd. |
3.7 |
|
Air
Liquide SA |
3.5 |
|
SAP
SE |
3.2 |
|
Sony
Group Corp. |
3.1 |
|
Koninklijke
KPN NV |
3.1 |
|
FinecoBank
Banca Fineco SpA |
3.1 |
|
RELX
PLC |
3.1 |
|
Banco
Bilbao Vizcaya Argentaria SA |
3.0 |
|
GEOGRAPHIC
ALLOCATION | |
|
Country/Geographic
Region |
Percent
of Total
Investments |
|
United
States |
17.4
% |
|
Germany |
10.6 |
|
United
Kingdom |
9.4 |
|
Japan |
8.5 |
|
Taiwan |
7.0 |
|
Switzerland |
6.8 |
|
Netherlands |
6.0 |
|
Canada |
5.2 |
|
France |
5.1 |
|
Spain |
4.9 |
|
Sweden |
4.4 |
|
India |
3.7 |
|
Italy |
3.1 |
|
China |
2.8 |
|
Denmark |
2.6 |
|
Singapore |
2.5 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
Symbol
on New York Stock Exchange |
CII |
|
Initial
Offering Date |
April
30, 2004 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($21.35)(a) |
7.93% |
|
Current
Monthly Distribution per Common Share(b) |
$0.141000 |
|
Current
Annualized Distribution per Common Share(b) |
$1.692000 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 21.35 |
$ 20.10 |
6.22
% |
$ 21.35 |
$ 16.50 |
|
Net
Asset Value |
22.65 |
21.43 |
5.69 |
22.65 |
17.95 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
10.26
% |
14.67
% |
15.37
% |
11.47
% |
|
Trust
at Market Price(a)(b) |
10.80 |
15.06 |
16.41 |
11.61 |
|
MSCI
USA Call Overwrite Index(c) |
2.81 |
13.56 |
14.34 |
N/A |
|
Russell
1000®
Index(d) |
6.12 |
15.66 |
16.30 |
13.35 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI USA Index
with a 55% overwrite level. The benchmark commenced on December 31, 2018
and therefore the
benchmark
does not have 10-year returns. |
|
(d)
|
An
index that measures the performance of the large-cap segment of
the U.S. equity universe. It is a subset of the Russell
3000®
Index and includes approximately 1,000 of the largest
securities
based on a combination of their market capitalization and current index
membership. The Russell 1000®
Index represents approximately 93% of the Russell 3000®
Index. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Microsoft
Corp. |
9.0
% |
|
Amazon.com,
Inc. |
7.3 |
|
Meta
Platforms, Inc. |
6.9 |
|
NVIDIA
Corp. |
6.0 |
|
Broadcom,
Inc. |
4.7 |
|
Visa,
Inc. |
4.5 |
|
Cardinal
Health, Inc. |
4.0 |
|
Intercontinental
Exchange, Inc. |
3.6 |
|
Ciena
Corp. |
3.6 |
|
Howmet
Aerospace, Inc. |
3.5 |
|
SECTOR
ALLOCATION | |
|
Sector(b)
|
Percent
of Total
Investments(a)
|
|
Information
Technology |
31.7
% |
|
Financials |
17.7 |
|
Communication
Services |
13.5 |
|
Health
Care |
11.8 |
|
Consumer
Discretionary |
9.9 |
|
Industrials |
9.6 |
|
Materials |
3.0 |
|
Energy |
2.8 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, sector sub-classifications may differ from those
utilized by the Trust for compliance
purposes. |
|
Symbol
on New York Stock Exchange |
BMEZ |
|
Initial
Offering Date |
January
30, 2020 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($14.26)(a) |
14.22% |
|
Current
Monthly Distribution per Common Share(b) |
$0.169020 |
|
Current
Annualized Distribution per Common Share(b) |
$2.028240 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
monthly distribution per Common Share, declared on August 1, 2025, was
decreased to $0.164960 per share. The current distribution rate on closing
market price, current monthly
distribution
per Common Share, and current annualized distribution per Common Share do
not reflect the new distribution rate. The new distribution rate is not
constant and is subject
to
change in the future. A portion of the distribution may be deemed a return
of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 14.26 |
$ 14.40 |
(0.97
)% |
$ 16.60 |
$ 13.25 |
|
Net
Asset Value |
15.33 |
16.43 |
(6.70
) |
17.38 |
13.73 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
Since
Inception(a) |
|
Trust
at NAV(b)(c) |
(0.06
)% |
(0.02
)% |
0.70
% |
3.98
% |
|
Trust
at Market Price(b)(c) |
6.07 |
6.32 |
1.61 |
2.60 |
|
MSCI
Custom ACWI SMID Growth HC Call Overwrite Index(d) |
5.41 |
8.87 |
N/A |
(1.79
) |
|
MSCI
ACWI (Net)(e) |
10.05 |
16.17 |
13.65 |
11.18 |
|
(a)
|
BMEZ
commenced operations on January 30, 2020. |
|
(b)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(c)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(d)
|
An
index representing the Health Care sector stocks within the MSCI ACWI
SMID Cap Growth Index and incorporating an option overlay component with a
25% overwrite level. The
MSCI
ACWI SMID Cap Growth Index captures mid- and small-cap securities
exhibiting overall growth style characteristics across certain developed
and emerging markets countries.
The
index commenced on March 31, 2022 and therefore the since inception return
presented is for the period March 31, 2022 through the current reporting
period. |
|
(e)
|
An
index that captures large- and mid-cap representation across certain
developed and emerging
markets. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Alnylam
Pharmaceuticals, Inc. |
4.9
% |
|
Veeva
Systems, Inc. |
3.5 |
|
Dexcom,
Inc. |
2.8 |
|
PsiQuantum
Corp. |
2.4 |
|
Mettler-Toledo
International, Inc. |
2.4 |
|
Waters
Corp. |
2.2 |
|
West
Pharmaceutical Services, Inc. |
2.1 |
|
Labcorp
Holdings, Inc. |
2.1 |
|
IDEXX
Laboratories, Inc. |
2.1 |
|
Insulet
Corp. |
1.9 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Biotechnology |
37.9
% |
|
Health
Care Equipment & Supplies |
20.7 |
|
Life
Sciences Tools & Services |
15.3 |
|
Health
Care Providers & Services |
12.8 |
|
Pharmaceuticals |
6.1 |
|
Health
Care Technology |
4.2 |
|
Semiconductors
& Semiconductor Equipment |
2.4 |
|
Capital
Markets |
0.6 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
Symbol
on New York Stock Exchange |
BME |
|
Initial
Offering Date |
March
31, 2005 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($36.46)(a) |
8.63% |
|
Current
Monthly Distribution per Common Share(b) |
$0.262100 |
|
Current
Annualized Distribution per Common Share(b) |
$3.145200 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 36.46 |
$ 37.93 |
(3.88
)% |
$ 41.00 |
$ 34.86 |
|
Net
Asset Value |
39.31 |
41.20 |
(4.59
) |
43.95 |
37.85 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
(0.61
)% |
(4.28
)% |
5.49
% |
6.94
% |
|
Trust
at Market Price(a)(b) |
0.14 |
(3.94
) |
3.99 |
6.26 |
|
MSCI
USA Investable Market Index Health Care Call Overwrite Index(c) |
(0.74
) |
(4.74
) |
5.86 |
N/A |
|
Russell
3000®
Health Care Index(d) |
(2.56
) |
(6.13
) |
6.25 |
7.36 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI USA IMI
Health Care Index with a 33% overwrite level. The benchmark commenced on
December 31, 2018 and
therefore
the benchmark does not have 10-year returns. |
|
(d)
|
An
unmanaged index that features companies involved in medical services or
health care in the Russell 3000®
Index, which includes the largest 3,000 U.S. companies as determined
by
total market capitalization. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Eli
Lilly & Co. |
9.1
% |
|
Boston
Scientific Corp. |
6.3 |
|
Abbott
Laboratories |
5.9 |
|
AbbVie,
Inc. |
4.9 |
|
UnitedHealth
Group, Inc. |
4.6 |
|
Johnson
& Johnson |
4.1 |
|
Stryker
Corp. |
3.8 |
|
Amgen,
Inc. |
3.3 |
|
Intuitive
Surgical, Inc. |
3.3 |
|
Medtronic
PLC |
3.1 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Health
Care Equipment & Supplies |
31.4
% |
|
Biotechnology |
24.3 |
|
Pharmaceuticals |
20.2 |
|
Health
Care Providers & Services |
16.4 |
|
Life
Sciences Tools & Services |
7.6 |
|
Other* |
0.1 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
*
|
Includes
one or more investment categories that individually represents less than
1.0% of the Trust’s
total investments. Please refer to the Schedule of Investments for
details. |
|
Symbol
on New York Stock Exchange |
BCX |
|
Initial
Offering Date |
March
30, 2011 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($9.45)(a) |
8.85% |
|
Current
Monthly Distribution per Common Share(b) |
$0.069700 |
|
Current
Annualized Distribution per Common Share(b) |
$0.836400 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 9.45 |
$ 8.54 |
10.66
% |
$ 9.55 |
$ 8.00 |
|
Net
Asset Value |
10.25 |
9.58 |
6.99 |
10.35 |
8.76 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
11.93
% |
6.21
% |
14.24
% |
6.98
% |
|
Trust
at Market Price(a)(b) |
15.76 |
11.45 |
16.36 |
7.82 |
|
MSCI
ACWI Select Liquidity Natural Resources Call Overwrite Index(c) |
11.88 |
2.57 |
11.94 |
N/A |
|
S&P
Global Natural Resources Index (Net)(d) |
10.42 |
0.60 |
11.98 |
5.98 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI ACWI
Select Liquidity Natural Resources Index with a 33% overwrite level. The
benchmark commenced on
December
31, 2018 and therefore the benchmark does not have 10-year
returns. |
|
(d)
|
An
index that includes approximately 90 of the largest publicly-traded
companies in the natural resources and commodities businesses that meet
specific investability requirements
across
three primary commodity-related sectors: agribusiness, energy, and metals
and mining. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
Shell
PLC |
7.7
% |
|
Nutrien
Ltd. |
7.6 |
|
Exxon
Mobil Corp. |
6.7 |
|
Wheaton
Precious Metals Corp. |
5.7 |
|
Corteva,
Inc. |
5.6 |
|
Anglo
American PLC |
4.7 |
|
Newmont
Corp. |
4.2 |
|
Freeport-McMoRan,
Inc. |
4.0 |
|
Smurfit
WestRock PLC |
3.7 |
|
Vale
SA |
3.6 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Metals
& Mining |
39.3
% |
|
Oil,
Gas & Consumable Fuels |
26.8 |
|
Chemicals |
16.7 |
|
Containers
& Packaging |
7.5 |
|
Paper
& Forest Products |
3.2 |
|
Food
Products |
2.8 |
|
Construction
Materials |
2.8 |
|
Energy
Equipment & Services |
0.9 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
Symbol
on New York Stock Exchange |
BSTZ |
|
Initial
Offering Date |
June 27,
2019 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($20.75)(a) |
12.59% |
|
Current
Monthly Distribution per Common Share(b) |
$0.217770 |
|
Current
Annualized Distribution per Common Share(b) |
$2.613240 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
monthly distribution per Common Share, declared on August 1, 2025, was
decreased to $0.216470 per share. The current distribution rate on closing
market price, current monthly
distribution
per Common Share, and current annualized distribution per Common Share do
not reflect the new distribution rate. The new distribution rate is not
constant and is subject
to
change in the future. A portion of the distribution may be deemed a return
of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 20.75 |
$ 20.71 |
0.19
% |
$ 22.07 |
$ 16.12 |
|
Net
Asset Value |
22.30 |
23.14 |
(3.63
) |
24.34 |
17.48 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
Since
Inception(a) |
|
Trust
at NAV(b)(c) |
3.08
% |
11.41
% |
6.89
% |
11.33
% |
|
Trust
at Market Price(b)(c) |
7.17 |
18.82 |
8.17 |
10.00 |
|
MSCI
Custom ACWI SMID Growth IT Call Overwrite Index(d) |
3.89 |
11.25 |
N/A |
5.77 |
|
MSCI
ACWI (Net)(e) |
10.05 |
16.17 |
13.65 |
11.71 |
|
(a)
|
BSTZ
commenced operations on June 27, 2019. |
|
(b)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(c)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(d)
|
An
index representing the Information Technology sector stocks within the
MSCI ACWI SMID Cap Growth Index and incorporating an option overlay
component with a 25% overwrite
level.
An index that captures mid- and small-cap securities exhibiting
overall growth style characteristics across certain developed and emerging
markets. The index commenced on
March
31, 2022 and therefore the since inception return presented is for the
period March 31, 2022 through the current reporting
period. |
|
(e)
|
An
index that captures large- and mid-cap representation across certain
developed and emerging
markets. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
NVIDIA
Corp. |
9.6
% |
|
Databricks,
Inc. |
6.5 |
|
PsiQuantum
Corp. |
4.7 |
|
Spotify
Technology SA |
3.0 |
|
Klarna
Group PLC |
2.7 |
|
Databricks,
Inc. |
2.4 |
|
ByteDance
Ltd. |
2.3 |
|
Databricks,
Inc. |
2.2 |
|
MercadoLibre,
Inc. |
2.2 |
|
GrubMarket,
Inc. |
2.1 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Semiconductors
& Semiconductor Equipment |
31.3
% |
|
Software |
24.4 |
|
Entertainment |
8.1 |
|
IT
Services |
5.5 |
|
Electronic
Equipment, Instruments & Components |
3.6 |
|
Consumer
Finance |
3.2 |
|
Financial
Services |
3.1 |
|
Communications
Equipment |
2.8 |
|
Technology
Hardware, Storage & Peripherals |
2.7 |
|
Interactive
Media & Services |
2.3 |
|
Broadline
Retail |
2.2 |
|
Consumer
Staples Distribution & Retail |
2.1 |
|
Professional
Services |
1.8 |
|
Industrial
Conglomerates |
1.5 |
|
Automobiles |
1.0 |
|
Other* |
4.4 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
*
|
Includes
one or more investment categories that individually represents less than
1.0% of the Trust’s
total investments. Please refer to the Consolidated Schedule of
Investments for details. |
|
Symbol
on New York Stock Exchange |
BST |
|
Initial
Offering Date |
October
30, 2014 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($38.17)(a) |
7.86% |
|
Current
Monthly Distribution per Common Share(b) |
$0.250000 |
|
Current
Annualized Distribution per Common Share(b) |
$3.000000 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 38.17 |
$ 36.56 |
4.40
% |
$ 38.94 |
$ 29.62 |
|
Net
Asset Value |
40.67 |
39.60 |
2.70 |
41.28 |
31.27 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
7.06
% |
13.63
% |
9.77
% |
15.86
% |
|
Trust
at Market Price(a)(b) |
8.83 |
10.15 |
8.64 |
16.54 |
|
MSCI
ACWI Information Technology Call Overwrite Index(c) |
5.17 |
12.85 |
16.70 |
N/A |
|
MSCI
ACWI Information Technology Index (Net)(d) |
8.93 |
14.86 |
19.79 |
19.96 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI ACWI IT
Index with a 33% overwrite level. The benchmark commenced on December 31,
2018 and therefore the
benchmark
does not have 10-year returns. |
|
(d)
|
An
index that includes large- and mid-cap securities across certain Developed
Markets countries and certain Emerging Markets countries. All securities
in the index are classified in the
Information
Technology sector as per the Global Industry Classification
Standard. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
NVIDIA
Corp. |
13.7
% |
|
Microsoft
Corp. |
8.5 |
|
Broadcom,
Inc. |
6.9 |
|
Apple,
Inc. |
5.0 |
|
Meta
Platforms, Inc. |
3.8 |
|
Oracle
Corp. |
2.9 |
|
Amazon.com,
Inc. |
2.7 |
|
Anduril
Industries, Inc. |
2.6 |
|
Snowflake,
Inc. |
2.3 |
|
Databricks,
Inc. |
2.1 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Semiconductors
& Semiconductor Equipment |
32.4
% |
|
Software |
26.0 |
|
Technology
Hardware, Storage & Peripherals |
5.4 |
|
Broadline
Retail |
4.9 |
|
IT
Services |
4.9 |
|
Interactive
Media & Services |
4.4 |
|
Entertainment |
3.7 |
|
Financial
Services |
3.3 |
|
Aerospace
& Defense |
3.0 |
|
Professional
Services |
2.0 |
|
Media |
1.7 |
|
Communications
Equipment |
1.3 |
|
Capital
Markets |
1.0 |
|
Other* |
6.0 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
*
|
Includes
one or more investment categories that individually represents less than
1.0% of the Trust’s
total investments. Please refer to the Consolidated Schedule of
Investments for details. |
|
Symbol
on New York Stock Exchange |
BTX |
|
Initial
Offering Date |
March
29, 2021 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($7.34)(a) |
13.19% |
|
Current
Monthly Distribution per Common Share(b) |
$0.080690 |
|
Current
Annualized Distribution per Common Share(b) |
$0.968280 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
monthly distribution per Common Share, declared on August 1, 2025, was
decreased to $0.078840 per share. The current distribution rate on closing
market price, current monthly
distribution
per Common Share, and current annualized distribution per Common Share do
not reflect the new distribution rate. The new distribution rate is not
constant and is subject
to
change in the future. A portion of the distribution may be deemed a return
of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 7.34 |
$ 7.44 |
(1.34
)% |
$ 8.25 |
$ 5.50 |
|
Net
Asset Value |
7.55 |
8.37 |
(9.80
) |
8.84 |
5.96 |
|
|
|
Average
Annual Total Returns | |
|
|
6-month |
1
Year |
Since
Inception(a) |
|
Trust
at NAV(b)(c) |
(3.08
)% |
2.66
% |
(11.98
)% |
|
Trust
at Market Price(b)(c) |
6.00 |
16.79 |
(12.56
) |
|
MSCI
ACWI SMID Growth/Information Technology Index(d)(e) |
6.85 |
13.00 |
7.17 |
|
MSCI
ACWI (Net)(e)(f) |
10.05 |
16.17 |
9.38 |
|
MSCI
USA SMID Growth Call Overwrite Index(g) |
1.71 |
12.17 |
4.12 |
|
Russell
2500™ Growth Index(h) |
(0.71
) |
8.81 |
1.21 |
|
(a)
|
BTX
commenced operations on March 29, 2021. |
|
(b)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(c)
|
The Trust’s
discount to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(d)
|
The
MSCI ACWI SMID Cap Growth/ Information Technology Index captures mid- and
small-cap securities exhibiting overall growth style characteristics
across certain Developed
Markets
and Emerging Markets countries. The growth investment style
characteristics for index construction are defined using five variables:
long-term forward EPS growth rate,
short-term
forward EPS growth rate, current internal growth rate and long-term
historical EPS growth trend and long-term historical sales per share
growth trend. All securities in the
index
are classified in the Information Technology sector as per the Global
Industry Classification Standard (GICS®). |
|
(e)
|
Effective
February 20, 2025, the Trust changed its reporting benchmarks from MSCI
USA SMID Growth Call Overwrite Index and Russell 2500TM
Growth Index to MSCI ACWI SMID
Growth/Information
Technology Index and MSCI ACWI (Net) in connection with certain changes to
the Trust’s principal investment strategies. |
|
(f)
|
An
index that captures large- and mid-cap representation across certain
developed and emerging markets. |
|
(g)
|
A
custom benchmark that is made up of the MSCI USA SMID Growth Index, MSCI
USA SMID Growth 25% Call Overwrite Cash and MSCI USA SMID Growth 25% Call
Overwrite Option.
The
MSCI USA SMID Growth Index captures mid and small cap representations of
securities exhibiting overall growth style characteristics in the
U.S. |
|
(h)
|
An
index that measures the performance of the small to mid-cap growth segment
of the U.S. equity universe. It includes those Russell 2500 companies with
higher growth earning
potential
as defined by FTSE Russell’s
leading style
methodology. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
NVIDIA
Corp. |
10.5
% |
|
PsiQuantum
Corp. |
4.0 |
|
Spotify
Technology SA |
3.3 |
|
MercadoLibre,
Inc. |
2.4 |
|
SK
Hynix, Inc. |
2.3 |
|
Snowflake,
Inc. |
2.2 |
|
Dragos,
Inc. |
2.2 |
|
Via
Transportation, Inc. |
2.1 |
|
The
Production Board LLC |
2.1 |
|
Celestica,
Inc. |
2.1 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Semiconductors
& Semiconductor Equipment |
29.9
% |
|
Software |
20.4 |
|
Entertainment |
9.7 |
|
IT
Services |
8.5 |
|
Electronic
Equipment, Instruments & Components |
4.2 |
|
Capital
Markets |
3.5 |
|
Technology
Hardware, Storage & Peripherals |
3.2 |
|
Broadline
Retail |
2.4 |
|
Communications
Equipment |
2.2 |
|
Industrial
Conglomerates |
1.9 |
|
Professional
Services |
1.7 |
|
Financial
Services |
1.6 |
|
Hotels,
Restaurants & Leisure |
1.3 |
|
Diversified
Telecommunication Services |
1.2 |
|
Automobiles |
1.1 |
|
Diversified
Consumer Services |
1.0 |
|
Wireless
Telecommunication Services |
1.0 |
|
Other* |
5.2 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
*
|
Includes
one or more investment categories that individually represents less than
1.0% of the Trust’s
total investments. Please refer to the Schedule of Investments for
details. |
|
Symbol
on New York Stock Exchange |
BUI |
|
Initial
Offering Date |
November
25, 2011 |
|
Current
Distribution Rate on Closing Market Price as of June 30, 2025
($25.75)(a) |
6.34% |
|
Current
Monthly Distribution per Common Share(b) |
$0.136000 |
|
Current
Annualized Distribution per Common Share(b) |
$1.632000 |
|
(a)
|
Current
distribution rate on closing market price is calculated by dividing the
current annualized distribution per share by the closing market price. The
current distribution rate may
consist
of income, net realized gains and/or a return of capital. Past performance
is not an indication of future results. |
|
(b)
|
The
distribution rate is not constant and is subject to change. A portion of
the distribution may be deemed a return of capital or net realized
gain. |
|
|
06/30/25 |
12/31/24 |
Change |
High |
Low |
|
Closing
Market Price |
$ 25.75 |
$ 23.43 |
9.90
% |
$ 25.75 |
$ 20.72 |
|
Net
Asset Value |
24.95 |
22.65 |
10.15 |
24.95 |
20.64 |
|
|
|
Average
Annual Total Returns | ||
|
|
6-month |
1
Year |
5
Years |
10
Years |
|
Trust
at NAV(a)(b) |
14.05
% |
19.87
% |
11.45
% |
9.06
% |
|
Trust
at Market Price(a)(b) |
13.79 |
24.22 |
10.82 |
10.94 |
|
MSCI
World Select Energy, Utilities and Industry Call Overwrite
Index(c) |
15.80 |
24.98 |
11.13 |
N/A |
|
MSCI
ACWI (Net)(d) |
10.05 |
16.17 |
13.65 |
9.99 |
|
(a)
|
All
returns reflect reinvestment of dividends and/or distributions at actual
reinvestment prices. |
|
(b)
|
The Trust’s
premium to NAV narrowed during the period, which accounts for the
difference between performance based on market price and performance based
on NAV. |
|
(c)
|
An
index that incorporates an option overlay component on the MSCI World
Select Energy, Utilities and Industry Index with a 33% overwrite level.The
benchmark commenced on
December
31, 2018 and therefore the benchmark does not have 10-year
returns. |
|
(d)
|
An
index that captures large- and mid-cap representation across certain
developed and emerging
markets. |
|
TEN
LARGEST HOLDINGS | |
|
Security |
Percent
of Total
Investments(a)
|
|
NextEra
Energy, Inc. |
4.9
% |
|
SSE
PLC |
3.6 |
|
Enel
SpA |
3.5 |
|
Williams
Cos., Inc. |
3.3 |
|
GE
Vernova, Inc. |
3.2 |
|
National
Grid PLC |
3.2 |
|
Trane
Technologies PLC |
3.2 |
|
Constellation
Energy Corp. |
3.0 |
|
Cheniere
Energy, Inc. |
2.9 |
|
Cie
de Saint-Gobain SA |
2.7 |
|
INDUSTRY
ALLOCATION | |
|
Industry(b)
|
Percent
of Total
Investments(a)
|
|
Electric
Utilities |
26.6
% |
|
Electrical
Equipment |
15.5 |
|
Multi-Utilities |
15.0 |
|
Oil,
Gas & Consumable Fuels |
10.3 |
|
Building
Products |
9.1 |
|
Independent
Power and Renewable Electricity Producers |
6.1 |
|
Construction
& Engineering |
4.5 |
|
Commercial
Services & Supplies |
4.3 |
|
Chemicals |
2.7 |
|
Ground
Transportation |
1.8 |
|
Semiconductors
& Semiconductor Equipment |
1.5 |
|
Construction
Materials |
1.1 |
|
Other* |
1.5 |
|
(a)
|
Excludes
short-term securities, short investments and options, if
any. |
|
(b)
|
For
purposes of this report, industry sub-classifications may differ from
those utilized by the Trust for compliance
purposes. |
|
*
|
Includes
one or more investment categories that individually represents less than
1.0% of the Trust’s
total investments. Please refer to the Schedule of Investments for
details. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Energy
Equipment & Services — 2.0% |
| ||
|
TechnipFMC
PLC |
208,299 |
$ 7,173,818 | |
|
Oil,
Gas & Consumable Fuels — 97.2% |
| ||
|
Cameco
Corp. |
105,001 |
7,797,871 | |
|
Canadian
Natural Resources Ltd. |
|
467,679 |
14,699,219 |
|
Cheniere
Energy, Inc. |
58,336 |
14,205,983 | |
|
Chevron
Corp.(a)(b) |
|
241,625 |
34,598,284 |
|
ConocoPhillips(b) |
131,755 |
11,823,659 | |
|
EOG
Resources, Inc.(b) |
|
112,965 |
13,511,744 |
|
EQT
Corp. |
145,222 |
8,469,347 | |
|
Exxon
Mobil Corp.(b) |
|
644,429 |
69,469,447 |
|
Gazprom
PJSC(c)(d) |
879,200 |
112 | |
|
Gaztransport
Et Technigaz SA |
|
16,579 |
3,279,711 |
|
Hess
Corp. |
62,927 |
8,717,906 | |
|
Kinder
Morgan, Inc. |
|
454,858 |
13,372,825 |
|
Kosmos
Energy Ltd.(d) |
837,902 |
1,441,191 | |
|
Pembina
Pipeline Corp. |
|
169,622 |
6,368,844 |
|
Permian
Resources Corp., Class A |
572,780 |
7,801,264 | |
|
Shell
PLC, ADR |
|
539,841 |
38,010,205 |
|
Suncor
Energy, Inc. |
265,970 |
9,963,011 | |
|
Targa
Resources Corp. |
|
63,887 |
11,121,449 |
|
TC
Energy Corp. |
269,500 |
13,156,864 | |
|
TotalEnergies
SE |
|
407,808 |
24,926,316 |
|
Tourmaline
Oil Corp. |
101,801 |
4,911,566 | |
|
Valero
Energy Corp. |
|
81,200 |
10,914,904 |
|
Williams
Cos., Inc. |
228,648 |
14,361,381 | |
|
|
|
|
342,923,103 |
|
Total
Long-Term Investments — 99.2%
(Cost:
$247,990,744) |
350,096,921 | ||
|
Security |
|
Shares |
Value |
|
Short-Term
Securities | |||
|
Money
Market Funds — 0.9% |
| ||
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(e)(f) |
2,979,548 |
$ 2,979,548 | |
|
Total
Short-Term Securities — 0.9%
(Cost:
$2,979,548) |
2,979,548 | ||
|
Total
Investments Before Options Written — 100.1%
(Cost:
$250,970,292) |
353,076,469 | ||
|
Options
Written — (0.6)%
(Premiums
Received: $(2,561,374)) |
(2,132,083
) | ||
|
Total
Investments, Net of Options Written — 99.5%
(Cost:
$248,408,918) |
350,944,386 | ||
|
Other
Assets Less Liabilities — 0.5% |
1,876,212 | ||
|
Net
Assets — 100.0% |
$ 352,820,598 | ||
|
(a)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(b)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(c)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(d)
|
Non-income
producing security. |
|
(e)
|
Affiliate
of the Trust. |
|
(f)
|
Annualized
7-day yield as of period
end. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares |
$ 7,583,996 |
$ — |
$ (4,604,448
)(a) |
$ — |
$ — |
$ 2,979,548 |
2,979,548 |
$ 148,975 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call |
|
|
|
|
|
|
|
|
Shell
PLC, ADR |
274 |
07/03/25 |
USD |
67.00 |
USD |
1,929 |
$ (110,970
) |
Cheniere
Energy, Inc. |
37 |
07/09/25 |
USD |
245.00 |
USD |
901 |
(13,040
) |
|
Chevron
Corp. |
175 |
07/11/25 |
USD |
145.00 |
USD |
2,506 |
(24,500
) |
EOG
Resources, Inc. |
137 |
07/11/25 |
USD |
116.00 |
USD |
1,639 |
(64,390
) |
|
EQT
Corp. |
125 |
07/11/25 |
USD |
58.00 |
USD |
729 |
(17,938
) |
Exxon
Mobil Corp. |
328 |
07/11/25 |
USD |
105.00 |
USD |
3,536 |
(114,800
) |
|
Exxon
Mobil Corp. |
189 |
07/11/25 |
USD |
113.00 |
USD |
2,037 |
(4,158
) |
Hess
Corp. |
26 |
07/11/25 |
USD |
140.00 |
USD |
360 |
(3,835
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call (continued) |
|
|
|
|
|
|
|
|
Kinder
Morgan, Inc. |
755 |
07/11/25 |
USD |
29.00 |
USD |
2,220 |
$ (49,452
) |
Shell
PLC, ADR |
463 |
07/11/25 |
USD |
70.00 |
USD |
3,260 |
(54,402
) |
|
Suncor
Energy, Inc. |
152 |
07/11/25 |
CAD |
51.00 |
CAD |
775 |
(9,711
) |
Canadian
Natural Resources Ltd. |
364 |
07/18/25 |
CAD |
46.00 |
CAD |
1,558 |
(2,940
) |
|
Chevron
Corp. |
519 |
07/18/25 |
USD |
140.00 |
USD |
7,432 |
(254,310
) |
ConocoPhillips |
134 |
07/18/25 |
USD |
95.00 |
USD |
1,203 |
(7,906
) |
|
EOG
Resources, Inc. |
137 |
07/18/25 |
USD |
120.00 |
USD |
1,639 |
(32,538
) |
EQT
Corp. |
179 |
07/18/25 |
USD |
60.00 |
USD |
1,044 |
(17,632
) |
|
Exxon
Mobil Corp. |
328 |
07/18/25 |
USD |
110.00 |
USD |
3,536 |
(40,672
) |
Hess
Corp. |
157 |
07/18/25 |
USD |
140.00 |
USD |
2,175 |
(54,557
) |
|
Kinder
Morgan, Inc. |
70 |
07/18/25 |
USD |
29.00 |
USD |
206 |
(6,230
) |
Permian
Resources Corp., Class A |
694 |
07/18/25 |
USD |
15.00 |
USD |
945 |
(5,205
) |
|
Shell
PLC, ADR |
172 |
07/18/25 |
USD |
67.50 |
USD |
1,211 |
(58,480
) |
Targa
Resources Corp. |
121 |
07/18/25 |
USD |
185.00 |
USD |
2,106 |
(10,890
) |
|
TechnipFMC
PLC |
239 |
07/18/25 |
USD |
34.00 |
USD |
823 |
(29,278
) |
Tourmaline
Oil Corp. |
172 |
07/18/25 |
CAD |
65.30 |
CAD |
1,130 |
(19,704
) |
|
Valero
Energy Corp. |
149 |
07/18/25 |
USD |
140.00 |
USD |
2,003 |
(22,127
) |
Williams
Cos., Inc. |
174 |
07/18/25 |
USD |
60.00 |
USD |
1,093 |
(57,420
) |
|
Canadian
Natural Resources Ltd. |
300 |
07/25/25 |
CAD |
45.00 |
CAD |
1,284 |
(7,490
) |
Cheniere
Energy, Inc. |
103 |
07/25/25 |
USD |
245.00 |
USD |
2,508 |
(65,405
) |
|
Chevron
Corp. |
108 |
07/25/25 |
USD |
145.00 |
USD |
1,546 |
(28,728
) |
ConocoPhillips |
142 |
07/25/25 |
USD |
99.00 |
USD |
1,274 |
(8,094
) |
|
EOG
Resources, Inc. |
101 |
07/25/25 |
USD |
132.00 |
USD |
1,208 |
(8,080
) |
Exxon
Mobil Corp. |
220 |
07/25/25 |
USD |
106.00 |
USD |
2,372 |
(88,550
) |
|
Exxon
Mobil Corp. |
188 |
07/25/25 |
USD |
114.00 |
USD |
2,027 |
(10,434
) |
Hess
Corp. |
25 |
07/25/25 |
USD |
145.00 |
USD |
346 |
(6,000
) |
|
Kinder
Morgan, Inc. |
685 |
07/25/25 |
USD |
29.00 |
USD |
2,014 |
(60,622
) |
Shell
PLC, ADR |
462 |
07/25/25 |
USD |
73.00 |
USD |
3,253 |
(21,945
) |
|
Suncor
Energy, Inc. |
500 |
07/25/25 |
CAD |
53.00 |
CAD |
2,551 |
(16,706
) |
Suncor
Energy, Inc. |
115 |
07/25/25 |
CAD |
57.00 |
CAD |
587 |
(845
) |
|
Tourmaline
Oil Corp. |
165 |
07/25/25 |
CAD |
69.00 |
CAD |
1,084 |
(5,028
) |
Valero
Energy Corp. |
120 |
07/25/25 |
USD |
142.00 |
USD |
1,613 |
(21,480
) |
|
Canadian
Natural Resources Ltd. |
422 |
08/01/25 |
CAD |
45.00 |
CAD |
1,806 |
(14,100
) |
EQT
Corp. |
178 |
08/01/25 |
USD |
60.00 |
USD |
1,038 |
(35,511
) |
|
Exxon
Mobil Corp. |
376 |
08/01/25 |
USD |
120.00 |
USD |
4,053 |
(12,408
) |
Suncor
Energy, Inc. |
115 |
08/01/25 |
CAD |
57.00 |
CAD |
587 |
(549
) |
|
Williams
Cos., Inc. |
174 |
08/01/25 |
USD |
60.00 |
USD |
1,093 |
(65,250
) |
ConocoPhillips |
161 |
08/08/25 |
USD |
95.00 |
USD |
1,445 |
(26,807
) |
|
Canadian
Natural Resources Ltd. |
466 |
08/15/25 |
CAD |
44.00 |
CAD |
1,994 |
(35,590
) |
Exxon
Mobil Corp. |
510 |
08/15/25 |
USD |
110.00 |
USD |
5,498 |
(136,935
) |
|
Permian
Resources Corp., Class A |
657 |
08/15/25 |
USD |
15.00 |
USD |
895 |
(21,353
) |
Permian
Resources Corp., Class A |
550 |
08/15/25 |
USD |
15.66 |
USD |
749 |
(9,553
) |
|
Shell
PLC, ADR |
410 |
08/15/25 |
USD |
75.00 |
USD |
2,887 |
(20,500
) |
Targa
Resources Corp. |
91 |
08/15/25 |
USD |
185.00 |
USD |
1,584 |
(35,035
) |
|
TechnipFMC
PLC |
452 |
08/15/25 |
USD |
35.00 |
USD |
1,557 |
(66,670
) |
Williams
Cos., Inc. |
411 |
08/15/25 |
USD |
65.00 |
USD |
2,581 |
(56,512
) |
|
|
|
|
|
|
|
|
$ (1,973,265
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
Cheniere
Energy, Inc. |
UBS
AG |
5,300 |
07/07/25 |
USD |
234.00 |
USD |
1,291 |
$ (55,143
) |
|
Pembina
Pipeline Corp. |
Citibank
N.A. |
19,200 |
07/09/25 |
CAD |
53.05 |
CAD |
982 |
(2,717
) |
|
TC
Energy Corp. |
Citibank
N.A. |
43,000 |
07/14/25 |
CAD |
69.70 |
CAD |
2,859 |
(11,096
) |
|
Pembina
Pipeline Corp. |
Morgan
Stanley & Co. International PLC |
37,100 |
07/22/25 |
CAD |
52.05 |
CAD |
1,897 |
(16,690
) |
|
TC
Energy Corp. |
Citibank
N.A. |
46,400 |
07/22/25 |
CAD |
70.26 |
CAD |
3,085 |
(17,352
) |
|
TotalEnergies
SE |
Barclays
Bank PLC |
76,100 |
07/23/25 |
EUR |
55.64 |
EUR |
3,949 |
(13,835
) |
|
TotalEnergies
SE |
Bank
of America N.A. |
46,400 |
07/30/25 |
EUR |
56.62 |
EUR |
2,408 |
(8,358
) |
|
Gaztransport
& Technigaz SA |
JPMorgan
Chase Bank N.A. |
5,700 |
08/05/25 |
EUR |
168.20 |
EUR |
957 |
(33,627
) |
|
|
|
|
|
|
|
|
|
$ (158,818
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (2,561,374
) |
$ 904,774 |
$ (475,483
) |
$ (2,132,083
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 2,132,083 |
$ — |
$ — |
$ — |
$ 2,132,083 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ 2,906,505 |
$ — |
$ — |
$ — |
$ 2,906,505 |
|
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (489,976
) |
$ — |
$ — |
$ — |
$ (489,976
) |
|
Options: |
|
|
Average
value of option contracts written |
$3,325,928 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 2,132,083 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
2,132,083 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(1,973,265
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 158,818 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 8,358 |
$ — |
$ — |
$ — |
$ 8,358 |
|
Barclays
Bank PLC |
13,835 |
— |
— |
— |
13,835 |
|
Citibank
N.A. |
31,165 |
— |
(31,165
) |
— |
— |
|
JPMorgan
Chase Bank N.A. |
33,627 |
— |
— |
— |
33,627 |
|
Morgan
Stanley & Co. International PLC |
16,690 |
— |
— |
— |
16,690 |
|
UBS
AG |
55,143 |
— |
— |
— |
55,143 |
|
|
$ 158,818 |
$ — |
$ (31,165
) |
$ — |
$ 127,653 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
Assets |
|
|
|
|
|
Investments |
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
Energy
Equipment & Services |
$ 7,173,818 |
$ — |
$ — |
$ 7,173,818 |
|
Oil,
Gas & Consumable Fuels |
314,716,964 |
28,206,027 |
112 |
342,923,103 |
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
2,979,548 |
— |
— |
2,979,548 |
|
$324,870,330 |
$28,206,027 |
$112 |
$353,076,469 | |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (1,950,672
) |
$ (181,411
) |
$ — |
$ (2,132,083
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Aerospace
& Defense — 3.8% |
| ||
|
Airbus
SE |
44,644 |
$ 9,339,555 | |
|
Boeing
Co.(a) |
|
42,001 |
8,800,470 |
|
L3Harris
Technologies, Inc.(b) |
118,353 |
29,687,666 | |
|
Lockheed
Martin Corp. |
|
16,790 |
7,776,121 |
|
RTX
Corp. |
50,305 |
7,345,536 | |
|
|
|
|
62,949,348 |
|
Automobile
Components — 0.4% |
| ||
|
Lear
Corp. |
|
72,868 |
6,921,003 |
|
Automobiles
— 0.7% |
| ||
|
General
Motors Co.(b) |
|
245,868 |
12,099,164 |
|
Banks
— 12.3% |
| ||
|
Bank
of America Corp. |
|
411,516 |
19,472,937 |
|
Citigroup,
Inc.(b) |
696,290 |
59,268,205 | |
|
First
Citizens BancShares, Inc., Class A(c) |
|
24,781 |
48,483,283 |
|
JPMorgan
Chase & Co.(b) |
72,516 |
21,023,113 | |
|
Wells
Fargo & Co.(b) |
|
698,373 |
55,953,645 |
|
|
|
204,201,183 | |
|
Beverages
— 0.6% |
| ||
|
Keurig
Dr. Pepper, Inc. |
283,227 |
9,363,485 | |
|
Broadline
Retail — 2.5% |
| ||
|
Amazon.com,
Inc.(a)(b) |
189,384 |
41,548,956 | |
|
Building
Products — 0.8% |
| ||
|
Allegion
PLC |
31,370 |
4,521,045 | |
|
Johnson
Controls International PLC |
|
83,565 |
8,826,135 |
|
|
|
13,347,180 | |
|
Capital
Markets — 3.5% |
| ||
|
Carlyle
Group, Inc. |
355,078 |
18,251,009 | |
|
Charles
Schwab Corp. |
|
125,152 |
11,418,869 |
|
Intercontinental
Exchange, Inc.(b) |
158,428 |
29,066,785 | |
|
|
|
|
58,736,663 |
|
Chemicals
— 2.4% |
| ||
|
Air
Products and Chemicals, Inc. |
|
47,092 |
13,282,770 |
|
International
Flavors & Fragrances, Inc. |
132,357 |
9,734,857 | |
|
PPG
Industries, Inc. |
|
152,914 |
17,393,967 |
|
|
|
40,411,594 | |
|
Commercial
Services & Supplies — 0.8% |
| ||
|
Rentokil
Initial PLC |
2,875,236 |
13,872,341 | |
|
Communications
Equipment — 1.3% |
| ||
|
Cisco
Systems, Inc.(b) |
307,856 |
21,359,049 | |
|
Consumer
Finance — 0.4% |
| ||
|
Capital
One Financial Corp. |
32,400 |
6,893,424 | |
|
Consumer
Staples Distribution & Retail — 1.8% |
| ||
|
Dollar
General Corp. |
259,210 |
29,648,440 | |
|
Containers
& Packaging — 1.4% |
| ||
|
Crown
Holdings, Inc. |
76,929 |
7,922,148 | |
|
Sealed
Air Corp. |
|
475,252 |
14,747,070 |
|
|
|
22,669,218 | |
|
Diversified
Telecommunication Services — 1.0% |
| ||
|
Verizon
Communications, Inc.(d) |
364,974 |
15,792,425 | |
|
Electric
Utilities — 2.9% |
| ||
|
American
Electric Power Co., Inc. |
78,675 |
8,163,318 | |
|
Security |
|
Shares |
Value |
|
Electric
Utilities (continued) |
| ||
|
Edison
International |
|
107,730 |
$ 5,558,868 |
|
Evergy,
Inc. |
119,870 |
8,262,639 | |
|
Exelon
Corp. |
|
371,139 |
16,114,855 |
|
PG&E
Corp. |
725,205 |
10,109,358 | |
|
|
|
|
48,209,038 |
|
Electronic
Equipment, Instruments & Components — 0.1% |
| ||
|
Ralliant
Corp.(a) |
|
50,465 |
2,447,032 |
|
Entertainment
— 1.9% |
| ||
|
Electronic
Arts, Inc. |
|
135,026 |
21,563,652 |
|
Walt
Disney Co. |
83,424 |
10,345,410 | |
|
|
|
|
31,909,062 |
|
Financial
Services — 3.3% |
| ||
|
AP
Arsenal Co. Invest LP(a)(e) |
|
15,830,106 |
16,146,708 |
|
Fidelity
National Information Services, Inc.(d) |
361,250 |
29,409,362 | |
|
Visa,
Inc., Class A |
|
26,772 |
9,505,399 |
|
|
|
55,061,469 | |
|
Food
Products — 2.0% |
| ||
|
Kraft
Heinz Co.(b) |
857,217 |
22,133,343 | |
|
Lamb
Weston Holdings, Inc. |
|
200,495 |
10,395,666 |
|
|
|
32,529,009 | |
|
Ground
Transportation — 0.5% |
| ||
|
CSX
Corp. |
277,370 |
9,050,583 | |
|
Health
Care Equipment & Supplies — 5.4% |
| ||
|
Baxter
International, Inc.(b) |
1,094,560 |
33,143,277 | |
|
Becton
Dickinson & Co. |
|
139,521 |
24,032,492 |
|
Medtronic
PLC |
369,133 |
32,177,324 | |
|
|
|
|
89,353,093 |
|
Health
Care Providers & Services — 6.9% |
| ||
|
Cardinal
Health, Inc.(b)(d) |
|
203,171 |
34,132,728 |
|
Cigna
Group |
28,834 |
9,531,944 | |
|
CVS
Health Corp.(b)(d) |
|
589,573 |
40,668,745 |
|
Elevance
Health, Inc.(b) |
40,176 |
15,626,857 | |
|
Labcorp
Holdings, Inc. |
|
54,631 |
14,341,184 |
|
|
|
114,301,458 | |
|
Health
Care REITs — 0.3% |
| ||
|
Healthcare
Realty Trust, Inc. |
339,019 |
5,376,841 | |
|
Household
Durables — 0.5% |
| ||
|
Sony
Group Corp. |
336,100 |
8,738,703 | |
|
Industrial
Conglomerates — 0.8% |
| ||
|
Honeywell
International, Inc. |
53,969 |
12,568,301 | |
|
Industrial
REITs — 0.6% |
| ||
|
Rexford
Industrial Realty, Inc. |
87,590 |
3,115,576 | |
|
STAG
Industrial, Inc. |
|
186,822 |
6,777,902 |
|
|
|
9,893,478 | |
|
Insurance
— 3.9% |
| ||
|
American
International Group, Inc.(b) |
183,283 |
15,687,192 | |
|
Fidelity
National Financial, Inc., Class A |
|
307,112 |
17,216,699 |
|
Willis
Towers Watson PLC |
104,134 |
31,917,071 | |
|
|
|
|
64,820,962 |
|
Interactive
Media & Services — 2.0% |
| ||
|
Alphabet,
Inc., Class C |
|
141,760 |
25,146,807 |
|
Meta
Platforms, Inc., Class A |
11,670 |
8,613,510 | |
|
|
|
|
33,760,317 |
|
Security |
|
Shares |
Value |
|
IT
Services — 0.9% |
| ||
|
Cognizant
Technology Solutions Corp., Class A(b) |
|
186,268 |
$ 14,534,492 |
|
Leisure
Products — 1.1% |
| ||
|
Hasbro,
Inc. |
|
240,339 |
17,741,825 |
|
Machinery
— 1.5% |
| ||
|
CNH
Industrial NV |
|
610,248 |
7,908,814 |
|
Fortive
Corp. |
151,394 |
7,892,169 | |
|
Westinghouse
Air Brake Technologies Corp. |
|
46,703 |
9,777,273 |
|
|
|
25,578,256 | |
|
Media
— 2.4% |
| ||
|
Comcast
Corp., Class A(b) |
791,414 |
28,245,566 | |
|
WPP
PLC |
|
1,624,635 |
11,439,032 |
|
|
|
39,684,598 | |
|
Metals
& Mining — 0.6% |
| ||
|
Teck
Resources Ltd., Class B(c) |
243,665 |
9,839,193 | |
|
Multi-Utilities
— 1.8% |
| ||
|
Dominion
Energy, Inc. |
247,354 |
13,980,448 | |
|
Sempra |
|
205,412 |
15,564,067 |
|
|
|
29,544,515 | |
|
Oil,
Gas & Consumable Fuels — 6.0% |
| ||
|
BP
PLC |
6,186,140 |
30,821,152 | |
|
Enterprise
Products Partners LP(b) |
|
426,900 |
13,238,169 |
|
Formentera
Partners Fund II LP(a)(e)(f) |
—
(g) |
14,002,368 | |
|
Hess
Corp.(d) |
|
99,462 |
13,779,466 |
|
Shell
PLC |
787,946 |
27,491,055 | |
|
|
|
|
99,332,210 |
|
Pharmaceuticals
— 2.7% |
| ||
|
AstraZeneca
PLC |
|
78,906 |
10,981,280 |
|
Bristol-Myers
Squibb Co. |
86,010 |
3,981,403 | |
|
Eli
Lilly & Co. |
|
9,899 |
7,716,567 |
|
Merck
& Co., Inc. |
50,870 |
4,026,869 | |
|
Pfizer,
Inc. |
|
168,940 |
4,095,106 |
|
Sanofi
SA |
142,183 |
13,765,270 | |
|
|
|
|
44,566,495 |
|
Professional
Services(b)
— 3.6% |
| ||
|
Leidos
Holdings, Inc. |
|
91,292 |
14,402,226 |
|
SS&C
Technologies Holdings, Inc. |
550,720 |
45,599,616 | |
|
|
|
|
60,001,842 |
|
Residential
REITs — 0.6% |
| ||
|
AvalonBay
Communities, Inc. |
|
52,770 |
10,738,695 |
|
Semiconductors
& Semiconductor Equipment — 2.5% |
| ||
|
Amkor
Technology, Inc. |
|
190,567 |
4,000,001 |
|
Intel
Corp. |
230,307 |
5,158,877 | |
|
NVIDIA
Corp. |
|
46,226 |
7,303,246 |
|
STMicroelectronics
NV |
364,539 |
11,177,493 | |
|
Taiwan
Semiconductor Manufacturing Co. Ltd., ADR |
|
57,856 |
13,103,805 |
|
|
|
40,743,422 | |
|
Software
— 2.7% |
| ||
|
Microsoft
Corp.(b)(d) |
72,504 |
36,064,215 | |
|
Salesforce,
Inc. |
|
30,890 |
8,423,394 |
|
|
|
44,487,609 | |
|
Specialized
REITs — 1.2% |
| ||
|
Crown
Castle, Inc.(b)(d) |
185,728 |
19,079,837 | |
|
Technology
Hardware, Storage & Peripherals — 4.4% |
| ||
|
Hewlett
Packard Enterprise Co. |
734,265 |
15,015,719 | |
|
Security |
|
Shares |
Value |
|
Technology
Hardware, Storage & Peripherals (continued) |
| ||
|
HP,
Inc. |
|
830,337 |
$ 20,310,043 |
|
Samsung
Electronics Co. Ltd., GDR(h) |
24,900 |
27,504,163 | |
|
Western
Digital Corp. |
|
162,680 |
10,409,893 |
|
|
|
73,239,818 | |
|
Tobacco
— 1.0% |
| ||
|
British
American Tobacco PLC, ADR |
362,759 |
17,169,384 | |
|
Trading
Companies & Distributors — 0.2% |
| ||
|
WESCO
International, Inc. |
22,177 |
4,107,180 | |
|
Total
Common Stocks — 98.0%
(Cost:
$1,264,617,930) |
1,628,222,190 | ||
|
Preferred
Securities | |||
|
Preferred
Stocks — 0.8% | |||
|
Household
Products — 0.8% |
| ||
|
Henkel
AG & Co. KGaA |
|
171,568 |
13,482,430 |
|
|
13,482,430 | ||
|
Total
Preferred Securities — 0.8%
(Cost:
$14,354,261) |
13,482,430 | ||
|
Total
Long-Term Investments — 98.8%
(Cost:
$1,278,972,191) |
1,641,704,620 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 3.3% |
| ||
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares,
4.47%(i)(j)(k) |
|
7,490,800 |
7,493,796 |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares,
4.20%(i)(j) |
47,729,870 |
47,729,870 | |
|
Total
Short-Term Securities — 3.3%
(Cost:
$55,223,667) |
55,223,666 | ||
|
Total
Investments Before Options Written — 102.1%
(Cost:
$1,334,195,858) |
1,696,928,286 | ||
|
Options
Written — (1.7)%
(Premiums
Received: $(21,353,369)) |
(28,938,002
) | ||
|
Total
Investments, Net of Options Written — 100.4%
(Cost:
$1,312,842,489) |
1,667,990,284 | ||
|
Liabilities
in Excess of Other Assets — (0.4)% |
(7,182,541
) | ||
|
Net
Assets — 100.0% |
$ 1,660,807,743 | ||
|
(a)
|
Non-income
producing security. |
|
(b)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(c)
|
All
or a portion of this security is on loan. |
|
(d)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(e)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(f)
|
All
or a portion of the security is held by a wholly-owned subsidiary. See
Note 1
of the
Notes
to Financial Statements for details on the wholly-owned
subsidiary. |
|
(g)
|
Investment
does not issue shares. |
|
(h)
|
This
security may be resold to qualified foreign investors and foreign
institutional buyers
under
Regulation S of the Securities Act of 1933. |
|
(i)
|
Affiliate
of the Trust. |
|
(j)
|
Annualized
7-day yield as of period end. |
|
(k)
|
All
or a portion of this security was purchased with the cash collateral from
loaned
securities. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency Shares |
$ — |
$ 7,494,004
(a) |
$ — |
$ (208
) |
$ — |
$ 7,493,796 |
7,490,800 |
$ 890
(b) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares |
46,597,729 |
1,132,141
(a) |
— |
— |
— |
47,729,870 |
47,729,870 |
828,079 |
— |
|
|
|
|
|
$ (208
) |
$ — |
$ 55,223,666 |
|
$ 828,969 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
(b)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call |
|
|
|
|
|
|
|
|
American
International Group, Inc. |
294 |
07/03/25 |
USD |
86.00 |
USD |
2,516 |
$ (14,700
) |
CSX
Corp. |
500 |
07/03/25 |
USD |
32.00 |
USD |
1,632 |
(36,250
) |
|
General
Motors Co. |
522 |
07/03/25 |
USD |
49.00 |
USD |
2,569 |
(36,018
) |
Verizon
Communications, Inc. |
272 |
07/03/25 |
USD |
45.00 |
USD |
1,177 |
(408
) |
|
Verizon
Communications, Inc. |
271 |
07/03/25 |
USD |
44.00 |
USD |
1,173 |
(1,220
) |
Dominion
Energy, Inc. |
282 |
07/07/25 |
USD |
55.50 |
USD |
1,594 |
(34,432
) |
|
Alphabet,
Inc., Class C |
260 |
07/11/25 |
USD |
172.50 |
USD |
4,612 |
(168,350
) |
Amazon.com,
Inc. |
139 |
07/11/25 |
USD |
221.01 |
USD |
3,050 |
(48,955
) |
|
Bank
of America Corp. |
742 |
07/11/25 |
USD |
46.00 |
USD |
3,511 |
(120,204
) |
Charles
Schwab Corp. |
183 |
07/11/25 |
USD |
91.00 |
USD |
1,670 |
(26,261
) |
|
Cisco
Systems, Inc. |
423 |
07/11/25 |
USD |
64.00 |
USD |
2,935 |
(222,075
) |
Comcast
Corp., Class A |
1,185 |
07/11/25 |
USD |
35.00 |
USD |
4,229 |
(87,690
) |
|
CVS
Health Corp. |
517 |
07/11/25 |
USD |
64.00 |
USD |
3,566 |
(271,425
) |
Dollar
General Corp. |
600 |
07/11/25 |
USD |
120.00 |
USD |
6,863 |
(17,100
) |
|
Microsoft
Corp. |
237 |
07/11/25 |
USD |
470.00 |
USD |
11,789 |
(680,190
) |
NVIDIA
Corp. |
115 |
07/11/25 |
USD |
149.04 |
USD |
1,817 |
(116,489
) |
|
PPG
Industries, Inc. |
280 |
07/11/25 |
USD |
113.00 |
USD |
3,185 |
(63,700
) |
Taiwan
Semiconductor Manufacturing Co. Ltd., ADR |
257 |
07/11/25 |
USD |
220.00 |
USD |
5,821 |
(226,802
) |
|
Teck
Resources Ltd., Class B |
258 |
07/11/25 |
USD |
39.00 |
USD |
1,042 |
(49,665
) |
Verizon
Communications, Inc. |
362 |
07/11/25 |
USD |
44.00 |
USD |
1,566 |
(5,249
) |
|
Visa,
Inc., Class A |
142 |
07/11/25 |
USD |
365.00 |
USD |
5,042 |
(15,052
) |
Wells
Fargo & Co. |
1,715 |
07/11/25 |
USD |
77.00 |
USD |
13,741 |
(560,805
) |
|
Air
Products & Chemicals, Inc. |
181 |
07/18/25 |
USD |
281.41 |
USD |
5,105 |
(89,984
) |
Allegion
PLC |
60 |
07/18/25 |
USD |
145.12 |
USD |
865 |
(13,068
) |
|
Alphabet,
Inc., Class C |
260 |
07/18/25 |
USD |
175.00 |
USD |
4,612 |
(151,450
) |
Amazon.com,
Inc. |
53 |
07/18/25 |
USD |
210.00 |
USD |
1,163 |
(62,540
) |
|
Amazon.com,
Inc. |
97 |
07/18/25 |
USD |
220.00 |
USD |
2,128 |
(50,683
) |
American
Electric Power Co., Inc. |
179 |
07/18/25 |
USD |
105.00 |
USD |
1,857 |
(18,795
) |
|
American
International Group, Inc. |
294 |
07/18/25 |
USD |
85.00 |
USD |
2,516 |
(58,065
) |
AvalonBay
Communities, Inc. |
145 |
07/18/25 |
USD |
212.73 |
USD |
2,951 |
(23,596
) |
|
Baxter
International, Inc. |
2,161 |
07/18/25 |
USD |
32.50 |
USD |
6,544 |
(59,428
) |
Becton
Dickinson & Co. |
515 |
07/18/25 |
USD |
180.00 |
USD |
8,871 |
(56,650
) |
|
Boeing
Co. |
164 |
07/18/25 |
USD |
200.00 |
USD |
3,436 |
(195,980
) |
Capital
One Financial Corp. |
178 |
07/18/25 |
USD |
210.00 |
USD |
3,787 |
(124,600
) |
|
Carlyle
Group, Inc. |
1,022 |
07/18/25 |
USD |
48.12 |
USD |
5,253 |
(393,068
) |
Charles
Schwab Corp. |
189 |
07/18/25 |
USD |
92.50 |
USD |
1,724 |
(41,391
) |
|
Citigroup,
Inc. |
805 |
07/18/25 |
USD |
77.50 |
USD |
6,852 |
(658,087
) |
Cognizant
Technology Solutions Corp., Class A |
847 |
07/18/25 |
USD |
85.00 |
USD |
6,609 |
(76,230
) |
|
Comcast
Corp., Class A |
954 |
07/18/25 |
USD |
37.50 |
USD |
3,405 |
(7,155
) |
Crown
Holdings, Inc. |
423 |
07/18/25 |
USD |
100.00 |
USD |
4,356 |
(173,430
) |
|
CVS
Health Corp. |
1,012 |
07/18/25 |
USD |
70.00 |
USD |
6,981 |
(102,718
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call (continued) |
|
|
|
|
|
|
|
|
Dollar
General Corp. |
368 |
07/18/25 |
USD |
120.00 |
USD |
4,209 |
$ (22,632
) |
Dominion
Energy, Inc. |
539 |
07/18/25 |
USD |
55.00 |
USD |
3,046 |
(113,190
) |
|
Eli
Lilly & Co. |
21 |
07/18/25 |
USD |
860.00 |
USD |
1,637 |
(4,851
) |
Enterprise
Products Partners LP |
773 |
07/18/25 |
USD |
32.00 |
USD |
2,397 |
(8,117
) |
|
Exelon
Corp. |
486 |
07/18/25 |
USD |
45.00 |
USD |
2,110 |
(7,290
) |
Exelon
Corp. |
486 |
07/18/25 |
USD |
46.00 |
USD |
2,110 |
(7,290
) |
|
Fidelity
National Financial, Inc. |
870 |
07/18/25 |
USD |
56.98 |
USD |
4,877 |
(70,824
) |
Fidelity
National Information Services, Inc. |
361 |
07/18/25 |
USD |
82.50 |
USD |
2,939 |
(52,345
) |
|
First
Citizens BancShares, Inc., Class A |
28 |
07/18/25 |
USD |
2,050.00 |
USD |
5,478 |
(30,800
) |
First
Citizens BancShares, Inc., Class A |
28 |
07/18/25 |
USD |
1,870.00 |
USD |
5,478 |
(298,620
) |
|
Fortive
Corp. |
535 |
07/18/25 |
USD |
75.00 |
USD |
2,789 |
(34,775
) |
General
Motors Co. |
211 |
07/18/25 |
USD |
52.50 |
USD |
1,038 |
(6,014
) |
|
Hasbro,
Inc. |
86 |
07/18/25 |
USD |
70.00 |
USD |
635 |
(38,700
) |
Hasbro,
Inc. |
235 |
07/18/25 |
USD |
75.00 |
USD |
1,735 |
(25,850
) |
|
Hewlett
Packard Enterprise Co. |
2,599 |
07/18/25 |
USD |
20.00 |
USD |
5,315 |
(223,514
) |
Honeywell
International, Inc. |
97 |
07/18/25 |
USD |
225.00 |
USD |
2,259 |
(97,000
) |
|
Honeywell
International, Inc. |
96 |
07/18/25 |
USD |
230.00 |
USD |
2,236 |
(54,240
) |
HP,
Inc. |
1,017 |
07/18/25 |
USD |
26.00 |
USD |
2,488 |
(10,679
) |
|
Intercontinental
Exchange, Inc. |
263 |
07/18/25 |
USD |
180.00 |
USD |
4,825 |
(138,075
) |
International
Flavors & Fragrances, Inc. |
539 |
07/18/25 |
USD |
80.00 |
USD |
3,964 |
(61,985
) |
|
Johnson
Controls International PLC |
147 |
07/18/25 |
USD |
100.00 |
USD |
1,553 |
(94,815
) |
JPMorgan
Chase & Co. |
154 |
07/18/25 |
USD |
270.00 |
USD |
4,465 |
(320,320
) |
|
Keurig
Dr. Pepper, Inc. |
820 |
07/18/25 |
USD |
34.00 |
USD |
2,711 |
(12,300
) |
Kraft
Heinz Co. |
565 |
07/18/25 |
USD |
27.50 |
USD |
1,459 |
(3,108
) |
|
L3Harris
Technologies, Inc. |
380 |
07/18/25 |
USD |
220.00 |
USD |
9,532 |
(1,202,700
) |
Lamb
Weston Holdings, Inc. |
731 |
07/18/25 |
USD |
55.00 |
USD |
3,790 |
(29,240
) |
|
Leidos
Holdings, Inc. |
236 |
07/18/25 |
USD |
155.00 |
USD |
3,723 |
(134,520
) |
Medtronic
PLC |
667 |
07/18/25 |
USD |
87.50 |
USD |
5,814 |
(98,716
) |
|
Microsoft
Corp. |
92 |
07/18/25 |
USD |
460.00 |
USD |
4,576 |
(360,870
) |
NVIDIA
Corp. |
31 |
07/18/25 |
USD |
135.00 |
USD |
490 |
(73,392
) |
|
NVIDIA
Corp. |
24 |
07/18/25 |
USD |
130.00 |
USD |
379 |
(68,520
) |
PPG
Industries, Inc. |
280 |
07/18/25 |
USD |
115.00 |
USD |
3,185 |
(58,800
) |
|
Sealed
Air Corp. |
1,123 |
07/18/25 |
USD |
33.35 |
USD |
3,485 |
(5,306
) |
Sempra |
756 |
07/18/25 |
USD |
80.00 |
USD |
5,728 |
(15,120
) |
|
SS&C
Technologies Holdings, Inc. |
1,612 |
07/18/25 |
USD |
80.00 |
USD |
13,347 |
(544,050
) |
STAG
Industrial, Inc. |
513 |
07/18/25 |
USD |
37.44 |
USD |
1,861 |
(19,208
) |
|
Teck
Resources Ltd., Class B |
250 |
07/18/25 |
USD |
38.00 |
USD |
1,010 |
(55,625
) |
Walt
Disney Co. |
430 |
07/18/25 |
USD |
115.00 |
USD |
5,332 |
(408,500
) |
|
Wells
Fargo & Co. |
595 |
07/18/25 |
USD |
75.00 |
USD |
4,767 |
(351,050
) |
WESCO
International, Inc. |
60 |
07/18/25 |
USD |
195.00 |
USD |
1,111 |
(6,600
) |
|
Western
Digital Corp. |
270 |
07/18/25 |
USD |
55.00 |
USD |
1,728 |
(251,100
) |
Westinghouse
Air Brake Technologies Corp. |
153 |
07/18/25 |
USD |
200.00 |
USD |
3,203 |
(174,420
) |
|
Willis
Towers Watson PLC |
311 |
07/18/25 |
USD |
310.00 |
USD |
9,532 |
(140,727
) |
CNH
Industrial NV |
2,417 |
07/23/25 |
USD |
13.85 |
USD |
3,132 |
(35,934
) |
|
Alphabet,
Inc., Class C |
260 |
07/25/25 |
USD |
180.00 |
USD |
4,612 |
(138,450
) |
Amazon.com,
Inc. |
102 |
07/25/25 |
USD |
220.00 |
USD |
2,238 |
(64,005
) |
|
American
International Group, Inc. |
210 |
07/25/25 |
USD |
86.00 |
USD |
1,797 |
(36,225
) |
Bank
of America Corp. |
761 |
07/25/25 |
USD |
45.00 |
USD |
3,601 |
(215,363
) |
|
Boeing
Co. |
205 |
07/25/25 |
USD |
230.00 |
USD |
4,295 |
(20,705
) |
Cardinal
Health, Inc. |
314 |
07/25/25 |
USD |
170.00 |
USD |
5,275 |
(73,005
) |
|
Cigna
Group |
32 |
07/25/25 |
USD |
330.00 |
USD |
1,058 |
(25,120
) |
Cisco
Systems, Inc. |
635 |
07/25/25 |
USD |
68.00 |
USD |
4,406 |
(124,460
) |
|
Citigroup,
Inc. |
1,471 |
07/25/25 |
USD |
80.00 |
USD |
12,521 |
(912,020
) |
Comcast
Corp., Class A |
899 |
07/25/25 |
USD |
36.00 |
USD |
3,209 |
(44,950
) |
|
CSX
Corp. |
512 |
07/25/25 |
USD |
33.00 |
USD |
1,671 |
(37,120
) |
CVS
Health Corp. |
984 |
07/25/25 |
USD |
69.00 |
USD |
6,788 |
(163,836
) |
|
Electronic
Arts, Inc. |
394 |
07/25/25 |
USD |
155.00 |
USD |
6,292 |
(263,980
) |
Eli
Lilly & Co. |
22 |
07/25/25 |
USD |
860.00 |
USD |
1,715 |
(8,151
) |
|
Enterprise
Products Partners LP |
465 |
07/25/25 |
USD |
32.00 |
USD |
1,442 |
(7,440
) |
Fidelity
National Information Services, Inc. |
950 |
07/25/25 |
USD |
82.00 |
USD |
7,734 |
(144,875
) |
|
General
Motors Co. |
507 |
07/25/25 |
USD |
50.00 |
USD |
2,495 |
(88,471
) |
Hewlett
Packard Enterprise Co. |
618 |
07/25/25 |
USD |
19.00 |
USD |
1,264 |
(102,897
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call (continued) |
|
|
|
|
|
|
|
|
HP,
Inc. |
1,229 |
07/25/25 |
USD |
26.00 |
USD |
3,006 |
$ (25,195
) |
JPMorgan
Chase & Co. |
175 |
07/25/25 |
USD |
275.00 |
USD |
5,073 |
(307,562
) |
|
Medtronic
PLC |
738 |
07/25/25 |
USD |
88.00 |
USD |
6,433 |
(128,781
) |
Meta
Platforms, Inc., Class A |
64 |
07/25/25 |
USD |
725.00 |
USD |
4,724 |
(193,120
) |
|
Microsoft
Corp. |
58 |
07/25/25 |
USD |
495.00 |
USD |
2,885 |
(63,945
) |
Microsoft
Corp. |
57 |
07/25/25 |
USD |
485.00 |
USD |
2,835 |
(103,027
) |
|
Teck
Resources Ltd., Class B |
270 |
07/25/25 |
USD |
43.00 |
USD |
1,090 |
(18,900
) |
Verizon
Communications, Inc. |
696 |
07/25/25 |
USD |
44.00 |
USD |
3,012 |
(34,452
) |
|
Wells
Fargo & Co. |
678 |
07/25/25 |
USD |
76.00 |
USD |
5,432 |
(359,340
) |
Amazon.com,
Inc. |
325 |
08/01/25 |
USD |
225.00 |
USD |
7,130 |
(234,812
) |
|
American
International Group, Inc. |
210 |
08/01/25 |
USD |
87.00 |
USD |
1,797 |
(43,575
) |
Baxter
International, Inc. |
526 |
08/01/25 |
USD |
31.00 |
USD |
1,593 |
(44,710
) |
|
Cardinal
Health, Inc. |
295 |
08/01/25 |
USD |
162.50 |
USD |
4,956 |
(227,150
) |
Charles
Schwab Corp. |
316 |
08/01/25 |
USD |
89.00 |
USD |
2,883 |
(137,460
) |
|
Cisco
Systems, Inc. |
635 |
08/01/25 |
USD |
68.00 |
USD |
4,406 |
(133,667
) |
Comcast
Corp., Class A |
1,314 |
08/01/25 |
USD |
36.00 |
USD |
4,690 |
(86,724
) |
|
Dollar
General Corp. |
457 |
08/01/25 |
USD |
110.00 |
USD |
5,227 |
(277,627
) |
Eli
Lilly & Co. |
11 |
08/01/25 |
USD |
810.00 |
USD |
857 |
(22,825
) |
|
Fidelity
National Information Services, Inc. |
675 |
08/01/25 |
USD |
82.00 |
USD |
5,495 |
(155,250
) |
General
Motors Co. |
112 |
08/01/25 |
USD |
51.00 |
USD |
551 |
(18,312
) |
|
HP,
Inc. |
2,320 |
08/01/25 |
USD |
26.00 |
USD |
5,675 |
(77,720
) |
Medtronic
PLC |
143 |
08/01/25 |
USD |
86.00 |
USD |
1,247 |
(42,257
) |
|
NVIDIA
Corp. |
14 |
08/01/25 |
USD |
160.00 |
USD |
221 |
(8,470
) |
Pfizer,
Inc. |
465 |
08/01/25 |
USD |
25.00 |
USD |
1,127 |
(9,533
) |
|
PPG
Industries, Inc. |
281 |
08/01/25 |
USD |
115.00 |
USD |
3,196 |
(87,812
) |
Taiwan
Semiconductor Manufacturing Co. Ltd., ADR |
61 |
08/01/25 |
USD |
225.00 |
USD |
1,382 |
(67,252
) |
|
Walt
Disney Co. |
28 |
08/01/25 |
USD |
118.00 |
USD |
347 |
(20,860
) |
Wells
Fargo & Co. |
942 |
08/01/25 |
USD |
77.00 |
USD |
7,547 |
(459,225
) |
|
Western
Digital Corp. |
354 |
08/01/25 |
USD |
60.00 |
USD |
2,265 |
(209,745
) |
Bristol-Myers
Squibb Co. |
239 |
08/08/25 |
USD |
49.00 |
USD |
1,106 |
(15,774
) |
|
Cardinal
Health, Inc. |
254 |
08/08/25 |
USD |
167.50 |
USD |
4,267 |
(132,080
) |
Cigna
Group |
126 |
08/08/25 |
USD |
335.00 |
USD |
4,165 |
(149,310
) |
|
CVS
Health Corp. |
220 |
08/08/25 |
USD |
69.00 |
USD |
1,518 |
(58,850
) |
JPMorgan
Chase & Co. |
78 |
08/08/25 |
USD |
290.00 |
USD |
2,261 |
(69,810
) |
|
Kraft
Heinz Co. |
1,249 |
08/08/25 |
USD |
27.00 |
USD |
3,225 |
(57,454
) |
Medtronic
PLC |
483 |
08/08/25 |
USD |
86.00 |
USD |
4,210 |
(126,787
) |
|
Air
Products & Chemicals, Inc. |
78 |
08/15/25 |
USD |
290.00 |
USD |
2,200 |
(54,210
) |
Allegion
PLC |
112 |
08/15/25 |
USD |
139.39 |
USD |
1,614 |
(89,531
) |
|
Amazon.com,
Inc. |
325 |
08/15/25 |
USD |
225.00 |
USD |
7,130 |
(274,625
) |
American
Electric Power Co., Inc. |
253 |
08/15/25 |
USD |
107.00 |
USD |
2,625 |
(33,809
) |
|
AvalonBay
Communities, Inc. |
145 |
08/15/25 |
USD |
212.73 |
USD |
2,951 |
(54,680
) |
Bank
of America Corp. |
761 |
08/15/25 |
USD |
45.00 |
USD |
3,601 |
(251,130
) |
|
Baxter
International, Inc. |
563 |
08/15/25 |
USD |
32.50 |
USD |
1,705 |
(36,595
) |
British
American Tobacco PLC, ADR |
817 |
08/15/25 |
USD |
48.80 |
USD |
3,867 |
(89,300
) |
|
Cardinal
Health, Inc. |
254 |
08/15/25 |
USD |
170.00 |
USD |
4,267 |
(124,460
) |
Carlyle
Group, Inc. |
616 |
08/15/25 |
USD |
47.50 |
USD |
3,166 |
(348,040
) |
|
Carlyle
Group, Inc. |
314 |
08/15/25 |
USD |
50.64 |
USD |
1,614 |
(93,984
) |
Citigroup,
Inc. |
1,553 |
08/15/25 |
USD |
82.50 |
USD |
13,219 |
(753,205
) |
|
Cognizant
Technology Solutions Corp., Class A |
775 |
08/15/25 |
USD |
77.50 |
USD |
6,047 |
(271,250
) |
CVS
Health Corp. |
516 |
08/15/25 |
USD |
70.00 |
USD |
3,559 |
(138,546
) |
|
Dominion
Energy, Inc. |
539 |
08/15/25 |
USD |
55.00 |
USD |
3,046 |
(149,572
) |
Electronic
Arts, Inc. |
348 |
08/15/25 |
USD |
160.00 |
USD |
5,558 |
(222,720
) |
|
Enterprise
Products Partners LP |
1,109 |
08/15/25 |
USD |
32.00 |
USD |
3,439 |
(28,280
) |
Exelon
Corp. |
1,196 |
08/15/25 |
USD |
44.50 |
USD |
5,193 |
(83,434
) |
|
First
Citizens BancShares, Inc., Class A |
80 |
08/15/25 |
USD |
1,880.00 |
USD |
15,652 |
(1,163,600
) |
Fortive
Corp. |
297 |
08/15/25 |
USD |
70.00 |
USD |
1,548 |
(69,795
) |
|
Hasbro,
Inc. |
1,000 |
08/15/25 |
USD |
70.00 |
USD |
7,382 |
(625,000
) |
Hewlett
Packard Enterprise Co. |
821 |
08/15/25 |
USD |
19.00 |
USD |
1,679 |
(159,274
) |
|
Honeywell
International, Inc. |
103 |
08/15/25 |
USD |
230.00 |
USD |
2,399 |
(98,365
) |
Intercontinental
Exchange, Inc. |
514 |
08/15/25 |
USD |
179.86 |
USD |
9,430 |
(376,033
) |
|
International
Flavors & Fragrances, Inc. |
339 |
08/15/25 |
USD |
80.00 |
USD |
2,493 |
(40,680
) |
Johnson
Controls International PLC |
409 |
08/15/25 |
USD |
105.00 |
USD |
4,320 |
(214,725
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call (continued) |
|
|
|
|
|
|
|
|
Keurig
Dr. Pepper, Inc. |
499 |
08/15/25 |
USD |
33.59 |
USD |
1,650 |
$ (38,974
) |
Kraft
Heinz Co. |
1,614 |
08/15/25 |
USD |
28.01 |
USD |
4,167 |
(46,730
) |
|
L3Harris
Technologies, Inc. |
371 |
08/15/25 |
USD |
250.00 |
USD |
9,306 |
(359,870
) |
Labcorp
Holdings, Inc. |
179 |
08/15/25 |
USD |
270.00 |
USD |
4,699 |
(102,030
) |
|
Lamb
Weston Holdings, Inc. |
371 |
08/15/25 |
USD |
57.50 |
USD |
1,924 |
(45,448
) |
Lear
Corp. |
400 |
08/15/25 |
USD |
96.43 |
USD |
3,799 |
(168,319
) |
|
Leidos
Holdings, Inc. |
266 |
08/15/25 |
USD |
155.00 |
USD |
4,196 |
(248,710
) |
Pfizer,
Inc. |
465 |
08/15/25 |
USD |
25.00 |
USD |
1,127 |
(18,368
) |
|
PG&E
Corp. |
1,129 |
08/15/25 |
USD |
15.00 |
USD |
1,574 |
(41,209
) |
RTX
Corp. |
344 |
08/15/25 |
USD |
150.00 |
USD |
5,023 |
(116,960
) |
|
Sealed
Air Corp. |
778 |
08/15/25 |
USD |
32.40 |
USD |
2,414 |
(38,117
) |
Sempra |
544 |
08/15/25 |
USD |
80.00 |
USD |
4,122 |
(44,880
) |
|
SS&C
Technologies Holdings, Inc. |
1,416 |
08/15/25 |
USD |
80.00 |
USD |
11,724 |
(722,160
) |
STAG
Industrial, Inc. |
513 |
08/15/25 |
USD |
37.44 |
USD |
1,861 |
(33,121
) |
|
Teck
Resources Ltd., Class B |
562 |
08/15/25 |
USD |
39.00 |
USD |
2,269 |
(179,840
) |
Visa,
Inc., Class A |
32 |
08/15/25 |
USD |
355.00 |
USD |
1,136 |
(39,840
) |
|
WESCO
International, Inc. |
60 |
08/15/25 |
USD |
195.00 |
USD |
1,111 |
(44,100
) |
Western
Digital Corp. |
270 |
08/15/25 |
USD |
57.50 |
USD |
1,728 |
(216,000
) |
|
Westinghouse
Air Brake Technologies Corp. |
153 |
08/15/25 |
USD |
210.00 |
USD |
3,203 |
(120,105
) |
Willis
Towers Watson PLC |
261 |
08/15/25 |
USD |
306.00 |
USD |
8,000 |
(282,567
) |
|
CNH
Industrial NV |
940 |
08/25/25 |
USD |
13.25 |
USD |
1,218 |
(59,571
) |
Baxter
International, Inc. |
1,128 |
09/19/25 |
USD |
32.50 |
USD |
3,416 |
(112,800
) |
|
British
American Tobacco PLC, ADR |
1,179 |
09/19/25 |
USD |
48.00 |
USD |
5,580 |
(226,957
) |
|
|
|
|
|
|
|
$ (26,763,655
) | |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
Shell
PLC |
Goldman
Sachs International |
245,700 |
07/02/25 |
GBP |
25.40 |
GBP |
6,245 |
$ (77,668
) |
|
WPP
PLC |
Barclays
Bank PLC |
308,000 |
07/02/25 |
GBP |
5.97 |
GBP |
1,580 |
— |
|
Crown
Castle, Inc. |
Bank
of America N.A. |
20,200 |
07/07/25 |
USD |
105.00 |
USD |
2,075 |
(11,403
) |
|
Intercontinental
Exchange, Inc. |
Bank
of America N.A. |
25,100 |
07/07/25 |
USD |
170.50 |
USD |
4,605 |
(329,734
) |
|
Fidelity
National Financial, Inc. |
Morgan
Stanley & Co. International PLC |
81,900 |
07/08/25 |
USD |
65.33 |
USD |
4,591 |
— |
|
PG&E
Corp. |
Morgan
Stanley & Co. International PLC |
22,200 |
07/08/25 |
USD |
17.46 |
USD |
309 |
— |
|
Henkel
AG & Co. KGaA, Preferred Shares |
Bank
of America N.A. |
86,900 |
07/10/25 |
EUR |
73.24 |
EUR |
5,797 |
(717
) |
|
PG&E
Corp. |
Barclays
Bank PLC |
176,000 |
07/10/25 |
USD |
17.85 |
USD |
2,453 |
(5
) |
|
Rentokil
Initial PLC |
UBS
AG |
531,000 |
07/10/25 |
GBP |
3.66 |
GBP |
1,866 |
(20,751
) |
|
Crown
Castle, Inc. |
Barclays
Bank PLC |
64,800 |
07/15/25 |
USD |
104.80 |
USD |
6,657 |
(77,117
) |
|
Rentokil
Initial PLC |
Morgan
Stanley & Co. International PLC |
250,300 |
07/15/25 |
GBP |
3.59 |
GBP |
880 |
(23,902
) |
|
PG&E
Corp. |
Barclays
Bank PLC |
28,100 |
07/16/25 |
USD |
17.89 |
USD |
392 |
(22
) |
|
Samsung
Electronics Co. Ltd., GDR |
Bank
of America N.A. |
9,900 |
07/16/25 |
USD |
1,114.70 |
USD |
10,935 |
(243,391
) |
|
Sony
Group Corp. |
UBS
AG |
14,900 |
07/16/25 |
JPY |
4,101.63 |
JPY |
55,788 |
(1,822
) |
|
STMicroelectronics
NV |
UBS
AG |
43,700 |
07/22/25 |
EUR |
27.79 |
EUR |
1,138 |
(18,668
) |
|
AstraZeneca
PLC |
Barclays
Bank PLC |
10,900 |
07/23/25 |
GBP |
113.61 |
GBP |
1,105 |
(825
) |
|
BP
PLC |
Barclays
Bank PLC |
1,522,600 |
07/23/25 |
GBP |
3.92 |
GBP |
5,527 |
(52,313
) |
|
Labcorp
Holdings, Inc. |
Morgan
Stanley & Co. International PLC |
29,000 |
07/23/25 |
USD |
251.71 |
USD |
7,613 |
(384,681
) |
|
Sanofi
SA |
Bank
of America N.A. |
78,300 |
07/23/25 |
EUR |
88.24 |
EUR |
6,435 |
(15,752
) |
|
Sony
Group Corp. |
JPMorgan
Chase Bank N.A. |
316,500 |
07/23/25 |
JPY |
3,887.22 |
JPY |
1,185,031 |
(152,785
) |
|
STMicroelectronics
NV |
Barclays
Bank PLC |
128,000 |
07/23/25 |
EUR |
26.87 |
EUR |
3,332 |
(97,531
) |
|
WPP
PLC |
Barclays
Bank PLC |
245,500 |
07/23/25 |
GBP |
5.70 |
GBP |
1,259 |
(2,962
) |
|
BP
PLC |
UBS
AG |
749,416 |
07/30/25 |
GBP |
4.01 |
GBP |
2,720 |
(26,108
) |
|
Crown
Castle, Inc. |
Barclays
Bank PLC |
17,100 |
07/30/25 |
USD |
100.73 |
USD |
1,757 |
(66,529
) |
|
European
Aeronautic Defence and Space
Company |
Barclays
Bank PLC |
7,800 |
07/30/25 |
EUR |
163.95 |
EUR |
1,385 |
(140,086
) |
|
Shell
PLC |
Barclays
Bank PLC |
84,400 |
07/30/25 |
GBP |
27.16 |
GBP |
2,145 |
(13,458
) |
|
WPP
PLC |
UBS
AG |
340,100 |
07/30/25 |
GBP |
5.50 |
GBP |
1,745 |
(20,345
) |
|
PG&E
Corp. |
Morgan
Stanley & Co. International PLC |
82,900 |
08/01/25 |
USD |
16.41 |
USD |
1,156 |
(5,692
) |
|
AstraZeneca
PLC |
BNP
Paribas SA |
32,400 |
08/05/25 |
GBP |
105.70 |
GBP |
3,285 |
(63,638
) |
|
Shell
PLC |
Goldman
Sachs International |
103,300 |
08/05/25 |
GBP |
26.40 |
GBP |
2,626 |
(50,388
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
|
PG&E
Corp. |
Barclays
Bank PLC |
132,900 |
08/08/25 |
USD |
14.16 |
USD |
1,853 |
$ (84,465
) |
|
European
Aeronautic Defence and Space
Company |
Bank
of America N.A. |
16,700 |
08/12/25 |
EUR |
185.33 |
EUR |
2,966 |
(66,832
) |
|
Rentokil
Initial PLC |
Bank
of America N.A. |
800,000 |
08/12/25 |
GBP |
3.66 |
GBP |
2,812 |
(124,757
) |
|
|
|
|
|
|
|
|
|
$ (2,174,347
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (21,353,369
) |
$ 3,831,195 |
$ (11,415,828
) |
$ (28,938,002
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 28,938,002 |
$ — |
$ — |
$ — |
$ 28,938,002 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
purchased(a) |
$ — |
$ — |
$ (108,736
) |
$ — |
$ — |
$ — |
$ (108,736
) |
|
Options
written |
— |
— |
(10,227,303
) |
— |
— |
— |
(10,227,303
) |
|
|
$ — |
$ — |
$ (10,336,039
) |
$ — |
$ — |
$ — |
$ (10,336,039
) |
|
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (17,219,246
) |
$ — |
$ — |
$ — |
$ (17,219,246
) |
|
(a)
|
Options
purchased are included in net realized gain (loss) from investments —
unaffiliated. |
|
Options: |
|
|
Average
value of option contracts purchased |
$—
(a) |
|
Average
value of option contracts written |
24,657,797 |
|
(a)
|
Derivative
financial instrument not held at any quarter-end. The risk exposure table
serves as an indicator of activity during the
period. |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 28,938,002 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
28,938,002 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(26,763,655
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 2,174,347 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities |
|
Bank
of America N.A. |
$ 792,586 |
$ — |
$ (792,586
) |
$ — |
$ — |
|
Barclays
Bank PLC |
535,313 |
— |
(535,313
) |
— |
— |
|
BNP
Paribas SA |
63,638 |
— |
(63,638
) |
— |
— |
|
Goldman
Sachs International |
128,056 |
— |
(28,056
) |
(100,000
) |
— |
|
JPMorgan
Chase Bank N.A. |
152,785 |
— |
(152,785
) |
— |
— |
|
Morgan
Stanley & Co. International PLC |
414,275 |
— |
(414,275
) |
— |
— |
|
UBS
AG |
87,694 |
— |
(87,694
) |
— |
— |
|
|
$ 2,174,347 |
$ — |
$ (2,074,347
) |
$ (100,000
) |
$ — |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting
purposes. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Aerospace
& Defense |
$ 53,609,793 |
$ 9,339,555 |
$ — |
$ 62,949,348 |
|
Automobile
Components |
6,921,003 |
— |
— |
6,921,003 |
|
Automobiles |
12,099,164 |
— |
— |
12,099,164 |
|
Banks |
204,201,183 |
— |
— |
204,201,183 |
|
Beverages |
9,363,485 |
— |
— |
9,363,485 |
|
Broadline
Retail |
41,548,956 |
— |
— |
41,548,956 |
|
Building
Products |
13,347,180 |
— |
— |
13,347,180 |
|
Capital
Markets |
58,736,663 |
— |
— |
58,736,663 |
|
Chemicals |
40,411,594 |
— |
— |
40,411,594 |
|
Commercial
Services & Supplies |
— |
13,872,341 |
— |
13,872,341 |
|
Communications
Equipment |
21,359,049 |
— |
— |
21,359,049 |
|
Consumer
Finance |
6,893,424 |
— |
— |
6,893,424 |
|
Consumer
Staples Distribution & Retail |
29,648,440 |
— |
— |
29,648,440 |
|
Containers
& Packaging |
22,669,218 |
— |
— |
22,669,218 |
|
Diversified
Telecommunication Services |
15,792,425 |
— |
— |
15,792,425 |
|
Electric
Utilities |
48,209,038 |
— |
— |
48,209,038 |
|
Electronic
Equipment, Instruments & Components |
2,447,032 |
— |
— |
2,447,032 |
|
Entertainment |
31,909,062 |
— |
— |
31,909,062 |
|
Financial
Services |
38,914,761 |
— |
16,146,708 |
55,061,469 |
|
Food
Products |
32,529,009 |
— |
— |
32,529,009 |
|
Ground
Transportation |
9,050,583 |
— |
— |
9,050,583 |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Common
Stocks (continued) |
|
|
|
|
|
Health
Care Equipment & Supplies |
$ 89,353,093 |
$ — |
$ — |
$ 89,353,093 |
|
Health
Care Providers & Services |
114,301,458 |
— |
— |
114,301,458 |
|
Health
Care REITs |
5,376,841 |
— |
— |
5,376,841 |
|
Household
Durables |
— |
8,738,703 |
— |
8,738,703 |
|
Industrial
Conglomerates |
12,568,301 |
— |
— |
12,568,301 |
|
Industrial
REITs |
9,893,478 |
— |
— |
9,893,478 |
|
Insurance |
64,820,962 |
— |
— |
64,820,962 |
|
Interactive
Media & Services |
33,760,317 |
— |
— |
33,760,317 |
|
IT
Services |
14,534,492 |
— |
— |
14,534,492 |
|
Leisure
Products |
17,741,825 |
— |
— |
17,741,825 |
|
Machinery |
25,578,256 |
— |
— |
25,578,256 |
|
Media |
28,245,566 |
11,439,032 |
— |
39,684,598 |
|
Metals
& Mining |
9,839,193 |
— |
— |
9,839,193 |
|
Multi-Utilities |
29,544,515 |
— |
— |
29,544,515 |
|
Oil,
Gas & Consumable Fuels |
27,017,635 |
58,312,207 |
14,002,368 |
99,332,210 |
|
Pharmaceuticals |
19,819,945 |
24,746,550 |
— |
44,566,495 |
|
Professional
Services |
60,001,842 |
— |
— |
60,001,842 |
|
Residential
REITs |
10,738,695 |
— |
— |
10,738,695 |
|
Semiconductors
& Semiconductor Equipment |
29,565,929 |
11,177,493 |
— |
40,743,422 |
|
Software |
44,487,609 |
— |
— |
44,487,609 |
|
Specialized
REITs |
19,079,837 |
— |
— |
19,079,837 |
|
Technology
Hardware, Storage & Peripherals |
45,735,655 |
27,504,163 |
— |
73,239,818 |
|
Tobacco |
17,169,384 |
— |
— |
17,169,384 |
|
Trading
Companies & Distributors |
4,107,180 |
— |
— |
4,107,180 |
|
Preferred
Securities |
|
|
|
|
|
Preferred
Stocks |
— |
13,482,430 |
— |
13,482,430 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
55,223,666 |
— |
— |
55,223,666 |
|
|
$1,488,166,736 |
$178,612,474 |
$30,149,076 |
$1,696,928,286 |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (24,424,621
) |
$ (4,513,381
) |
$ — |
$ (28,938,002
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
|
Common
Stocks |
|
Assets |
|
|
Opening
balance, as of December 31, 2024 |
$ 31,090,484 |
|
Transfers
into Level 3 |
— |
|
Transfers
out of Level 3 |
— |
|
Accrued
discounts/premiums |
— |
|
Net
realized gain (loss) |
— |
|
Net
change in unrealized appreciation (depreciation)(a)(b) |
(1,659,573
) |
|
Purchases |
718,165 |
|
Sales |
— |
|
Closing
balance, as of June 30, 2025 |
$ 30,149,076 |
|
Net
change in unrealized appreciation (depreciation) on investments still held
at June 30, 2025(b) |
$ (1,659,573
) |
|
(a)
|
Included
in the related net change in unrealized appreciation (depreciation) in the
Consolidated Statements of Operations. |
|
(b)
|
Any
difference between net change in unrealized appreciation (depreciation)
and net change in unrealized appreciation (depreciation) on investments
still held at June 30, 2025 is
generally
due to investments no longer held or categorized as Level 3 at period
end. |
|
|
Value |
Valuation
Approach |
Unobservable
Inputs |
Range
of
Unobservable
Inputs
Utilized(a)
|
Weighted
Average
of
Unobservable
Inputs
Based
on
Fair Value
|
|
Assets |
|
||||
|
Common
Stocks |
$30,149,076 |
Income |
Discount
Rate |
10% |
— |
|
|
|
Market |
EBITDA
Multiple |
6.88x |
— |
|
|
$30,149,076 |
|
|
|
|
|
(a)
|
A
significant change in unobservable input could result in a correlated or
inverse change in value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Canada
— 2.1% |
| ||
|
TELUS
Corp. |
878,592 |
$ 14,110,378 | |
|
Denmark
— 2.2% |
| ||
|
Novo
Nordisk A/S, Class B |
217,151 |
15,047,263 | |
|
France
— 2.1% |
| ||
|
Air
Liquide SA |
70,330 |
14,502,121 | |
|
India
— 0.0% |
| ||
|
AceVector
Limited, Series I, (Acquired 08/31/18, Cost:
$2,637,143)(a)(b)(c) |
566,400 |
195,294 | |
|
Japan
— 1.4% |
| ||
|
SMC
Corp. |
27,300 |
9,783,285 | |
|
Netherlands
— 2.1% |
| ||
|
Koninklijke
KPN NV |
3,031,314 |
14,787,327 | |
|
Spain
— 2.1% |
| ||
|
Banco
Bilbao Vizcaya Argentaria SA |
955,405 |
14,711,588 | |
|
Switzerland
— 2.0% |
| ||
|
Zurich
Insurance Group AG, Class N |
19,779 |
13,839,818 | |
|
Taiwan
— 5.4% |
| ||
|
MediaTek,
Inc. |
240,000 |
10,283,678 | |
|
Taiwan
Semiconductor Manufacturing Co. Ltd. |
|
740,000 |
27,061,317 |
|
|
|
37,344,995 | |
|
United
Kingdom — 9.0% |
| ||
|
AstraZeneca
PLC |
159,914 |
22,255,093 | |
|
BAE
Systems PLC |
|
434,178 |
11,268,161 |
|
RELX
PLC |
329,283 |
17,794,025 | |
|
Taylor
Wimpey PLC |
|
6,771,171 |
11,041,829 |
|
|
|
62,359,108 | |
|
United
States — 71.3% |
| ||
|
AbbVie,
Inc.(d) |
81,420 |
15,113,180 | |
|
Accenture
PLC, Class A |
|
58,744 |
17,557,994 |
|
Allegion
PLC |
103,069 |
14,854,304 | |
|
Alphabet,
Inc., Class A(d) |
|
83,022 |
14,630,967 |
|
Apple,
Inc.(d)(e) |
71,432 |
14,655,703 | |
|
Applied
Materials, Inc. |
|
55,539 |
10,167,525 |
|
Assurant,
Inc.(d) |
50,499 |
9,973,048 | |
|
Baker
Hughes Co., Class A |
|
175,025 |
6,710,459 |
|
Broadcom,
Inc.(e) |
102,340 |
28,210,021 | |
|
Charles
Schwab Corp. |
|
114,584 |
10,454,644 |
|
Citizens
Financial Group, Inc. |
265,514 |
11,881,752 | |
|
CMS
Energy Corp.(d)(e) |
|
293,639 |
20,343,310 |
|
Coca-Cola
Co. |
287,138 |
20,315,013 | |
|
Colgate-Palmolive
Co. |
|
188,214 |
17,108,653 |
|
General
Electric Co. |
63,043 |
16,226,638 | |
|
Home
Depot, Inc. |
|
34,647 |
12,702,976 |
|
Hubbell,
Inc. |
37,280 |
15,225,525 | |
|
Security |
|
Shares |
Value |
|
United
States (continued) |
| ||
|
Intercontinental
Exchange, Inc.(d) |
|
75,097 |
$ 13,778,047 |
|
M&T
Bank Corp. |
53,051 |
10,291,363 | |
|
Mastercard,
Inc., Class A |
|
12,977 |
7,292,295 |
|
Meta
Platforms, Inc., Class A(e) |
26,731 |
19,729,884 | |
|
Microsoft
Corp.(d) |
|
79,480 |
39,534,147 |
|
Moody’s
Corp. |
20,881 |
10,473,701 | |
|
Oracle
Corp. |
|
77,491 |
16,941,857 |
|
Otis
Worldwide Corp.(d) |
135,156 |
13,383,147 | |
|
Parker-Hannifin
Corp.(d)(e) |
|
21,989 |
15,358,657 |
|
Republic
Services, Inc.(e) |
40,201 |
9,913,969 | |
|
Salesforce,
Inc. |
|
38,999 |
10,634,637 |
|
Sanofi
SA |
119,571 |
11,576,118 | |
|
Shell
PLC |
|
306,689 |
10,770,768 |
|
Union
Pacific Corp. |
35,166 |
8,090,993 | |
|
UnitedHealth
Group, Inc.(d)(e) |
|
45,883 |
14,314,120 |
|
Walmart,
Inc. |
173,813 |
16,995,435 | |
|
Williams
Cos., Inc.(d) |
|
112,077 |
7,039,556 |
|
|
|
492,250,406 | |
|
Total
Long-Term Investments — 99.7%
(Cost:
$500,612,329) |
688,931,583 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 1.4% |
| ||
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(f)(g) |
9,754,911 |
9,754,911 | |
|
Total
Short-Term Securities — 1.4%
(Cost:
$9,754,911) |
9,754,911 | ||
|
Total
Investments Before Options Written — 101.1%
(Cost:
$510,367,240) |
698,686,494 | ||
|
Options
Written — (1.1)%
(Premiums
Received: $(7,221,732)) |
(8,112,955
) | ||
|
Total
Investments, Net of Options Written — 100.0%
(Cost:
$503,145,508) |
690,573,539 | ||
|
Other
Assets Less Liabilities — 0.0% |
254,549 | ||
|
Net
Assets — 100.0% |
$ 690,828,088 | ||
|
(a)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(b)
|
Non-income
producing security. |
|
(c)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $195,294, representing less than 0.05% of its net
assets
as
of period end, and an original cost of
$2,637,143. |
|
(d)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(e)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(f)
|
Affiliate
of the Trust. |
|
(g)
|
Annualized
7-day yield as of period
end. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares |
$ 7,033,278 |
$ 2,721,633
(a) |
$ — |
$ — |
$ — |
$ 9,754,911 |
9,754,911 |
$ 155,491 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Citizens
Financial Group, Inc. |
750 |
07/09/25 |
USD |
43.00 |
USD |
3,356 |
$ (162,342
) |
|
AbbVie,
Inc. |
104 |
07/11/25 |
USD |
195.00 |
USD |
1,930 |
(2,184
) |
|
Accenture
PLC, Class A |
86 |
07/11/25 |
USD |
325.00 |
USD |
2,570 |
(8,600
) |
|
Alphabet,
Inc., Class A |
48 |
07/11/25 |
USD |
175.00 |
USD |
846 |
(19,440
) |
|
Broadcom,
Inc. |
78 |
07/11/25 |
USD |
265.00 |
USD |
2,150 |
(105,300
) |
|
Colgate-Palmolive
Co. |
166 |
07/11/25 |
USD |
94.00 |
USD |
1,509 |
(4,150
) |
|
Home
Depot, Inc. |
87 |
07/11/25 |
USD |
385.00 |
USD |
3,190 |
(3,350
) |
|
Mastercard,
Inc., Class A |
15 |
07/11/25 |
USD |
590.00 |
USD |
843 |
(563
) |
|
Oracle
Corp. |
130 |
07/11/25 |
USD |
165.00 |
USD |
2,842 |
(709,800
) |
|
Salesforce,
Inc. |
86 |
07/11/25 |
USD |
275.00 |
USD |
2,345 |
(32,895
) |
|
TELUS
Corp. |
1,308 |
07/11/25 |
CAD |
22.50 |
CAD |
2,861 |
(4,803
) |
|
Union
Pacific Corp. |
28 |
07/11/25 |
USD |
225.00 |
USD |
644 |
(18,900
) |
|
M&T
Bank Corp. |
117 |
07/15/25 |
USD |
182.34 |
USD |
2,270 |
(155,610
) |
|
Allegion
PLC |
253 |
07/18/25 |
USD |
145.12 |
USD |
3,646 |
(55,102
) |
|
Alphabet,
Inc., Class A |
182 |
07/18/25 |
USD |
180.00 |
USD |
3,207 |
(51,597
) |
|
Applied
Materials, Inc. |
159 |
07/18/25 |
USD |
180.00 |
USD |
2,911 |
(117,262
) |
|
Assurant,
Inc. |
60 |
07/18/25 |
USD |
210.00 |
USD |
1,185 |
(6,900
) |
|
Baker
Hughes Co., Class A |
306 |
07/18/25 |
USD |
41.00 |
USD |
1,173 |
(5,355
) |
|
Broadcom,
Inc. |
162 |
07/18/25 |
USD |
250.00 |
USD |
4,466 |
(446,715
) |
|
Charles
Schwab Corp. |
307 |
07/18/25 |
USD |
92.50 |
USD |
2,801 |
(67,233
) |
|
Citizens
Financial Group, Inc. |
420 |
07/18/25 |
USD |
42.50 |
USD |
1,880 |
(124,950
) |
|
CMS
Energy Corp. |
506 |
07/18/25 |
USD |
70.00 |
USD |
3,506 |
(32,890
) |
|
Coca-Cola
Co. |
605 |
07/18/25 |
USD |
75.00 |
USD |
4,280 |
(3,328
) |
|
General
Electric Co. |
134 |
07/18/25 |
USD |
270.00 |
USD |
3,449 |
(21,172
) |
|
Hubbell,
Inc. |
82 |
07/18/25 |
USD |
400.00 |
USD |
3,349 |
(124,640
) |
|
M&T
Bank Corp. |
90 |
07/18/25 |
USD |
190.00 |
USD |
1,746 |
(69,750
) |
|
M&T
Bank Corp. |
26 |
07/18/25 |
USD |
185.00 |
USD |
504 |
(31,070
) |
|
Mastercard,
Inc., Class A |
42 |
07/18/25 |
USD |
585.00 |
USD |
2,360 |
(7,224
) |
|
Meta
Platforms, Inc., Class A |
41 |
07/18/25 |
USD |
725.00 |
USD |
3,026 |
(105,985
) |
|
Microsoft
Corp. |
158 |
07/18/25 |
USD |
460.00 |
USD |
7,859 |
(619,755
) |
|
Moody’s
Corp. |
52 |
07/18/25 |
USD |
490.00 |
USD |
2,608 |
(91,520
) |
|
Oracle
Corp. |
78 |
07/18/25 |
USD |
210.00 |
USD |
1,705 |
(89,895
) |
|
Republic
Services, Inc., Class A |
131 |
07/18/25 |
USD |
250.00 |
USD |
3,231 |
(25,873
) |
|
Salesforce,
Inc. |
86 |
07/18/25 |
USD |
280.00 |
USD |
2,345 |
(30,100
) |
|
TELUS
Corp. |
1,107 |
07/18/25 |
CAD |
22.50 |
CAD |
2,421 |
(5,690
) |
|
UnitedHealth
Group, Inc. |
160 |
07/18/25 |
USD |
340.00 |
USD |
4,992 |
(24,640
) |
|
Walmart,
Inc. |
509 |
07/18/25 |
USD |
100.00 |
USD |
4,977 |
(43,010
) |
|
Williams
Cos., Inc. |
154 |
07/18/25 |
USD |
60.00 |
USD |
967 |
(50,820
) |
|
AbbVie,
Inc. |
224 |
07/25/25 |
USD |
195.00 |
USD |
4,158 |
(21,280
) |
|
Alphabet,
Inc., Class A |
135 |
07/25/25 |
USD |
185.00 |
USD |
2,379 |
(40,837
) |
|
Apple,
Inc. |
37 |
07/25/25 |
USD |
210.00 |
USD |
759 |
(13,135
) |
|
Applied
Materials, Inc. |
21 |
07/25/25 |
USD |
182.50 |
USD |
384 |
(14,438
) |
|
Colgate-Palmolive
Co. |
495 |
07/25/25 |
USD |
94.00 |
USD |
4,500 |
(34,650
) |
|
Meta
Platforms, Inc., Class A |
52 |
07/25/25 |
USD |
725.00 |
USD |
3,838 |
(156,910
) |
|
Microsoft
Corp. |
33 |
07/25/25 |
USD |
495.00 |
USD |
1,641 |
(36,383
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
TELUS
Corp. |
1,310 |
07/25/25 |
CAD |
22.50 |
CAD |
2,865 |
$ (8,658
) |
|
Hubbell,
Inc. |
82 |
07/29/25 |
USD |
397.14 |
USD |
3,349 |
(164,346
) |
|
Accenture
PLC, Class A |
47 |
08/01/25 |
USD |
295.00 |
USD |
1,405 |
(49,115
) |
|
Apple,
Inc. |
205 |
08/01/25 |
USD |
210.00 |
USD |
4,206 |
(110,700
) |
|
Charles
Schwab Corp. |
197 |
08/01/25 |
USD |
89.00 |
USD |
1,797 |
(85,695
) |
|
Coca-Cola
Co. |
487 |
08/01/25 |
USD |
71.00 |
USD |
3,446 |
(77,189
) |
|
General
Electric Co. |
212 |
08/01/25 |
USD |
260.00 |
USD |
5,457 |
(226,310
) |
|
Home
Depot, Inc. |
65 |
08/01/25 |
USD |
365.00 |
USD |
2,383 |
(69,712
) |
|
Oracle
Corp. |
108 |
08/01/25 |
USD |
205.00 |
USD |
2,361 |
(186,030
) |
|
TELUS
Corp. |
1,107 |
08/01/25 |
CAD |
22.00 |
CAD |
2,421 |
(27,639
) |
|
Walmart,
Inc. |
255 |
08/01/25 |
USD |
98.00 |
USD |
2,493 |
(61,072
) |
|
Williams
Cos., Inc. |
154 |
08/01/25 |
USD |
60.00 |
USD |
967 |
(57,750
) |
|
Assurant,
Inc. |
162 |
08/05/25 |
USD |
203.50 |
USD |
3,199 |
(27,640
) |
|
Applied
Materials, Inc. |
64 |
08/08/25 |
USD |
185.00 |
USD |
1,172 |
(48,960
) |
|
Meta
Platforms, Inc., Class A |
24 |
08/08/25 |
USD |
745.00 |
USD |
1,771 |
(82,560
) |
|
AbbVie,
Inc. |
30 |
08/15/25 |
USD |
195.00 |
USD |
557 |
(8,550
) |
|
Accenture
PLC, Class A |
72 |
08/15/25 |
USD |
310.00 |
USD |
2,152 |
(32,400
) |
|
Allegion
PLC |
200 |
08/15/25 |
USD |
139.39 |
USD |
2,882 |
(159,876
) |
|
Apple,
Inc. |
72 |
08/15/25 |
USD |
210.00 |
USD |
1,477 |
(48,420
) |
|
Baker
Hughes Co., Class A |
306 |
08/15/25 |
USD |
41.00 |
USD |
1,173 |
(21,420
) |
|
Broadcom,
Inc. |
118 |
08/15/25 |
USD |
260.00 |
USD |
3,253 |
(292,345
) |
|
CMS
Energy Corp. |
787 |
08/15/25 |
USD |
70.00 |
USD |
5,452 |
(106,245
) |
|
Coca-Cola
Co. |
487 |
08/15/25 |
USD |
72.50 |
USD |
3,446 |
(61,118
) |
|
Colgate-Palmolive
Co. |
167 |
08/15/25 |
USD |
90.00 |
USD |
1,518 |
(55,110
) |
|
Intercontinental
Exchange, Inc. |
246 |
08/15/25 |
USD |
179.86 |
USD |
4,513 |
(179,969
) |
|
Microsoft
Corp. |
158 |
08/15/25 |
USD |
495.00 |
USD |
7,859 |
(302,175
) |
|
Moody’s
Corp. |
39 |
08/15/25 |
USD |
490.00 |
USD |
1,956 |
(96,330
) |
|
Otis
Worldwide Corp. |
376 |
08/15/25 |
USD |
97.50 |
USD |
3,723 |
(159,800
) |
|
Parker-Hannifin
Corp. |
96 |
08/15/25 |
USD |
680.00 |
USD |
6,705 |
(377,280
) |
|
Republic
Services, Inc., Class A |
45 |
08/15/25 |
USD |
250.00 |
USD |
1,110 |
(26,775
) |
|
Williams
Cos., Inc. |
308 |
08/15/25 |
USD |
65.00 |
USD |
1,935 |
(42,350
) |
|
|
|
|
|
|
|
|
$ (7,051,585
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
BAE
Systems PLC |
Bank
of America N.A. |
59,200 |
07/02/25 |
GBP |
18.08 |
GBP |
1,119 |
$ (64,588
) |
|
SMC
Corp. |
Goldman
Sachs International |
12,000 |
07/02/25 |
JPY |
58,004.70 |
JPY |
619,271 |
(1
) |
|
Zurich
Insurance Group AG, Class N |
UBS
AG |
8,700 |
07/02/25 |
CHF |
588.89 |
CHF |
4,830 |
— |
|
Intercontinental
Exchange, Inc. |
Bank
of America N.A. |
21,300 |
07/07/25 |
USD |
170.50 |
USD |
3,908 |
(279,814
) |
|
Koninklijke
KPN NV |
Barclays
Bank PLC |
50,000 |
07/08/25 |
EUR |
3.95 |
EUR |
207 |
(11,139
) |
|
Taiwan
Semiconductor Manufacturing Co. Ltd.,
ADR |
Morgan
Stanley & Co. International PLC |
219,600 |
07/08/25 |
TWD |
1,128.60 |
TWD |
234,591 |
(16,729
) |
|
Banco
Bilbao Vizcaya Argentaria SA |
Citibank
N.A. |
215,900 |
07/10/25 |
EUR |
14.11 |
EUR |
2,822 |
(4,245
) |
|
Koninklijke
KPN NV |
Goldman
Sachs International |
160,800 |
07/15/25 |
EUR |
4.27 |
EUR |
666 |
(3,014
) |
|
MediaTek,
Inc. |
Morgan
Stanley & Co. International PLC |
106,000 |
07/17/25 |
TWD |
1,342.57 |
TWD |
132,680 |
(15,295
) |
|
Novo
Nordisk A/S, Class B |
BNP
Paribas SA |
27,300 |
07/17/25 |
DKK |
494.33 |
DKK |
11,982 |
(7,508
) |
|
Novo
Nordisk A/S, Class B |
Morgan
Stanley & Co. International PLC |
12,300 |
07/17/25 |
DKK |
505.30 |
DKK |
5,398 |
(2,006
) |
|
Otis
Worldwide Corp. |
Morgan
Stanley & Co. International PLC |
21,800 |
07/17/25 |
USD |
100.12 |
USD |
2,159 |
(25,074
) |
|
RELX
PLC |
BNP
Paribas SA |
12,950 |
07/17/25 |
EUR |
48.07 |
EUR |
594 |
(1,443
) |
|
Koninklijke
KPN NV |
BNP
Paribas SA |
643,700 |
07/22/25 |
EUR |
4.18 |
EUR |
2,666 |
(30,777
) |
|
RELX
PLC |
Goldman
Sachs International |
52,750 |
07/22/25 |
EUR |
47.42 |
EUR |
2,420 |
(14,803
) |
|
Air
Liquide SA |
Barclays
Bank PLC |
22,100 |
07/23/25 |
EUR |
187.88 |
EUR |
3,869 |
(5,845
) |
|
AstraZeneca
PLC |
Barclays
Bank PLC |
27,500 |
07/23/25 |
GBP |
113.61 |
GBP |
2,788 |
(2,082
) |
|
BAE
Systems PLC |
Barclays
Bank PLC |
79,900 |
07/23/25 |
GBP |
19.41 |
GBP |
1,511 |
(31,213
) |
|
Banco
Bilbao Vizcaya Argentaria SA |
Barclays
Bank PLC |
173,050 |
07/23/25 |
EUR |
13.61 |
EUR |
2,262 |
(26,004
) |
|
Koninklijke
KPN NV |
Goldman
Sachs International |
254,400 |
07/23/25 |
EUR |
4.23 |
EUR |
1,054 |
(9,449
) |
|
Novo
Nordisk A/S, Class B |
Bank
of America N.A. |
17,700 |
07/23/25 |
DKK |
545.16 |
DKK |
7,768 |
(1,377
) |
|
RELX
PLC |
Barclays
Bank PLC |
26,200 |
07/23/25 |
EUR |
47.08 |
EUR |
1,202 |
(10,048
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
|
Sanofi
SA |
Bank
of America N.A. |
11,400 |
07/23/25 |
EUR |
88.24 |
EUR |
937 |
$ (2,293
) |
|
Taylor
Wimpey PLC |
Barclays
Bank PLC |
1,276,300 |
07/23/25 |
GBP |
1.26 |
GBP |
1,516 |
(21,111
) |
|
Air
Liquide SA |
JPMorgan
Chase Bank N.A. |
8,900 |
07/29/25 |
EUR |
189.85 |
EUR |
1,558 |
(2,636
) |
|
BAE
Systems PLC |
Goldman
Sachs International |
135,200 |
07/29/25 |
GBP |
21.01 |
GBP |
2,556 |
(14,338
) |
|
Banco
Bilbao Vizcaya Argentaria SA |
Barclays
Bank PLC |
71,400 |
07/30/25 |
EUR |
13.31 |
EUR |
933 |
(20,945
) |
|
Banco
Bilbao Vizcaya Argentaria SA |
UBS
AG |
89,700 |
07/30/25 |
EUR |
13.54 |
EUR |
1,173 |
(19,127
) |
|
Shell
PLC |
Barclays
Bank PLC |
107,400 |
07/30/25 |
EUR |
32.00 |
EUR |
3,202 |
(18,576
) |
|
Taylor
Wimpey PLC |
Barclays
Bank PLC |
1,306,000 |
07/30/25 |
GBP |
1.23 |
GBP |
1,552 |
(43,383
) |
|
AstraZeneca
PLC |
BNP
Paribas SA |
42,900 |
08/05/25 |
GBP |
105.70 |
GBP |
4,350 |
(84,261
) |
|
Koninklijke
KPN NV |
BNP
Paribas SA |
254,000 |
08/05/25 |
EUR |
4.09 |
EUR |
1,052 |
(23,035
) |
|
RELX
PLC |
JPMorgan
Chase Bank N.A. |
26,300 |
08/05/25 |
EUR |
47.51 |
EUR |
1,207 |
(10,630
) |
|
Taiwan
Semiconductor Manufacturing Co. Ltd.,
ADR |
JPMorgan
Chase Bank N.A. |
132,000 |
08/05/25 |
TWD |
1,102.10 |
TWD |
141,011 |
(109,552
) |
|
Taylor
Wimpey PLC |
Barclays
Bank PLC |
397,000 |
08/05/25 |
GBP |
1.24 |
GBP |
472 |
(14,299
) |
|
Koninklijke
KPN NV |
Barclays
Bank PLC |
304,400 |
08/08/25 |
EUR |
4.24 |
EUR |
1,261 |
(8,527
) |
|
Novo
Nordisk A/S, Class B |
Bank
of America N.A. |
18,800 |
08/08/25 |
DKK |
511.45 |
DKK |
8,251 |
(18,171
) |
|
Sanofi
SA |
Barclays
Bank PLC |
41,300 |
08/08/25 |
EUR |
85.63 |
EUR |
3,394 |
(44,823
) |
|
RELX
PLC |
UBS
AG |
60,000 |
08/12/25 |
EUR |
46.94 |
EUR |
2,753 |
(43,209
) |
|
|
|
|
|
|
|
|
|
$ (1,061,370
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (7,221,732
) |
$ 2,197,912 |
$ (3,089,135
) |
$ (8,112,955
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 8,112,955 |
$ — |
$ — |
$ — |
$ 8,112,955 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (6,230,812
) |
$ — |
$ — |
$ — |
$ (6,230,812
) |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (4,463,875
) |
$ — |
$ — |
$ — |
$ (4,463,875
) |
|
Options: |
|
|
Average
value of option contracts written |
$6,524,106 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 8,112,955 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
8,112,955 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(7,051,585
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 1,061,370 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 366,243 |
$ — |
$ (366,243
) |
$ — |
$ — |
|
Barclays
Bank PLC |
257,995 |
— |
(257,995
) |
— |
— |
|
BNP
Paribas SA |
147,024 |
— |
(147,024
) |
— |
— |
|
Citibank
N.A. |
4,245 |
— |
— |
— |
4,245 |
|
Goldman
Sachs International |
41,605 |
— |
(41,605
) |
— |
— |
|
JPMorgan
Chase Bank N.A. |
122,818 |
— |
(122,818
) |
— |
— |
|
Morgan
Stanley & Co. International PLC |
59,104 |
— |
(59,104
) |
— |
— |
|
UBS
AG |
62,336 |
— |
(62,336
) |
— |
— |
|
|
$ 1,061,370 |
$ — |
$ (1,057,125
) |
$ — |
$ 4,245 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Canada |
$ 14,110,378 |
$ — |
$ — |
$ 14,110,378 |
|
Denmark |
— |
15,047,263 |
— |
15,047,263 |
|
France |
— |
14,502,121 |
— |
14,502,121 |
|
India |
— |
— |
195,294 |
195,294 |
|
Japan |
— |
9,783,285 |
— |
9,783,285 |
|
Netherlands |
— |
14,787,327 |
— |
14,787,327 |
|
Spain |
— |
14,711,588 |
— |
14,711,588 |
|
Switzerland |
— |
13,839,818 |
— |
13,839,818 |
|
Taiwan |
— |
37,344,995 |
— |
37,344,995 |
|
United
Kingdom |
— |
62,359,108 |
— |
62,359,108 |
|
United
States |
469,903,520 |
22,346,886 |
— |
492,250,406 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
9,754,911 |
— |
— |
9,754,911 |
|
|
$ 493,768,809 |
$ 204,722,391 |
$ 195,294 |
$ 698,686,494 |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (6,146,700
) |
$ (1,966,255
) |
$ — |
$ (8,112,955
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Canada
— 5.2% |
| ||
|
Teck
Resources Ltd., Class B |
382,735 |
$ 15,478,037 | |
|
Toronto-Dominion
Bank |
|
190,640 |
14,022,032 |
|
|
|
29,500,069 | |
|
China
— 2.9% |
| ||
|
Tencent
Holdings Ltd., ADR(a) |
251,350 |
16,212,075 | |
|
Denmark
— 2.7% |
| ||
|
Novo
Nordisk A/S, Class B |
218,231 |
15,122,101 | |
|
France
— 5.1% |
| ||
|
Air
Liquide SA |
96,400 |
19,877,782 | |
|
Cie
de Saint-Gobain SA |
|
79,007 |
9,281,365 |
|
|
|
29,159,147 | |
|
Germany
— 10.6% |
| ||
|
adidas
AG, Class N |
46,413 |
10,834,184 | |
|
Beiersdorf
AG |
|
122,485 |
15,396,119 |
|
Deutsche
Telekom AG, Class N, Registered Shares |
437,595 |
16,017,552 | |
|
SAP
SE |
|
58,835 |
17,990,543 |
|
|
|
60,238,398 | |
|
India
— 3.7% |
| ||
|
AceVector
Limited, Series I, (Acquired 01/25/22, Cost:
$3,948,600)(b)(c)(d) |
848,000 |
292,390 | |
|
HDFC
Bank Ltd. |
|
895,320 |
20,901,655 |
|
|
|
21,194,045 | |
|
Italy
— 3.1% |
| ||
|
FinecoBank
Banca Fineco SpA |
786,716 |
17,452,153 | |
|
Japan
— 8.5% |
| ||
|
Keyence
Corp. |
34,600 |
13,834,049 | |
|
SMC
Corp. |
|
46,800 |
16,771,346 |
|
Sony
Group Corp. |
682,200 |
17,737,409 | |
|
|
|
|
48,342,804 |
|
Netherlands
— 6.0% |
| ||
|
ASM
International NV |
|
25,563 |
16,398,097 |
|
Koninklijke
KPN NV |
3,619,107 |
17,654,693 | |
|
|
|
|
34,052,790 |
|
Singapore
— 2.5% |
| ||
|
United
Overseas Bank Ltd. |
|
503,700 |
14,256,574 |
|
Spain
— 4.9%
|
| ||
|
Banco
Bilbao Vizcaya Argentaria SA |
|
1,092,483 |
16,822,353 |
|
Industria
de Diseno Textil SA |
212,385 |
11,079,438 | |
|
|
|
|
27,901,791 |
|
Sweden
— 4.4% |
| ||
|
Assa
Abloy AB, Class B |
|
369,461 |
11,550,694 |
|
Atlas
Copco AB, A Shares |
848,937 |
13,723,917 | |
|
|
|
|
25,274,611 |
|
Switzerland
— 6.8% |
| ||
|
Nestle
SA, Class N, Registered Shares |
|
154,264 |
15,337,905 |
|
UBS
Group AG, Registered Shares |
349,172 |
11,854,996 | |
|
Zurich
Insurance Group AG, Class N |
|
16,457 |
11,515,339 |
|
|
|
38,708,240 | |
|
Security |
|
Shares |
Value |
|
Taiwan
— 7.0% |
| ||
|
MediaTek,
Inc. |
|
190,000 |
$ 8,141,245 |
|
Taiwan
Semiconductor Manufacturing Co. Ltd. |
865,000 |
31,632,485 | |
|
|
|
|
39,773,730 |
|
United
Kingdom — 9.4% |
| ||
|
AstraZeneca
PLC |
|
120,565 |
16,778,927 |
|
British
American Tobacco PLC |
196,584 |
9,346,845 | |
|
RELX
PLC |
|
322,715 |
17,439,099 |
|
Taylor
Wimpey PLC |
6,166,586 |
10,055,925 | |
|
|
|
|
53,620,796 |
|
United
States — 17.0% |
| ||
|
General
Electric Co.(a)(e) |
|
49,170 |
12,655,866 |
|
Haleon
PLC |
2,161,320 |
11,108,377 | |
|
Mastercard,
Inc., Class A(a)(e) |
|
20,780 |
11,677,113 |
|
Otis
Worldwide Corp.(a)(e) |
120,604 |
11,942,208 | |
|
Sanofi
SA |
|
141,923 |
13,740,099 |
|
Shell
PLC |
648,441 |
22,772,932 | |
|
Waste
Connections, Inc. |
|
68,416 |
12,780,365 |
|
|
|
96,676,960 | |
|
Total
Long-Term Investments — 99.8%
(Cost:
$445,604,277) |
567,486,284 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 0.5% |
| ||
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(f)(g) |
2,898,908 |
2,898,908 | |
|
Total
Short-Term Securities — 0.5%
(Cost:
$2,898,908) |
2,898,908 | ||
|
Total
Investments Before Options Written — 100.3%
(Cost:
$448,503,185) |
570,385,192 | ||
|
Options
Written — (0.7)%
(Premiums
Received: $(5,309,740)) |
(3,825,190
) | ||
|
Total
Investments, Net of Options Written — 99.6%
(Cost:
$443,193,445) |
566,560,002 | ||
|
Other
Assets Less Liabilities — 0.4% |
2,028,035 | ||
|
Net
Assets — 100.0% |
$ 568,588,037 | ||
|
(a)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(b)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(c)
|
Non-income
producing security. |
|
(d)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $292,390, representing 0.1% of its net assets as
of
period
end, and an original cost of $3,948,600. |
|
(e)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(f)
|
Affiliate
of the Trust. |
|
(g)
|
Annualized
7-day yield as of period
end. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
BlackRock
Cash Funds: Institutional, SL Agency Shares(a) |
$ — |
$ 354
(b) |
$ — |
$ (354
) |
$ — |
$ — |
— |
$ 1,260
(c) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares |
3,742,337 |
— |
(843,429
)(b) |
— |
— |
2,898,908 |
2,898,908 |
157,270 |
— |
|
|
|
|
$ (354
) |
$ — |
$ 2,898,908 |
|
$ 158,530 |
$ — |
|
(a)
|
As
of period end, the entity is no longer held. |
|
(b)
|
Represents
net amount purchased (sold). |
|
(c)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Mastercard,
Inc., Class A |
57 |
07/11/25 |
USD |
590.00 |
USD |
3,203 |
$ (2,137
) |
|
Teck
Resources Ltd., Class B |
660 |
07/11/25 |
CAD |
53.00 |
CAD |
3,635 |
(122,622
) |
|
General
Electric Co. |
92 |
07/18/25 |
USD |
270.00 |
USD |
2,368 |
(14,536
) |
|
Mastercard,
Inc., Class A |
36 |
07/18/25 |
USD |
585.00 |
USD |
2,023 |
(6,192
) |
|
Teck
Resources Ltd., Class B |
679 |
07/18/25 |
CAD |
56.00 |
CAD |
3,739 |
(56,594
) |
|
Toronto-Dominion
Bank |
428 |
07/18/25 |
CAD |
96.00 |
CAD |
4,287 |
(131,221
) |
|
Waste
Connections, Inc. |
136 |
07/18/25 |
CAD |
260.00 |
CAD |
3,460 |
(14,981
) |
|
General
Electric Co. |
178 |
08/01/25 |
USD |
260.00 |
USD |
4,582 |
(190,015
) |
|
Toronto-Dominion
Bank |
429 |
08/01/25 |
CAD |
99.00 |
CAD |
4,297 |
(53,556
) |
|
Otis
Worldwide Corp. |
201 |
08/15/25 |
USD |
97.50 |
USD |
1,990 |
(85,425
) |
|
Waste
Connections, Inc. |
240 |
08/15/25 |
CAD |
270.00 |
CAD |
6,105 |
(23,352
) |
|
|
|
|
|
|
|
|
$ (700,631
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call |
|
|
|
|
|
|
|
|
|
Atlas
Copco AB, A Shares |
Goldman
Sachs International |
103,100 |
07/02/25 |
SEK |
171.00 |
SEK |
15,769 |
$ — |
Beiersdorf
AG |
Bank
of America N.A. |
27,200 |
07/02/25 |
EUR |
122.41 |
EUR |
2,902 |
— |
|
MediaTek,
Inc. |
Morgan
Stanley & Co. International PLC |
85,000 |
07/02/25 |
TWD |
1,443.75 |
TWD |
106,250 |
— |
SMC
Corp. |
Goldman
Sachs International |
4,100 |
07/02/25 |
JPY |
58,004.70 |
JPY |
211,584 |
— |
|
United
Overseas Bank Ltd. |
UBS
AG |
74,737 |
07/02/25 |
SGD |
36.51 |
SGD |
2,690 |
(5,945
) |
Zurich
Insurance Group AG, Class N |
UBS
AG |
7,400 |
07/02/25 |
CHF |
588.89 |
CHF |
4,108 |
— |
|
Deutsche
Telekom AG |
Goldman
Sachs International |
25,400 |
07/08/25 |
EUR |
34.50 |
EUR |
789 |
(46
) |
Deutsche
Telekom AG |
Morgan
Stanley & Co. International PLC |
45,700 |
07/08/25 |
EUR |
33.03 |
EUR |
1,420 |
(296
) |
|
Koninklijke
KPN NV |
Barclays
Bank PLC |
156,000 |
07/08/25 |
EUR |
3.95 |
EUR |
646 |
(34,755
) |
Taiwan
Semiconductor Manufacturing Co. Ltd.,
ADR |
Morgan
Stanley & Co. International PLC |
102,500 |
07/08/25 |
TWD |
1,128.60 |
TWD |
109,497 |
(7,808
) |
|
United
Overseas Bank Ltd. |
Bank
of America N.A. |
140,721 |
07/08/25 |
SGD |
37.05 |
SGD |
5,064 |
(21,310
) |
Tencent
Holdings Ltd., ADR |
Goldman
Sachs International |
38,400 |
07/09/25 |
USD |
72.93 |
USD |
2,477 |
(587
) |
|
ASM
International NV |
Citibank
N.A. |
11,500 |
07/10/25 |
EUR |
497.55 |
EUR |
6,263 |
(647,629
) |
Banco
Bilbao Vizcaya Argentaria SA |
Citibank
N.A. |
275,700 |
07/10/25 |
EUR |
14.11 |
EUR |
3,604 |
(5,420
) |
|
Industria
de Diseno Textil SA |
Bank
of America N.A. |
95,500 |
07/10/25 |
EUR |
49.46 |
EUR |
4,229 |
(7
) |
Nestle
SA, Registered Shares |
Goldman
Sachs International |
28,900 |
07/10/25 |
CHF |
90.23 |
CHF |
2,280 |
(31
) |
|
SAP
SE |
Goldman
Sachs International |
14,500 |
07/10/25 |
EUR |
273.77 |
EUR |
3,764 |
(6,782
) |
Taiwan
Semiconductor Manufacturing Co. Ltd.,
ADR |
Morgan
Stanley & Co. International PLC |
46,000 |
07/10/25 |
TWD |
1,029.60 |
TWD |
49,140 |
(62,514
) |
|
Koninklijke
KPN NV |
Goldman
Sachs International |
802,200 |
07/15/25 |
EUR |
4.27 |
EUR |
3,322 |
(15,034
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call (continued) |
|
|
|
|
|
|
|
|
|
Sony
Group Corp. |
UBS
AG |
67,000 |
07/16/25 |
JPY |
4,101.63 |
JPY |
250,860 |
$ (8,191
) |
British
American Tobacco PLC, ADR |
Bank
of America N.A. |
88,400 |
07/17/25 |
GBP |
34.42 |
GBP |
3,062 |
(84,377
) |
|
Haleon
PLC |
Goldman
Sachs International |
655,900 |
07/17/25 |
GBP |
4.07 |
GBP |
2,456 |
(999
) |
Keyence
Corp. |
BNP
Paribas SA |
12,000 |
07/17/25 |
JPY |
63,196.01 |
JPY |
690,927 |
(21,381
) |
|
Novo
Nordisk A/S, Class B |
Morgan
Stanley & Co. International PLC |
1,800 |
07/17/25 |
DKK |
505.30 |
DKK |
790 |
(294
) |
Otis
Worldwide Corp. |
Morgan
Stanley & Co. International PLC |
34,100 |
07/17/25 |
USD |
100.12 |
USD |
3,377 |
(39,222
) |
|
Shell
PLC |
Goldman
Sachs International |
114,700 |
07/17/25 |
EUR |
30.41 |
EUR |
3,420 |
(39,589
) |
Koninklijke
KPN NV |
BNP
Paribas SA |
162,300 |
07/22/25 |
EUR |
4.18 |
EUR |
672 |
(7,760
) |
|
RELX
PLC |
Goldman
Sachs International |
32,650 |
07/22/25 |
EUR |
47.42 |
EUR |
1,498 |
(9,162
) |
Tencent
Holdings Ltd., ADR |
Citibank
N.A. |
35,500 |
07/22/25 |
USD |
66.76 |
USD |
2,290 |
(47,852
) |
|
Air
Liquide SA |
Barclays
Bank PLC |
22,100 |
07/23/25 |
EUR |
187.88 |
EUR |
3,869 |
(5,845
) |
Assa
Abloy AB, Series B |
Bank
of America N.A. |
72,500 |
07/23/25 |
SEK |
311.20 |
SEK |
21,444 |
(13,923
) |
|
AstraZeneca
PLC |
Barclays
Bank PLC |
37,000 |
07/23/25 |
GBP |
113.61 |
GBP |
3,751 |
(2,801
) |
Atlas
Copco AB, A Shares |
Bank
of America N.A. |
69,100 |
07/23/25 |
SEK |
158.72 |
SEK |
10,568 |
(18,249
) |
|
Beiersdorf
AG |
Barclays
Bank PLC |
28,000 |
07/23/25 |
EUR |
119.61 |
EUR |
2,988 |
(4,039
) |
FinecoBank
Banca Fineco SpA |
UBS
AG |
285,800 |
07/23/25 |
EUR |
20.12 |
EUR |
5,382 |
(42,392
) |
|
Koninklijke
KPN NV |
Goldman
Sachs International |
359,000 |
07/23/25 |
EUR |
4.23 |
EUR |
1,487 |
(13,334
) |
Nestle
SA, Registered Shares |
Goldman
Sachs International |
37,200 |
07/23/25 |
CHF |
86.67 |
CHF |
2,935 |
(3,588
) |
|
Novo
Nordisk A/S, Class B |
Bank
of America N.A. |
51,200 |
07/23/25 |
DKK |
545.16 |
DKK |
22,471 |
(3,984
) |
RELX
PLC |
Barclays
Bank PLC |
38,300 |
07/23/25 |
EUR |
47.08 |
EUR |
1,757 |
(14,688
) |
|
Sony
Group Corp. |
JPMorgan
Chase Bank N.A. |
53,000 |
07/23/25 |
JPY |
3,887.22 |
JPY |
198,441 |
(25,585
) |
Taylor
Wimpey PLC |
Barclays
Bank PLC |
1,377,000 |
07/23/25 |
GBP |
1.26 |
GBP |
1,636 |
(22,776
) |
|
Air
Liquide SA |
JPMorgan
Chase Bank N.A. |
21,300 |
07/29/25 |
EUR |
189.85 |
EUR |
3,729 |
(6,309
) |
Compagnie
de Saint-Gobain S.A. |
JPMorgan
Chase Bank N.A. |
35,500 |
07/29/25 |
EUR |
103.82 |
EUR |
3,540 |
(54,630
) |
|
adidas
AG, Class N |
Barclays
Bank PLC |
6,600 |
07/30/25 |
EUR |
201.67 |
EUR |
1,308 |
(46,312
) |
Banco
Bilbao Vizcaya Argentaria SA |
UBS
AG |
58,600 |
07/30/25 |
EUR |
13.54 |
EUR |
766 |
(12,495
) |
|
Deutsche
Telekom AG |
Barclays
Bank PLC |
87,700 |
07/30/25 |
EUR |
31.20 |
EUR |
2,725 |
(66,041
) |
Shell
PLC |
Barclays
Bank PLC |
63,400 |
07/30/25 |
EUR |
32.00 |
EUR |
1,890 |
(10,966
) |
|
Taylor
Wimpey PLC |
Barclays
Bank PLC |
1,022,000 |
07/30/25 |
GBP |
1.23 |
GBP |
1,214 |
(33,949
) |
AstraZeneca
PLC |
BNP
Paribas SA |
17,300 |
08/05/25 |
GBP |
105.70 |
GBP |
1,754 |
(33,980
) |
|
Banco
Bilbao Vizcaya Argentaria SA |
BNP
Paribas SA |
266,500 |
08/05/25 |
EUR |
13.09 |
EUR |
3,484 |
(121,915
) |
Deutsche
Telekom AG |
Goldman
Sachs International |
81,800 |
08/05/25 |
EUR |
32.02 |
EUR |
2,542 |
(39,268
) |
|
FinecoBank
Banca Fineco SpA |
Goldman
Sachs International |
140,800 |
08/05/25 |
EUR |
19.60 |
EUR |
2,652 |
(48,499
) |
Koninklijke
KPN NV |
BNP
Paribas SA |
360,000 |
08/05/25 |
EUR |
4.09 |
EUR |
1,491 |
(32,649
) |
|
RELX
PLC |
JPMorgan
Chase Bank N.A. |
38,400 |
08/05/25 |
EUR |
47.51 |
EUR |
1,762 |
(15,520
) |
SAP
SE |
BNP
Paribas SA |
14,500 |
08/05/25 |
EUR |
262.22 |
EUR |
3,764 |
(120,638
) |
|
Shell
PLC |
Goldman
Sachs International |
48,800 |
08/05/25 |
EUR |
31.26 |
EUR |
1,455 |
(17,750
) |
Taiwan
Semiconductor Manufacturing Co. Ltd.,
ADR |
JPMorgan
Chase Bank N.A. |
248,000 |
08/05/25 |
TWD |
1,102.10 |
TWD |
264,929 |
(205,825
) |
|
Taylor
Wimpey PLC |
Barclays
Bank PLC |
375,900 |
08/05/25 |
GBP |
1.23 |
GBP |
447 |
(13,539
) |
United
Overseas Bank Ltd. |
Morgan
Stanley & Co. International PLC |
11,300 |
08/05/25 |
SGD |
36.76 |
SGD |
407 |
(7,873
) |
|
Keyence
Corp. |
JPMorgan
Chase Bank N.A. |
3,600 |
08/06/25 |
JPY |
58,978.40 |
JPY |
207,278 |
(45,025
) |
SMC
Corp. |
BNP
Paribas SA |
16,400 |
08/06/25 |
JPY |
53,150.88 |
JPY |
846,337 |
(188,783
) |
|
Tencent
Holdings Ltd., ADR |
Morgan
Stanley & Co. International PLC |
39,200 |
08/06/25 |
USD |
67.20 |
USD |
2,528 |
(72,472
) |
UBS
Group AG, Registered |
Morgan
Stanley & Co. International PLC |
78,500 |
08/06/25 |
CHF |
27.07 |
CHF |
2,115 |
(79,288
) |
|
Assa
Abloy AB, Series B |
Bank
of America N.A. |
93,800 |
08/08/25 |
SEK |
305.19 |
SEK |
27,744 |
(47,565
) |
Koninklijke
KPN NV |
Barclays
Bank PLC |
151,100 |
08/08/25 |
EUR |
4.24 |
EUR |
626 |
(4,233
) |
|
Nestle
SA, Registered Shares |
UBS
AG |
18,700 |
08/08/25 |
CHF |
85.71 |
CHF |
1,475 |
(4,618
) |
Novo
Nordisk A/S, Class B |
Bank
of America N.A. |
23,400 |
08/08/25 |
DKK |
511.45 |
DKK |
10,270 |
(22,617
) |
|
Sanofi
SA |
Barclays
Bank PLC |
63,900 |
08/08/25 |
EUR |
85.63 |
EUR |
5,252 |
(69,350
) |
Sony
Group Corp. |
Goldman
Sachs International |
187,000 |
08/08/25 |
JPY |
4,047.81 |
JPY |
700,161 |
(73,628
) |
|
UBS
Group AG, Registered |
Citibank
N.A. |
78,500 |
08/08/25 |
CHF |
25.87 |
CHF |
2,115 |
(149,234
) |
adidas
AG, Class N |
Barclays
Bank PLC |
14,300 |
08/12/25 |
EUR |
205.38 |
EUR |
2,834 |
(100,403
) |
|
Atlas
Copco AB, A Shares |
Barclays
Bank PLC |
209,800 |
08/12/25 |
SEK |
159.91 |
SEK |
32,088 |
(68,394
) |
Haleon
PLC |
Bank
of America N.A. |
316,700 |
08/12/25 |
GBP |
3.88 |
GBP |
1,186 |
(29,387
) |
|
RELX
PLC |
UBS
AG |
60,000 |
08/12/25 |
EUR |
46.94 |
EUR |
2,753 |
(43,209
) |
|
|
|
|
|
|
|
|
$ (3,124,559
) | |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (5,309,740
) |
$ 2,440,699 |
$ (956,149
) |
$ (3,825,190
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 3,825,190 |
$ — |
$ — |
$ — |
$ 3,825,190 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (2,365,048
) |
$ — |
$ — |
$ — |
$ (2,365,048
) |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (100,224
) |
$ — |
$ — |
$ — |
$ (100,224
) |
|
Options: |
|
|
Average
value of option contracts written |
$3,631,501 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 3,825,190 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
3,825,190 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(700,631
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 3,124,559 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 241,419 |
$ — |
$ — |
$ (215,443
) |
$ 25,976 |
|
Barclays
Bank PLC |
498,091 |
— |
— |
(406,176
) |
91,915 |
|
BNP
Paribas SA |
527,106 |
— |
(527,106
) |
— |
— |
|
Citibank
N.A. |
850,135 |
— |
(575,960
) |
(274,175
) |
— |
|
Goldman
Sachs International |
268,297 |
— |
(93,297
) |
(175,000
) |
— |
|
JPMorgan
Chase Bank N.A. |
352,894 |
— |
(281,894
) |
(71,000
) |
— |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Morgan
Stanley & Co. International PLC |
$ 269,767 |
$ — |
$ — |
$ (65,000
) |
$ 204,767 |
|
UBS
AG |
116,850 |
— |
(16,850
) |
(100,000
) |
— |
|
|
$ 3,124,559 |
$ — |
$ (1,495,107
) |
$ (1,306,794
) |
$ 322,658 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Canada |
$ 29,500,069 |
$ — |
$ — |
$ 29,500,069 |
|
China |
16,212,075 |
— |
— |
16,212,075 |
|
Denmark |
— |
15,122,101 |
— |
15,122,101 |
|
France |
— |
29,159,147 |
— |
29,159,147 |
|
Germany |
— |
60,238,398 |
— |
60,238,398 |
|
India |
— |
20,901,655 |
292,390 |
21,194,045 |
|
Italy |
— |
17,452,153 |
— |
17,452,153 |
|
Japan |
— |
48,342,804 |
— |
48,342,804 |
|
Netherlands |
— |
34,052,790 |
— |
34,052,790 |
|
Singapore |
— |
14,256,574 |
— |
14,256,574 |
|
Spain |
— |
27,901,791 |
— |
27,901,791 |
|
Sweden |
— |
25,274,611 |
— |
25,274,611 |
|
Switzerland |
— |
38,708,240 |
— |
38,708,240 |
|
Taiwan |
— |
39,773,730 |
— |
39,773,730 |
|
United
Kingdom |
— |
53,620,796 |
— |
53,620,796 |
|
United
States |
49,055,552 |
47,621,408 |
— |
96,676,960 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
2,898,908 |
— |
— |
2,898,908 |
|
|
$ 97,666,604 |
$ 472,426,198 |
$ 292,390 |
$ 570,385,192 |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (700,631
) |
$ (3,124,559
) |
$ — |
$ (3,825,190
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Aerospace
& Defense — 3.6% |
| ||
|
Howmet
Aerospace, Inc. |
179,387 |
$ 33,389,302 | |
|
Banks
— 3.2% |
| ||
|
Wells
Fargo & Co. |
374,286 |
29,987,794 | |
|
Broadline
Retail — 7.5% |
| ||
|
Amazon.com,
Inc.(a)(b) |
316,889 |
69,522,278 | |
|
Building
Products — 3.5% |
| ||
|
Johnson
Controls International PLC |
305,472 |
32,263,953 | |
|
Capital
Markets — 7.1% |
| ||
|
Intercontinental
Exchange, Inc. |
186,854 |
34,282,103 | |
|
S&P
Global, Inc. |
|
60,042 |
31,659,546 |
|
|
|
65,941,649 | |
|
Chemicals
— 3.1% |
| ||
|
Air
Products and Chemicals, Inc. |
101,393 |
28,598,910 | |
|
Communications
Equipment — 3.7% |
| ||
|
Ciena
Corp.(b) |
420,188 |
34,173,890 | |
|
Entertainment
— 4.6% |
| ||
|
Spotify
Technology SA(b) |
37,631 |
28,875,771 | |
|
TKO
Group Holdings, Inc., Class A |
|
75,762 |
13,784,896 |
|
|
|
42,660,667 | |
|
Financial
Services — 7.8% |
| ||
|
Mr.
Cooper Group, Inc.(b) |
199,708 |
29,798,431 | |
|
Visa,
Inc., Class A |
|
118,944 |
42,231,067 |
|
|
|
72,029,498 | |
|
Health
Care Equipment & Supplies — 3.2% |
| ||
|
Boston
Scientific Corp.(b) |
273,417 |
29,367,720 | |
|
Health
Care Providers & Services — 7.6% |
| ||
|
Cardinal
Health, Inc. |
226,565 |
38,062,920 | |
|
Cencora,
Inc. |
|
13,174 |
3,950,224 |
|
Elevance
Health, Inc. |
46,475 |
18,076,916 | |
|
Humana,
Inc. |
|
42,154 |
10,305,810 |
|
|
|
70,395,870 | |
|
Interactive
Media & Services — 9.2% |
| ||
|
Alphabet,
Inc., Class A |
114,492 |
20,176,925 | |
|
Meta
Platforms, Inc., Class A(a) |
|
88,239 |
65,128,324 |
|
|
|
85,305,249 | |
|
Leisure
Products — 2.7% |
| ||
|
Hasbro,
Inc. |
337,863 |
24,941,047 | |
|
Oil,
Gas & Consumable Fuels — 2.9% |
| ||
|
Hess
Corp. |
159,411 |
22,084,800 | |
|
Suncor
Energy, Inc. |
|
122,967 |
4,605,114 |
|
|
|
26,689,914 | |
|
Security |
|
Shares |
Value |
|
Pharmaceuticals
— 1.4% |
| ||
|
Eli
Lilly & Co. |
|
16,262 |
$ 12,676,717 |
|
Professional
Services — 2.7% |
| ||
|
SS&C
Technologies Holdings, Inc. |
|
307,342 |
25,447,918 |
|
Semiconductors
& Semiconductor Equipment — 15.3% |
| ||
|
Advanced
Micro Devices, Inc.(b) |
|
120,369 |
17,080,361 |
|
Broadcom,
Inc. |
163,416 |
45,045,620 | |
|
Micron
Technology, Inc. |
|
186,023 |
22,927,335 |
|
NVIDIA
Corp.(a) |
359,671 |
56,824,421 | |
|
|
|
|
141,877,737 |
|
Software
— 11.5% |
| ||
|
AppLovin
Corp., Class A(b) |
|
59,014 |
20,659,621 |
|
Microsoft
Corp.(a)(c) |
172,455 |
85,780,842 | |
|
|
|
|
106,440,463 |
|
Technology
Hardware, Storage & Peripherals — 2.0% |
| ||
|
Apple,
Inc. |
|
22,571 |
4,630,892 |
|
Western
Digital Corp. |
215,252 |
13,773,975 | |
|
|
|
|
18,404,867 |
|
Total
Long-Term Investments — 102.6%
(Cost:
$626,430,005) |
950,115,443 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 0.6% |
| ||
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(d)(e) |
|
5,646,470 |
5,646,470 |
|
Total
Short-Term Securities — 0.6%
(Cost:
$5,646,470) |
5,646,470 | ||
|
Total
Investments Before Options Written — 103.2%
(Cost:
$632,076,475) |
955,761,913 | ||
|
Options
Written — (2.9)%
(Premiums
Received: $(16,830,615)) |
(26,761,464
) | ||
|
Total
Investments, Net of Options Written — 100.3%
(Cost:
$615,245,860) |
929,000,449 | ||
|
Liabilities
in Excess of Other Assets — (0.3)% |
(2,331,262
) | ||
|
Net
Assets — 100.0% |
$ 926,669,187 | ||
|
(a)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(b)
|
Non-income
producing security. |
|
(c)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(d)
|
Affiliate
of the Trust. |
|
(e)
|
Annualized
7-day yield as of period
end. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency Shares(a) |
$ 435,128 |
$ — |
$ (434,864
)(b) |
$ (305
) |
$ 41 |
$ — |
— |
$ 559
(c) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares |
6,320,794 |
— |
(674,324
)(b) |
— |
— |
5,646,470 |
5,646,470 |
272,879 |
— |
|
|
|
|
|
$ (305
) |
$ 41 |
$ 5,646,470 |
|
$ 273,438 |
$ — |
|
(a)
|
As
of period end, the entity is no longer held. |
|
(b)
|
Represents
net amount purchased (sold). |
|
(c)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call |
|
|
|
|
|
|
|
|
Boston
Scientific Corp. |
368 |
07/03/25 |
USD |
105.00 |
USD |
3,953 |
$ (76,360
) |
Alphabet,
Inc., Class A |
164 |
07/11/25 |
USD |
175.00 |
USD |
2,890 |
(66,420
) |
|
Amazon.com,
Inc. |
390 |
07/11/25 |
USD |
221.01 |
USD |
8,556 |
(137,356
) |
Applovin
Corp., Class A |
104 |
07/11/25 |
USD |
390.00 |
USD |
3,641 |
(45,760
) |
|
Broadcom,
Inc. |
5 |
07/11/25 |
USD |
265.00 |
USD |
138 |
(6,750
) |
Humana,
Inc. |
120 |
07/11/25 |
USD |
245.00 |
USD |
2,934 |
(71,400
) |
|
Micron
Technology, Inc. |
353 |
07/11/25 |
USD |
106.00 |
USD |
4,351 |
(638,047
) |
Microsoft
Corp. |
134 |
07/11/25 |
USD |
470.00 |
USD |
6,665 |
(384,580
) |
|
NVIDIA
Corp. |
497 |
07/11/25 |
USD |
152.50 |
USD |
7,852 |
(357,840
) |
NVIDIA
Corp. |
348 |
07/11/25 |
USD |
149.04 |
USD |
5,498 |
(352,507
) |
|
Spotify
Technology SA |
72 |
07/11/25 |
USD |
700.00 |
USD |
5,525 |
(501,660
) |
Visa,
Inc., Class A |
320 |
07/11/25 |
USD |
365.00 |
USD |
11,362 |
(33,920
) |
|
Western
Digital Corp. |
461 |
07/11/25 |
USD |
53.00 |
USD |
2,950 |
(490,965
) |
Advanced
Micro Devices, Inc. |
350 |
07/18/25 |
USD |
130.00 |
USD |
4,967 |
(464,625
) |
|
Air
Products & Chemicals, Inc. |
284 |
07/18/25 |
USD |
281.41 |
USD |
8,011 |
(141,191
) |
Alphabet,
Inc., Class A |
315 |
07/18/25 |
USD |
180.00 |
USD |
5,551 |
(89,303
) |
|
Amazon.com,
Inc. |
331 |
07/18/25 |
USD |
210.00 |
USD |
7,262 |
(390,580
) |
Amazon.com,
Inc. |
224 |
07/18/25 |
USD |
220.00 |
USD |
4,914 |
(117,040
) |
|
Applovin
Corp., Class A |
85 |
07/18/25 |
USD |
380.00 |
USD |
2,976 |
(79,050
) |
Broadcom,
Inc. |
223 |
07/18/25 |
USD |
250.00 |
USD |
6,147 |
(614,922
) |
|
Cencora,
Inc. |
36 |
07/18/25 |
USD |
290.00 |
USD |
1,079 |
(44,820
) |
Ciena
Corp. |
1,580 |
07/18/25 |
USD |
82.50 |
USD |
12,850 |
(331,800
) |
|
Eli
Lilly & Co. |
35 |
07/18/25 |
USD |
860.00 |
USD |
2,728 |
(8,085
) |
Hasbro,
Inc. |
747 |
07/18/25 |
USD |
72.50 |
USD |
5,514 |
(192,353
) |
|
Hasbro,
Inc. |
364 |
07/18/25 |
USD |
75.00 |
USD |
2,687 |
(40,040
) |
Hess
Corp. |
221 |
07/18/25 |
USD |
140.00 |
USD |
3,062 |
(76,798
) |
|
Howmet
Aerospace, Inc. |
430 |
07/18/25 |
USD |
160.00 |
USD |
8,004 |
(1,139,500
) |
Intercontinental
Exchange, Inc. |
536 |
07/18/25 |
USD |
180.00 |
USD |
9,834 |
(281,400
) |
|
Johnson
Controls International PLC |
856 |
07/18/25 |
USD |
100.00 |
USD |
9,041 |
(552,120
) |
Meta
Platforms, Inc., Class A |
217 |
07/18/25 |
USD |
725.00 |
USD |
16,017 |
(560,945
) |
|
Microsoft
Corp. |
262 |
07/18/25 |
USD |
460.00 |
USD |
13,032 |
(1,027,695
) |
Mr.
Cooper Group Inc. |
608 |
07/18/25 |
USD |
120.00 |
USD |
9,072 |
(1,799,680
) |
|
NVIDIA
Corp. |
165 |
07/18/25 |
USD |
135.00 |
USD |
2,607 |
(390,637
) |
NVIDIA
Corp. |
100 |
07/18/25 |
USD |
130.00 |
USD |
1,580 |
(285,500
) |
|
NVIDIA
Corp. |
107 |
07/18/25 |
USD |
150.00 |
USD |
1,690 |
(108,873
) |
S&P
Global, Inc. |
117 |
07/18/25 |
USD |
520.00 |
USD |
6,169 |
(165,555
) |
|
SS&C
Technologies Holdings, Inc. |
783 |
07/18/25 |
USD |
80.00 |
USD |
6,483 |
(264,262
) |
TKO
Group Holdings, Inc., Class A |
208 |
07/18/25 |
USD |
165.00 |
USD |
3,785 |
(380,640
) |
|
Wells
Fargo & Co. |
989 |
07/18/25 |
USD |
75.00 |
USD |
7,924 |
(583,510
) |
Western
Digital Corp. |
161 |
07/18/25 |
USD |
55.00 |
USD |
1,030 |
(149,730
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call (continued) |
|
|
|
|
|
|
|
|
Alphabet,
Inc., Class A |
150 |
07/25/25 |
USD |
185.00 |
USD |
2,643 |
$ (45,375
) |
Amazon.com,
Inc. |
473 |
07/25/25 |
USD |
220.00 |
USD |
10,377 |
(296,807
) |
|
Applovin
Corp., Class A |
135 |
07/25/25 |
USD |
415.00 |
USD |
4,726 |
(74,925
) |
Boston
Scientific Corp. |
515 |
07/25/25 |
USD |
106.00 |
USD |
5,532 |
(195,700
) |
|
Broadcom,
Inc. |
529 |
07/25/25 |
USD |
260.00 |
USD |
14,582 |
(1,092,385
) |
Cardinal
Health, Inc. |
135 |
07/25/25 |
USD |
170.00 |
USD |
2,268 |
(31,388
) |
|
Eli
Lilly & Co. |
1 |
07/25/25 |
USD |
860.00 |
USD |
78 |
(371
) |
Hess
Corp. |
666 |
07/25/25 |
USD |
145.00 |
USD |
9,227 |
(159,840
) |
|
Howmet
Aerospace, Inc. |
260 |
07/25/25 |
USD |
182.50 |
USD |
4,839 |
(219,700
) |
Meta
Platforms, Inc., Class A |
124 |
07/25/25 |
USD |
725.00 |
USD |
9,152 |
(374,170
) |
|
Microsoft
Corp. |
290 |
07/25/25 |
USD |
495.00 |
USD |
14,425 |
(319,725
) |
NVIDIA
Corp. |
165 |
07/25/25 |
USD |
147.00 |
USD |
2,607 |
(221,100
) |
|
NVIDIA
Corp. |
108 |
07/25/25 |
USD |
150.00 |
USD |
1,706 |
(119,610
) |
Spotify
Technology SA |
115 |
07/25/25 |
USD |
765.00 |
USD |
8,824 |
(369,437
) |
|
Suncor
Energy, Inc. |
169 |
07/25/25 |
USD |
42.00 |
USD |
633 |
(37,180
) |
Visa,
Inc., Class A |
75 |
07/25/25 |
USD |
355.00 |
USD |
2,663 |
(61,875
) |
|
Wells
Fargo & Co. |
47 |
07/25/25 |
USD |
76.00 |
USD |
377 |
(24,910
) |
Advanced
Micro Devices, Inc. |
219 |
08/01/25 |
USD |
130.00 |
USD |
3,108 |
(325,762
) |
|
Amazon.com,
Inc. |
162 |
08/01/25 |
USD |
225.00 |
USD |
3,554 |
(117,045
) |
Apple,
Inc. |
41 |
08/01/25 |
USD |
210.00 |
USD |
841 |
(22,140
) |
|
Boston
Scientific Corp. |
368 |
08/01/25 |
USD |
105.00 |
USD |
3,953 |
(191,360
) |
Broadcom,
Inc. |
310 |
08/01/25 |
USD |
260.00 |
USD |
8,545 |
(690,525
) |
|
Cardinal
Health, Inc. |
163 |
08/01/25 |
USD |
162.50 |
USD |
2,738 |
(125,510
) |
Eli
Lilly & Co. |
53 |
08/01/25 |
USD |
810.00 |
USD |
4,132 |
(109,975
) |
|
Micron
Technology, Inc. |
350 |
08/01/25 |
USD |
130.00 |
USD |
4,314 |
(110,250
) |
NVIDIA
Corp. |
216 |
08/01/25 |
USD |
160.00 |
USD |
3,413 |
(130,680
) |
|
Suncor
Energy, Inc. |
169 |
08/01/25 |
USD |
42.00 |
USD |
633 |
(38,025
) |
Wells
Fargo & Co. |
33 |
08/01/25 |
USD |
77.00 |
USD |
264 |
(16,088
) |
|
Western
Digital Corp. |
100 |
08/01/25 |
USD |
60.00 |
USD |
640 |
(59,250
) |
Cardinal
Health, Inc. |
474 |
08/08/25 |
USD |
167.50 |
USD |
7,963 |
(246,480
) |
|
Meta
Platforms, Inc., Class A |
144 |
08/08/25 |
USD |
745.00 |
USD |
10,628 |
(495,360
) |
S&P
Global, Inc. |
109 |
08/08/25 |
USD |
530.00 |
USD |
5,747 |
(166,225
) |
|
Advanced
Micro Devices, Inc. |
94 |
08/15/25 |
USD |
140.00 |
USD |
1,334 |
(101,285
) |
Air
Products & Chemicals, Inc. |
272 |
08/15/25 |
USD |
290.00 |
USD |
7,672 |
(189,040
) |
|
Amazon.com,
Inc. |
162 |
08/15/25 |
USD |
225.00 |
USD |
3,554 |
(136,890
) |
Apple,
Inc. |
40 |
08/15/25 |
USD |
210.00 |
USD |
821 |
(26,900
) |
|
Cardinal
Health, Inc. |
474 |
08/15/25 |
USD |
170.00 |
USD |
7,963 |
(232,260
) |
Cencora,
Inc. |
36 |
08/15/25 |
USD |
300.00 |
USD |
1,079 |
(38,700
) |
|
Ciena
Corp. |
731 |
08/15/25 |
USD |
75.00 |
USD |
5,945 |
(621,350
) |
Hasbro,
Inc. |
747 |
08/15/25 |
USD |
72.50 |
USD |
5,514 |
(407,115
) |
|
Howmet
Aerospace, Inc. |
296 |
08/15/25 |
USD |
180.00 |
USD |
5,509 |
(415,880
) |
Intercontinental
Exchange, Inc. |
440 |
08/15/25 |
USD |
179.86 |
USD |
8,073 |
(321,896
) |
|
Johnson
Controls International PLC |
851 |
08/15/25 |
USD |
105.00 |
USD |
8,988 |
(446,775
) |
Micron
Technology, Inc. |
320 |
08/15/25 |
USD |
120.00 |
USD |
3,944 |
(289,600
) |
|
Microsoft
Corp. |
262 |
08/15/25 |
USD |
495.00 |
USD |
13,032 |
(501,075
) |
Mr.
Cooper Group Inc. |
490 |
08/15/25 |
USD |
145.00 |
USD |
7,311 |
(651,700
) |
|
NVIDIA
Corp. |
272 |
08/15/25 |
USD |
150.00 |
USD |
4,297 |
(369,240
) |
S&P
Global, Inc. |
104 |
08/15/25 |
USD |
530.00 |
USD |
5,484 |
(168,480
) |
|
Spotify
Technology SA |
19 |
08/15/25 |
USD |
720.00 |
USD |
1,458 |
(162,355
) |
SS&C
Technologies Holdings, Inc. |
909 |
08/15/25 |
USD |
80.00 |
USD |
7,527 |
(463,590
) |
|
Suncor
Energy, Inc. |
338 |
08/15/25 |
USD |
39.00 |
USD |
1,266 |
(27,040
) |
TKO
Group Holdings, Inc., Class A |
208 |
08/15/25 |
USD |
175.00 |
USD |
3,785 |
(287,040
) |
|
Visa,
Inc., Class A |
259 |
08/15/25 |
USD |
355.00 |
USD |
9,196 |
(322,455
) |
Wells
Fargo & Co. |
989 |
08/15/25 |
USD |
80.00 |
USD |
7,924 |
(318,952
) |
|
Western
Digital Corp. |
461 |
09/19/25 |
USD |
65.00 |
USD |
2,950 |
(205,145
) |
|
|
|
|
|
|
|
$ (26,638,155
) | |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
Intercontinental
Exchange, Inc. |
Bank
of America N.A. |
6,600 |
07/07/25 |
USD |
170.50 |
USD |
1,211 |
$ (86,703
) |
|
Boston
Scientific Corp. |
Citibank
N.A. |
25,200 |
07/09/25 |
USD |
107.87 |
USD |
2,707 |
(36,606
) |
|
|
|
|
|
|
|
|
|
$ (123,309
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (16,830,615
) |
$ 1,805,309 |
$ (11,736,158
) |
$ (26,761,464
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 26,761,464 |
$ — |
$ — |
$ — |
$ 26,761,464 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (11,793,743
) |
$ — |
$ — |
$ — |
$ (11,793,743
) |
|
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (13,083,917
) |
$ — |
$ — |
$ — |
$ (13,083,917
) |
|
Options: |
|
|
Average
value of option contracts written |
$17,802,133 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 26,761,464 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
26,761,464 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(26,638,155
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 123,309 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 86,703 |
$ — |
$ (86,703
) |
$ — |
$ — |
|
Citibank
N.A. |
36,606 |
— |
— |
— |
36,606 |
|
|
$ 123,309 |
$ — |
$ (86,703
) |
$ — |
$ 36,606 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
$ 950,115,443 |
$ — |
$ — |
$ 950,115,443 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
5,646,470 |
— |
— |
5,646,470 |
|
|
$955,761,913 |
$— |
$— |
$955,761,913 |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (25,685,205
) |
$ (1,076,259
) |
$ — |
$ (26,761,464
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Biotechnology
— 31.1% |
| ||
|
4D
Molecular Therapeutics, Inc.(a) |
63,685 |
$ 236,271 | |
|
Abbisko
Cayman Ltd.(a) |
|
6,051,250 |
7,894,538 |
|
AbbVie,
Inc. |
65,256 |
12,112,819 | |
|
Abcuro,
Inc.(a)(b) |
|
241,900 |
1,325,612 |
|
Akeso,
Inc.(a)(c) |
548,000 |
6,448,915 | |
|
Alkermes
PLC(a) |
|
162,816 |
4,658,166 |
|
Allogene
Therapeutics, Inc.(a)(d) |
425,415 |
480,719 | |
|
Alnylam
Pharmaceuticals, Inc.(a)(e) |
|
144,211 |
47,025,765 |
|
Annexon,
Inc.(a) |
144,084 |
345,802 | |
|
Arcellx,
Inc.(a) |
|
26,392 |
1,737,910 |
|
Arcus
Biosciences, Inc.(a) |
99,007 |
805,917 | |
|
Arrowhead
Pharmaceuticals, Inc.(a) |
|
51,323 |
810,903 |
|
Ascendis
Pharma A/S, ADR(a) |
28,048 |
4,841,085 | |
|
Autolus
Therapeutics PLC, ADR(a)(d) |
|
463,993 |
1,057,904 |
|
Avidity
Biosciences, Inc.(a) |
36,258 |
1,029,727 | |
|
Beam
Therapeutics, Inc.(a) |
|
95,917 |
1,631,548 |
|
Bicycle
Therapeutics PLC, ADR(a) |
53,067 |
368,816 | |
|
Biohaven
Ltd.(a) |
|
88,609 |
1,250,273 |
|
BioMarin
Pharmaceutical, Inc.(a) |
84,744 |
4,658,378 | |
|
BioNTech
SE, ADR(a)(d) |
|
18,918 |
2,014,199 |
|
Black
Diamond Therapeutics, Inc.(a)(d) |
504,978 |
1,252,345 | |
|
Blueprint
Medicines Corp.(a) |
|
36,582 |
4,689,081 |
|
Bridgebio
Pharma, Inc.(a) |
102,653 |
4,432,557 | |
|
CG
oncology, Inc.(a) |
|
25,078 |
652,028 |
|
Denali
Therapeutics, Inc.(a) |
169,834 |
2,375,978 | |
|
Disc
Medicine, Inc.(a) |
|
28,021 |
1,483,992 |
|
Dyne
Therapeutics, Inc.(a) |
116,674 |
1,110,736 | |
|
Exact
Sciences Corp.(a) |
|
263,762 |
14,016,313 |
|
Exelixis,
Inc.(a) |
227,940 |
10,046,455 | |
|
Genmab
A/S(a) |
|
50,248 |
10,434,920 |
|
Halozyme
Therapeutics, Inc.(a) |
58,978 |
3,068,036 | |
|
Immatics
NV(a)(d) |
|
162,650 |
875,057 |
|
Immunocore
Holdings PLC, Series C, ADR(a) |
321,900 |
10,101,222 | |
|
Incyte
Corp.(a) |
|
66,510 |
4,529,331 |
|
Insmed,
Inc.(a) |
180,581 |
18,173,672 | |
|
Ionis
Pharmaceuticals, Inc.(a) |
|
59,102 |
2,335,120 |
|
Kiniksa
Pharmaceuticals International PLC(a) |
84,235 |
2,330,782 | |
|
Kymera
Therapeutics, Inc.(a) |
|
15,237 |
664,943 |
|
Legend
Biotech Corp., ADR(a) |
42,405 |
1,504,953 | |
|
Merus
NV(a) |
|
21,187 |
1,114,436 |
|
Moderna,
Inc.(a) |
14,490 |
399,779 | |
|
Monte
Rosa Therapeutics, Inc.(a) |
|
155,206 |
699,979 |
|
MoonLake
Immunotherapeutics(a) |
44,860 |
2,117,392 | |
|
Natera,
Inc.(a) |
|
67,562 |
11,413,924 |
|
Neurocrine
Biosciences, Inc.(a) |
91,508 |
11,501,641 | |
|
Neurogene,
Inc.(a)(d) |
|
82,832 |
1,238,338 |
|
Nuvalent,
Inc., Class A(a) |
134,486 |
10,261,282 | |
|
OnKure
Therapeutics, Inc.(a) |
|
463,586 |
1,107,971 |
|
ORIC
Pharmaceuticals, Inc.(a) |
138,524 |
1,406,019 | |
|
Protagonist
Therapeutics, Inc.(a) |
|
92,637 |
5,120,047 |
|
PTC
Therapeutics, Inc.(a) |
136,766 |
6,679,651 | |
|
REGENXBIO,
Inc.(a) |
|
64,920 |
532,993 |
|
Renagade
Therapeutics, Series A-2(a)(b) |
3,584,906 |
8,173,586 | |
|
Revolution
Medicines, Inc.(a) |
|
24,290 |
893,629 |
|
Rhythm
Pharmaceuticals, Inc.(a)(e) |
185,663 |
11,732,045 | |
|
Roivant
Sciences Ltd.(a) |
|
524,238 |
5,908,162 |
|
Sagimet
Biosciences, Inc., Series A(a) |
237,980 |
1,813,408 | |
|
Scholar
Rock Holding Corp.(a) |
|
42,838 |
1,517,322 |
|
Spyre
Therapeutics, Inc.(a) |
18,248 |
273,173 | |
|
Stoke
Therapeutics, Inc.(a) |
|
309,103 |
3,508,319 |
|
Security |
|
Shares |
Value |
|
Biotechnology
(continued) |
| ||
|
Summit
Therapeutics, Inc.(a)(d) |
|
28,660 |
$ 609,885 |
|
TScan
Therapeutics, Inc.(a) |
609,800 |
884,210 | |
|
Twist
Bioscience Corp.(a) |
|
80,595 |
2,965,090 |
|
Ultragenyx
Pharmaceutical, Inc.(a) |
26,815 |
974,993 | |
|
United
Therapeutics Corp.(a) |
|
3,060 |
879,291 |
|
Vaxcyte,
Inc.(a) |
32,817 |
1,066,881 | |
|
Vigil
Neuroscience, Inc.(a) |
|
131,344 |
1,044,185 |
|
Viking
Therapeutics, Inc.(a) |
24,596 |
651,794 | |
|
Vir
Biotechnology, Inc.(a) |
|
44,171 |
222,622 |
|
Voyager
Therapeutics, Inc.(a) |
211,857 |
658,875 | |
|
Xenon
Pharmaceuticals, Inc.(a) |
|
139,115 |
4,354,300 |
|
Zealand
Pharma A/S(a) |
29,510 |
1,654,983 | |
|
|
|
|
298,192,993 |
|
Capital
Markets — 0.6% |
| ||
|
Helix
Acquisition Corp. II, Class A(a) |
|
544,465 |
5,798,552 |
|
Health
Care Equipment & Supplies — 20.5% |
| ||
|
Abbott
Laboratories |
|
127,328 |
17,317,880 |
|
Alcon
AG |
70,623 |
6,234,598 | |
|
Becton
Dickinson & Co. |
|
24,837 |
4,278,173 |
|
Boston
Scientific Corp.(a)(e)(f) |
140,160 |
15,054,586 | |
|
Dexcom,
Inc.(a) |
|
308,482 |
26,927,394 |
|
Edwards
Lifesciences Corp.(a) |
216,810 |
16,956,710 | |
|
EXO
Imaging, Inc., Series C, (Acquired 06/24/21, Cost:
$13,225,003)(a)(b)(g) |
|
22,576 |
8,127 |
|
Glaukos
Corp.(a) |
26,050 |
2,690,704 | |
|
IDEXX
Laboratories, Inc.(a) |
|
36,740 |
19,705,132 |
|
Inspire
Medical Systems, Inc.(a) |
39,579 |
5,136,167 | |
|
Insulet
Corp.(a) |
|
58,827 |
18,482,267 |
|
Intuitive
Surgical, Inc.(a) |
3,135 |
1,703,590 | |
|
Lantheus
Holdings, Inc.(a) |
|
41,510 |
3,398,009 |
|
Medtronic
PLC |
165,394 |
14,417,395 | |
|
Novocure
Ltd.(a) |
|
155,581 |
2,769,342 |
|
Nucleix
Ltd., (Acquired 04/10/24, Cost:
$1,300,000)(a)(b)(g) |
1,300 |
935,480 | |
|
Nyxoah
SA(a)(d) |
|
254,299 |
1,902,157 |
|
Orchestra
BioMed Holdings, Inc.(a) |
136,066 |
364,657 | |
|
Penumbra,
Inc.(a) |
|
36,577 |
9,386,755 |
|
Sonova
Holding AG, Registered Shares |
57,600 |
17,177,783 | |
|
Stryker
Corp. |
|
29,432 |
11,644,182 |
|
|
|
196,491,088 | |
|
Health
Care Providers & Services — 10.4% |
| ||
|
Cencora,
Inc. |
31,471 |
9,436,580 | |
|
Chemed
Corp. |
|
6,754 |
3,288,725 |
|
CVS
Health Corp. |
59,711 |
4,118,865 | |
|
Encompass
Health Corp. |
|
111,418 |
13,663,189 |
|
Guardant
Health, Inc.(a) |
215,976 |
11,239,391 | |
|
Labcorp
Holdings, Inc. |
|
75,131 |
19,722,639 |
|
McKesson
Corp. |
13,076 |
9,581,831 | |
|
Quest
Diagnostics, Inc. |
|
77,532 |
13,927,073 |
|
RadNet,
Inc.(a) |
38,559 |
2,194,393 | |
|
Tenet
Healthcare Corp.(a) |
|
70,897 |
12,477,872 |
|
|
|
99,650,558 | |
|
Health
Care Technology — 4.2% |
| ||
|
Carbon
Health Technologies, Inc., (Acquired 05/28/25,
Cost:
$18,326,000)(a)(b)(g) |
2,759,320 |
27,593 | |
|
M3,
Inc. |
|
462,800 |
6,357,345 |
|
Veeva
Systems, Inc., Class A(a)(e)(f) |
116,456 |
33,536,999 | |
|
|
|
|
39,921,937 |
|
Life
Sciences Tools & Services — 14.5% |
| ||
|
Agilent
Technologies, Inc. |
|
40,785 |
4,813,038 |
|
Security |
|
Shares |
Value |
|
Life
Sciences Tools & Services (continued) |
| ||
|
Bio-Techne
Corp. |
|
119,215 |
$ 6,133,612 |
|
Bruker
Corp. |
175,045 |
7,211,854 | |
|
Charles
River Laboratories International, Inc.(a) |
|
32,635 |
4,951,709 |
|
Gerresheimer
AG |
29,709 |
1,677,766 | |
|
Lonza
Group AG, Registered Shares |
|
14,800 |
10,584,419 |
|
Mettler-Toledo
International, Inc.(a) |
19,264 |
22,629,806 | |
|
QIAGEN
NV |
|
169,456 |
8,144,055 |
|
Rapid
Micro Biosystems, Inc., Class A(a)(d) |
333,064 |
1,149,071 | |
|
Repligen
Corp.(a) |
|
119,498 |
14,863,161 |
|
Waters
Corp.(a)(e)(f) |
60,021 |
20,949,730 | |
|
West
Pharmaceutical Services, Inc.(e) |
|
94,164 |
20,603,083 |
|
Wuxi
Biologics Cayman, Inc.(a)(c) |
4,546,000 |
14,937,717 | |
|
|
|
|
138,649,021 |
|
Pharmaceuticals
— 5.2% |
| ||
|
Arvinas,
Inc.(a) |
|
147,562 |
1,086,056 |
|
Axsome
Therapeutics, Inc.(a)(d) |
42,781 |
4,465,909 | |
|
Daiichi
Sankyo Co. Ltd. |
|
121,700 |
2,819,556 |
|
Edgewise
Therapeutics, Inc.(a) |
109,871 |
1,440,409 | |
|
Galderma
Group AG |
|
126,839 |
18,436,769 |
|
Johnson
& Johnson |
30,775 |
4,700,881 | |
|
Nuvation
Bio, Inc., Class A(a) |
|
191,533 |
373,489 |
|
Roche
Holding AG |
10,284 |
3,356,900 | |
|
Teva
Pharmaceutical Industries Ltd., ADR(a) |
|
446,565 |
7,484,430 |
|
UCB
SA |
25,950 |
5,105,864 | |
|
WaVe
Life Sciences Ltd.(a) |
|
151,116 |
982,254 |
|
|
|
50,252,517 | |
|
Total
Common Stocks — 86.5%
(Cost:
$775,451,707) |
828,956,666 | ||
|
|
|
Benefical
Interest
(000) |
|
|
Other
Interests | |||
|
Biotechnology(b)(g)(h)
— 0.4% |
| ||
|
Affinivax,
Inc., (Acquired 08/18/22, Cost: $ —) |
$ |
183 |
1,769,364 |
|
Amunix
Pharmaceuticals, Inc., (Acquired 02/08/22,
Cost:
$ —) |
|
5,657 |
1,753,691 |
|
Total
Other Interests — 0.4%
(Cost:
$ — ) |
3,523,055 | ||
|
|
|
Shares |
|
|
Preferred
Securities | |||
|
Preferred
Stocks — 13.3% | |||
|
Biotechnology(a)(b)
— 6.5% |
| ||
|
ABCURO,
Series B |
|
1,092,954 |
5,880,093 |
|
Adarx
Pharamaceuticals, Inc., Series C, (Acquired
08/02/23,
Cost: $7,160,001)(g) |
860,577 |
9,776,155 | |
|
Bright
Peak Therapeutics, Inc., Series B, (Acquired
05/14/21,
Cost: $8,000,004)(g) |
|
3,191,830 |
2,936,484 |
|
Cellarity,
Inc., Series B, (Acquired 01/15/21, Cost:
$14,584,998)(g) |
2,430,833 |
5,177,674 | |
|
Genesis
Therapeutics, Inc., Series B, (Acquired
08/10/23,
Cost: $6,999,996)(g) |
|
1,370,506 |
7,482,963 |
|
Goldfinch
Bio, Inc., Series B, (Acquired 06/26/20, Cost:
$4,543,847)(g) |
3,850,718 |
1,078,201 | |
|
Security |
|
Shares |
Value |
|
Biotechnology
(continued) |
| ||
|
Kartos
Therapeutics, Inc.(g)
|
|
|
|
|
Series
C, (Acquired 08/22/23, Cost: $7,539,875) |
1,333,783 |
$ 7,562,550 | |
|
Series
D, (Acquired 02/19/25, Cost: $2,074,436) |
|
366,962 |
2,080,675 |
|
Laronde,
Inc., Series B, (Acquired 07/28/21, Cost:
$13,498,156)(g) |
482,077 |
11,020,280 | |
|
Mirvie,
Inc., Series B, (Acquired 10/15/21, Cost:
$6,250,000)(g) |
|
2,793,833 |
4,917,146 |
|
NiKang
Therapeutics, Inc., Series C, (Acquired
05/20/21,
Cost: $7,999,996)(g) |
1,394,189 |
4,210,451 | |
|
|
|
|
62,122,672 |
|
Health
Care Equipment & Supplies(a)(b)(g)
— 0.2% |
| ||
|
EXO
Imaging, Inc., (Acquired 07/24/24, Cost:
$640,450) |
|
1,053,928 |
779,907 |
|
Nucleix
Ltd., Series AA, (Acquired 03/25/21, Cost:
$6,929,998) |
2,379,480 |
1,451,483 | |
|
Swift
Health Systems, Inc., Series D, (Acquired
08/27/21,
Cost: $6,441,930) |
|
2,078 |
4,634 |
|
|
|
2,236,024 | |
|
Health
Care Providers & Services(b)(g)
— 2.5% |
| ||
|
Everly
Well, Inc., Series D, (Acquired 11/25/20, Cost:
$9,999,986)(a) |
382,775 |
5,362,678 | |
|
Numab
Therapeutics AG, Series C, (Acquired 05/07/21,
Cost:
$9,204,219) |
|
1,139,305 |
8,428,660 |
|
Quanta
Dialysis Technologies Ltd., Series D, (Acquired
06/18/21,
Cost: $14,071,890)(a) |
115,766,240 |
9,852,203 | |
|
|
|
|
23,643,541 |
|
Life
Sciences Tools & Services — 0.8% |
| ||
|
Sartorius
AG |
|
31,307 |
7,973,827 |
|
Pharmaceuticals(a)(b)(g)
— 0.9% |
| ||
|
Insitro,
Inc. |
|
|
|
|
Series
B, (Acquired 05/21/20, Cost: $5,000,000) |
802,478 |
6,764,890 | |
|
Series
C, (Acquired 03/10/21, Cost: $3,600,018) |
|
196,818 |
1,659,176 |
|
|
|
8,424,066 | |
|
Semiconductors
& Semiconductor Equipment — 2.4% |
| ||
|
PsiQuantum
Corp., Series D, (Acquired 05/21/21, Cost:
$14,999,996)(a)(b)(g) |
571,947 |
23,301,121 | |
|
|
127,701,251 | ||
|
Total
Preferred Securities — 13.3%
(Cost:
$163,860,471) |
127,701,251 | ||
|
Rights | |||
|
Biotechnology(b)
— 0.0% |
| ||
|
Korro
Bio, Inc., CVR |
|
231,775 |
2 |
|
Mirati
Therapeutics, Inc. CVR(d) |
180,175 |
135,131 | |
|
|
|
|
135,133 |
|
Health
Care Equipment & Supplies — 0.1% |
| ||
|
Abiomed,
Inc., CVR(b) |
|
98,636 |
217,986 |
|
Total
Rights — 0.1%
(Cost:
$226,731) |
353,119 | ||
|
Warrants | |||
|
Health
Care Providers & Services — 0.0% |
| ||
|
CareMax,
Inc., (Issued/Exercisable 09/15/20, 1 Share
for
1 Warrant, Expires 08/06/26, Strike Price USD
11.50)(a)(b) |
|
63,808 |
— |
|
Security |
|
Shares |
Value |
|
Pharmaceuticals
— 0.0% |
| ||
|
Nuvation
Bio, Inc., (Issued/Exercisable 08/17/20,
1
Share for 1 Warrant, Expires 07/07/27, Strike Price
USD
11.50)(a) |
|
68,880 |
$ 18,591 |
|
Total
Warrants — 0.0%
(Cost:
$227,725) |
18,591 | ||
|
Total
Long-Term Investments — 100.3%
(Cost:
$939,766,634) |
960,552,682 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 1.5% |
| ||
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares,
4.47%(i)(j)(k) |
2,640,195 |
2,641,251 | |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(i)(j) |
|
11,774,970 |
11,774,970 |
|
Total
Short-Term Securities — 1.5%
(Cost:
$14,416,220) |
14,416,221 | ||
|
Total
Investments Before Options Written — 101.8%
(Cost:
$954,182,854) |
974,968,903 | ||
|
Options
Written — (1.3)%
(Premiums
Received: $(9,308,544)) |
(12,526,383
) | ||
|
Total
Investments, Net of Options Written — 100.5%
(Cost:
$944,874,310) |
962,442,520 | ||
|
Liabilities
in Excess of Other Assets — (0.5)% |
(4,425,136
) | ||
|
Net
Assets — 100.0% |
$ 958,017,384 | ||
|
(a)
|
Non-income
producing security. |
|
(b)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(c)
|
Security
exempt from registration pursuant to Rule 144A under the Securities Act of
1933,
as
amended. These securities may be resold in transactions exempt from
registration to
qualified
institutional investors. |
|
(d)
|
All
or a portion of this security is on loan. |
|
(e)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(f)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(g)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $118,341,586, representing 12.4% of its net assets
as of
period
end, and an original cost of $182,390,799. |
|
(h)
|
Other
interests represent beneficial interests in liquidation trusts and other
reorganization
or
private entities. |
|
(i)
|
Affiliate
of the Trust. |
|
(j)
|
Annualized
7-day yield as of period end. |
|
(k)
|
All
or a portion of this security was purchased with the cash collateral from
loaned
securities. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
BlackRock
Cash Funds: Institutional, SL Agency
Shares |
$ 10,228,113 |
$ — |
$ (7,587,277
)(a) |
$ (364
) |
$ 779 |
$ 2,641,251 |
2,640,195 |
$ 29,460
(b) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares |
51,121,570 |
— |
(39,346,600
)(a) |
— |
— |
11,774,970 |
11,774,970 |
1,627,665 |
— |
|
|
|
|
$ (364
) |
$ 779 |
$ 14,416,221 |
|
$ 1,657,125 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
(b)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Abbott
Laboratories |
113 |
07/03/25 |
USD |
135.00 |
USD |
1,537 |
$ (30,171
) |
|
Boston
Scientific Corp. |
99 |
07/03/25 |
USD |
105.00 |
USD |
1,063 |
(20,542
) |
|
Boston
Scientific Corp. |
264 |
07/11/25 |
USD |
106.00 |
USD |
2,836 |
(66,000
) |
|
CVS
Health Corp. |
16 |
07/11/25 |
USD |
64.00 |
USD |
110 |
(8,400
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Dexcom,
Inc. |
417 |
07/11/25 |
USD |
87.00 |
USD |
3,640 |
$ (89,655
) |
|
Johnson
& Johnson |
117 |
07/11/25 |
USD |
160.00 |
USD |
1,787 |
(644
) |
|
Alcon,
Inc. |
134 |
07/18/25 |
USD |
87.50 |
USD |
1,183 |
(30,150
) |
|
Alkermes
PLC |
393 |
07/18/25 |
USD |
34.00 |
USD |
1,124 |
(86,460
) |
|
Alnylam
Pharmaceuticals, Inc. |
225 |
07/18/25 |
USD |
310.00 |
USD |
7,337 |
(457,875
) |
|
Arrowhead
Pharmaceuticals, Inc. |
97 |
07/18/25 |
USD |
17.00 |
USD |
153 |
(6,790
) |
|
Arvinas,
Inc. |
320 |
07/18/25 |
USD |
7.50 |
USD |
236 |
(11,200
) |
|
Ascendis
Pharma A/S, ADR |
107 |
07/18/25 |
USD |
170.00 |
USD |
1,847 |
(83,995
) |
|
Axsome
Therapeutics, Inc. |
81 |
07/18/25 |
USD |
105.00 |
USD |
846 |
(22,275
) |
|
Beam
Therapeutics, Inc. |
182 |
07/18/25 |
USD |
20.39 |
USD |
310 |
(2,405
) |
|
Becton
Dickinson & Co. |
94 |
07/18/25 |
USD |
180.00 |
USD |
1,619 |
(10,340
) |
|
Biohaven
Ltd. |
335 |
07/18/25 |
USD |
25.00 |
USD |
473 |
(3,350
) |
|
BioMarin
Pharmaceutical, Inc. |
560 |
07/18/25 |
USD |
65.00 |
USD |
3,078 |
(8,400
) |
|
BioNTech
SE, ADR |
35 |
07/18/25 |
USD |
110.00 |
USD |
373 |
(5,338
) |
|
Bridgebio
Pharma, Inc. |
388 |
07/18/25 |
USD |
37.50 |
USD |
1,675 |
(228,920
) |
|
Charles
River Laboratories International, Inc. |
62 |
07/18/25 |
USD |
155.00 |
USD |
941 |
(19,530
) |
|
Chemed
Corp. |
25 |
07/18/25 |
USD |
560.00 |
USD |
1,217 |
(12,000
) |
|
Denali
Therapeutics, Inc. |
481 |
07/18/25 |
USD |
17.50 |
USD |
673 |
(16,835
) |
|
Dexcom,
Inc. |
418 |
07/18/25 |
USD |
90.00 |
USD |
3,649 |
(57,475
) |
|
Disc
Medicine, Inc. |
53 |
07/18/25 |
USD |
55.00 |
USD |
281 |
(12,853
) |
|
Edwards
Lifesciences Corp. |
350 |
07/18/25 |
USD |
77.50 |
USD |
2,737 |
(76,125
) |
|
Exact
Sciences Corp. |
478 |
07/18/25 |
USD |
60.00 |
USD |
2,540 |
(17,925
) |
|
Exelixis,
Inc. |
550 |
07/18/25 |
USD |
43.00 |
USD |
2,424 |
(104,500
) |
|
Guardant
Health, Inc. |
595 |
07/18/25 |
USD |
45.00 |
USD |
3,096 |
(458,150
) |
|
Halozyme
Therapeutics, Inc. |
224 |
07/18/25 |
USD |
55.00 |
USD |
1,165 |
(10,080
) |
|
IDEXX
Laboratories, Inc. |
69 |
07/18/25 |
USD |
550.00 |
USD |
3,701 |
(28,980
) |
|
IDEXX
Laboratories, Inc. |
69 |
07/18/25 |
USD |
560.00 |
USD |
3,701 |
(25,357
) |
|
Incyte
Corp. |
126 |
07/18/25 |
USD |
70.00 |
USD |
858 |
(36,540
) |
|
Insmed,
Inc. |
607 |
07/18/25 |
USD |
77.50 |
USD |
6,109 |
(1,423,415
) |
|
Insulet
Corp. |
67 |
07/18/25 |
USD |
320.00 |
USD |
2,105 |
(30,820
) |
|
Insulet
Corp. |
156 |
07/18/25 |
USD |
310.00 |
USD |
4,901 |
(129,480
) |
|
Ionis
Pharmaceuticals, Inc. |
224 |
07/18/25 |
USD |
35.00 |
USD |
885 |
(112,000
) |
|
Medtronic
PLC |
207 |
07/18/25 |
USD |
87.50 |
USD |
1,804 |
(30,636
) |
|
Merus
NV |
80 |
07/18/25 |
USD |
45.00 |
USD |
421 |
(66,400
) |
|
Mettler-Toledo
International, Inc. |
37 |
07/18/25 |
USD |
1,250.00 |
USD |
4,346 |
(19,148
) |
|
Natera,
Inc. |
128 |
07/18/25 |
USD |
165.00 |
USD |
2,162 |
(104,320
) |
|
Neurocrine
Biosciences, Inc. |
270 |
07/18/25 |
USD |
125.00 |
USD |
3,394 |
(98,550
) |
|
Novocure
Ltd. |
295 |
07/18/25 |
USD |
21.00 |
USD |
525 |
(6,638
) |
|
Novocure
Ltd. |
295 |
07/18/25 |
USD |
19.00 |
USD |
525 |
(11,800
) |
|
Nuvalent,
Inc., Class A |
505 |
07/18/25 |
USD |
80.00 |
USD |
3,853 |
(102,262
) |
|
Penumbra,
Inc. |
138 |
07/18/25 |
USD |
300.00 |
USD |
3,541 |
(35,190
) |
|
Protagonist
Therapeutics, Inc. |
176 |
07/18/25 |
USD |
50.00 |
USD |
973 |
(116,160
) |
|
Protagonist
Therapeutics, Inc. |
176 |
07/18/25 |
USD |
55.00 |
USD |
973 |
(56,320
) |
|
PTC
Therapeutics, Inc. |
452 |
07/18/25 |
USD |
50.00 |
USD |
2,208 |
(74,580
) |
|
QIAGEN
NV |
322 |
07/18/25 |
USD |
45.00 |
USD |
1,548 |
(105,455
) |
|
Repligen
Corp. |
260 |
07/18/25 |
USD |
135.00 |
USD |
3,234 |
(78,000
) |
|
REVOLUTION
Medicines, Inc. |
46 |
07/18/25 |
USD |
44.00 |
USD |
169 |
(575
) |
|
Rhythm
Pharmaceuticals, Inc. |
428 |
07/18/25 |
USD |
65.00 |
USD |
2,705 |
(179,760
) |
|
Scholar
Rock Holding Corp. |
162 |
07/18/25 |
USD |
35.00 |
USD |
574 |
(34,425
) |
|
Stryker
Corp. |
55 |
07/18/25 |
USD |
390.00 |
USD |
2,176 |
(57,750
) |
|
Twist
Bioscience Corp. |
306 |
07/18/25 |
USD |
40.00 |
USD |
1,126 |
(29,070
) |
|
Ultragenyx
Pharmaceutical, Inc. |
133 |
07/18/25 |
USD |
41.20 |
USD |
484 |
(41,163
) |
|
Veeva
Systems, Inc., Class A |
365 |
07/18/25 |
USD |
260.00 |
USD |
10,511 |
(1,058,500
) |
|
Veeva
Systems, Inc., Class A |
77 |
07/18/25 |
USD |
290.00 |
USD |
2,217 |
(38,885
) |
|
Viking
Therapeutics, Inc. |
93 |
07/18/25 |
USD |
35.00 |
USD |
246 |
(4,046
) |
|
Waters
Corp. |
155 |
07/18/25 |
USD |
370.00 |
USD |
5,410 |
(37,975
) |
|
Wave
Life Sciences Ltd. |
127 |
07/18/25 |
USD |
7.24 |
USD |
83 |
(14,737
) |
|
West
Pharmaceutical Services, Inc. |
237 |
07/18/25 |
USD |
220.00 |
USD |
5,186 |
(126,795
) |
|
AbbVie,
Inc. |
12 |
07/25/25 |
USD |
195.00 |
USD |
223 |
(1,140
) |
|
Boston
Scientific Corp. |
37 |
07/25/25 |
USD |
106.00 |
USD |
397 |
(14,060
) |
|
CVS
Health Corp. |
97 |
07/25/25 |
USD |
69.00 |
USD |
669 |
(16,151
) |
|
Intuitive
Surgical, Inc. |
11 |
07/25/25 |
USD |
565.00 |
USD |
598 |
(15,125
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Medtronic
PLC |
384 |
07/25/25 |
USD |
88.00 |
USD |
3,347 |
$ (67,008
) |
|
Teva
Pharmaceutical Industries Ltd. |
549 |
07/25/25 |
USD |
19.00 |
USD |
920 |
(6,588
) |
|
Abbott
Laboratories |
113 |
08/01/25 |
USD |
135.00 |
USD |
1,537 |
(44,635
) |
|
Dexcom,
Inc. |
337 |
08/01/25 |
USD |
94.00 |
USD |
2,942 |
(69,927
) |
|
McKesson
Corp. |
49 |
08/01/25 |
USD |
730.00 |
USD |
3,591 |
(100,205
) |
|
Encompass
Health Corp. |
211 |
08/04/25 |
USD |
122.29 |
USD |
2,587 |
(90,097
) |
|
CVS
Health Corp. |
97 |
08/08/25 |
USD |
69.00 |
USD |
669 |
(25,947
) |
|
Abbott
Laboratories |
257 |
08/15/25 |
USD |
135.00 |
USD |
3,495 |
(130,427
) |
|
AbbVie,
Inc. |
235 |
08/15/25 |
USD |
195.00 |
USD |
4,362 |
(66,975
) |
|
Alcon,
Inc. |
134 |
08/15/25 |
USD |
87.50 |
USD |
1,183 |
(45,560
) |
|
Alkermes
PLC |
225 |
08/15/25 |
USD |
33.00 |
USD |
644 |
(47,812
) |
|
Alnylam
Pharmaceuticals, Inc. |
323 |
08/15/25 |
USD |
330.00 |
USD |
10,533 |
(607,240
) |
|
Arcellx,
Inc. |
101 |
08/15/25 |
USD |
65.00 |
USD |
665 |
(56,560
) |
|
Arrowhead
Pharmaceuticals, Inc. |
97 |
08/15/25 |
USD |
16.81 |
USD |
153 |
(10,087
) |
|
Arvinas,
Inc. |
240 |
08/15/25 |
USD |
10.00 |
USD |
177 |
(4,800
) |
|
Axsome
Therapeutics, Inc. |
81 |
08/15/25 |
USD |
105.47 |
USD |
846 |
(53,534
) |
|
Beam
Therapeutics, Inc. |
182 |
08/15/25 |
USD |
20.00 |
USD |
310 |
(12,740
) |
|
BioNTech
SE, ADR |
35 |
08/15/25 |
USD |
115.00 |
USD |
373 |
(10,150
) |
|
Bio-Techne
Corp. |
453 |
08/15/25 |
USD |
55.00 |
USD |
2,331 |
(130,237
) |
|
Boston
Scientific Corp. |
132 |
08/15/25 |
USD |
110.00 |
USD |
1,418 |
(38,280
) |
|
Cencora,
Inc. |
120 |
08/15/25 |
USD |
300.00 |
USD |
3,598 |
(129,000
) |
|
Charles
River Laboratories International, Inc. |
62 |
08/15/25 |
USD |
160.00 |
USD |
941 |
(47,430
) |
|
CVS
Health Corp. |
16 |
08/15/25 |
USD |
70.00 |
USD |
110 |
(4,296
) |
|
Denali
Therapeutics, Inc. |
164 |
08/15/25 |
USD |
15.00 |
USD |
229 |
(21,730
) |
|
Disc
Medicine, Inc. |
53 |
08/15/25 |
USD |
55.00 |
USD |
281 |
(21,730
) |
|
Edwards
Lifesciences Corp. |
473 |
08/15/25 |
USD |
77.50 |
USD |
3,699 |
(170,280
) |
|
Encompass
Health Corp. |
212 |
08/15/25 |
USD |
125.00 |
USD |
2,600 |
(77,380
) |
|
Exact
Sciences Corp. |
524 |
08/15/25 |
USD |
52.50 |
USD |
2,785 |
(254,140
) |
|
Exelixis,
Inc. |
316 |
08/15/25 |
USD |
45.00 |
USD |
1,393 |
(64,780
) |
|
Glaukos
Corp. |
98 |
08/15/25 |
USD |
110.00 |
USD |
1,012 |
(64,190
) |
|
Guardant
Health, Inc. |
225 |
08/15/25 |
USD |
55.00 |
USD |
1,171 |
(92,250
) |
|
Incyte
Corp. |
126 |
08/15/25 |
USD |
70.00 |
USD |
858 |
(33,390
) |
|
Insmed,
Inc. |
79 |
08/15/25 |
USD |
105.00 |
USD |
795 |
(46,215
) |
|
Inspire
Medical Systems, Inc. |
150 |
08/15/25 |
USD |
145.00 |
USD |
1,947 |
(82,500
) |
|
Kymera
Therapeutics, Inc. |
57 |
08/15/25 |
USD |
50.00 |
USD |
249 |
(12,113
) |
|
Labcorp
Holdings, Inc. |
62 |
08/15/25 |
USD |
270.00 |
USD |
1,628 |
(35,340
) |
|
Medtronic
PLC |
37 |
08/15/25 |
USD |
87.50 |
USD |
323 |
(8,825
) |
|
Mettler-Toledo
International, Inc. |
37 |
08/15/25 |
USD |
1,220.00 |
USD |
4,346 |
(151,700
) |
|
MoonLake
Immunotherapeutics, Class A |
92 |
08/15/25 |
USD |
45.00 |
USD |
434 |
(40,480
) |
|
Natera,
Inc. |
128 |
08/15/25 |
USD |
175.00 |
USD |
2,162 |
(116,480
) |
|
Neurocrine
Biosciences, Inc. |
77 |
08/15/25 |
USD |
130.00 |
USD |
968 |
(39,655
) |
|
PTC
Therapeutics, Inc. |
67 |
08/15/25 |
USD |
55.00 |
USD |
327 |
(10,385
) |
|
Quest
Diagnostics, Inc. |
424 |
08/15/25 |
USD |
185.00 |
USD |
7,616 |
(156,880
) |
|
Repligen
Corp. |
194 |
08/15/25 |
USD |
130.00 |
USD |
2,413 |
(123,190
) |
|
REVOLUTION
Medicines, Inc. |
46 |
08/15/25 |
USD |
43.00 |
USD |
169 |
(4,370
) |
|
Rhythm
Pharmaceuticals, Inc. |
277 |
08/15/25 |
USD |
65.00 |
USD |
1,750 |
(188,360
) |
|
Stryker
Corp. |
55 |
08/15/25 |
USD |
390.00 |
USD |
2,176 |
(92,125
) |
|
Summit
Therapeutics, Inc. |
108 |
08/15/25 |
USD |
26.00 |
USD |
230 |
(11,070
) |
|
Tenet
Healthcare Corp. |
210 |
08/15/25 |
USD |
160.00 |
USD |
3,696 |
(424,200
) |
|
Waters
Corp. |
73 |
08/15/25 |
USD |
360.00 |
USD |
2,548 |
(98,915
) |
|
Wave
Life Sciences Ltd. |
447 |
08/15/25 |
USD |
7.08 |
USD |
291 |
(21,524
) |
|
West
Pharmaceutical Services, Inc. |
120 |
08/15/25 |
USD |
230.00 |
USD |
2,626 |
(117,000
) |
|
Xenon
Pharmaceuticals, Inc. |
526 |
08/15/25 |
USD |
32.50 |
USD |
1,646 |
(134,130
) |
|
|
|
|
|
|
|
|
$ (10,835,453
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
Akeso,
Inc. |
JPMorgan
Chase Bank N.A. |
73,000 |
07/02/25 |
HKD |
89.14 |
HKD |
6,744 |
$ (39,942
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
|
Abbisko
Cayman Ltd. |
JPMorgan
Chase Bank N.A. |
250,000 |
07/08/25 |
HKD |
8.83 |
HKD |
2,560 |
$ (46,750
) |
|
QIAGEN
NV |
Barclays
Bank PLC |
32,100 |
07/09/25 |
USD |
44.14 |
USD |
1,543 |
(124,567
) |
|
Akeso,
Inc. |
JPMorgan
Chase Bank N.A. |
74,000 |
07/10/25 |
HKD |
94.39 |
HKD |
6,836 |
(42,622
) |
|
Sartorius
AG |
Morgan
Stanley & Co. International PLC |
12,000 |
07/10/25 |
EUR |
243.91 |
EUR |
2,595 |
(1,821
) |
|
Zealand
Pharma A/S |
Bank
of America N.A. |
12,500 |
07/10/25 |
DKK |
444.99 |
DKK |
4,440 |
(850
) |
|
Abbisko
Cayman Ltd. |
JPMorgan
Chase Bank N.A. |
785,000 |
07/15/25 |
HKD |
9.42 |
HKD |
8,039 |
(111,927
) |
|
Abbisko
Cayman Ltd. |
UBS
AG |
500,000 |
07/15/25 |
HKD |
8.99 |
HKD |
5,121 |
(91,164
) |
|
Galderma
Group AG |
Goldman
Sachs International |
27,200 |
07/15/25 |
CHF |
111.19 |
CHF |
3,137 |
(170,516
) |
|
Wuxi
Biologics Cayman, Inc. |
UBS
AG |
500,000 |
07/15/25 |
HKD |
24.58 |
HKD |
12,897 |
(106,832
) |
|
Quest
Diagnostics, Inc. |
Citibank
N.A. |
7,300 |
07/16/25 |
USD |
177.40 |
USD |
7 |
(27,691
) |
|
Akeso,
Inc. |
Morgan
Stanley & Co. International PLC |
61,000 |
07/17/25 |
HKD |
90.56 |
HKD |
5,635 |
(61,466
) |
|
Genmab
A/S, ADR |
BNP
Paribas SA |
14,700 |
07/17/25 |
DKK |
1,452.10 |
DKK |
19,335 |
(9,774
) |
|
Wuxi
Biologics Cayman, Inc. |
JPMorgan
Chase Bank N.A. |
500,000 |
07/17/25 |
HKD |
27.80 |
HKD |
12,897 |
(30,191
) |
|
Abbisko
Cayman Ltd. |
JPMorgan
Chase Bank N.A. |
250,000 |
07/22/25 |
HKD |
10.26 |
HKD |
2,560 |
(24,854
) |
|
Galderma
Group AG |
Goldman
Sachs International |
20,900 |
07/22/25 |
CHF |
115.70 |
CHF |
2,410 |
(70,749
) |
|
UCB
SA |
Goldman
Sachs International |
9,800 |
07/22/25 |
EUR |
170.15 |
EUR |
1,637 |
(53,768
) |
|
Abbisko
Cayman Ltd. |
JPMorgan
Chase Bank N.A. |
14,000 |
07/23/25 |
HKD |
10.75 |
HKD |
143 |
(1,065
) |
|
Labcorp
Holdings, Inc. |
Morgan
Stanley & Co. International PLC |
22,300 |
07/23/25 |
USD |
251.71 |
USD |
22 |
(295,806
) |
|
Abbisko
Cayman Ltd. |
UBS
AG |
250,000 |
07/30/25 |
HKD |
10.35 |
HKD |
2,560 |
(27,844
) |
|
Daiichi
Sankyo Co. Ltd. |
UBS
AG |
23,100 |
07/30/25 |
JPY |
4,235.83 |
JPY |
77,069 |
(1,532
) |
|
Lonza
Group AG, Registered Shares |
UBS
AG |
5,700 |
07/30/25 |
CHF |
572.97 |
CHF |
3,234 |
(75,774
) |
|
Sonova
Holding AG, Registered Shares |
Barclays
Bank PLC |
3,700 |
07/30/25 |
CHF |
251.20 |
CHF |
876 |
(4,921
) |
|
Sonova
Holding AG, Registered Shares |
UBS
AG |
14,500 |
07/30/25 |
CHF |
253.64 |
CHF |
3,431 |
(15,547
) |
|
Daiichi
Sankyo Co. Ltd. |
UBS
AG |
23,100 |
08/05/25 |
JPY |
4,235.83 |
JPY |
77,069 |
(1,817
) |
|
Wuxi
Biologics Cayman, Inc. |
Citibank
N.A. |
727,000 |
08/06/25 |
HKD |
26.39 |
HKD |
18,752 |
(133,835
) |
|
Abbisko
Cayman Ltd. |
JPMorgan
Chase Bank N.A. |
250,000 |
08/12/25 |
HKD |
11.01 |
HKD |
2,560 |
(25,520
) |
|
M3,
Inc. |
BNP
Paribas SA |
175,800 |
08/12/25 |
JPY |
2,093.86 |
JPY |
347,759 |
(75,860
) |
|
Roche
Holding AG |
Bank
of America N.A. |
4,000 |
08/12/25 |
CHF |
269.34 |
CHF |
1,036 |
(15,925
) |
|
|
|
|
|
|
|
|
|
$ (1,690,930
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (9,308,544
) |
$ 1,731,563 |
$ (4,949,402
) |
$ (12,526,383
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 12,526,383 |
$ — |
$ — |
$ — |
$ 12,526,383 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
purchased(a) |
$ — |
$ — |
$ (3,866
) |
$ — |
$ — |
$ — |
$ (3,866
) |
|
Options
written |
— |
— |
15,292,220 |
— |
— |
— |
15,292,220 |
|
|
$ — |
$ — |
$ 15,288,354 |
$ — |
$ — |
$ — |
$ 15,288,354 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (8,668,458
) |
$ — |
$ — |
$ — |
$ (8,668,458
) |
|
(a)
|
Options
purchased are included in net realized gain (loss) from investments —
unaffiliated. |
|
Options: |
|
|
Average
value of option contracts purchased |
$—
(a) |
|
Average
value of option contracts written |
10,684,451 |
|
(a)
|
Derivative
financial instrument not held at any quarter-end. The risk exposure table
serves as an indicator of activity during the
period. |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 12,526,383 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
12,526,383 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(10,835,453
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 1,690,930 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 16,775 |
$ — |
$ (5,371
) |
$ — |
$ 11,404 |
|
Barclays
Bank PLC |
129,488 |
— |
— |
— |
129,488 |
|
BNP
Paribas SA |
85,634 |
— |
— |
— |
85,634 |
|
Citibank
N.A. |
161,526 |
— |
(42,333
) |
— |
119,193 |
|
Goldman
Sachs International |
295,033 |
— |
(295,033
) |
— |
— |
|
JPMorgan
Chase Bank N.A. |
322,871 |
— |
(322,871
) |
— |
— |
|
Morgan
Stanley & Co. International PLC |
359,093 |
— |
(359,093
) |
— |
— |
|
UBS
AG |
320,510 |
— |
— |
— |
320,510 |
|
|
$ 1,690,930 |
$ — |
$ (1,024,701
) |
$ — |
$ 666,229 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and
Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Biotechnology |
$ 262,260,439 |
$ 26,433,356 |
$ 9,499,198 |
$ 298,192,993 |
|
Capital
Markets |
5,798,552 |
— |
— |
5,798,552 |
|
Health
Care Equipment & Supplies |
178,369,698 |
17,177,783 |
943,607 |
196,491,088 |
|
Health
Care Providers & Services |
99,650,558 |
— |
— |
99,650,558 |
|
Health
Care Technology |
33,536,999 |
6,357,345 |
27,593 |
39,921,937 |
|
Life
Sciences Tools & Services |
111,449,119 |
27,199,902 |
— |
138,649,021 |
|
Pharmaceuticals |
20,533,428 |
29,719,089 |
— |
50,252,517 |
|
Other
Interests |
— |
— |
3,523,055 |
3,523,055 |
|
Preferred
Securities |
|
|
|
|
|
Preferred
Stocks |
— |
7,973,827 |
119,727,424 |
127,701,251 |
|
Rights |
— |
— |
353,119 |
353,119 |
|
Warrants |
18,591 |
— |
— |
18,591 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
14,416,221 |
— |
— |
14,416,221 |
|
|
$726,033,605 |
$114,861,302 |
$134,073,996 |
$974,968,903 |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (10,601,906
) |
$ (1,924,477
) |
$ — |
$ (12,526,383
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
|
Common
Stocks |
Corporate
Bonds |
Other
Interests |
Preferred
Stocks |
Rights |
Warrants |
Total
|
|
Assets |
|
|
|
|
|
|
|
|
Opening
balance, as of December 31, 2024 |
$ 9,980,354 |
$ 2,185,644 |
$ 3,207,232 |
$ 118,719,968 |
$ 346,386 |
$ 217,359 |
$ 134,656,943 |
|
Transfers
into Level 3 |
— |
— |
— |
— |
— |
289 |
289 |
|
Transfers
out of Level 3 |
— |
— |
— |
— |
— |
— |
— |
|
Accrued
discounts/premiums |
— |
— |
— |
— |
— |
— |
— |
|
Net
realized gain (loss) |
— |
— |
— |
— |
— |
— |
— |
|
Net
change in unrealized appreciation (depreciation)(a)(b) |
(32,521,720
) |
(319,194
) |
315,823 |
27,183,791 |
6,733 |
(217,648
) |
(5,552,215
) |
|
Purchases |
33,011,764 |
— |
— |
4,148,665 |
— |
— |
37,160,429 |
|
Sales |
— |
(1,866,450
) |
— |
(30,325,000
) |
— |
— |
(32,191,450
) |
|
Closing
balance, as of June 30, 2025 |
$ 10,470,398 |
$ — |
$ 3,523,055 |
$ 119,727,424 |
$ 353,119 |
$ — |
$ 134,073,996 |
|
Net
change in unrealized appreciation (depreciation) on investments still held
at
June
30, 2025(b) |
$ (32,521,720
) |
$ — |
$ 315,823 |
$ (1,412,662
) |
$ 6,733 |
$ (289
) |
$ (33,612,115
) |
|
(a)
|
Included
in the related net change in unrealized appreciation (depreciation) in the
Statements of Operations. |
|
(b)
|
Any
difference between net change in unrealized appreciation (depreciation)
and net change in unrealized appreciation (depreciation) on investments
still held at June 30, 2025 is
generally
due to investments no longer held or categorized as Level 3 at period
end. |
|
|
Value |
Valuation
Approach |
Unobservable
Inputs |
Range
of
Unobservable
Inputs
Utilized(a)
|
Weighted
Average
of
Unobservable
Inputs
Based
on
Fair Value
|
|
Assets |
|
||||
|
Preferred
Stocks |
$119,727,424 |
Market |
Revenue
Multiple |
3.11x -
8.86x |
6.07x |
|
|
|
Volatility |
60%-90% |
76% | |
|
|
|
|
Time
to Exit |
1.0 -4.0
years |
3.0
years |
|
|
|
Market
Adjustment Multiple |
0.50x
-1.50x |
0.99x | |
|
|
|
|
|
|
|
|
Common
Stocks |
10,470,398 |
Market |
Revenue
Multiple |
0.94x -
3.11x |
1.43x |
|
|
|
|
Volatility |
60%
-90% |
79% |
|
|
|
Time
to Exit |
1.0 -
3.0 years |
2.7
years | |
|
|
|
|
Market
Adjustment Multiple |
0.60x -
1.05x |
0.99x |
|
|
|
||||
|
Other
Interests |
3,523,055 |
Income |
Discount
Rate |
5%
-5% |
5% |
|
|
|
||||
|
Rights |
353,119 |
Income |
Discount
Rate |
5%
-5% |
5% |
|
|
|
||||
|
|
$134,073,996 |
|
|
|
|
|
(a)
|
A
significant change in unobservable input could result in a correlated or
inverse change in value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Biotechnology
— 23.6% |
| ||
|
4D
Molecular Therapeutics, Inc.(a) |
11,778 |
$ 43,696 | |
|
AbbVie,
Inc.(b) |
|
132,996 |
24,686,718 |
|
Alkermes
PLC(a) |
12,700 |
363,347 | |
|
Allogene
Therapeutics, Inc.(a)(c) |
|
108,101 |
122,154 |
|
Alnylam
Pharmaceuticals, Inc.(a) |
38,276 |
12,481,421 | |
|
Amgen,
Inc.(b) |
|
59,717 |
16,673,584 |
|
Arcellx,
Inc.(a) |
16,531 |
1,088,566 | |
|
Argenx
SE, ADR(a) |
|
6,773 |
3,733,413 |
|
Ascendis
Pharma A/S, ADR(a) |
9,904 |
1,709,431 | |
|
Autolus
Therapeutics PLC, ADR(a) |
|
64,258 |
146,508 |
|
Beam
Therapeutics, Inc.(a) |
14,977 |
254,759 | |
|
Biohaven
Ltd.(a) |
|
18,429 |
260,033 |
|
BioMarin
Pharmaceutical, Inc.(a) |
21,076 |
1,158,548 | |
|
BioNTech
SE, ADR(a)(c) |
|
3,788 |
403,308 |
|
Blueprint
Medicines Corp.(a) |
15,552 |
1,993,455 | |
|
Bridgebio
Pharma, Inc.(a) |
|
18,507 |
799,132 |
|
CG
oncology, Inc.(a) |
5,223 |
135,798 | |
|
Denali
Therapeutics, Inc.(a) |
|
20,283 |
283,759 |
|
Disc
Medicine, Inc.(a) |
7,717 |
408,692 | |
|
Dyne
Therapeutics, Inc.(a) |
|
24,506 |
233,297 |
|
Exact
Sciences Corp.(a) |
49,509 |
2,630,908 | |
|
Exelixis,
Inc.(a) |
|
27,330 |
1,204,570 |
|
Gilead
Sciences, Inc. |
89,782 |
9,954,130 | |
|
Incyte
Corp.(a) |
|
12,838 |
874,268 |
|
Insmed,
Inc.(a) |
52,511 |
5,284,707 | |
|
Ionis
Pharmaceuticals, Inc.(a) |
|
15,357 |
606,755 |
|
Kymera
Therapeutics, Inc.(a) |
4,830 |
210,781 | |
|
Legend
Biotech Corp., ADR(a) |
|
11,174 |
396,565 |
|
Merus
NV(a) |
18,404 |
968,051 | |
|
Moderna,
Inc.(a) |
|
32,542 |
897,834 |
|
MoonLake
Immunotherapeutics(a) |
10,035 |
473,652 | |
|
Natera,
Inc.(a) |
|
12,117 |
2,047,046 |
|
Neurocrine
Biosciences, Inc.(a) |
11,545 |
1,451,091 | |
|
Nuvalent,
Inc., Class A(a) |
|
29,333 |
2,238,108 |
|
Protagonist
Therapeutics, Inc.(a) |
20,969 |
1,158,957 | |
|
PTC
Therapeutics, Inc.(a) |
|
21,916 |
1,070,378 |
|
Regeneron
Pharmaceuticals, Inc. |
10,842 |
5,692,050 | |
|
REGENXBIO,
Inc.(a) |
|
18,875 |
154,964 |
|
Rhythm
Pharmaceuticals, Inc.(a) |
55,078 |
3,480,379 | |
|
Roivant
Sciences Ltd.(a) |
|
60,456 |
681,339 |
|
Scholar
Rock Holding Corp.(a) |
7,855 |
278,224 | |
|
Stoke
Therapeutics, Inc.(a) |
|
73,875 |
838,481 |
|
Summit
Therapeutics, Inc.(a)(c) |
18,168 |
386,615 | |
|
TScan
Therapeutics, Inc.(a) |
|
49,480 |
71,746 |
|
Vaxcyte,
Inc.(a) |
7,730 |
251,302 | |
|
Vertex
Pharmaceuticals, Inc.(a) |
|
18,020 |
8,022,504 |
|
Viking
Therapeutics, Inc.(a) |
9,491 |
251,512 | |
|
Vir
Biotechnology, Inc.(a) |
|
20,570 |
103,673 |
|
Voyager
Therapeutics, Inc.(a) |
32,205 |
100,158 | |
|
Xenon
Pharmaceuticals, Inc.(a) |
|
26,398 |
826,257 |
|
Zealand
Pharma A/S(a) |
6,909 |
387,471 | |
|
|
|
|
119,974,095 |
|
Capital
Markets — 0.2% |
| ||
|
Helix
Acquisition Corp. II, Class A(a) |
|
61,530 |
655,295 |
|
Health
Care Equipment & Supplies — 31.1% |
| ||
|
Abbott
Laboratories(b) |
|
217,322 |
29,557,967 |
|
Alcon
AG(c) |
32,610 |
2,878,811 | |
|
Becton
Dickinson & Co. |
|
38,538 |
6,638,171 |
|
Boston
Scientific Corp.(a)(b) |
294,384 |
31,619,785 | |
|
Security |
|
Shares |
Value |
|
Health
Care Equipment & Supplies (continued) |
| ||
|
Cooper
Cos., Inc.(a) |
|
27,416 |
$ 1,950,923 |
|
Dexcom,
Inc.(a) |
38,114 |
3,326,971 | |
|
Edwards
Lifesciences Corp.(a) |
|
198,507 |
15,525,232 |
|
EXO
Imaging, Inc., Series C, (Acquired 06/24/21, Cost:
$595,999)(a)(d)(e) |
1,017 |
366 | |
|
GE
HealthCare Technologies, Inc. |
|
21,440 |
1,588,061 |
|
Glaukos
Corp.(a) |
7,815 |
807,211 | |
|
Hologic,
Inc.(a) |
|
12,498 |
814,370 |
|
IDEXX
Laboratories, Inc.(a) |
6,922 |
3,712,545 | |
|
Inspire
Medical Systems, Inc.(a) |
|
4,705 |
610,568 |
|
Insulet
Corp.(a) |
5,334 |
1,675,836 | |
|
Intuitive
Surgical, Inc.(a) |
|
30,454 |
16,549,008 |
|
Medtronic
PLC |
180,776 |
15,758,244 | |
|
Novocure
Ltd.(a) |
|
51,195 |
911,271 |
|
Nucleix
Ltd., (Acquired 04/10/24, Cost: $200,000)(a)(d)(e) |
200 |
143,920 | |
|
Nyxoah
SA(a) |
|
29,870 |
223,428 |
|
Orchestra
BioMed Holdings, Inc.(a) |
18,076 |
48,444 | |
|
Penumbra,
Inc.(a) |
|
11,896 |
3,052,870 |
|
STERIS
PLC |
6,027 |
1,447,806 | |
|
Stryker
Corp. |
|
48,820 |
19,314,657 |
|
|
|
158,156,465 | |
|
Health
Care Providers & Services — 16.2% |
| ||
|
Cencora,
Inc. |
26,637 |
7,987,104 | |
|
Centene
Corp.(a) |
|
20,030 |
1,087,228 |
|
Cigna
Group |
17,768 |
5,873,745 | |
|
CVS
Health Corp. |
|
74,290 |
5,124,524 |
|
Elevance
Health, Inc. |
21,193 |
8,243,229 | |
|
Guardant
Health, Inc.(a) |
|
31,531 |
1,640,873 |
|
HCA
Healthcare, Inc. |
20,375 |
7,805,663 | |
|
Humana,
Inc. |
|
11,695 |
2,859,194 |
|
Labcorp
Holdings, Inc. |
20,462 |
5,371,480 | |
|
McKesson
Corp. |
|
11,805 |
8,650,468 |
|
Quest
Diagnostics, Inc. |
24,219 |
4,350,459 | |
|
UnitedHealth
Group, Inc.(b) |
|
74,545 |
23,255,804 |
|
|
|
82,249,771 | |
|
Health
Care Technology — 0.0% |
| ||
|
Carbon
Health Technologies, Inc., (Acquired 05/28/25,
Cost:
$972,000)(a)(d)(e) |
146,332 |
1,463 | |
|
Life
Sciences Tools & Services — 7.6% |
| ||
|
Agilent
Technologies, Inc. |
37,005 |
4,366,960 | |
|
Bio-Rad
Laboratories, Inc., Class A(a) |
|
2,236 |
539,592 |
|
Bio-Techne
Corp. |
17,518 |
901,301 | |
|
Bruker
Corp. |
|
31,339 |
1,291,167 |
|
Charles
River Laboratories International, Inc.(a) |
5,060 |
767,754 | |
|
Danaher
Corp. |
|
44,278 |
8,746,676 |
|
Illumina,
Inc.(a) |
13,625 |
1,299,961 | |
|
IQVIA
Holdings, Inc.(a) |
|
7,072 |
1,114,476 |
|
Mettler-Toledo
International, Inc.(a) |
1,235 |
1,450,779 | |
|
Repligen
Corp.(a) |
|
12,836 |
1,596,542 |
|
Thermo
Fisher Scientific, Inc. |
21,348 |
8,655,760 | |
|
Waters
Corp.(a) |
|
15,785 |
5,509,596 |
|
West
Pharmaceutical Services, Inc. |
10,207 |
2,233,292 | |
|
|
|
|
38,473,856 |
|
Pharmaceuticals
— 20.0% |
| ||
|
AstraZeneca
PLC |
|
25,902 |
3,604,759 |
|
Bristol-Myers
Squibb Co. |
172,080 |
7,965,583 | |
|
Daiichi
Sankyo Co. Ltd. |
|
57,800 |
1,339,115 |
|
Edgewise
Therapeutics, Inc.(a) |
22,836 |
299,380 | |
|
Eli
Lilly & Co.(b) |
|
58,854 |
45,878,459 |
|
Galderma
Group AG |
9,263 |
1,346,430 | |
|
Security |
|
Shares |
Value |
|
Pharmaceuticals
(continued) |
| ||
|
Johnson
& Johnson |
|
137,003 |
$ 20,927,208 |
|
Merck
& Co., Inc.(b) |
32,077 |
2,539,215 | |
|
Pfizer,
Inc. |
|
274,163 |
6,645,711 |
|
Teva
Pharmaceutical Industries Ltd., ADR(a) |
243,163 |
4,075,412 | |
|
UCB
SA |
|
10,073 |
1,981,941 |
|
WaVe
Life Sciences Ltd.(a) |
24,727 |
160,726 | |
|
Zoetis,
Inc., Class A |
|
31,654 |
4,936,441 |
|
|
|
101,700,380 | |
|
Total
Common Stocks — 98.7%
(Cost:
$341,763,546) |
501,211,325 | ||
|
|
|
Benefical
Interest
(000) |
|
|
Other
Interests | |||
|
Biotechnology
— 0.0% |
| ||
Affinivax,
Inc., (Acquired 08/18/22, Cost: $ —)(d)(e)(f) |
$ |
6 |
61,157 |
|
Health
Care Providers & Services — 0.0% |
| ||
Afferent
Pharmaceuticals, Inc., (Acquired 09/30/15,
Cost:
$ —)(d)(e)(f) |
190 |
2 | |
|
Total
Other Interests — 0.0%
(Cost:
$ — ) |
61,159 | ||
|
|
|
Shares |
|
|
Preferred
Securities | |||
|
Preferred
Stocks — 0.6%(a)(d)(e) | |||
|
Biotechnology
— 0.4% |
| ||
|
Adarx
Pharamaceuticals, Inc., Series C, (Acquired
08/02/23,
Cost: $440,003) |
|
52,885 |
600,774 |
|
Cellarity,
Inc., Series B, (Acquired 01/15/21, Cost:
$265,002) |
44,167 |
94,076 | |
|
Genesis
Therapeutics, Inc., Series B, (Acquired
08/10/23,
Cost: $292,001) |
|
57,170 |
312,148 |
|
Goldfinch
Bio, Inc., Series B, (Acquired 06/26/20, Cost:
$224,200) |
190,000 |
53,200 | |
|
Kartos
Therapeutics, Inc. |
|
|
|
|
Series
C, (Acquired 08/22/23, Cost: $485,124) |
85,817 |
486,582 | |
|
Series
D, (Acquired 02/19/25, Cost: $133,467) |
|
23,610 |
133,869 |
|
Laronde,
Inc., Series B, (Acquired 07/28/21, Cost:
$590,800) |
21,100 |
482,346 | |
|
|
|
|
2,162,995 |
|
Health
Care Equipment & Supplies — 0.1% |
| ||
|
EXO
Imaging, Inc., (Acquired 07/24/24, Cost: $28,863) |
|
47,496 |
35,147 |
|
Nucleix
Ltd., Series AA, (Acquired 03/25/21, Cost:
$1,070,001) |
367,395 |
224,111 | |
|
Swift
Health Systems, Inc., Series D, (Acquired 08/27/21,
Cost:
$286,998) |
|
93 |
206 |
|
|
|
259,464 | |
|
Security |
|
Shares |
Value |
|
Health
Care Providers & Services — 0.1% |
| ||
|
Quanta
Dialysis Technologies Ltd., Series D, (Acquired
06/18/21,
Cost: $515,759) |
|
4,243,029 |
$ 361,100 |
|
Pharmaceuticals
— 0.0% |
| ||
|
Insitro,
Inc., Series C, (Acquired 03/10/21, Cost:
$560,000) |
|
30,616 |
258,093 |
|
|
3,041,652 | ||
|
Total
Preferred Securities — 0.6%
(Cost:
$4,892,218) |
3,041,652 | ||
|
Rights | |||
|
Biotechnology(d)
— 0.0% |
| ||
|
Korro
Bio, Inc., CVR |
28,060 |
— | |
|
Mirati
Therapeutics, Inc. CVR |
|
15,747 |
11,810 |
|
|
|
11,810 | |
|
Health
Care Equipment & Supplies — 0.0% |
| ||
|
Abiomed,
Inc., CVR(d) |
14,359 |
31,733 | |
|
Total
Rights — 0.0%
(Cost:
$25,669) |
43,543 | ||
|
Warrants | |||
|
Health
Care Providers & Services — 0.0% |
| ||
|
CareMax,
Inc., (Issued/Exercisable 09/15/20, 1 Share for
1
Warrant, Expires 08/06/26, Strike Price USD
11.50)(a)(d) |
4,201 |
— | |
|
Pharmaceuticals
— 0.0% |
| ||
|
Nuvation
Bio, Inc., (Issued/Exercisable 08/17/20, 1 Share
for
1 Warrant, Expires 07/07/27, Strike Price USD
11.50)(a) |
4,050 |
1,093 | |
|
Total
Warrants — 0.0%
(Cost:
$14,030) |
1,093 | ||
|
Total
Long-Term Investments — 99.3%
(Cost:
$346,695,463) |
504,358,772 | ||
|
Security |
|
Shares |
Value |
|
Short-Term
Securities | |||
|
Money
Market Funds — 4.4% |
| ||
|
BlackRock
Cash Funds: Institutional, SL Agency Shares,
4.47%(g)(h)(i) |
1,408,663 |
$ 1,409,226 | |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(g)(h) |
|
21,098,844 |
21,098,844 |
|
Total
Short-Term Securities — 4.4%
(Cost:
$22,508,070) |
22,508,070 | ||
|
Options
Purchased — 0.0%
(Cost:
$2,060) |
2,525 | ||
|
Total
Investments Before Options Written — 103.7%
(Cost:
$369,205,593) |
526,869,367 | ||
|
Options
Written — (0.8)%
(Premiums
Received: $(4,582,810)) |
(4,276,183
) | ||
|
Total
Investments, Net of Options Written — 102.9%
(Cost:
$364,622,783) |
522,593,184 | ||
|
Liabilities
in Excess of Other Assets — (2.9)% |
(14,495,374
) | ||
|
Net
Assets — 100.0% |
$ 508,097,810 | ||
|
(a)
|
Non-income
producing security. |
|
(b)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(c)
|
All
or a portion of this security is on loan. |
|
(d)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(e)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $3,248,560, representing 0.6% of its net assets as
of
period
end, and an original cost of $6,660,217. |
|
(f)
|
Other
interests represent beneficial interests in liquidation trusts and other
reorganization
or
private entities. |
|
(g)
|
Affiliate
of the Trust. |
|
(h)
|
Annualized
7-day yield as of period end. |
|
(i)
|
All
or a portion of this security was purchased with the cash collateral from
loaned
securities. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares |
$ 277,709 |
$ 1,131,899
(a) |
$ — |
$ (366
) |
$ (16
) |
$ 1,409,226 |
1,408,663 |
$ 2,753
(b) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares |
26,275,044 |
— |
(5,176,200
)(a) |
— |
— |
21,098,844 |
21,098,844 |
468,619 |
— |
|
|
|
|
|
$ (366
) |
$ (16
) |
$ 22,508,070 |
|
$ 471,372 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
(b)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Abbott
Laboratories |
373 |
07/03/25 |
USD |
135.00 |
USD |
5,073 |
$ (99,591
) |
|
AbbVie,
Inc. |
279 |
07/11/25 |
USD |
195.00 |
USD |
5,179 |
(5,859
) |
|
Boston
Scientific Corp. |
281 |
07/11/25 |
USD |
106.00 |
USD |
3,018 |
(70,250
) |
|
CVS
Health Corp. |
38 |
07/11/25 |
USD |
64.00 |
USD |
262 |
(19,950
) |
|
Danaher
Corp. |
101 |
07/11/25 |
USD |
205.00 |
USD |
1,995 |
(13,382
) |
|
Dexcom,
Inc. |
50 |
07/11/25 |
USD |
87.00 |
USD |
436 |
(10,750
) |
|
Gilead
Sciences, Inc. |
264 |
07/11/25 |
USD |
116.00 |
USD |
2,927 |
(19,800
) |
|
Humana,
Inc. |
1 |
07/11/25 |
USD |
245.00 |
USD |
24 |
(595
) |
|
Johnson
& Johnson |
343 |
07/11/25 |
USD |
160.00 |
USD |
5,239 |
(1,887
) |
|
Pfizer,
Inc. |
800 |
07/11/25 |
USD |
24.00 |
USD |
1,939 |
(36,000
) |
|
Thermo
Fisher Scientific, Inc. |
33 |
07/11/25 |
USD |
415.00 |
USD |
1,338 |
(15,840
) |
|
Alcon,
Inc. |
61 |
07/18/25 |
USD |
87.50 |
USD |
539 |
(13,725
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Alnylam
Pharmaceuticals, Inc. |
50 |
07/18/25 |
USD |
310.00 |
USD |
1,630 |
$ (101,750
) |
|
Ascendis
Pharma A/S, ADR |
33 |
07/18/25 |
USD |
170.00 |
USD |
570 |
(25,905
) |
|
Beam
Therapeutics, Inc. |
26 |
07/18/25 |
USD |
20.39 |
USD |
44 |
(344
) |
|
Becton
Dickinson & Co. |
142 |
07/18/25 |
USD |
180.00 |
USD |
2,446 |
(15,620
) |
|
Biohaven
Ltd. |
65 |
07/18/25 |
USD |
25.00 |
USD |
92 |
(650
) |
|
BioMarin
Pharmaceutical, Inc. |
80 |
07/18/25 |
USD |
65.00 |
USD |
440 |
(1,200
) |
|
BioNTech
SE, ADR |
7 |
07/18/25 |
USD |
110.00 |
USD |
75 |
(1,068
) |
|
Bridgebio
Pharma, Inc. |
62 |
07/18/25 |
USD |
37.50 |
USD |
268 |
(36,580
) |
|
Bristol-Myers
Squibb Co. |
332 |
07/18/25 |
USD |
52.50 |
USD |
1,537 |
(1,328
) |
|
Cencora,
Inc. |
34 |
07/18/25 |
USD |
290.00 |
USD |
1,019 |
(42,330
) |
|
Cooper
Cos, Inc. |
99 |
07/18/25 |
USD |
74.93 |
USD |
704 |
(6,668
) |
|
Danaher
Corp. |
60 |
07/18/25 |
USD |
205.00 |
USD |
1,185 |
(12,450
) |
|
Denali
Therapeutics, Inc. |
39 |
07/18/25 |
USD |
17.50 |
USD |
55 |
(1,365
) |
|
Dexcom,
Inc. |
50 |
07/18/25 |
USD |
90.00 |
USD |
436 |
(6,875
) |
|
Disc
Medicine, Inc. |
14 |
07/18/25 |
USD |
55.00 |
USD |
74 |
(3,395
) |
|
Edwards
Lifesciences Corp. |
346 |
07/18/25 |
USD |
77.50 |
USD |
2,706 |
(75,255
) |
|
Eli
Lilly & Co. |
63 |
07/18/25 |
USD |
860.00 |
USD |
4,911 |
(14,553
) |
|
Exact
Sciences Corp. |
48 |
07/18/25 |
USD |
60.00 |
USD |
255 |
(1,800
) |
|
Exelixis,
Inc. |
49 |
07/18/25 |
USD |
43.00 |
USD |
216 |
(9,310
) |
|
Guardant
Health, Inc. |
46 |
07/18/25 |
USD |
45.00 |
USD |
239 |
(35,420
) |
|
HCA
Healthcare, Inc. |
38 |
07/18/25 |
USD |
395.00 |
USD |
1,456 |
(14,440
) |
|
IDEXX
Laboratories, Inc. |
25 |
07/18/25 |
USD |
510.00 |
USD |
1,341 |
(74,875
) |
|
Incyte
Corp. |
22 |
07/18/25 |
USD |
70.00 |
USD |
150 |
(6,380
) |
|
Insmed,
Inc. |
100 |
07/18/25 |
USD |
77.50 |
USD |
1,006 |
(234,500
) |
|
Insulet
Corp. |
19 |
07/18/25 |
USD |
320.00 |
USD |
597 |
(8,740
) |
|
Ionis
Pharmaceuticals, Inc. |
56 |
07/18/25 |
USD |
35.00 |
USD |
221 |
(28,000
) |
|
Medtronic
PLC |
154 |
07/18/25 |
USD |
87.50 |
USD |
1,342 |
(22,792
) |
|
Merus
NV |
66 |
07/18/25 |
USD |
45.00 |
USD |
347 |
(54,780
) |
|
Mettler-Toledo
International, Inc. |
2 |
07/18/25 |
USD |
1,250.00 |
USD |
235 |
(1,035
) |
|
Neurocrine
Biosciences, Inc. |
35 |
07/18/25 |
USD |
125.00 |
USD |
440 |
(12,775
) |
|
Novocure
Ltd. |
92 |
07/18/25 |
USD |
21.00 |
USD |
164 |
(2,070
) |
|
Novocure
Ltd. |
92 |
07/18/25 |
USD |
19.00 |
USD |
164 |
(3,680
) |
|
Nuvalent,
Inc., Class A |
105 |
07/18/25 |
USD |
80.00 |
USD |
801 |
(21,262
) |
|
Penumbra,
Inc. |
45 |
07/18/25 |
USD |
300.00 |
USD |
1,155 |
(11,475
) |
|
Protagonist
Therapeutics, Inc. |
37 |
07/18/25 |
USD |
50.00 |
USD |
204 |
(24,420
) |
|
Protagonist
Therapeutics, Inc. |
38 |
07/18/25 |
USD |
55.00 |
USD |
210 |
(12,160
) |
|
PTC
Therapeutics, Inc. |
38 |
07/18/25 |
USD |
50.00 |
USD |
186 |
(6,270
) |
|
Regeneron
Pharmaceuticals, Inc. |
20 |
07/18/25 |
USD |
650.00 |
USD |
1,050 |
(6,400
) |
|
Repligen
Corp. |
24 |
07/18/25 |
USD |
135.00 |
USD |
299 |
(7,200
) |
|
Rhythm
Pharmaceuticals, Inc. |
84 |
07/18/25 |
USD |
65.00 |
USD |
531 |
(35,280
) |
|
Scholar
Rock Holding Corp. |
29 |
07/18/25 |
USD |
35.00 |
USD |
103 |
(6,163
) |
|
STERIS
PLC |
3 |
07/18/25 |
USD |
260.00 |
USD |
72 |
(525
) |
|
Stryker
Corp. |
92 |
07/18/25 |
USD |
390.00 |
USD |
3,640 |
(96,600
) |
|
Thermo
Fisher Scientific, Inc. |
44 |
07/18/25 |
USD |
430.00 |
USD |
1,784 |
(12,320
) |
|
UnitedHealth
Group, Inc. |
272 |
07/18/25 |
USD |
340.00 |
USD |
8,486 |
(41,888
) |
|
Vertex
Pharmaceuticals, Inc. |
66 |
07/18/25 |
USD |
460.00 |
USD |
2,938 |
(35,970
) |
|
Viking
Therapeutics, Inc. |
34 |
07/18/25 |
USD |
35.00 |
USD |
90 |
(1,479
) |
|
Waters
Corp. |
27 |
07/18/25 |
USD |
370.00 |
USD |
942 |
(6,615
) |
|
Wave
Life Sciences Ltd. |
36 |
07/18/25 |
USD |
7.24 |
USD |
23 |
(4,178
) |
|
West
Pharmaceutical Services, Inc. |
18 |
07/18/25 |
USD |
220.00 |
USD |
394 |
(9,630
) |
|
Zoetis,
Inc., Class A |
44 |
07/18/25 |
USD |
175.00 |
USD |
686 |
(1,980
) |
|
AbbVie,
Inc. |
248 |
07/25/25 |
USD |
195.00 |
USD |
4,603 |
(23,560
) |
|
Amgen,
Inc. |
119 |
07/25/25 |
USD |
295.00 |
USD |
3,323 |
(13,804
) |
|
Boston
Scientific Corp. |
394 |
07/25/25 |
USD |
106.00 |
USD |
4,232 |
(149,720
) |
|
Cigna
Group |
44 |
07/25/25 |
USD |
330.00 |
USD |
1,455 |
(34,540
) |
|
CVS
Health Corp. |
101 |
07/25/25 |
USD |
69.00 |
USD |
697 |
(16,816
) |
|
Eli
Lilly & Co. |
63 |
07/25/25 |
USD |
860.00 |
USD |
4,911 |
(23,341
) |
|
GE
HealthCare Technologies, Inc. |
38 |
07/25/25 |
USD |
73.00 |
USD |
281 |
(12,350
) |
|
Gilead
Sciences, Inc. |
60 |
07/25/25 |
USD |
110.00 |
USD |
665 |
(23,400
) |
|
Intuitive
Surgical, Inc. |
109 |
07/25/25 |
USD |
565.00 |
USD |
5,923 |
(149,875
) |
|
Johnson
& Johnson |
157 |
07/25/25 |
USD |
160.00 |
USD |
2,398 |
(8,321
) |
|
Medtronic
PLC |
224 |
07/25/25 |
USD |
88.00 |
USD |
1,953 |
(39,088
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Merck
& Co., Inc. |
180 |
07/25/25 |
USD |
83.00 |
USD |
1,425 |
$ (15,120
) |
|
Regeneron
Pharmaceuticals, Inc. |
21 |
07/25/25 |
USD |
550.00 |
USD |
1,103 |
(20,895
) |
|
Teva
Pharmaceutical Industries Ltd. |
864 |
07/25/25 |
USD |
19.00 |
USD |
1,448 |
(10,368
) |
|
Abbott
Laboratories |
192 |
08/01/25 |
USD |
135.00 |
USD |
2,611 |
(75,840
) |
|
Boston
Scientific Corp. |
22 |
08/01/25 |
USD |
105.00 |
USD |
236 |
(11,440
) |
|
Dexcom,
Inc. |
42 |
08/01/25 |
USD |
94.00 |
USD |
367 |
(8,715
) |
|
Eli
Lilly & Co. |
102 |
08/01/25 |
USD |
810.00 |
USD |
7,951 |
(211,650
) |
|
GE
HealthCare Technologies, Inc. |
38 |
08/01/25 |
USD |
76.00 |
USD |
281 |
(9,120
) |
|
McKesson
Corp. |
42 |
08/01/25 |
USD |
730.00 |
USD |
3,078 |
(85,890
) |
|
Medtronic
PLC |
69 |
08/01/25 |
USD |
86.00 |
USD |
601 |
(20,389
) |
|
Pfizer,
Inc. |
105 |
08/01/25 |
USD |
25.00 |
USD |
255 |
(2,153
) |
|
Amgen,
Inc. |
99 |
08/08/25 |
USD |
285.00 |
USD |
2,764 |
(82,417
) |
|
Bristol-Myers
Squibb Co. |
321 |
08/08/25 |
USD |
49.00 |
USD |
1,486 |
(21,186
) |
|
Cigna
Group |
19 |
08/08/25 |
USD |
335.00 |
USD |
628 |
(22,515
) |
|
CVS
Health Corp. |
101 |
08/08/25 |
USD |
69.00 |
USD |
697 |
(27,017
) |
|
Medtronic
PLC |
68 |
08/08/25 |
USD |
86.00 |
USD |
593 |
(17,850
) |
|
Abbott
Laboratories |
220 |
08/15/25 |
USD |
135.00 |
USD |
2,992 |
(111,650
) |
|
AbbVie,
Inc. |
67 |
08/15/25 |
USD |
195.00 |
USD |
1,244 |
(19,095
) |
|
Alcon,
Inc. |
61 |
08/15/25 |
USD |
87.50 |
USD |
539 |
(20,740
) |
|
Alkermes
PLC |
48 |
08/15/25 |
USD |
33.00 |
USD |
137 |
(10,200
) |
|
Alnylam
Pharmaceuticals, Inc. |
95 |
08/15/25 |
USD |
330.00 |
USD |
3,098 |
(178,600
) |
|
Arcellx,
Inc. |
59 |
08/15/25 |
USD |
65.00 |
USD |
389 |
(33,040
) |
|
Argenx
SE, ADR |
31 |
08/15/25 |
USD |
590.00 |
USD |
1,709 |
(45,105
) |
|
Beam
Therapeutics, Inc. |
26 |
08/15/25 |
USD |
20.00 |
USD |
44 |
(1,820
) |
|
BioNTech
SE, ADR |
6 |
08/15/25 |
USD |
115.00 |
USD |
64 |
(1,740
) |
|
Bio-Techne
Corp. |
63 |
08/15/25 |
USD |
55.00 |
USD |
324 |
(18,112
) |
|
Boston
Scientific Corp. |
281 |
08/15/25 |
USD |
110.00 |
USD |
3,018 |
(81,490
) |
|
Cencora,
Inc. |
62 |
08/15/25 |
USD |
300.00 |
USD |
1,859 |
(66,650
) |
|
CVS
Health Corp. |
38 |
08/15/25 |
USD |
70.00 |
USD |
262 |
(10,203
) |
|
Denali
Therapeutics, Inc. |
38 |
08/15/25 |
USD |
15.00 |
USD |
53 |
(5,035
) |
|
Disc
Medicine, Inc. |
14 |
08/15/25 |
USD |
55.00 |
USD |
74 |
(5,740
) |
|
Edwards
Lifesciences Corp. |
385 |
08/15/25 |
USD |
77.50 |
USD |
3,011 |
(138,600
) |
|
Exact
Sciences Corp. |
132 |
08/15/25 |
USD |
52.50 |
USD |
701 |
(64,020
) |
|
Exelixis,
Inc. |
49 |
08/15/25 |
USD |
45.00 |
USD |
216 |
(10,045
) |
|
Glaukos
Corp. |
32 |
08/15/25 |
USD |
110.00 |
USD |
331 |
(20,960
) |
|
Guardant
Health, Inc. |
71 |
08/15/25 |
USD |
55.00 |
USD |
369 |
(29,110
) |
|
HCA
Healthcare, Inc. |
37 |
08/15/25 |
USD |
400.00 |
USD |
1,417 |
(38,665
) |
|
Incyte
Corp. |
22 |
08/15/25 |
USD |
70.00 |
USD |
150 |
(5,830
) |
|
Insmed,
Inc. |
86 |
08/15/25 |
USD |
105.00 |
USD |
866 |
(50,310
) |
|
Inspire
Medical Systems, Inc. |
17 |
08/15/25 |
USD |
145.00 |
USD |
221 |
(9,350
) |
|
IQVIA
Holdings, Inc. |
25 |
08/15/25 |
USD |
160.00 |
USD |
394 |
(21,750
) |
|
Kymera
Therapeutics, Inc. |
17 |
08/15/25 |
USD |
50.00 |
USD |
74 |
(3,613
) |
|
Labcorp
Holdings, Inc. |
62 |
08/15/25 |
USD |
270.00 |
USD |
1,628 |
(35,340
) |
|
Medtronic
PLC |
154 |
08/15/25 |
USD |
87.50 |
USD |
1,342 |
(36,729
) |
|
Mettler-Toledo
International, Inc. |
2 |
08/15/25 |
USD |
1,220.00 |
USD |
235 |
(8,200
) |
|
MoonLake
Immunotherapeutics, Class A |
18 |
08/15/25 |
USD |
45.00 |
USD |
85 |
(7,920
) |
|
Natera,
Inc. |
43 |
08/15/25 |
USD |
175.00 |
USD |
726 |
(39,130
) |
|
Neurocrine
Biosciences, Inc. |
6 |
08/15/25 |
USD |
130.00 |
USD |
75 |
(3,090
) |
|
Pfizer,
Inc. |
105 |
08/15/25 |
USD |
25.00 |
USD |
255 |
(4,148
) |
|
PTC
Therapeutics, Inc. |
37 |
08/15/25 |
USD |
55.00 |
USD |
181 |
(5,735
) |
|
Quest
Diagnostics, Inc. |
58 |
08/15/25 |
USD |
185.00 |
USD |
1,042 |
(21,460
) |
|
Repligen
Corp. |
24 |
08/15/25 |
USD |
130.00 |
USD |
299 |
(15,240
) |
|
Rhythm
Pharmaceuticals, Inc. |
103 |
08/15/25 |
USD |
65.00 |
USD |
651 |
(70,040
) |
|
STERIS
PLC |
18 |
08/15/25 |
USD |
250.00 |
USD |
432 |
(8,280
) |
|
Stryker
Corp. |
92 |
08/15/25 |
USD |
390.00 |
USD |
3,640 |
(154,100
) |
|
Summit
Therapeutics, Inc. |
65 |
08/15/25 |
USD |
26.00 |
USD |
138 |
(6,663
) |
|
Waters
Corp. |
31 |
08/15/25 |
USD |
360.00 |
USD |
1,082 |
(42,005
) |
|
Wave
Life Sciences Ltd. |
55 |
08/15/25 |
USD |
7.08 |
USD |
36 |
(2,648
) |
|
West
Pharmaceutical Services, Inc. |
20 |
08/15/25 |
USD |
230.00 |
USD |
438 |
(19,500
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Xenon
Pharmaceuticals, Inc. |
94 |
08/15/25 |
USD |
32.50 |
USD |
294 |
$ (23,970
) |
|
Zoetis,
Inc., Class A |
76 |
08/15/25 |
USD |
165.00 |
USD |
1,185 |
(20,520
) |
|
|
|
|
|
|
|
|
$ (4,170,948
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
Boston
Scientific Corp. |
Citibank
N.A. |
14,000 |
07/09/25 |
USD |
107.86 |
USD |
1,504 |
$ (20,337
) |
|
Zealand
Pharma A/S |
Bank
of America N.A. |
2,400 |
07/10/25 |
DKK |
444.99 |
DKK |
853 |
(163
) |
|
Galderma
Group AG |
Goldman
Sachs International |
2,200 |
07/15/25 |
CHF |
111.19 |
CHF |
254 |
(13,792
) |
|
Quest
Diagnostics, Inc. |
Citibank
N.A. |
2,900 |
07/16/25 |
USD |
177.40 |
USD |
521 |
(11,001
) |
|
Galderma
Group AG |
Goldman
Sachs International |
1,200 |
07/22/25 |
CHF |
115.70 |
CHF |
138 |
(4,062
) |
|
UCB
SA |
Bank
of America N.A. |
3,700 |
07/22/25 |
EUR |
175.30 |
EUR |
618 |
(12,504
) |
|
AstraZeneca
PLC |
Barclays
Bank PLC |
6,200 |
07/23/25 |
GBP |
113.61 |
GBP |
629 |
(469
) |
|
Labcorp
Holdings, Inc. |
Morgan
Stanley & Co. International PLC |
1,300 |
07/23/25 |
USD |
251.71 |
USD |
341 |
(17,244
) |
|
AstraZeneca
PLC |
BNP
Paribas SA |
3,300 |
08/05/25 |
GBP |
105.70 |
GBP |
335 |
(6,482
) |
|
Daiichi
Sankyo Co. Ltd. |
BNP
Paribas SA |
21,900 |
08/06/25 |
JPY |
3,463.95 |
JPY |
73,065 |
(19,181
) |
|
|
|
|
|
|
|
|
|
$ (105,235
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
Options
Written |
$ N/A |
$ (4,582,810
) |
$ 1,358,466 |
$ (1,051,839
) |
$ (4,276,183
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Assets
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
purchased
Investments
at value — unaffiliated |
$ — |
$ — |
$ 2,525 |
$ — |
$ — |
$ — |
$ 2,525 |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 4,276,183 |
$ — |
$ — |
$ — |
$ 4,276,183 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
purchased(a) |
$ — |
$ — |
$ (243
) |
$ — |
$ — |
$ — |
$ (243
) |
Options
written |
— |
— |
3,732,625 |
— |
— |
— |
3,732,625 |
|
|
$ — |
$ — |
$ 3,732,382 |
$ — |
$ — |
$ — |
$ 3,732,382 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
purchased(b) |
$ — |
$ — |
$ 465 |
$ — |
$ — |
$ — |
$ 465 |
Options
written |
— |
— |
(2,217,202
) |
— |
— |
— |
(2,217,202
) |
|
|
$ — |
$ — |
$ (2,216,737
) |
$ — |
$ — |
$ — |
$ (2,216,737
) |
|
(a)
|
Options
purchased are included in net realized gain (loss) from investments —
unaffiliated. |
|
(b)
|
Options
purchased are included in net change in unrealized appreciation
(depreciation) on investments —
unaffiliated. |
|
Options: |
|
|
Average
value of option contracts purchased |
$1,263 |
|
Average
value of option contracts written |
3,966,180 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ 2,525 |
$ 4,276,183 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
2,525 |
4,276,183 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
(2,525
) |
(4,170,948
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 105,235 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 12,667 |
$ — |
$ — |
$ — |
$ 12,667 |
|
Barclays
Bank PLC |
469 |
— |
— |
— |
469 |
|
BNP
Paribas SA |
25,663 |
— |
— |
— |
25,663 |
|
Citibank
N.A. |
31,338 |
— |
— |
— |
31,338 |
|
Goldman
Sachs International |
17,854 |
— |
— |
— |
17,854 |
|
Morgan
Stanley & Co. International PLC |
17,244 |
— |
— |
— |
17,244 |
|
|
$ 105,235 |
$ — |
$ — |
$ — |
$ 105,235 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and
Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Biotechnology |
$ 119,586,624 |
$ 387,471 |
$ — |
$ 119,974,095 |
|
Capital
Markets |
655,295 |
— |
— |
655,295 |
|
Health
Care Equipment & Supplies |
158,012,179 |
— |
144,286 |
158,156,465 |
|
Health
Care Providers & Services |
82,249,771 |
— |
— |
82,249,771 |
|
Health
Care Technology |
— |
— |
1,463 |
1,463 |
|
Life
Sciences Tools & Services |
38,473,856 |
— |
— |
38,473,856 |
|
Pharmaceuticals |
93,428,135 |
8,272,245 |
— |
101,700,380 |
|
Other
Interests |
— |
— |
61,159 |
61,159 |
|
Preferred
Securities |
|
|
|
|
|
Preferred
Stocks |
— |
— |
3,041,652 |
3,041,652 |
|
Rights |
— |
— |
43,543 |
43,543 |
|
Warrants |
1,093 |
— |
— |
1,093 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
22,508,070 |
— |
— |
22,508,070 |
|
Options
Purchased |
|
|
|
|
|
Equity
Contracts |
2,525 |
— |
— |
2,525 |
|
|
$514,917,548 |
$8,659,716 |
$3,292,103 |
$526,869,367 |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (4,157,110
) |
$ (119,073
) |
$ — |
$ (4,276,183
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Chemicals
— 16.3% |
| ||
|
CF
Industries Holdings, Inc. |
6,850 |
$ 630,200 | |
|
Corteva,
Inc.(a) |
|
569,327 |
42,431,941 |
|
Mosaic
Co. |
726,993 |
26,520,705 | |
|
Nutrien
Ltd. |
|
998,594 |
58,158,115 |
|
|
|
127,740,961 | |
|
Construction
Materials — 2.7% |
| ||
|
CRH
PLC |
133,648 |
12,268,886 | |
|
Heidelberg
Materials AG |
|
37,030 |
8,720,444 |
|
|
|
20,989,330 | |
|
Containers
& Packaging — 7.3% |
| ||
|
Graphic
Packaging Holding Co. |
686,321 |
14,460,783 | |
|
Packaging
Corp. of America(b) |
|
77,720 |
14,646,334 |
|
Smurfit
WestRock PLC |
645,971 |
27,873,649 | |
|
|
|
|
56,980,766 |
|
Energy
Equipment & Services — 0.9% |
| ||
|
TechnipFMC
PLC |
|
199,972 |
6,887,036 |
|
Food
Products — 2.8% |
| ||
|
Bunge
Global SA |
|
91,451 |
7,341,686 |
|
Darling
Ingredients, Inc.(c) |
188,532 |
7,152,904 | |
|
Hofseth
International, (Acquired 05/26/21, Cost:
$10,198,056)(c)(d)(e) |
|
18,993,283 |
7,235,967 |
|
|
|
21,730,557 | |
|
Metals
& Mining — 37.4% |
| ||
|
Anglo
American PLC |
1,208,936 |
35,636,872 | |
|
ArcelorMittal
SA, ADR, Registered Shares(f) |
|
478,876 |
15,122,905 |
|
Barrick
Mining Corp. |
985,670 |
20,521,649 | |
|
First
Quantum Minerals Ltd.(c) |
|
1,180,284 |
20,966,455 |
|
Freeport-McMoRan,
Inc. |
709,980 |
30,777,633 | |
|
Glencore
PLC |
|
6,076,795 |
23,679,087 |
|
Kinross
Gold Corp. |
473,059 |
7,393,912 | |
|
Newmont
Corp.(a) |
|
553,566 |
32,250,755 |
|
Norsk
Hydro ASA |
2,562,746 |
14,675,305 | |
|
Polyus
PJSC(c)(d) |
|
1,047,320 |
13 |
|
Teck
Resources Ltd., Class B(f) |
373,623 |
15,086,897 | |
|
Vale
SA, ADR |
|
2,860,254 |
27,773,066 |
|
Valterra
Platinum Ltd. |
109,152 |
4,794,479 | |
|
Wheaton
Precious Metals Corp. |
|
488,221 |
43,842,246 |
|
|
|
292,521,274 | |
|
Oil,
Gas & Consumable Fuels — 26.2% |
| ||
|
Chevron
Corp.(b) |
180,959 |
25,911,519 | |
|
EOG
Resources, Inc. |
|
135,893 |
16,254,162 |
|
EQT
Corp. |
144,835 |
8,446,777 | |
|
Exxon
Mobil Corp.(b) |
|
476,925 |
51,412,515 |
|
Gazprom
PJSC(c)(d) |
5,430,000 |
694 | |
|
Hess
Corp. |
|
103,473 |
14,335,149 |
|
Permian
Resources Corp., Class A |
379,198 |
5,164,677 | |
|
Shell
PLC, ADR(b) |
|
838,292 |
59,024,140 |
|
Suncor
Energy, Inc. |
653,067 |
24,463,336 | |
|
|
|
|
205,012,969 |
|
Paper
& Forest Products — 3.1% |
| ||
|
Mondi
PLC |
|
645,124 |
10,541,649 |
|
Precious
Woods Holding AG, Registered Shares(c) |
20,000 |
127,292 | |
|
UPM-Kymmene
OYJ |
|
496,004 |
13,544,886 |
|
|
|
24,213,827 | |
|
Total
Common Stocks — 96.7%
(Cost:
$666,437,689) |
756,076,720 | ||
|
Security |
|
Par
(000) |
Value |
|
Corporate
Bonds | |||
|
Metals
& Mining — 1.0% | |||
|
Allied
Gold Corp., 8.75%, 09/07/28(c)(g)(h) |
$ |
7,200 |
$ 7,560,000 |
|
Total
Corporate Bonds — 1.0%
(Cost:
$7,200,000) |
7,560,000 | ||
|
Total
Long-Term Investments — 97.7%
(Cost:
$673,637,689) |
763,636,720 | ||
|
|
|
Shares |
|
|
Short-Term
Securities | |||
|
Money
Market Funds — 3.6% |
| ||
|
BlackRock
Cash Funds: Institutional, SL Agency Shares,
4.47%(i)(j)(k) |
5,994,113 |
5,996,511 | |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(i)(j) |
|
22,274,837 |
22,274,837 |
|
Total
Short-Term Securities — 3.6%
(Cost:
$28,271,348) |
28,271,348 | ||
|
Total
Investments Before Options Written — 101.3%
(Cost:
$701,909,037) |
791,908,068 | ||
|
Options
Written — (0.8)%
(Premiums
Received: $(6,518,042)) |
(6,383,331
) | ||
|
Total
Investments, Net of Options Written — 100.5%
(Cost:
$695,390,995) |
785,524,737 | ||
|
Liabilities
in Excess of Other Assets — (0.5)% |
(3,778,577
) | ||
|
Net
Assets — 100.0% |
$ 781,746,160 | ||
|
(a)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(b)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(c)
|
Non-income
producing security. |
|
(d)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(e)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $7,235,967, representing 0.9% of its net assets as
of
period
end, and an original cost of $10,198,056. |
|
(f)
|
All
or a portion of this security is on loan. |
|
(g)
|
Convertible
security. |
|
(h)
|
Security
exempt from registration pursuant to Rule 144A under the Securities Act of
1933,
as
amended. These securities may be resold in transactions exempt from
registration to
qualified
institutional investors. |
|
(i)
|
Affiliate
of the Trust. |
|
(j)
|
Annualized
7-day yield as of period end. |
|
(k)
|
All
or a portion of this security was purchased with the cash collateral from
loaned
securities. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares |
$ 1,847,286 |
$ 4,151,559
(a) |
$ — |
$ (2,474
) |
$ 140 |
$ 5,996,511 |
5,994,113 |
$ 18,110
(b) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares |
28,918,529 |
— |
(6,643,692
)(a) |
— |
— |
22,274,837 |
22,274,837 |
466,512 |
— |
|
|
|
|
|
$ (2,474
) |
$ 140 |
$ 28,271,348 |
|
$ 484,622 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
(b)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Shell
PLC, ADR |
406 |
07/03/25 |
USD |
67.00 |
USD |
2,859 |
$ (164,430
) |
|
Vale
SA, ADR |
1,001 |
07/09/25 |
USD |
9.75 |
USD |
972 |
(14,088
) |
|
Smurfit
Westrock PLC |
603 |
07/10/25 |
USD |
48.00 |
USD |
2,602 |
(20,296
) |
|
Chevron
Corp. |
270 |
07/11/25 |
USD |
145.00 |
USD |
3,866 |
(37,800
) |
|
EOG
Resources, Inc. |
86 |
07/11/25 |
USD |
116.00 |
USD |
1,029 |
(40,420
) |
|
Exxon
Mobil Corp. |
243 |
07/11/25 |
USD |
105.00 |
USD |
2,620 |
(85,050
) |
|
Exxon
Mobil Corp. |
104 |
07/11/25 |
USD |
113.00 |
USD |
1,121 |
(2,288
) |
|
First
Quantum Minerals Ltd. |
447 |
07/11/25 |
CAD |
21.50 |
CAD |
1,081 |
(89,942
) |
|
Hess
Corp. |
305 |
07/11/25 |
USD |
140.00 |
USD |
4,225 |
(44,988
) |
|
Mosaic
Co. |
1,118 |
07/11/25 |
USD |
37.00 |
USD |
4,078 |
(57,018
) |
|
Shell
PLC, ADR |
534 |
07/11/25 |
USD |
70.00 |
USD |
3,760 |
(62,745
) |
|
Suncor
Energy, Inc. |
387 |
07/11/25 |
CAD |
51.00 |
CAD |
1,974 |
(24,725
) |
|
Teck
Resources Ltd., Class B |
212 |
07/11/25 |
USD |
39.00 |
USD |
856 |
(40,810
) |
|
Vale
SA, ADR |
2,861 |
07/11/25 |
USD |
10.31 |
USD |
2,778 |
(9,281
) |
|
ArcelorMittal
SA, ADR, Registered Shares |
538 |
07/18/25 |
USD |
32.00 |
USD |
1,699 |
(36,315
) |
|
Barrick
Mining Corp. |
570 |
07/18/25 |
USD |
20.00 |
USD |
1,187 |
(60,990
) |
|
Chevron
Corp. |
260 |
07/18/25 |
USD |
140.00 |
USD |
3,723 |
(127,400
) |
|
Corteva,
Inc. |
1,082 |
07/18/25 |
USD |
70.00 |
USD |
8,064 |
(535,590
) |
|
CRH
PLC |
110 |
07/18/25 |
USD |
97.50 |
USD |
1,010 |
(5,225
) |
|
Darling
Ingredients, Inc. |
355 |
07/18/25 |
USD |
35.00 |
USD |
1,347 |
(122,475
) |
|
EOG
Resources, Inc. |
86 |
07/18/25 |
USD |
120.00 |
USD |
1,029 |
(20,425
) |
|
EQT
Corp. |
220 |
07/18/25 |
USD |
60.00 |
USD |
1,283 |
(21,670
) |
|
Exxon
Mobil Corp. |
243 |
07/18/25 |
USD |
110.00 |
USD |
2,620 |
(30,132
) |
|
First
Quantum Minerals Ltd. |
1,598 |
07/18/25 |
CAD |
21.50 |
CAD |
3,866 |
(333,271
) |
|
Freeport-McMoRan,
Inc. |
772 |
07/18/25 |
USD |
43.00 |
USD |
3,347 |
(119,660
) |
|
Nutrien
Ltd. |
960 |
07/18/25 |
USD |
60.00 |
USD |
5,591 |
(50,400
) |
|
Nutrien
Ltd. |
174 |
07/18/25 |
USD |
62.50 |
USD |
1,013 |
(2,610
) |
|
Packaging
Corp. of America |
143 |
07/18/25 |
USD |
190.00 |
USD |
2,695 |
(32,175
) |
|
Permian
Resources Corp., Class A |
756 |
07/18/25 |
USD |
15.00 |
USD |
1,030 |
(5,670
) |
|
Shell
PLC, ADR |
448 |
07/18/25 |
USD |
67.50 |
USD |
3,154 |
(152,320
) |
|
Smurfit
Westrock PLC |
603 |
07/18/25 |
USD |
50.00 |
USD |
2,602 |
(9,045
) |
|
TechnipFMC
PLC |
417 |
07/18/25 |
USD |
34.00 |
USD |
1,436 |
(51,082
) |
|
Teck
Resources Ltd., Class B |
400 |
07/18/25 |
USD |
38.00 |
USD |
1,615 |
(89,000
) |
|
Vale
SA, ADR |
2,296 |
07/18/25 |
USD |
10.00 |
USD |
2,229 |
(26,404
) |
|
ArcelorMittal
SA, ADR, Registered Shares |
130 |
07/25/25 |
USD |
32.00 |
USD |
411 |
(10,725
) |
|
Chevron
Corp. |
139 |
07/25/25 |
USD |
145.00 |
USD |
1,990 |
(36,974
) |
|
EOG
Resources, Inc. |
173 |
07/25/25 |
USD |
132.00 |
USD |
2,069 |
(13,840
) |
|
Exxon
Mobil Corp. |
341 |
07/25/25 |
USD |
106.00 |
USD |
3,676 |
(137,252
) |
|
Exxon
Mobil Corp. |
105 |
07/25/25 |
USD |
114.00 |
USD |
1,132 |
(5,828
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
First
Quantum Minerals Ltd. |
1,177 |
07/25/25 |
CAD |
23.50 |
CAD |
2,847 |
$ (124,463
) |
|
Freeport-McMoRan,
Inc. |
1,054 |
07/25/25 |
USD |
46.00 |
USD |
4,569 |
(74,834
) |
|
Hess
Corp. |
8 |
07/25/25 |
USD |
145.00 |
USD |
111 |
(1,920
) |
|
Nutrien
Ltd. |
750 |
07/25/25 |
USD |
64.00 |
USD |
4,368 |
(15,000
) |
|
Shell
PLC, ADR |
861 |
07/25/25 |
USD |
73.00 |
USD |
6,062 |
(40,898
) |
|
Suncor
Energy, Inc. |
970 |
07/25/25 |
CAD |
53.00 |
CAD |
4,948 |
(32,411
) |
|
Suncor
Energy, Inc. |
123 |
07/25/25 |
CAD |
57.00 |
CAD |
627 |
(903
) |
|
Teck
Resources Ltd., Class B |
186 |
07/25/25 |
USD |
43.00 |
USD |
751 |
(13,020
) |
|
Vale
SA, ADR |
2,722 |
07/25/25 |
USD |
10.14 |
USD |
2,643 |
(30,484
) |
|
ArcelorMittal
SA, ADR, Registered Shares |
565 |
08/01/25 |
USD |
33.00 |
USD |
1,784 |
(38,138
) |
|
Barrick
Mining Corp. |
1,620 |
08/01/25 |
USD |
20.25 |
USD |
3,373 |
(174,819
) |
|
CRH
PLC |
162 |
08/01/25 |
USD |
95.00 |
USD |
1,487 |
(29,970
) |
|
EQT
Corp. |
315 |
08/01/25 |
USD |
60.00 |
USD |
1,837 |
(62,842
) |
|
Exxon
Mobil Corp. |
209 |
08/01/25 |
USD |
120.00 |
USD |
2,253 |
(6,897
) |
|
First
Quantum Minerals Ltd. |
1,145 |
08/01/25 |
CAD |
24.00 |
CAD |
2,770 |
(118,137
) |
|
Freeport-McMoRan,
Inc. |
800 |
08/01/25 |
USD |
43.00 |
USD |
3,468 |
(173,200
) |
|
Mosaic
Co. |
747 |
08/01/25 |
USD |
37.00 |
USD |
2,725 |
(102,339
) |
|
Nutrien
Ltd. |
750 |
08/01/25 |
USD |
64.00 |
USD |
4,368 |
(18,750
) |
|
Suncor
Energy, Inc. |
123 |
08/01/25 |
CAD |
57.00 |
CAD |
627 |
(587
) |
|
Vale
SA, ADR |
2,611 |
08/01/25 |
USD |
9.50 |
USD |
2,535 |
(116,189
) |
|
Corteva,
Inc. |
1,030 |
08/05/25 |
USD |
70.40 |
USD |
7,677 |
(560,733
) |
|
ArcelorMittal
SA, ADR, Registered Shares |
538 |
08/15/25 |
USD |
33.00 |
USD |
1,699 |
(49,765
) |
|
Barrick
Mining Corp. |
1,450 |
08/15/25 |
USD |
22.00 |
USD |
3,019 |
(75,400
) |
|
CRH
PLC |
222 |
08/15/25 |
USD |
97.50 |
USD |
2,038 |
(41,070
) |
|
Darling
Ingredients, Inc. |
342 |
08/15/25 |
USD |
41.28 |
USD |
1,298 |
(46,249
) |
|
Exxon
Mobil Corp. |
519 |
08/15/25 |
USD |
110.00 |
USD |
5,595 |
(139,351
) |
|
Nutrien
Ltd. |
1,060 |
08/15/25 |
USD |
60.00 |
USD |
6,173 |
(172,250
) |
|
Packaging
Corp. of America |
143 |
08/15/25 |
USD |
195.00 |
USD |
2,695 |
(63,992
) |
|
Permian
Resources Corp., Class A |
647 |
08/15/25 |
USD |
15.66 |
USD |
881 |
(11,238
) |
|
Shell
PLC, ADR |
852 |
08/15/25 |
USD |
75.00 |
USD |
5,999 |
(42,600
) |
|
Smurfit
Westrock PLC |
858 |
08/15/25 |
USD |
44.68 |
USD |
3,702 |
(137,664
) |
|
Suncor
Energy, Inc. |
813 |
08/15/25 |
CAD |
54.00 |
CAD |
4,147 |
(37,911
) |
|
TechnipFMC
PLC |
322 |
08/15/25 |
USD |
35.00 |
USD |
1,109 |
(47,495
) |
|
Teck
Resources Ltd., Class B |
584 |
08/15/25 |
USD |
39.00 |
USD |
2,358 |
(186,880
) |
|
Vale
SA, ADR |
2,611 |
08/15/25 |
USD |
10.00 |
USD |
2,535 |
(62,664
) |
|
|
|
|
|
|
|
|
$ (5,581,422
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
Anglo
American PLC |
UBS
AG |
177,687 |
07/02/25 |
GBP |
22.09 |
GBP |
3,816 |
$ (10,268
) |
|
Norsk
Hydro ASA |
Citibank
N.A. |
644,000 |
07/02/25 |
NOK |
59.47 |
NOK |
37,171 |
(964
) |
|
Mondi
PLC |
Goldman
Sachs International |
98,700 |
07/08/25 |
GBP |
12.17 |
GBP |
1,175 |
(5,762
) |
|
UPM-Kymmene
OYJ |
Bank
of America N.A. |
77,900 |
07/08/25 |
EUR |
25.83 |
EUR |
1,806 |
(81
) |
|
Anglo
American PLC |
Bank
of America N.A. |
238,309 |
07/10/25 |
GBP |
21.76 |
GBP |
5,118 |
(131,844
) |
|
Norsk
Hydro ASA |
Bank
of America N.A. |
497,614 |
07/10/25 |
NOK |
59.32 |
NOK |
28,722 |
(15,854
) |
|
Graphic
Packaging Holding Co. |
Morgan
Stanley & Co. International PLC |
178,000 |
07/11/25 |
USD |
22.55 |
USD |
3,750 |
(25,050
) |
|
UPM-Kymmene
OYJ |
Goldman
Sachs International |
75,000 |
07/15/25 |
EUR |
26.04 |
EUR |
1,739 |
(875
) |
|
Heidelberg
Materials AG |
Goldman
Sachs International |
8,200 |
07/24/25 |
EUR |
180.54 |
EUR |
1,639 |
(200,535
) |
|
Glencore
PLC |
UBS
AG |
470,000 |
07/29/25 |
GBP |
3.01 |
GBP |
1,334 |
(31,612
) |
|
Glencore
PLC |
Barclays
Bank PLC |
716,400 |
07/30/25 |
GBP |
2.84 |
GBP |
2,034 |
(110,039
) |
|
Mondi
PLC |
Bank
of America N.A. |
91,700 |
07/30/25 |
GBP |
12.05 |
GBP |
1,092 |
(28,112
) |
|
Norsk
Hydro ASA |
UBS
AG |
108,800 |
07/30/25 |
NOK |
57.16 |
NOK |
6,280 |
(21,601
) |
|
Glencore
PLC |
Barclays
Bank PLC |
592,000 |
08/05/25 |
GBP |
3.03 |
GBP |
1,681 |
(46,579
) |
|
Mondi
PLC |
BNP
Paribas SA |
56,500 |
08/05/25 |
GBP |
12.05 |
GBP |
673 |
(19,751
) |
|
UPM-Kymmene
OYJ |
Barclays
Bank PLC |
36,900 |
08/05/25 |
EUR |
23.35 |
EUR |
855 |
(25,081
) |
|
Heidelberg
Materials AG |
Bank
of America N.A. |
5,600 |
08/06/25 |
EUR |
197.07 |
EUR |
1,120 |
(61,312
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
|
Graphic
Packaging Holding Co. |
Morgan
Stanley & Co. International PLC |
76,000 |
08/11/25 |
USD |
22.80 |
USD |
1,601 |
$ (26,396
) |
|
Glencore
PLC |
UBS
AG |
470,000 |
08/12/25 |
GBP |
3.04 |
GBP |
1,334 |
(40,193
) |
|
|
|
|
|
|
|
|
|
$ (801,909
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
Options
Written |
$ N/A |
$ (6,518,042
) |
$ 2,198,853 |
$ (2,064,142
) |
$ (6,383,331
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 6,383,331 |
$ — |
$ — |
$ — |
$ 6,383,331 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ 7,236,452 |
$ — |
$ — |
$ — |
$ 7,236,452 |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (2,882,828
) |
$ — |
$ — |
$ — |
$ (2,882,828
) |
|
Options: |
|
|
Average
value of option contracts written |
$6,203,827 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 6,383,331 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
6,383,331 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(5,581,422
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 801,909 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 237,203 |
$ — |
$ (237,203
) |
$ — |
$ — |
|
Barclays
Bank PLC |
181,699 |
— |
— |
— |
181,699 |
|
BNP
Paribas SA |
19,751 |
— |
— |
— |
19,751 |
|
Citibank
N.A. |
964 |
— |
(964
) |
— |
— |
|
Goldman
Sachs International |
207,172 |
— |
(207,172
) |
— |
— |
|
Morgan
Stanley & Co. International PLC |
51,446 |
— |
(51,446
) |
— |
— |
|
UBS
AG |
103,674 |
— |
— |
— |
103,674 |
|
|
$ 801,909 |
$ — |
$ (496,785
) |
$ — |
$ 305,124 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
Assets |
|
|
|
|
|
Investments |
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
Chemicals |
$ 127,740,961 |
$ — |
$ — |
$ 127,740,961 |
|
Construction
Materials |
12,268,886 |
8,720,444 |
— |
20,989,330 |
Containers
& Packaging |
56,980,766 |
— |
— |
56,980,766 |
|
Energy
Equipment & Services |
6,887,036 |
— |
— |
6,887,036 |
Food
Products |
14,494,590 |
— |
7,235,967 |
21,730,557 |
|
Metals
& Mining |
218,529,997 |
73,991,264 |
13 |
292,521,274 |
Oil,
Gas & Consumable Fuels |
205,012,275 |
— |
694 |
205,012,969 |
|
Paper
& Forest Products |
— |
24,213,827 |
— |
24,213,827 |
Corporate
Bonds |
— |
7,560,000 |
— |
7,560,000 |
|
Short-Term
Securities |
|
|
|
|
Money
Market Funds |
28,271,348 |
— |
— |
28,271,348 |
|
|
$670,185,859 |
$114,485,535 |
$7,236,674 |
$791,908,068 |
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
Equity
Contracts |
$ (4,576,570
) |
$ (1,806,761
) |
$ — |
$ (6,383,331
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
|
Common
Stocks |
|
Assets |
|
|
Opening
balance, as of December 31, 2024 |
$ 8,643,354 |
|
Transfers
into Level 3 |
— |
|
Transfers
out of Level 3 |
— |
|
Accrued
discounts/premiums |
— |
|
Net
realized gain (loss) |
— |
|
|
Common
Stocks |
|
Net
change in unrealized appreciation (depreciation)(a)(b) |
$ (1,406,680
) |
|
Purchases |
— |
|
Sales |
— |
|
Closing
balance, as of June 30, 2025 |
$ 7,236,674 |
|
Net
change in unrealized appreciation (depreciation) on investments still held
at June 30, 2025(b) |
$ (1,406,680
) |
|
(a)
|
Included
in the related net change in unrealized appreciation (depreciation) in the
Statements of Operations. |
|
(b)
|
Any
difference between net change in unrealized appreciation (depreciation)
and net change in unrealized appreciation (depreciation) on investments
still held at June 30, 2025 is
generally
due to investments no longer held or categorized as Level 3 at period
end. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Aerospace
& Defense — 0.4% |
| ||
|
Archer
Aviation, Inc., Class A(a) |
640,749 |
$ 6,952,127 | |
|
Automobiles
— 1.0% |
| ||
|
BYD
Co. Ltd., Class H |
238,000 |
3,705,665 | |
|
Tesla,
Inc.(a) |
|
36,083 |
11,462,126 |
|
|
|
15,167,791 | |
|
Broadline
Retail — 2.2% |
| ||
|
MercadoLibre,
Inc.(a) |
12,705 |
33,206,168 | |
|
Capital
Markets — 0.7% |
| ||
|
Cboe
Global Markets, Inc. |
45,364 |
10,579,338 | |
|
Communications
Equipment — 2.2% |
| ||
|
Accton
Technology Corp. |
453,000 |
11,322,170 | |
|
Lumentum
Holdings, Inc.(a) |
|
238,530 |
22,674,662 |
|
|
|
33,996,832 | |
|
Consumer
Finance(a)
— 3.2% |
| ||
|
Klarna
Group PLC, (Acquired 08/07/19, Cost:
$23,354,996)(b)(c) |
1,042,068 |
42,255,857 | |
|
SoFi
Technologies, Inc. |
|
357,518 |
6,510,403 |
|
|
|
48,766,260 | |
|
Diversified
Consumer Services — 0.0% |
| ||
|
Think
& Learn Private Ltd., Class J-B, (Acquired
09/30/20,
Cost: $7,113,729)(a)(b)(c) |
4,651 |
— | |
|
Diversified
Telecommunication Services — 0.6% |
| ||
|
AST
SpaceMobile, Inc., Class A(a)(d) |
203,902 |
9,528,341 | |
|
Electrical
Equipment — 0.5% |
| ||
|
Doosan
Enerbility Co. Ltd.(a) |
149,766 |
7,587,607 | |
|
Electronic
Equipment, Instruments & Components(a)
— 3.6% |
| ||
|
Celestica,
Inc. |
168,675 |
26,331,854 | |
|
Fabrinet(d) |
|
97,399 |
28,701,538 |
|
|
|
55,033,392 | |
|
Entertainment
— 7.9% |
| ||
|
Konami
Group Corp. |
50,200 |
7,936,704 | |
|
Krafton,
Inc.(a)(d) |
|
20,513 |
5,507,521 |
|
Nintendo
Co. Ltd. |
123,100 |
11,821,266 | |
|
ROBLOX
Corp., Class A(a) |
|
92,630 |
9,744,676 |
|
Spotify
Technology SA(a) |
59,976 |
46,021,984 | |
|
Take-Two
Interactive Software, Inc.(a) |
|
104,305 |
25,330,469 |
|
Tencent
Music Entertainment Group, ADR |
721,503 |
14,062,093 | |
|
|
|
|
120,424,713 |
|
Financial
Services — 1.2% |
| ||
|
Adyen
NV(a)(e) |
|
10,054 |
18,464,543 |
|
Health
Care Technology — 0.5% |
| ||
|
M3,
Inc. |
|
555,100 |
7,625,243 |
|
Independent
Power and Renewable Electricity Producers — 0.6% |
| ||
|
Talen
Energy Corp.(a) |
|
34,432 |
10,011,793 |
|
Industrial
Conglomerates — 1.5% |
| ||
|
Hitachi
Ltd. |
|
813,600 |
23,646,739 |
|
IT
Services(a)
— 4.9% |
| ||
|
Automattic,
Inc., (Acquired 02/03/21, Cost:
$34,000,000)(b)(c) |
|
400,000 |
11,096,000 |
|
Cloudflare,
Inc., Class A |
106,295 |
20,815,750 | |
|
Deep
Instinct Ltd.(b) |
|
197,437 |
11,846 |
|
Security |
|
Shares |
Value |
|
IT
Services (continued) |
| ||
|
Farmer’s
Business Network, Inc.(b) |
|
361,834 |
$ 466,766 |
|
Snowflake,
Inc., Class A(f) |
139,107 |
31,127,973 | |
|
Twilio,
Inc., Class A |
|
93,089 |
11,576,548 |
|
|
|
75,094,883 | |
|
Life
Sciences Tools & Services — 0.5% |
| ||
|
Tempus
AI, Inc.(a)(d) |
115,143 |
7,316,186 | |
|
Media
— 0.6% |
| ||
|
MNTN,
Inc.(a)(d) |
414,940 |
9,074,738 | |
|
Professional
Services — 1.4% |
| ||
|
Thomson
Reuters Corp. |
104,153 |
20,948,293 | |
|
Semiconductors
& Semiconductor Equipment — 22.5% |
| ||
|
Advantest
Corp. |
229,400 |
17,005,650 | |
|
Alchip
Technologies Ltd. |
|
140,000 |
14,844,471 |
|
ASM
International NV |
21,422 |
13,741,737 | |
|
Astera
Labs, Inc.(a) |
|
135,389 |
12,241,874 |
|
Credo
Technology Group Holding Ltd.(a) |
257,870 |
23,876,183 | |
|
Disco
Corp. |
|
39,500 |
11,701,612 |
|
eMemory
Technology, Inc. |
68,000 |
5,505,032 | |
|
KLA
Corp. |
|
17,485 |
15,662,014 |
|
Kokusai
Electric Corp. |
800,300 |
19,149,188 | |
|
Monolithic
Power Systems, Inc. |
|
15,719 |
11,496,562 |
|
Mythic
AI, Inc., Series C, (Acquired 01/26/21, Cost:
$7,000,000)(a)(b)(c) |
10,189 |
— | |
|
NVIDIA
Corp.(f)(g) |
|
934,432 |
147,630,912 |
|
ON
Semiconductor Corp.(a)(d) |
237,359 |
12,439,985 | |
|
SK
Hynix, Inc. |
|
149,763 |
32,271,163 |
|
Tower
Semiconductor Ltd.(a)(d) |
163,951 |
7,107,276 | |
|
|
|
|
344,673,659 |
|
Software(a)
— 14.0% |
| ||
|
AppLovin
Corp., Class A(g) |
|
52,889 |
18,515,381 |
|
Chime
Financial, Inc., Class A, Class A |
251,925 |
8,693,932 | |
|
CyberArk
Software Ltd. |
|
60,852 |
24,759,462 |
|
Databricks,
Inc., (Acquired 07/24/20, Cost:
$5,501,686)(b)(c) |
343,659 |
37,177,031 | |
|
DataRobot,
Inc., (Acquired 03/01/21, Cost:
$1,384,813)(b)(c) |
|
92,093 |
117,879 |
|
Guidewire
Software, Inc. |
71,200 |
16,764,040 | |
|
Monday.com
Ltd. |
|
27,423 |
8,623,985 |
|
Palantir
Technologies, Inc., Class A |
88,051 |
12,003,112 | |
|
Q2
Holdings, Inc. |
|
93,339 |
8,735,597 |
|
Samsara,
Inc., Class A(d) |
214,423 |
8,529,747 | |
|
ServiceTitan,
Inc., Class A |
|
46,715 |
5,006,913 |
|
SiteMinder
Ltd. |
1,723,622 |
5,027,683 | |
|
Snorkel
AI, Inc., (Acquired 10/13/20, Cost:
$2,017,593)(b)(c) |
|
500,250 |
4,792,395 |
|
Snyk
Ltd., Ordinary Shares, (Acquired 11/02/20, Cost:
$9,287,400)(b)(c) |
1,267,643 |
7,326,977 | |
|
Synopsys,
Inc.(g) |
|
39,462 |
20,231,378 |
|
Unity
Software, Inc. |
292,824 |
7,086,341 | |
|
Xero
Ltd. |
|
180,548 |
21,364,110 |
|
|
|
214,755,963 | |
|
Technology
Hardware, Storage & Peripherals — 2.7% |
| ||
|
Asia
Vital Components Co. Ltd. |
432,000 |
11,034,336 | |
|
Security |
|
Shares |
Value |
|
Technology
Hardware, Storage & Peripherals (continued) |
| ||
|
Pure
Storage, Inc., Class A(a)(f) |
|
366,443 |
$ 21,099,788 |
|
Sandisk
Corp.(a) |
219,235 |
9,942,307 | |
|
|
|
|
42,076,431 |
|
Total
Common Stocks — 72.7%
(Cost:
$667,569,651) |
1,114,931,040 | ||
|
Preferred
Securities | |||
|
Preferred
Stocks — 27.6%(a)(b) | |||
|
Communications
Equipment — 0.6% |
| ||
|
Astranis
Space Technologies Corp., Series C |
775,515 |
9,244,139 | |
|
Consumer
Staples Distribution & Retail — 2.1% |
| ||
|
GrubMarket,
Inc., Series D, (Acquired 07/23/20, Cost:
$8,000,001)(c) |
1,762,969 |
32,844,112 | |
|
Diversified
Consumer Services — 0.0% |
| ||
|
Think
& Learn Private Ltd., Series F, (Acquired
09/30/20,
Cost: $14,251,080)(c) |
4,920 |
— | |
|
Entertainment
— 0.3% |
| ||
|
ResearchGate
GmbH, Series D, (Acquired 09/24/20,
Cost:
$6,999,988)(c) |
424,688 |
4,310,583 | |
|
Financial
Services(c)(h)
— 1.9% |
| ||
|
Trumid
Holdings LLC |
|
| |
|
Class
J-A, (Acquired 07/24/20, Cost: $9,999,857) |
|
20,154 |
14,493,144 |
|
Class
J-B, (Acquired 07/24/20, Cost: $5,999,914) |
20,154 |
14,493,144 | |
|
|
|
|
28,986,288 |
|
Interactive
Media & Services — 2.3% |
| ||
|
ByteDance
Ltd., Series E-1, (Acquired 11/11/20, Cost:
$16,961,509)(c) |
|
150,113 |
34,832,221 |
|
IT
Services(c)
— 0.6% |
| ||
|
TRAX
Ltd. |
|
|
|
|
(Acquired
02/18/21, Cost: $9,999,998) |
191,806 |
3,596,363 | |
|
(Acquired
09/12/19, Cost: $10,999,988) |
|
293,333 |
5,499,994 |
|
|
|
9,096,357 | |
|
Professional
Services — 0.4% |
| ||
|
Rapyd
Financial Network Ltd., Series E, (Acquired
03/31/21,
Cost: $13,999,978)(c) |
190,705 |
6,747,143 | |
|
Semiconductors
& Semiconductor Equipment(c)
— 8.9% |
| ||
|
PsiQuantum
Corp. |
|
| |
|
Series
C, (Acquired 09/09/19, Cost: $9,101,310) |
|
1,962,335 |
72,900,745 |
|
Series
D, (Acquired 05/21/21, Cost: $19,999,969) |
762,595 |
31,068,120 | |
|
SambaNova
Systems, Inc. |
|
|
|
|
Series
C, (Acquired 02/20/20, Cost: $33,904,162) |
636,800 |
28,318,496 | |
|
Series
D, (Acquired 04/09/21, Cost: $6,999,979) |
|
73,670 |
3,894,933 |
|
|
|
136,182,294 | |
|
Software(c)
— 10.5% |
| ||
|
Databricks,
Inc. |
|
| |
|
Series
F, (Acquired 10/22/19, Cost: $13,200,019) |
|
922,038 |
99,746,071 |
|
Series
G, (Acquired 02/01/21, Cost: $18,500,004) |
312,909 |
33,850,496 | |
|
DataRobot,
Inc., Series F, (Acquired 10/27/20, Cost:
$11,499,999) |
|
875,059 |
3,377,728 |
|
Security |
|
Shares |
Value |
|
Software
(continued) |
| ||
|
Snorkel
AI, Inc., Series B, (Acquired 10/13/20, Cost:
$999,996) |
|
247,943 |
$ 2,375,294 |
|
Snyk
Ltd., Seed Preferred, (Acquired 11/02/20, Cost:
$13,212,590) |
2,663,936 |
15,397,550 | |
|
Unqork,
Inc. |
|
|
|
|
Series
B, (Acquired 09/19/19, Cost: $6,801,016) |
597,680 |
3,669,755 | |
|
Series
C, (Acquired 09/18/20, Cost: $7,994,787) |
|
292,000 |
2,344,760 |
|
|
|
160,761,654 | |
|
|
423,004,791 | ||
|
Total
Preferred Securities — 27.6%
(Cost:
$256,426,154) |
423,004,791 | ||
|
Total
Long-Term Investments — 100.3%
(Cost:
$923,995,805) |
1,537,935,831 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 3.3% |
| ||
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares,
4.47%(i)(j)(k) |
27,913,021 |
27,924,187 | |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares,
4.20%(i)(j) |
|
23,069,698 |
23,069,698 |
|
Total
Short-Term Securities — 3.3%
(Cost:
$50,993,340) |
50,993,885 | ||
|
Total
Investments Before Options Written — 103.6%
(Cost:
$974,989,145) |
1,588,929,716 | ||
|
Options
Written — (0.7)%
(Premiums
Received: $(6,127,064)) |
(10,877,948
) | ||
|
Total
Investments, Net of Options Written — 102.9%
(Cost:
$968,862,081) |
1,578,051,768 | ||
|
Liabilities
in Excess of Other Assets — (2.9)% |
(44,795,972
) | ||
|
Net
Assets — 100.0% |
$ 1,533,255,796 | ||
|
(a)
|
Non-income
producing security. |
|
(b)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(c)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $516,526,791, representing 33.7% of its net assets
as of
period
end, and an original cost of $329,086,361. |
|
(d)
|
All
or a portion of this security is on loan. |
|
(e)
|
Security
exempt from registration pursuant to Rule 144A under the Securities Act of
1933,
as
amended. These securities may be resold in transactions exempt from
registration to
qualified
institutional investors. |
|
(f)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(g)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(h)
|
All
or a portion of the security is held by a wholly-owned subsidiary. See
Note 1
of the
Notes
to Financial Statements for details on the wholly-owned
subsidiary. |
|
(i)
|
Affiliate
of the Trust. |
|
(j)
|
Annualized
7-day yield as of period end. |
|
(k)
|
All
or a portion of this security was purchased with the cash collateral from
loaned
securities. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency Shares |
$ 7,491,149 |
$ 20,437,428
(a) |
$ — |
$ (3,497
) |
$ (893
) |
$ 27,924,187 |
27,913,021 |
$ 94,504
(b) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares |
2,010,552 |
21,059,146
(a) |
— |
— |
— |
23,069,698 |
23,069,698 |
396,525 |
— |
|
|
|
|
|
$ (3,497
) |
$ (893
) |
$ 50,993,885 |
|
$ 491,029 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
(b)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Applovin
Corp., Class A |
45 |
07/11/25 |
USD |
390.00 |
USD |
1,575 |
$ (19,800
) |
|
Archer
Aviation, Inc., Class A |
523 |
07/11/25 |
USD |
15.50 |
USD |
567 |
(25,627
) |
|
Celestica,
Inc. |
98 |
07/11/25 |
USD |
117.00 |
USD |
1,530 |
(385,140
) |
|
MercadoLibre,
Inc. |
10 |
07/11/25 |
USD |
2,600.00 |
USD |
2,614 |
(58,950
) |
|
NVIDIA
Corp. |
209 |
07/11/25 |
USD |
152.50 |
USD |
3,302 |
(150,480
) |
|
NVIDIA
Corp. |
312 |
07/11/25 |
USD |
149.04 |
USD |
4,929 |
(316,041
) |
|
Samsara,
Inc., Class A |
305 |
07/11/25 |
USD |
49.00 |
USD |
1,213 |
(45,750
) |
|
Spotify
Technology SA |
96 |
07/11/25 |
USD |
700.00 |
USD |
7,366 |
(668,880
) |
|
Unity
Software, Inc. |
440 |
07/11/25 |
USD |
30.00 |
USD |
1,065 |
(6,600
) |
|
Astera
Labs, Inc. |
186 |
07/18/25 |
USD |
95.00 |
USD |
1,682 |
(66,030
) |
|
Cboe
Global Markets, Inc. |
28 |
07/18/25 |
USD |
230.00 |
USD |
653 |
(17,640
) |
|
Celestica,
Inc. |
85 |
07/18/25 |
USD |
150.00 |
USD |
1,327 |
(92,650
) |
|
Chime
Financial, Inc., Class A |
403 |
07/18/25 |
USD |
40.00 |
USD |
1,391 |
(66,495
) |
|
Credo
Technology Group Holding Ltd. |
225 |
07/18/25 |
USD |
70.00 |
USD |
2,083 |
(519,750
) |
|
CyberArk
Software, Ltd. |
99 |
07/18/25 |
USD |
400.00 |
USD |
4,028 |
(158,895
) |
|
Fabrinet |
116 |
07/18/25 |
USD |
250.00 |
USD |
3,418 |
(531,280
) |
|
Fabrinet |
40 |
07/18/25 |
USD |
260.00 |
USD |
1,179 |
(147,000
) |
|
Guidewire
Software, Inc. |
65 |
07/18/25 |
USD |
230.00 |
USD |
1,530 |
(57,850
) |
|
Lumentum
Holdings, Inc. |
191 |
07/18/25 |
USD |
85.00 |
USD |
1,816 |
(207,235
) |
|
Monday.Com
Ltd. |
14 |
07/18/25 |
USD |
320.00 |
USD |
440 |
(14,630
) |
|
Monolithic
Power Systems, Inc. |
12 |
07/18/25 |
USD |
760.00 |
USD |
878 |
(21,000
) |
|
NVIDIA
Corp. |
85 |
07/18/25 |
USD |
135.00 |
USD |
1,343 |
(201,237
) |
|
NVIDIA
Corp. |
154 |
07/18/25 |
USD |
130.00 |
USD |
2,433 |
(439,670
) |
|
NVIDIA
Corp. |
59 |
07/18/25 |
USD |
150.00 |
USD |
932 |
(60,032
) |
|
Palantir
Technologies, Inc. |
70 |
07/18/25 |
USD |
140.00 |
USD |
954 |
(33,250
) |
|
Q2
Holdings, Inc. |
85 |
07/18/25 |
USD |
95.00 |
USD |
796 |
(21,463
) |
|
Samsara,
Inc., Class A |
126 |
07/18/25 |
USD |
46.00 |
USD |
501 |
(1,260
) |
|
SanDisk
Corp. |
356 |
07/18/25 |
USD |
45.00 |
USD |
1,614 |
(79,210
) |
|
ServiceTitan,
Inc. |
74 |
07/18/25 |
USD |
105.00 |
USD |
793 |
(35,150
) |
|
Snowflake,
Inc., Class A |
61 |
07/18/25 |
USD |
220.00 |
USD |
1,365 |
(49,868
) |
|
Synopsys,
Inc. |
32 |
07/18/25 |
USD |
510.00 |
USD |
1,641 |
(52,000
) |
|
Take-Two
Interactive Software, Inc. |
79 |
07/18/25 |
USD |
240.00 |
USD |
1,919 |
(55,695
) |
|
Talen
Energy Corp. |
47 |
07/18/25 |
USD |
250.00 |
USD |
1,367 |
(201,865
) |
|
Tempus
AI, Inc., Class A |
92 |
07/18/25 |
USD |
75.00 |
USD |
585 |
(10,580
) |
|
Tencent
Music Entertainment Group, ADR |
580 |
07/18/25 |
USD |
16.00 |
USD |
1,130 |
(208,800
) |
|
Tesla,
Inc. |
8 |
07/18/25 |
USD |
350.00 |
USD |
254 |
(4,000
) |
|
Tesla,
Inc. |
10 |
07/18/25 |
USD |
365.00 |
USD |
318 |
(2,885
) |
|
Thomson
Reuters Corp. |
32 |
07/18/25 |
USD |
195.00 |
USD |
644 |
(23,520
) |
|
Tower
Semiconductor Ltd. |
113 |
07/18/25 |
USD |
44.00 |
USD |
490 |
(16,668
) |
|
Twilio,
Inc., Class A |
71 |
07/18/25 |
USD |
130.00 |
USD |
883 |
(15,301
) |
|
Applovin
Corp., Class A |
39 |
07/25/25 |
USD |
415.00 |
USD |
1,365 |
(21,645
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
MercadoLibre,
Inc. |
10 |
07/25/25 |
USD |
2,700.00 |
USD |
2,614 |
$ (42,800
) |
|
NVIDIA
Corp. |
85 |
07/25/25 |
USD |
147.00 |
USD |
1,343 |
(113,900
) |
|
NVIDIA
Corp. |
59 |
07/25/25 |
USD |
150.00 |
USD |
932 |
(65,342
) |
|
ON
Semiconductor Corp. |
243 |
07/25/25 |
USD |
62.00 |
USD |
1,274 |
(11,664
) |
|
Snowflake,
Inc., Class A |
96 |
07/25/25 |
USD |
215.00 |
USD |
2,148 |
(126,000
) |
|
Take-Two
Interactive Software, Inc. |
87 |
07/25/25 |
USD |
250.00 |
USD |
2,113 |
(30,015
) |
|
Tesla,
Inc. |
21 |
07/25/25 |
USD |
350.00 |
USD |
667 |
(19,845
) |
|
Twilio,
Inc., Class A |
77 |
07/25/25 |
USD |
123.00 |
USD |
958 |
(42,543
) |
|
AST
SpaceMobile, Inc., Class A |
157 |
08/01/25 |
USD |
47.00 |
USD |
734 |
(92,237
) |
|
Celestica,
Inc. |
86 |
08/01/25 |
USD |
137.00 |
USD |
1,343 |
(217,580
) |
|
NVIDIA
Corp. |
107 |
08/01/25 |
USD |
160.00 |
USD |
1,690 |
(64,735
) |
|
Palantir
Technologies, Inc. |
70 |
08/01/25 |
USD |
145.00 |
USD |
954 |
(39,025
) |
|
ROBLOX
Corp., Class A |
65 |
08/01/25 |
USD |
105.00 |
USD |
684 |
(50,213
) |
|
Tempus
AI, Inc., Class A |
77 |
08/01/25 |
USD |
75.00 |
USD |
489 |
(16,940
) |
|
Tesla,
Inc. |
11 |
08/01/25 |
USD |
365.00 |
USD |
349 |
(9,295
) |
|
AST
SpaceMobile, Inc., Class A |
169 |
08/15/25 |
USD |
43.00 |
USD |
790 |
(148,297
) |
|
Cboe
Global Markets, Inc. |
44 |
08/15/25 |
USD |
240.00 |
USD |
1,026 |
(20,020
) |
|
Cloudflare,
Inc., Class A |
172 |
08/15/25 |
USD |
185.00 |
USD |
3,368 |
(388,290
) |
|
Credo
Technology Group Holding Ltd. |
76 |
08/15/25 |
USD |
80.00 |
USD |
704 |
(126,160
) |
|
Credo
Technology Group Holding Ltd. |
109 |
08/15/25 |
USD |
90.00 |
USD |
1,009 |
(112,815
) |
|
Guidewire
Software, Inc. |
50 |
08/15/25 |
USD |
254.50 |
USD |
1,177 |
(17,190
) |
|
KLA
Corp. |
27 |
08/15/25 |
USD |
900.00 |
USD |
2,418 |
(125,010
) |
|
Lumentum
Holdings, Inc. |
190 |
08/15/25 |
USD |
100.00 |
USD |
1,806 |
(107,350
) |
|
Monday.Com
Ltd. |
29 |
08/15/25 |
USD |
330.00 |
USD |
912 |
(47,705
) |
|
Monolithic
Power Systems, Inc. |
12 |
08/15/25 |
USD |
770.00 |
USD |
878 |
(47,340
) |
|
NVIDIA
Corp. |
425 |
08/15/25 |
USD |
150.00 |
USD |
6,715 |
(576,937
) |
|
ON
Semiconductor Corp. |
127 |
08/15/25 |
USD |
55.00 |
USD |
666 |
(40,005
) |
|
Pure
Storage, Inc., Class A |
590 |
08/15/25 |
USD |
55.00 |
USD |
3,397 |
(283,200
) |
|
Q2
Holdings, Inc. |
70 |
08/15/25 |
USD |
95.00 |
USD |
655 |
(34,300
) |
|
ROBLOX
Corp., Class A |
83 |
08/15/25 |
USD |
100.00 |
USD |
873 |
(97,525
) |
|
Snowflake,
Inc., Class A |
65 |
08/15/25 |
USD |
230.00 |
USD |
1,455 |
(51,837
) |
|
Synopsys,
Inc. |
32 |
08/15/25 |
USD |
500.00 |
USD |
1,641 |
(105,920
) |
|
Tencent
Music Entertainment Group, ADR |
574 |
08/15/25 |
USD |
18.80 |
USD |
1,119 |
(81,797
) |
|
Thomson
Reuters Corp. |
134 |
08/15/25 |
USD |
200.00 |
USD |
2,695 |
(91,120
) |
|
Tower
Semiconductor Ltd. |
150 |
08/15/25 |
USD |
42.00 |
USD |
650 |
(71,250
) |
|
|
|
|
|
|
|
|
$ (8,628,024
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call |
|
|
|
|
|
|
|
|
|
Alchip
Technologies Ltd. |
Morgan
Stanley & Co. International PLC |
21,000 |
07/02/25 |
TWD |
2,884.38 |
TWD |
65,046 |
$ (155,312
) |
Disco
Corp. |
Goldman
Sachs International |
7,000 |
07/02/25 |
JPY |
38,128.20 |
JPY |
298,624 |
(220,136
) |
|
Hitachi
Ltd. |
UBS
AG |
130,100 |
07/02/25 |
JPY |
4,101.14 |
JPY |
544,522 |
(111,200
) |
M3,
Inc. |
UBS
AG |
85,200 |
07/02/25 |
JPY |
2,036.32 |
JPY |
168,539 |
(3,566
) |
|
SiteMinder
Ltd. |
Morgan
Stanley & Co. International PLC |
29,400 |
07/02/25 |
AUD |
4.62 |
AUD |
130 |
(190
) |
Xero
Ltd. |
JPMorgan
Chase Bank N.A. |
21,200 |
07/02/25 |
AUD |
187.51 |
AUD |
3,812 |
(46
) |
|
Asia
Vital Components Co. Ltd. |
Bank
of America N.A. |
11,000 |
07/10/25 |
TWD |
732.34 |
TWD |
8,208 |
(13,900
) |
Asia
Vital Components Co. Ltd. |
JPMorgan
Chase Bank N.A. |
46,800 |
07/10/25 |
TWD |
635.35 |
TWD |
34,920 |
(176,217
) |
|
BYD
Co. Ltd., Class H |
Citibank
N.A. |
57,005 |
07/10/25 |
HKD |
155.59 |
HKD |
6,967 |
(21
) |
Kokusai
Electric Corp. |
Morgan
Stanley & Co. International PLC |
64,700 |
07/10/25 |
JPY |
3,198.02 |
JPY |
222,936 |
(150,151
) |
|
SiteMinder
Ltd. |
Morgan
Stanley & Co. International PLC |
88,000 |
07/10/25 |
AUD |
4.68 |
AUD |
390 |
(3,106
) |
SiteMinder
Ltd. |
Morgan
Stanley & Co. International PLC |
59,500 |
07/15/25 |
AUD |
4.79 |
AUD |
264 |
(2,183
) |
|
Kokusai
Electric Corp. |
Morgan
Stanley & Co. International PLC |
63,300 |
07/17/25 |
JPY |
3,186.15 |
JPY |
218,112 |
(169,647
) |
Xero
Ltd. |
Goldman
Sachs International |
7,600 |
07/17/25 |
AUD |
192.20 |
AUD |
1,366 |
(1,421
) |
|
Adyen
NV |
Barclays
Bank PLC |
1,500 |
07/23/25 |
EUR |
1,751.00 |
EUR |
2,339 |
(11,300
) |
Konami
Group Corp. |
JPMorgan
Chase Bank N.A. |
5,300 |
07/23/25 |
JPY |
20,945.86 |
JPY |
120,667 |
(75,557
) |
|
Nintendo
Co. Ltd. |
JPMorgan
Chase Bank N.A. |
18,300 |
07/23/25 |
JPY |
12,393.62 |
JPY |
253,066 |
(209,297
) |
Advantest
Corp. |
JPMorgan
Chase Bank N.A. |
28,800 |
07/24/25 |
JPY |
8,783.73 |
JPY |
307,447 |
(439,097
) |
|
SK
Hynix, Inc. |
JPMorgan
Chase Bank N.A. |
25,000 |
08/05/25 |
KRW |
297,440.00 |
KRW |
7,270,347 |
(293,400
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
Call (continued) |
|
|
|
|
|
|
|
|
|
Accton
Technology Corp. |
Morgan
Stanley & Co. International PLC |
63,000 |
08/06/25 |
TWD |
803.74 |
TWD |
45,997 |
$ (52,834
) |
eMemory
Technology, Inc. |
JPMorgan
Chase Bank N.A. |
10,000 |
08/06/25 |
TWD |
2,593.80 |
TWD |
23,649 |
(37,624
) |
|
ASM
International NV |
Barclays
Bank PLC |
3,400 |
08/08/25 |
EUR |
554.69 |
EUR |
1,852 |
(90,416
) |
Krafton,
Inc. |
Goldman
Sachs International |
7,200 |
08/08/25 |
KRW |
409,854.94 |
KRW |
2,608,943 |
(28,562
) |
|
SiteMinder
Ltd. |
Morgan
Stanley & Co. International PLC |
98,800 |
08/08/25 |
AUD |
5.14 |
AUD |
438 |
(4,741
) |
|
|
|
|
|
|
|
|
$ (2,249,924
) | |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (6,127,064
) |
$ 852,986 |
$ (5,603,870
) |
$ (10,877,948
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 10,877,948 |
$ — |
$ — |
$ — |
$ 10,877,948 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ 2,731,607 |
$ — |
$ — |
$ — |
$ 2,731,607 |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (7,662,996
) |
$ — |
$ — |
$ — |
$ (7,662,996
) |
|
Options: |
|
|
Average
value of option contracts written |
$6,443,005 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 10,877,948 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
10,877,948 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(8,628,024
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 2,249,924 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 13,900 |
$ — |
$ — |
$ (13,900
) |
$ — |
|
Barclays
Bank PLC |
101,716 |
— |
— |
— |
101,716 |
|
Citibank
N.A. |
21 |
— |
— |
— |
21 |
|
Goldman
Sachs International |
250,119 |
— |
— |
— |
250,119 |
|
JPMorgan
Chase Bank N.A. |
1,231,238 |
— |
(1,231,238
) |
— |
— |
|
Morgan
Stanley & Co. International PLC |
538,164 |
— |
(538,164
) |
— |
— |
|
UBS
AG |
114,766 |
— |
(114,766
) |
— |
— |
|
|
$ 2,249,924 |
$ — |
$ (1,884,168
) |
$ (13,900
) |
$ 351,856 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Aerospace
& Defense |
$ 6,952,127 |
$ — |
$ — |
$ 6,952,127 |
|
Automobiles |
11,462,126 |
3,705,665 |
— |
15,167,791 |
|
Broadline
Retail |
33,206,168 |
— |
— |
33,206,168 |
|
Capital
Markets |
10,579,338 |
— |
— |
10,579,338 |
|
Communications
Equipment |
22,674,662 |
11,322,170 |
— |
33,996,832 |
|
Consumer
Finance |
6,510,403 |
— |
42,255,857 |
48,766,260 |
|
Diversified
Consumer Services |
— |
— |
— |
— |
|
Diversified
Telecommunication Services |
9,528,341 |
— |
— |
9,528,341 |
|
Electrical
Equipment |
— |
7,587,607 |
— |
7,587,607 |
|
Electronic
Equipment, Instruments & Components |
55,033,392 |
— |
— |
55,033,392 |
|
Entertainment |
95,159,222 |
25,265,491 |
— |
120,424,713 |
|
Financial
Services |
— |
18,464,543 |
— |
18,464,543 |
|
Health
Care Technology |
— |
7,625,243 |
— |
7,625,243 |
|
Independent
Power and Renewable Electricity Producers |
10,011,793 |
— |
— |
10,011,793 |
|
Industrial
Conglomerates |
— |
23,646,739 |
— |
23,646,739 |
|
IT
Services |
63,520,271 |
— |
11,574,612 |
75,094,883 |
|
Life
Sciences Tools & Services |
7,316,186 |
— |
— |
7,316,186 |
|
Media |
9,074,738 |
— |
— |
9,074,738 |
|
Professional
Services |
20,948,293 |
— |
— |
20,948,293 |
|
Semiconductors
& Semiconductor Equipment |
230,454,806 |
114,218,853 |
— |
344,673,659 |
|
Software |
138,949,888 |
26,391,793 |
49,414,282 |
214,755,963 |
|
Technology
Hardware, Storage & Peripherals |
31,042,095 |
11,034,336 |
— |
42,076,431 |
|
Preferred
Securities |
|
|
|
|
|
Preferred
Stocks |
— |
— |
423,004,791 |
423,004,791 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
50,993,885 |
— |
— |
50,993,885 |
|
|
$813,417,734 |
$249,262,440 |
$526,249,542 |
$1,588,929,716 |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (8,212,996
) |
$ (2,664,952
) |
$ — |
$ (10,877,948
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
|
Common
Stocks |
Preferred
Stocks
|
Total
|
|
Assets |
|
|
|
|
Opening
balance, as of December 31, 2024 |
$ 107,161,463 |
$ 419,768,363 |
$ 526,929,826 |
|
Transfers
into Level 3 |
— |
— |
— |
|
Transfers
out of Level 3 |
— |
— |
— |
|
Accrued
discounts/premiums |
— |
— |
— |
|
Net
realized gain (loss) |
(5,699,998
) |
(11,988,162
) |
(17,688,160
) |
|
Net
change in unrealized appreciation (depreciation)(a)(b) |
1,771,441 |
15,236,437 |
17,007,878 |
|
Purchases |
23,366,842 |
— |
23,366,842 |
|
Sales |
(23,354,997
) |
(11,847
) |
(23,366,844
) |
|
Closing
balance, as of June 30, 2025 |
$ 103,244,751 |
$ 423,004,791 |
$ 526,249,542 |
|
Net
change in unrealized appreciation (depreciation) on investments still held
at June 30, 2025(b) |
$ 16,160,015 |
$ 11,765,724 |
$ 27,925,739 |
|
(a)
|
Included
in the related net change in unrealized appreciation (depreciation) in the
Consolidated Statements of Operations. |
|
(b)
|
Any
difference between net change in unrealized appreciation (depreciation)
and net change in unrealized appreciation (depreciation) on investments
still held at June 30, 2025 is
generally
due to investments no longer held or categorized as Level 3 at period
end. |
|
|
Value |
Valuation
Approach |
Unobservable
Inputs |
Range
of
Unobservable
Inputs
Utilized(a)
|
Weighted
Average
of
Unobservable
Inputs
Based
on
Fair Value
|
|
Assets |
|
||||
|
Common
Stocks |
$103,244,751 |
Market |
Revenue
Multiple |
1.40x -
18.00x |
9.91x |
|
|
|
Volatility |
70% -
70% |
70% | |
|
|
|
|
Time
to Exit |
0.3 -
3.0 years |
2.8
years |
|
|
|
||||
|
Preferred
Stocks |
423,004,791 |
Market |
Revenue
Multiple |
1.50x -
21.00x |
14.02x |
|
|
|
Time
to Exit |
3.0 -
4.0 years |
3.7
years | |
|
|
|
|
Volatility |
35% -
90% |
74% |
|
|
|
Market
Adjustment Multiple |
1.10x |
— | |
|
|
|
|
Gross
Profit Multiple |
8.00x |
— |
|
|
$526,249,542 |
|
(a)
|
A
significant change in unobservable input could result in a correlated or
inverse change in value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Aerospace
& Defense — 0.4% |
| ||
Anduril
Industries, Inc.(a)(b) |
139,772 |
$ 5,713,879 | |
|
Automobiles
— 0.7% |
| ||
Tesla,
Inc.(b) |
29,731 |
9,444,350 | |
|
Broadline
Retail — 5.0% |
| ||
Alibaba
Group Holding Ltd. |
687,992 |
9,739,173 | |
|
Amazon.com,
Inc.(b)(c) |
|
173,841 |
38,138,977 |
MercadoLibre,
Inc.(b) |
8,611 |
22,505,968 | |
|
|
|
|
70,384,118 |
|
Capital
Markets — 1.0% |
| ||
|
CME
Group, Inc., Class A |
|
21,716 |
5,985,365 |
Deutsche
Boerse AG, Class N |
24,050 |
7,856,884 | |
|
|
|
|
13,842,249 |
|
Communications
Equipment — 0.8% |
| ||
|
Arista
Networks, Inc.(b) |
|
108,396 |
11,089,995 |
|
Consumer
Finance — 0.9% |
| ||
|
Klarna
Group PLC, (Acquired 08/07/19, Cost:
$7,971,978)(a)(b)(d) |
|
317,160 |
12,860,838 |
|
Diversified
Consumer Services(a)(b)(d)
— 0.6% |
| ||
|
Grammarly,
Inc., (Acquired 11/17/21, Cost:
$18,749,975) |
|
715,323 |
8,290,594 |
Think
& Learn Private Ltd., Class J-B, (Acquired
09/30/20,
Cost: $1,524,948) |
997 |
— | |
|
|
|
|
8,290,594 |
|
Electrical
Equipment — 0.5% |
| ||
|
Siemens
Energy AG(b) |
|
57,439 |
6,713,524 |
|
Entertainment
— 3.7% |
| ||
|
Nintendo
Co. Ltd. |
|
104,000 |
9,987,097 |
Spotify
Technology SA(b) |
38,972 |
29,904,775 | |
|
Take-Two
Interactive Software, Inc.(b) |
|
52,968 |
12,863,279 |
|
|
52,755,151 | ||
|
Financial
Services — 2.2% |
| ||
Adyen
NV(b)(e) |
4,417 |
8,111,984 | |
|
Mastercard,
Inc., Class A |
|
25,371 |
14,256,980 |
Plaid(a)(b) |
42,651 |
8,699,951 | |
|
|
|
|
31,068,915 |
|
Industrial
Conglomerates — 0.9% |
| ||
|
Hitachi
Ltd. |
|
423,500 |
12,308,744 |
|
Interactive
Media & Services — 3.9% |
| ||
|
Meta
Platforms, Inc., Class A |
|
72,524 |
53,529,239 |
Patreon,
Inc., (Acquired 08/19/21, Cost:
$3,352,226)(a)(b)(d) |
59,524 |
1,315,480 | |
|
|
|
|
54,844,719 |
|
IT
Services — 4.3% |
| ||
|
Automattic,
Inc., (Acquired 02/03/21, Cost:
$7,999,945)(a)(b)(d) |
|
94,117 |
2,610,806 |
Deep
Instinct Ltd.(a)(b) |
49,349 |
2,961 | |
|
Farmer’s
Business Network, Inc.(a)(b) |
|
203,366 |
262,342 |
International
Business Machines Corp. |
30,293 |
8,929,771 | |
|
Shopify,
Inc., Class A(b) |
|
77,586 |
8,949,545 |
Snowflake,
Inc., Class A(b) |
146,550 |
32,793,494 | |
|
Twilio,
Inc., Class A(b) |
|
59,712 |
7,425,784 |
|
|
60,974,703 | ||
|
Security |
|
Shares |
Value |
|
Media
— 1.7% |
| ||
|
MNTN,
Inc., Series D, (Acquired 11/05/21, Cost:
$24,999,980)(b)(d) |
|
1,088,598 |
$ 23,807,638 |
|
Professional
Services — 1.7% |
| ||
|
RELX
PLC |
|
307,282 |
16,653,967 |
Thomson
Reuters Corp. |
38,487 |
7,739,512 | |
|
|
|
|
24,393,479 |
|
Semiconductors
& Semiconductor Equipment — 28.3% |
| ||
|
Advantest
Corp. |
|
191,700 |
14,210,912 |
ASM
International NV |
16,092 |
10,322,661 | |
|
ASML
Holding NV |
|
11,330 |
9,079,148 |
Broadcom,
Inc.(c) |
356,296 |
98,212,992 | |
|
Celestial
Asia Securities Holdings Ltd.(a)(b) |
|
588,496 |
9,898,503 |
Credo
Technology Group Holding Ltd.(b) |
147,616 |
13,667,765 | |
|
Lam
Research Corp. |
|
174,672 |
17,002,573 |
Microchip
Technology, Inc. |
121,236 |
8,531,377 | |
|
Monolithic
Power Systems, Inc. |
|
12,326 |
9,014,990 |
NVIDIA
Corp.(f) |
1,229,476 |
194,244,913 | |
|
Taiwan
Semiconductor Manufacturing Co. Ltd., ADR |
|
67,568 |
15,303,476 |
|
|
399,489,310 | ||
|
Software
— 22.9% |
| ||
AppLovin
Corp., Class A(b) |
35,448 |
12,409,636 | |
|
Cadence
Design Systems, Inc.(b) |
|
76,668 |
23,625,244 |
Canva,
Inc.(a)(b) |
9,375 |
10,432,688 | |
|
Constellation
Software, Inc./Canada |
|
3,465 |
12,705,297 |
Crowdstrike
Holdings, Inc., Class A(b) |
33,681 |
17,154,070 | |
|
CyberArk
Software Ltd.(b) |
|
36,484 |
14,844,610 |
Databricks,
Inc., (Acquired 07/24/20, Cost:
$960,476)(a)(b)(d) |
59,997 |
6,490,475 | |
|
DataRobot,
Inc., (Acquired 03/01/21, Cost:
$583,275)(a)(b)(d) |
|
38,789 |
49,650 |
Guidewire
Software, Inc.(b) |
50,446 |
11,877,511 | |
|
Intuit,
Inc. |
|
12,957 |
10,205,322 |
Microsoft
Corp.(c) |
243,210 |
120,975,086 | |
|
Oracle
Corp. |
|
188,634 |
41,241,051 |
Rubrik,
Inc., Class A(b) |
80,703 |
7,230,182 | |
|
ServiceNow,
Inc.(b) |
|
17,993 |
18,498,243 |
Snorkel
AI, Inc., (Acquired 06/30/21, Cost:
$997,636)(a)(b)(d) |
66,422 |
636,323 | |
|
Snyk
Ltd., Ordinary Shares, (Acquired 09/02/21, Cost:
$5,192,307)(a)(b)(d) |
|
361,972 |
2,092,198 |
Teya
Services Ltd., Series C, (Acquired 12/17/21, Cost:
$24,999,987)(a)(b)(d) |
12,871 |
3,538,109 | |
|
Xero
Ltd.(b) |
|
81,800 |
9,679,333 |
|
|
323,685,028 | ||
|
Specialty
Retail — 0.0% |
| ||
AceVector
Limited, Series I, (Acquired 08/31/18, Cost:
$1,998,435)(a)(b)(d) |
168,640 |
58,147 | |
|
Technology
Hardware, Storage & Peripherals — 5.1% |
| ||
Apple,
Inc.(c) |
349,389 |
71,684,141 | |
|
Wireless
Telecommunication Services — 0.8% |
| ||
SoftBank
Group Corp. |
165,200 |
12,011,031 | |
|
Total
Common Stocks — 85.4%
(Cost:
$530,667,138) |
1,205,420,553 | ||
|
Security |
|
Par
(000) |
Value |
|
Convertible
Notes | |||
|
Financial
Services — 0.0% | |||
Wyre,
Inc., (Acquired 12/14/21, Cost: $8,000,000),
6.00%,
12/08/24(a)(d) |
$ |
80 |
$ 1 |
|
IT
Services — 0.1% | |||
Voltron
Capital, 0.00%(a) |
1,663 |
1,795,538 | |
|
Total
Convertible Notes — 0.1%
(Cost:
$9,662,535) |
1,795,539 | ||
|
|
|
Shares |
|
|
Preferred
Securities | |||
|
Preferred
Stocks — 15.3%(a) | |||
|
Aerospace
& Defense — 2.7% |
| ||
|
Anduril
Industries, Inc.(b) |
|
920,107 |
37,613,974 |
|
Chemicals
— 0.3% |
| ||
|
Solugen,
Inc., Series C, (Acquired 09/02/21, Cost:
$9,999,977)(b)(d) |
|
269,284 |
3,654,184 |
|
Communications
Equipment — 0.5% |
| ||
|
Astranis,
Series D(b) |
|
856,310 |
7,355,703 |
|
Consumer
Staples Distribution & Retail — 0.9% |
| ||
|
Grubmarket,
Inc., Series E, (Acquired 10/18/21, Cost:
$6,999,994)(b)(d) |
|
709,724 |
13,222,158 |
|
Diversified
Consumer Services(b)(d)
— 0.2% |
| ||
|
Grammarly,
Inc., Series 3, (Acquired 11/17/21, Cost:
$6,249,992) |
|
238,441 |
2,763,531 |
|
Think
& Learn Private Ltd., Series F, (Acquired 09/30/20,
Cost:
$3,052,975) |
1,054 |
— | |
|
|
|
|
2,763,531 |
|
Diversified
Telecommunication Services — 0.2% |
| ||
|
Discord,
Inc., Series I, (Acquired 09/13/21, Cost:
$7,000,088)(b)(d) |
|
12,713 |
3,002,048 |
|
Financial
Services(b)(d)(g)
— 1.1% |
| ||
|
Trumid
Holdings LLC |
|
|
|
|
Class
J-A, (Acquired 07/24/20, Cost: $2,499,716) |
5,038 |
3,622,927 | |
|
Class
J-B, (Acquired 07/24/20, Cost: $1,499,830) |
|
5,038 |
3,622,927 |
|
Class
L, (Acquired 09/15/21, Cost: $9,999,695) |
11,420 |
8,212,350 | |
|
|
|
|
15,458,204 |
|
Interactive
Media & Services(b)(d)
— 0.6% |
| ||
|
ByteDance
Ltd., Series E-1, (Acquired 11/11/20, Cost:
$2,857,834) |
|
24,110 |
5,594,484 |
|
Patreon,
Inc., Series D, (Acquired 07/14/21, Cost:
$6,666,632) |
119,047 |
2,630,939 | |
|
|
|
|
8,225,423 |
|
IT
Services(b)(d)
— 0.4% |
| ||
|
TRAX
Ltd. |
|
|
|
|
(Acquired
02/18/21, Cost: $1,999,989) |
38,361 |
719,269 | |
|
Security |
|
Shares |
Value |
|
IT
Services (continued) |
| ||
|
TRAX
Ltd. (continued) |
|
|
|
|
(Acquired
09/12/19, Cost: $4,000,013) |
106,667 |
$ 2,000,006 | |
|
Voltron
Data, Inc. |
|
|
|
|
Series
A, (Acquired 01/18/22, Cost: $10,000,000) |
6,201,935 |
2,356,735 | |
|
Series
SEED, (Acquired 07/14/21, Cost: $5,000,000) |
|
9,090,909 |
1,181,818 |
|
|
|
6,257,828 | |
|
Professional
Services — 0.3% |
| ||
|
ANT
Group Co. Ltd., Series C |
1,703,548 |
3,884,089 | |
|
Semiconductors
& Semiconductor Equipment(b)
— 4.4% |
| ||
|
Celestial
Asia Securities Holdings Ltd. |
|
| |
|
Series
A |
|
185,582 |
3,121,489 |
|
Series
B |
139,646 |
2,348,846 | |
|
PsiQuantum
Corp.(d)
|
|
|
|
|
Series
C, (Acquired 09/09/19, Cost: $3,200,234) |
690,003 |
25,633,611 | |
|
Series
D, (Acquired 05/21/21, Cost: $5,000,025) |
|
190,650 |
7,767,081 |
|
Rivos,
Inc. |
|
| |
|
Series
A1 |
|
2,700,558 |
6,859,417 |
|
Series
A2 |
2,464,862 |
5,693,831 | |
|
Series
A3 |
|
1,027,026 |
2,372,430 |
|
SambaNova
Systems, Inc., Series C, (Acquired
02/20/20,
Cost: $9,972,125)(d) |
187,300 |
8,329,231 | |
|
|
|
|
62,125,936 |
|
Software(b)(d)
— 3.3% |
| ||
|
Bolt
Financial, Inc., Series E, (Acquired 01/18/22, Cost:
$0) |
|
598,682 |
6 |
|
Databricks,
Inc. |
|
| |
|
Series
F, (Acquired 10/22/19, Cost: $3,999,999) |
|
279,405 |
30,226,033 |
|
Series
G, (Acquired 02/01/21, Cost: $4,500,001) |
76,113 |
8,233,904 | |
|
DataRobot,
Inc., Series F, (Acquired 10/27/20, Cost:
$2,999,996) |
|
228,276 |
881,145 |
|
Snorkel
AI, Inc., Series C, (Acquired 06/30/21, Cost:
$4,999,985) |
332,896 |
3,189,144 | |
|
Snyk
Ltd., Series F, (Acquired 09/02/21, Cost:
$4,807,688) |
|
337,018 |
1,947,964 |
|
Unqork,
Inc. |
|
| |
|
Series
B, (Acquired 09/19/19, Cost: $3,198,416) |
|
281,080 |
1,725,831 |
|
Series
C, (Acquired 09/18/20, Cost: $1,303,260) |
47,600 |
382,228 | |
|
|
|
|
46,586,255 |
|
Technology
Hardware, Storage & Peripherals — 0.4% |
| ||
|
PsiQuantum
Corp., Series E(b) |
|
121,615 |
5,403,354 |
|
|
215,552,687 | ||
|
Total
Preferred Securities — 15.3%
(Cost:
$180,077,736) |
215,552,687 | ||
|
Security |
|
Shares |
Value |
|
Warrants | |||
|
Software
— 0.0% |
| ||
|
Constellation
Software, Inc., (Issued 08/29/23, 1 Share
for
1 Warrant, Expires 03/31/40, Strike Price CAD
11.50)(a)(b) |
3,923 |
$ — | |
|
Total
Warrants — 0.0%
(Cost:
$ — ) |
— | ||
|
Total
Long-Term Investments — 100.8%
(Cost:
$720,407,409) |
1,422,768,779 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 0.1% |
| ||
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(h)(i) |
|
1,029,031 |
1,029,031 |
|
Total
Short-Term Securities — 0.1%
(Cost:
$1,029,031) |
1,029,031 | ||
|
Total
Investments Before Options Written — 100.9%
(Cost:
$721,436,440) |
1,423,797,810 | ||
|
Options
Written — (0.9)%
(Premiums
Received: $(6,646,248)) |
(12,241,210
) | ||
|
Total
Investments, Net of Options Written — 100.0%
(Cost:
$714,790,192) |
1,411,556,600 | ||
|
Other
Assets Less Liabilities — 0.0% |
397,991 | ||
|
Net
Assets — 100.0% |
$ 1,411,954,591 | ||
|
(a)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(b)
|
Non-income
producing security. |
|
(c)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(d)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $202,649,813, representing 14.4% of its net assets
as of
period
end, and an original cost of $229,139,632. |
|
(e)
|
Security
exempt from registration pursuant to Rule 144A under the Securities Act of
1933,
as
amended. These securities may be resold in transactions exempt from
registration to
qualified
institutional investors. |
|
(f)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(g)
|
All
or a portion of the security is held by a wholly-owned subsidiary. See
Note 1
of the
Notes
to Financial Statements for details on the wholly-owned
subsidiary. |
|
(h)
|
Affiliate
of the Trust. |
|
(i)
|
Annualized
7-day yield as of period
end. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency Shares(a) |
$ 565,400 |
$ — |
$ (565,347
)(b) |
$ (53
) |
$ — |
$ — |
— |
$ 4,134
(c) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares |
1,644,863 |
— |
(615,832
)(b) |
— |
— |
1,029,031 |
1,029,031 |
203,619 |
— |
|
|
|
|
|
$ (53
) |
$ — |
$ 1,029,031 |
|
$ 207,753 |
$ — |
|
(a)
|
As
of period end, the entity is no longer held. |
|
(b)
|
Represents
net amount purchased (sold). |
|
(c)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Applovin
Corp., Class A |
32 |
07/11/25 |
USD |
390.00 |
USD |
1,120 |
$ (14,080
) |
|
Broadcom,
Inc. |
115 |
07/11/25 |
USD |
265.00 |
USD |
3,170 |
(155,250
) |
|
Intuit,
Inc. |
17 |
07/11/25 |
USD |
790.00 |
USD |
1,339 |
(16,745
) |
|
Lam
Research Corp. |
75 |
07/11/25 |
USD |
93.00 |
USD |
730 |
(35,625
) |
|
Mastercard,
Inc., Class A |
75 |
07/11/25 |
USD |
590.00 |
USD |
4,215 |
(2,813
) |
|
MercadoLibre,
Inc. |
9 |
07/11/25 |
USD |
2,600.00 |
USD |
2,352 |
(53,055
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Microsoft
Corp. |
160 |
07/11/25 |
USD |
470.00 |
USD |
7,959 |
$ (459,200
) |
|
NVIDIA
Corp. |
418 |
07/11/25 |
USD |
152.50 |
USD |
6,604 |
(300,960
) |
|
NVIDIA
Corp. |
338 |
07/11/25 |
USD |
149.04 |
USD |
5,340 |
(342,377
) |
|
Oracle
Corp. |
27 |
07/11/25 |
USD |
165.00 |
USD |
590 |
(147,420
) |
|
ServiceNow,
Inc. |
20 |
07/11/25 |
USD |
1,050.00 |
USD |
2,056 |
(19,600
) |
|
Spotify
Technology SA |
77 |
07/11/25 |
USD |
700.00 |
USD |
5,909 |
(536,497
) |
|
Amazon.com,
Inc. |
243 |
07/18/25 |
USD |
210.00 |
USD |
5,331 |
(286,740
) |
|
Amazon.com,
Inc. |
57 |
07/18/25 |
USD |
220.00 |
USD |
1,251 |
(29,783
) |
|
Apple,
Inc. |
260 |
07/18/25 |
USD |
210.00 |
USD |
5,334 |
(72,280
) |
|
Broadcom,
Inc. |
227 |
07/18/25 |
USD |
250.00 |
USD |
6,257 |
(625,951
) |
|
Cadence
Design Systems, Inc. |
96 |
07/18/25 |
USD |
340.00 |
USD |
2,958 |
(5,760
) |
|
CME
Group, Inc., Class A |
21 |
07/18/25 |
USD |
280.00 |
USD |
579 |
(5,933
) |
|
Credo
Technology Group Holding Ltd. |
142 |
07/18/25 |
USD |
70.00 |
USD |
1,315 |
(328,020
) |
|
Crowdstrike
Holdings, Inc., Class A |
30 |
07/18/25 |
USD |
500.00 |
USD |
1,528 |
(63,225
) |
|
CyberArk
Software, Ltd. |
72 |
07/18/25 |
USD |
400.00 |
USD |
2,930 |
(115,560
) |
|
Guidewire
Software, Inc. |
50 |
07/18/25 |
USD |
230.00 |
USD |
1,177 |
(44,500
) |
|
Lam
Research Corp. |
274 |
07/18/25 |
USD |
85.00 |
USD |
2,667 |
(352,090
) |
|
Meta
Platforms, Inc., Class A |
99 |
07/18/25 |
USD |
725.00 |
USD |
7,307 |
(255,915
) |
|
Microchip
Technology, Inc. |
153 |
07/18/25 |
USD |
67.50 |
USD |
1,077 |
(64,260
) |
|
Microsoft
Corp. |
81 |
07/18/25 |
USD |
460.00 |
USD |
4,029 |
(317,722
) |
|
Monolithic
Power Systems, Inc. |
11 |
07/18/25 |
USD |
760.00 |
USD |
805 |
(19,250
) |
|
NVIDIA
Corp. |
106 |
07/18/25 |
USD |
135.00 |
USD |
1,675 |
(250,955
) |
|
NVIDIA
Corp. |
126 |
07/18/25 |
USD |
130.00 |
USD |
1,991 |
(359,730
) |
|
NVIDIA
Corp. |
195 |
07/18/25 |
USD |
150.00 |
USD |
3,081 |
(198,412
) |
|
Oracle
Corp. |
270 |
07/18/25 |
USD |
210.00 |
USD |
5,903 |
(311,175
) |
|
Rubrik,
Inc,. Class A |
106 |
07/18/25 |
USD |
95.00 |
USD |
950 |
(21,995
) |
|
Rubrik,
Inc,. Class A |
74 |
07/18/25 |
USD |
100.00 |
USD |
663 |
(7,030
) |
|
ServiceNow,
Inc. |
20 |
07/18/25 |
USD |
1,060.00 |
USD |
2,056 |
(23,600
) |
|
Shopify,
Inc., Class A |
80 |
07/18/25 |
USD |
115.00 |
USD |
923 |
(38,000
) |
|
Snowflake,
Inc., Class A |
124 |
07/18/25 |
USD |
220.00 |
USD |
2,775 |
(101,370
) |
|
Take-Two
Interactive Software, Inc. |
52 |
07/18/25 |
USD |
240.00 |
USD |
1,263 |
(36,660
) |
|
Tesla,
Inc. |
5 |
07/18/25 |
USD |
350.00 |
USD |
159 |
(2,500
) |
|
Tesla,
Inc. |
10 |
07/18/25 |
USD |
365.00 |
USD |
318 |
(2,885
) |
|
Twilio,
Inc., Class A |
44 |
07/18/25 |
USD |
130.00 |
USD |
547 |
(9,482
) |
|
Apple,
Inc. |
248 |
07/25/25 |
USD |
210.00 |
USD |
5,088 |
(88,040
) |
|
Applovin
Corp., Class A |
38 |
07/25/25 |
USD |
415.00 |
USD |
1,330 |
(21,090
) |
|
Arista
Networks, Inc. |
219 |
07/25/25 |
USD |
102.00 |
USD |
2,241 |
(108,405
) |
|
Broadcom,
Inc. |
98 |
07/25/25 |
USD |
260.00 |
USD |
2,701 |
(202,370
) |
|
MercadoLibre,
Inc. |
8 |
07/25/25 |
USD |
2,700.00 |
USD |
2,091 |
(34,240
) |
|
Microsoft
Corp. |
172 |
07/25/25 |
USD |
485.00 |
USD |
8,555 |
(310,890
) |
|
NVIDIA
Corp. |
106 |
07/25/25 |
USD |
147.00 |
USD |
1,675 |
(142,040
) |
|
NVIDIA
Corp. |
196 |
07/25/25 |
USD |
150.00 |
USD |
3,097 |
(217,070
) |
|
Snowflake,
Inc., Class A |
35 |
07/25/25 |
USD |
215.00 |
USD |
783 |
(45,938
) |
|
Take-Two
Interactive Software, Inc. |
53 |
07/25/25 |
USD |
250.00 |
USD |
1,287 |
(18,285
) |
|
Tesla,
Inc. |
20 |
07/25/25 |
USD |
350.00 |
USD |
635 |
(18,900
) |
|
Twilio,
Inc., Class A |
75 |
07/25/25 |
USD |
123.00 |
USD |
933 |
(41,438
) |
|
Amazon.com,
Inc. |
26 |
08/01/25 |
USD |
225.00 |
USD |
570 |
(18,785
) |
|
Broadcom,
Inc. |
109 |
08/01/25 |
USD |
260.00 |
USD |
3,005 |
(242,797
) |
|
Crowdstrike
Holdings, Inc., Class A |
30 |
08/01/25 |
USD |
500.00 |
USD |
1,528 |
(82,050
) |
|
NVIDIA
Corp. |
374 |
08/01/25 |
USD |
160.00 |
USD |
5,909 |
(226,270
) |
|
Oracle
Corp. |
80 |
08/01/25 |
USD |
205.00 |
USD |
1,749 |
(137,800
) |
|
Shopify,
Inc., Class A |
75 |
08/01/25 |
USD |
115.00 |
USD |
865 |
(51,375
) |
|
Taiwan
Semiconductor Manufacturing Co. Ltd., ADR |
129 |
08/01/25 |
USD |
225.00 |
USD |
2,922 |
(142,223
) |
|
Tesla,
Inc. |
10 |
08/01/25 |
USD |
365.00 |
USD |
318 |
(8,450
) |
|
Meta
Platforms, Inc., Class A |
54 |
08/08/25 |
USD |
745.00 |
USD |
3,986 |
(185,760
) |
|
Amazon.com,
Inc. |
25 |
08/15/25 |
USD |
225.00 |
USD |
548 |
(21,125
) |
|
Apple,
Inc. |
265 |
08/15/25 |
USD |
210.00 |
USD |
5,437 |
(178,212
) |
|
Broadcom,
Inc. |
163 |
08/15/25 |
USD |
260.00 |
USD |
4,493 |
(403,832
) |
|
Cadence
Design Systems, Inc. |
69 |
08/15/25 |
USD |
320.00 |
USD |
2,126 |
(70,380
) |
|
CME
Group, Inc., Class A |
22 |
08/15/25 |
USD |
280.00 |
USD |
606 |
(15,180
) |
|
Credo
Technology Group Holding Ltd. |
84 |
08/15/25 |
USD |
80.00 |
USD |
778 |
(139,440
) |
|
Credo
Technology Group Holding Ltd. |
69 |
08/15/25 |
USD |
90.00 |
USD |
639 |
(71,415
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Guidewire
Software, Inc. |
50 |
08/15/25 |
USD |
254.50 |
USD |
1,177 |
$ (17,190
) |
|
International
Business Machines Corp. |
58 |
08/15/25 |
USD |
285.00 |
USD |
1,710 |
(111,215
) |
|
Microchip
Technology, Inc. |
89 |
08/15/25 |
USD |
72.50 |
USD |
626 |
(32,930
) |
|
Microsoft
Corp. |
79 |
08/15/25 |
USD |
495.00 |
USD |
3,930 |
(151,088
) |
|
Monolithic
Power Systems, Inc. |
11 |
08/15/25 |
USD |
770.00 |
USD |
805 |
(43,395
) |
|
NVIDIA
Corp. |
600 |
08/15/25 |
USD |
150.00 |
USD |
9,479 |
(814,500
) |
|
Snowflake,
Inc., Class A |
134 |
08/15/25 |
USD |
230.00 |
USD |
2,999 |
(106,865
) |
|
Thomson
Reuters Corp. |
72 |
08/15/25 |
CAD |
270.00 |
CAD |
1,972 |
(53,402
) |
|
|
|
|
|
|
|
|
$ (10,608,790
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
SoftBank
Group Corp. |
Nomura
International PLC |
8,300 |
07/02/25 |
JPY |
8,321.00 |
JPY |
86,901 |
$ (126,468
) |
|
Xero
Ltd. |
JPMorgan
Chase Bank N.A. |
16,200 |
07/02/25 |
AUD |
187.51 |
AUD |
2,913 |
(35
) |
|
Alibaba
Group Holding Ltd. |
Bank
of America N.A. |
31,100 |
07/08/25 |
HKD |
128.41 |
HKD |
3,456 |
(26
) |
|
Adyen
NV |
Goldman
Sachs International |
700 |
07/10/25 |
EUR |
1,687.17 |
EUR |
1,091 |
(2,240
) |
|
SoftBank
Group Corp. |
Morgan
Stanley & Co. International PLC |
21,200 |
07/10/25 |
JPY |
7,847.84 |
JPY |
221,965 |
(393,241
) |
|
Nintendo
Co. Ltd. |
JPMorgan
Chase Bank N.A. |
13,300 |
07/15/25 |
JPY |
12,757.50 |
JPY |
183,923 |
(116,551
) |
|
Deutsche
Boerse AG |
BNP
Paribas SA |
4,800 |
07/17/25 |
EUR |
285.42 |
EUR |
1,331 |
(7,404
) |
|
Hitachi
Ltd. |
JPMorgan
Chase Bank N.A. |
86,700 |
07/23/25 |
JPY |
4,275.60 |
JPY |
362,875 |
(90,620
) |
|
Nintendo
Co. Ltd. |
JPMorgan
Chase Bank N.A. |
7,500 |
07/23/25 |
JPY |
12,393.62 |
JPY |
103,716 |
(85,777
) |
|
Advantest
Corp. |
JPMorgan
Chase Bank N.A. |
32,900 |
07/24/25 |
JPY |
8,783.73 |
JPY |
351,215 |
(501,608
) |
|
ASML
Holding NV |
Bank
of America N.A. |
2,400 |
07/29/25 |
EUR |
685.36 |
EUR |
1,633 |
(73,193
) |
|
ASM
International NV |
BNP
Paribas SA |
3,400 |
08/05/25 |
EUR |
559.08 |
EUR |
1,852 |
(77,496
) |
|
Alibaba
Group Holding Ltd. |
Citibank
N.A. |
58,000 |
08/06/25 |
HKD |
117.48 |
HKD |
6,445 |
(14,814
) |
|
Siemens
Energy AG |
Bank
of America N.A. |
10,700 |
08/06/25 |
EUR |
98.18 |
EUR |
1,062 |
(77,027
) |
|
Alibaba
Group Holding Ltd. |
Bank
of America N.A. |
58,000 |
08/08/25 |
HKD |
118.79 |
HKD |
6,445 |
(13,872
) |
|
RELX
PLC |
UBS
AG |
61,400 |
08/08/25 |
GBP |
40.07 |
GBP |
2,424 |
(52,048
) |
|
|
|
|
|
|
|
|
|
$ (1,632,420
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
|
Options
Written |
$ N/A |
$ (6,646,248
) |
$ 666,212 |
$ (6,261,174
) |
$ (12,241,210
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 12,241,210 |
$ — |
$ — |
$ — |
$ 12,241,210 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (1,364,329
) |
$ — |
$ — |
$ — |
$ (1,364,329
) |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (9,968,022
) |
$ — |
$ — |
$ — |
$ (9,968,022
) |
|
Options: |
|
|
Average
value of option contracts written |
$7,153,499 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 12,241,210 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
12,241,210 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(10,608,790
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 1,632,420 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 164,118 |
$ — |
$ — |
$ — |
$ 164,118 |
|
BNP
Paribas SA |
84,900 |
— |
— |
— |
84,900 |
|
Citibank
N.A. |
14,814 |
— |
— |
— |
14,814 |
|
Goldman
Sachs International |
2,240 |
— |
— |
— |
2,240 |
|
JPMorgan
Chase Bank N.A. |
794,591 |
— |
(794,591
) |
— |
— |
|
Morgan
Stanley & Co. International PLC |
393,241 |
— |
— |
— |
393,241 |
|
Nomura
International PLC |
126,468 |
— |
— |
— |
126,468 |
|
UBS
AG |
52,048 |
— |
— |
— |
52,048 |
|
|
$ 1,632,420 |
$ — |
$ (794,591
) |
$ — |
$ 837,829 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and
Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Aerospace
& Defense |
$ — |
$ — |
$ 5,713,879 |
$ 5,713,879 |
|
Automobiles |
9,444,350 |
— |
— |
9,444,350 |
|
Broadline
Retail |
60,644,945 |
9,739,173 |
— |
70,384,118 |
|
Capital
Markets |
5,985,365 |
7,856,884 |
— |
13,842,249 |
|
Communications
Equipment |
11,089,995 |
— |
— |
11,089,995 |
|
Consumer
Finance |
— |
— |
12,860,838 |
12,860,838 |
|
Diversified
Consumer Services |
— |
— |
8,290,594 |
8,290,594 |
|
Electrical
Equipment |
— |
6,713,524 |
— |
6,713,524 |
|
Entertainment |
42,768,054 |
9,987,097 |
— |
52,755,151 |
|
Financial
Services |
14,256,980 |
8,111,984 |
8,699,951 |
31,068,915 |
|
Industrial
Conglomerates |
— |
12,308,744 |
— |
12,308,744 |
|
Interactive
Media & Services |
53,529,239 |
— |
1,315,480 |
54,844,719 |
|
IT
Services |
58,098,594 |
— |
2,876,109 |
60,974,703 |
|
Media |
— |
23,807,638 |
— |
23,807,638 |
|
Professional
Services |
7,739,512 |
16,653,967 |
— |
24,393,479 |
|
Semiconductors
& Semiconductor Equipment |
355,978,086 |
33,612,721 |
9,898,503 |
399,489,310 |
|
Software |
290,766,252 |
9,679,333 |
23,239,443 |
323,685,028 |
|
Specialty
Retail |
— |
— |
58,147 |
58,147 |
|
Technology
Hardware, Storage & Peripherals |
71,684,141 |
— |
— |
71,684,141 |
|
Wireless
Telecommunication Services |
— |
12,011,031 |
— |
12,011,031 |
|
Convertible
Notes |
— |
— |
1,795,539 |
1,795,539 |
|
Preferred
Securities |
|
|
|
|
|
Preferred
Stocks |
— |
— |
215,552,687 |
215,552,687 |
|
Warrants |
— |
— |
— |
— |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
1,029,031 |
— |
— |
1,029,031 |
|
|
$983,014,544 |
$150,482,096 |
$290,301,170 |
$1,423,797,810 |
|
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Equity
Contracts |
$ (10,249,223
) |
$ (1,991,987
) |
$ — |
$ (12,241,210
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
|
Common
Stocks |
Convertible
Notes |
Preferred
Stocks |
Warrants |
Total
|
|
Assets |
|
|
|
|
|
|
Opening
balance, as of December 31, 2024 |
$ 55,665,715 |
$ 1,695,787 |
$ 220,068,321 |
$ —
(a) |
$ 277,429,823 |
|
Transfers
into Level 3 |
— |
— |
— |
— |
— |
|
Transfers
out of Level 3 |
— |
— |
— |
— |
— |
|
Accrued
discounts/premiums |
— |
— |
— |
— |
— |
|
Net
realized gain (loss) |
— |
— |
(7,996,429
) |
— |
(7,996,429
) |
|
Net
change in unrealized appreciation (depreciation)(b)(c) |
(7,311,316
) |
(7,900,248
) |
48,663,648 |
— |
33,452,084 |
|
Purchases |
32,570,524 |
8,000,000 |
9,820,043 |
— |
50,390,567 |
|
Sales |
(7,971,979
) |
— |
(55,002,896
) |
— |
(62,974,875
) |
|
Closing
balance, as of June 30, 2025 |
$ 72,952,944 |
$ 1,795,539 |
$ 215,552,687 |
$ —
(a) |
$ 290,301,170 |
|
Net
change in unrealized appreciation (depreciation) on investments still held
at June 30, 2025(c) |
$ (2,060,973
) |
$ (7,900,248
) |
$ 36,423,985 |
$ —
(a) |
$ 26,462,764 |
|
(a)
|
Rounds
to less than $1. |
|
(b)
|
Included
in the related net change in unrealized appreciation (depreciation) in the
Statements of Operations. |
|
(c)
|
Any
difference between net change in unrealized appreciation (depreciation)
and net change in unrealized appreciation (depreciation) on investments
still held at June 30, 2025 is
generally
due to investments no longer held or categorized as Level 3 at period
end. |
|
|
Value |
Valuation
Approach |
Unobservable
Inputs |
Range
of
Unobservable
Inputs
Utilized(a)
|
Weighted
Average
of
Unobservable
Inputs
Based
on
Fair Value
|
|
Assets |
|
||||
|
Common
Stocks |
$72,952,944 |
Market |
Revenue
Multiple |
1..40x -
24.25x |
11.71x |
|
|
|
Volatility |
70% -
70% |
70% | |
|
|
|
|
Time
to Exit |
0.3 -
3.0 years |
2.9
years |
|
|
|
Gross
Profit Multiple |
8.25x
-16.70x |
14.26x | |
|
|
|
|
|
|
|
|
Preferred
Stocks |
215,552,687 |
Market |
Revenue
Multiple |
1.50x -
24.25x |
14.31x |
|
|
|
|
Volatility |
70% -
90% |
73% |
|
|
|
Time
to Exit |
0.2 -
5.0 years |
3.7
years | |
|
|
|
|
Market
Adjustment Multiple |
1.10x-1.20x |
1.13x |
|
|
|
Terminal
Growth Rate |
5% |
— | |
|
|
|
|
Gross
Profit Multiple |
8.00x |
— |
|
|
|
||||
|
Convertible
Notes |
1,795,539 |
Market |
Revenue
Multiple |
8.00x |
— |
|
|
|
Volatility |
75% |
— | |
|
|
|
|
Time
to Exit |
0.2
years |
— |
|
|
$290,301,170 |
|
(a)
|
A
significant change in unobservable input could result in a correlated or
inverse change in value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Aerospace
& Defense — 0.5% |
| ||
|
Archer
Aviation, Inc., Class A(a) |
704,783 |
$ 7,646,896 | |
|
Automobiles
— 1.0% |
| ||
|
BYD
Co. Ltd., Class H |
287,000 |
4,468,596 | |
|
Tesla,
Inc.(a) |
|
39,557 |
12,565,677 |
|
|
|
17,034,273 | |
|
Broadline
Retail — 2.3% |
| ||
|
MercadoLibre,
Inc.(a) |
14,013 |
36,624,797 | |
|
Capital
Markets — 0.7% |
| ||
|
Cboe
Global Markets, Inc. |
48,248 |
11,251,916 | |
|
Communications
Equipment — 2.1% |
| ||
|
Accton
Technology Corp. |
419,000 |
10,472,383 | |
|
Lumentum
Holdings, Inc.(a) |
|
252,960 |
24,046,377 |
|
|
|
34,518,760 | |
|
Consumer
Finance — 0.4% |
| ||
|
SoFi
Technologies, Inc.(a) |
374,486 |
6,819,390 | |
|
Diversified
Consumer Services — 0.7% |
| ||
|
Grammarly,
Inc., (Acquired 11/17/21, Cost:
$26,250,012)(a)(b)(c) |
1,001,454 |
11,606,852 | |
|
Diversified
Telecommunication Services — 0.7% |
| ||
|
AST
SpaceMobile, Inc., Class A(a)(d) |
241,064 |
11,264,921 | |
|
Electrical
Equipment — 0.5% |
| ||
|
Doosan
Enerbility Co. Ltd.(a) |
155,434 |
7,874,766 | |
|
Electronic
Equipment, Instruments & Components(a)
— 4.0% |
| ||
|
Celestica,
Inc. |
208,585 |
32,562,203 | |
|
Fabrinet |
|
108,542 |
31,985,157 |
|
|
|
64,547,360 | |
|
Entertainment
— 8.9% |
| ||
|
Konami
Group Corp. |
63,700 |
10,071,076 | |
|
Krafton,
Inc.(a) |
|
17,182 |
4,613,183 |
|
Nintendo
Co. Ltd. |
222,100 |
21,328,215 | |
|
ROBLOX
Corp., Class A(a) |
|
100,505 |
10,573,126 |
|
Spotify
Technology SA(a) |
66,683 |
51,168,533 | |
|
Take-Two
Interactive Software, Inc.(a) |
|
124,469 |
30,227,297 |
|
Tencent
Music Entertainment Group, ADR |
763,915 |
14,888,703 | |
|
|
|
|
142,870,133 |
|
Financial
Services — 1.5% |
| ||
|
Adyen
NV(a)(e) |
|
12,953 |
23,788,664 |
|
Health
Care Technology — 0.5% |
| ||
|
M3,
Inc. |
|
609,000 |
8,365,651 |
|
Independent
Power and Renewable Electricity Producers — 0.8% |
| ||
|
Talen
Energy Corp.(a) |
|
45,315 |
13,176,242 |
|
Industrial
Conglomerates — 1.8% |
| ||
|
Hitachi
Ltd. |
|
999,700 |
29,055,611 |
|
Interactive
Media & Services — 0.3% |
| ||
|
Patreon,
Inc., (Acquired 08/19/21, Cost:
$11,732,736)(a)(b)(c) |
|
208,333 |
4,604,159 |
|
IT
Services — 5.5% |
| ||
|
Cloudflare,
Inc., Class A(a) |
|
130,492 |
25,554,248 |
|
Security |
|
Shares |
Value |
|
IT
Services (continued) |
| ||
|
NEC
Corp. |
|
537,700 |
$ 15,687,420 |
|
Snowflake,
Inc., Class A(a) |
154,525 |
34,578,059 | |
|
Twilio,
Inc., Class A(a) |
|
99,679 |
12,396,081 |
|
|
|
88,215,808 | |
|
Life
Sciences Tools & Services — 0.6% |
| ||
|
Tempus
AI, Inc.(a)(d) |
153,071 |
9,726,131 | |
|
Media
— 0.6%
|
| ||
|
MNTN,
Inc.(a)(d) |
419,134 |
9,166,461 | |
|
Professional
Services — 1.6% |
| ||
|
Thomson
Reuters Corp. |
130,561 |
26,259,734 | |
|
Semiconductors
& Semiconductor Equipment — 24.3% |
| ||
|
Advantest
Corp. |
242,300 |
17,961,940 | |
|
Alchip
Technologies Ltd. |
|
156,000 |
16,540,982 |
|
ASM
International NV |
26,755 |
17,162,738 | |
|
Astera
Labs, Inc.(a) |
|
145,328 |
13,140,558 |
|
Credo
Technology Group Holding Ltd.(a) |
288,262 |
26,690,179 | |
|
Disco
Corp. |
|
49,100 |
14,545,548 |
|
eMemory
Technology, Inc. |
79,000 |
6,395,552 | |
|
KLA
Corp. |
|
22,330 |
20,001,874 |
|
Kokusai
Electric Corp. |
1,044,700 |
24,997,072 | |
|
Monolithic
Power Systems, Inc. |
|
21,074 |
15,413,102 |
|
NVIDIA
Corp. |
1,028,524 |
162,496,507 | |
|
ON
Semiconductor Corp.(a) |
|
249,186 |
13,059,838 |
|
SK
Hynix, Inc. |
163,752 |
35,285,534 | |
|
Tower
Semiconductor Ltd.(a)(d) |
|
168,869 |
7,320,471 |
|
|
|
391,011,895 | |
|
Software(a)
— 12.4% |
| ||
|
AppLovin
Corp., Class A |
56,352 |
19,727,708 | |
|
Chime
Financial, Inc., Class A, Class A |
|
242,032 |
8,352,524 |
|
CyberArk
Software Ltd. |
65,539 |
26,666,508 | |
|
Guidewire
Software, Inc. |
|
76,198 |
17,940,819 |
|
Monday.com
Ltd. |
29,447 |
9,260,493 | |
|
Palantir
Technologies, Inc., Class A |
|
92,690 |
12,635,501 |
|
Q2
Holdings, Inc. |
111,735 |
10,457,279 | |
|
Samsara,
Inc., Class A |
|
229,758 |
9,139,773 |
|
ServiceTitan,
Inc., Class A |
50,743 |
5,438,635 | |
|
SiteMinder
Ltd. |
|
1,925,200 |
5,615,672 |
|
Snorkel
AI, Inc., (Acquired 06/30/21, Cost:
$2,999,997)(b)(c) |
199,738 |
1,913,490 | |
|
Snyk
Ltd., Ordinary Shares, (Acquired 09/02/21, Cost:
$25,961,537)(b)(c) |
|
1,809,860 |
10,460,991 |
|
Synopsys,
Inc. |
41,355 |
21,201,881 | |
|
Teya
Services Ltd., Series C, (Acquired 11/16/21, Cost:
$49,999,974)(b)(c) |
|
25,742 |
7,076,218 |
|
Unity
Software, Inc. |
313,011 |
7,574,866 | |
|
Vertex,
Inc., Class A |
|
167,861 |
5,931,368 |
|
Xero
Ltd. |
174,433 |
20,640,527 | |
|
|
|
|
200,034,253 |
|
Technology
Hardware, Storage & Peripherals — 3.1% |
| ||
|
Asia
Vital Components Co. Ltd. |
|
454,000 |
11,596,270 |
|
Security |
|
Shares |
Value |
|
Technology
Hardware, Storage & Peripherals (continued) |
| ||
|
Pure
Storage, Inc., Class A(a) |
|
471,445 |
$ 27,145,803 |
|
Sandisk
Corp.(a) |
239,615 |
10,866,540 | |
|
|
|
|
49,608,613 |
|
Total
Common Stocks — 74.8%
(Cost:
$1,101,355,635) |
1,205,073,286 | ||
|
Preferred
Securities | |||
|
Preferred
Stocks — 20.9%(b) | |||
|
Aerospace
& Defense — 0.1% |
| ||
|
Relativity
Space, Inc., Series E |
30,412 |
31,324 | |
|
SkySafe,
Inc., Series B, (Acquired 12/02/21, Cost:
$4,999,999)(a)(c) |
|
909,438 |
1,837,065 |
|
|
|
1,868,389 | |
|
Capital
Markets(a)(c)
— 2.7% |
| ||
|
Anchor
Labs, Inc., Series D, (Acquired 11/24/21, Cost:
$9,999,995) |
428,785 |
3,949,110 | |
|
The
Production Board LLC, Series A3, (Acquired
06/04/21,
Cost: $50,000,001) |
|
16,666,667 |
32,666,667 |
|
Varo
Money, Inc., Series E, (Acquired 08/27/21, Cost:
$40,000,001) |
4,316,904 |
6,000,497 | |
|
|
|
|
42,616,274 |
|
Diversified
Consumer Services — 0.2% |
| ||
|
Grammarly,
Inc., Series 3, (Acquired 11/17/21, Cost:
$8,750,004)(a)(c) |
|
333,818 |
3,868,951 |
|
Diversified
Telecommunication Services — 0.5% |
| ||
|
Discord,
Inc., Series I, (Acquired 09/13/21, Cost:
$17,999,912)(a)(c) |
|
32,690 |
7,719,417 |
|
Entertainment
— 0.4% |
| ||
|
Under
Canvas, Inc., Class A, (Acquired 08/19/21, Cost:
$49,999,983)(a)(c) |
|
2,172,486 |
6,517,458 |
|
Food
Products — 0.2% |
| ||
|
Motif
Food Works, Inc., Series B, (Acquired 06/08/21,
Cost:
$30,832,343)(c) |
|
1,972,240 |
3,525,971 |
|
Hotels,
Restaurants & Leisure(a)(c)
— 1.2% |
| ||
|
Dapper
Labs, Inc., Series 7, (Acquired 07/20/21, Cost:
$29,999,946) |
|
191,067 |
2,203,003 |
|
Underdog
Sports, Inc., Series B, (Acquired 01/11/22,
Cost:
$14,999,974) |
291,061 |
17,594,637 | |
|
|
|
|
19,797,640 |
|
Interactive
Media & Services — 0.6% |
| ||
|
Patreon,
Inc., Series D, (Acquired 07/14/21, Cost:
$23,333,352)(a)(c) |
|
416,667 |
9,208,341 |
|
IT
Services(a)(c)
— 2.6% |
| ||
|
Via
Transportation, Inc., Series G, (Acquired 11/05/21,
Cost:
$24,999,974) |
|
549,357 |
32,774,639 |
|
Wagestream
Holdings Ltd., Series C, (Acquired
02/11/22,
Cost: $10,024,684) |
762,746 |
9,328,619 | |
|
|
|
|
42,103,258 |
|
Semiconductors
& Semiconductor Equipment(a)
— 4.3% |
| ||
|
PsiQuantum
Corp., Series D, (Acquired 05/21/21, Cost:
$39,999,990)(c) |
|
1,525,192 |
62,136,322 |
|
Rivos,
Inc., Series A1 |
2,997,684 |
7,614,118 | |
|
|
|
|
69,750,440 |
|
Software(c)
— 7.1% |
| ||
|
AnyRoad,
Inc., Series B, (Acquired 12/07/21, Cost:
$14,999,995)(a) |
|
2,745,894 |
8,539,730 |
|
Security |
|
Shares |
Value |
|
Software
(continued) |
| ||
|
Bolt
Financial, Inc., Series E, (Acquired 01/18/22, Cost:
$0)(a) |
|
898,024 |
$ 9 |
|
Deepgram,
Inc., Series B, (Acquired 10/22/21, Cost:
$11,999,997)(a) |
2,165,400 |
17,496,432 | |
|
Dragos,
Inc., Series D, (Acquired 09/28/21, Cost:
$39,999,959)(a) |
|
900,760 |
33,715,447 |
|
Genesys
Cloud Services, Inc., (Acquired 11/24/21,
Cost:
$30,000,101) |
4,651,163 |
16,930,233 | |
|
Open
Space Labs, Inc., Series D, (Acquired 01/31/22,
Cost:
$15,000,003)(a) |
|
1,687,916 |
13,300,778 |
|
Snorkel
AI, Inc., Series C, (Acquired 06/30/21, Cost:
$10,999,993)(a) |
732,373 |
7,016,133 | |
|
Snyk
Ltd., Series F, (Acquired 09/02/21, Cost:
$24,038,470)(a) |
|
1,685,092 |
9,739,832 |
|
Validere
Technologies, Inc., Series B, (Acquired
10/21/21,
Cost: $10,000,000)(a) |
4,684,060 |
8,056,583 | |
|
|
|
|
114,795,177 |
|
Specialty
Retail — 0.0% |
| ||
|
Super73,
Inc., Series C-1, (Acquired 10/25/22, Cost:
$12,000,000)(a)(c) |
|
1,400,669 |
14 |
|
Wireless
Telecommunication Services — 1.0% |
| ||
|
Loft
Orbital Solutions, Inc., Series B, (Acquired
10/14/21,
Cost: $24,999,992)(a)(c) |
|
1,365,305 |
15,386,987 |
|
|
337,158,317 | ||
|
Total
Preferred Securities — 20.9%
(Cost:
$607,974,969) |
337,158,317 | ||
|
Total
Long-Term Investments — 95.7%
(Cost:
$1,709,330,604) |
1,542,231,603 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 5.5% |
| ||
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares,
4.47%(f)(g)(h) |
|
11,973,054 |
11,977,843 |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares,
4.20%(f)(g) |
75,455,498 |
75,455,498 | |
|
Total
Short-Term Securities — 5.5%
(Cost:
$87,432,677) |
87,433,341 | ||
|
Total
Investments — 101.2%
(Cost:
$1,796,763,281) |
1,629,664,944 | ||
|
Liabilities
in Excess of Other Assets — (1.2)% |
(18,561,134
) | ||
|
Net
Assets — 100.0% |
$ 1,611,103,810 | ||
|
(a)
|
Non-income
producing security. |
|
(b)
|
Security
is valued using significant unobservable inputs and is classified as Level
3 in the
fair
value hierarchy. |
|
(c)
|
Restricted
security as to resale, excluding 144A securities. The Trust held
restricted
securities
with a current value of $365,174,585, representing 22.7% of its net assets
as of
period
end, and an original cost of $666,922,924. |
|
(d)
|
All
or a portion of this security is on loan. |
|
(e)
|
Security
exempt from registration pursuant to Rule 144A under the Securities Act of
1933,
as
amended. These securities may be resold in transactions exempt from
registration to
qualified
institutional investors. |
|
(f)
|
Affiliate
of the Trust. |
|
(g)
|
Annualized
7-day yield as of period end. |
|
(h)
|
All
or a portion of this security was purchased with the cash collateral from
loaned
securities. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares |
$ 14,267,970 |
$ — |
$ (2,287,240
)(a) |
$ (3,114
) |
$ 227 |
$ 11,977,843 |
11,973,054 |
$ 67,660
(b) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares |
2,002,846 |
73,452,652
(a) |
— |
— |
— |
75,455,498 |
75,455,498 |
965,180 |
— |
|
|
|
|
|
$ (3,114
) |
$ 227 |
$ 87,433,341 |
|
$ 1,032,840 |
$ — |
|
(a)
|
Represents
net amount purchased (sold). |
|
(b)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ 4,924,967 |
$ — |
$ — |
$ — |
$ 4,924,967 |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (4,189,091
) |
$ — |
$ — |
$ — |
$ (4,189,091
) |
|
Options: |
|
|
Average
value of option contracts written |
$—
(a) |
|
(a)
|
Derivative
financial instrument not held at any quarter-end. The risk exposure table
serves as an indicator of activity during the
period. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Assets |
|
|
|
|
|
Investments |
|
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
|
Aerospace
& Defense |
$ 7,646,896 |
$ — |
$ — |
$ 7,646,896 |
|
Automobiles |
12,565,677 |
4,468,596 |
— |
17,034,273 |
|
Broadline
Retail |
36,624,797 |
— |
— |
36,624,797 |
|
Capital
Markets |
11,251,916 |
— |
— |
11,251,916 |
|
Communications
Equipment |
24,046,377 |
10,472,383 |
— |
34,518,760 |
|
Consumer
Finance |
6,819,390 |
— |
— |
6,819,390 |
|
Diversified
Consumer Services |
— |
— |
11,606,852 |
11,606,852 |
|
Diversified
Telecommunication Services |
11,264,921 |
— |
— |
11,264,921 |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
|
Common
Stocks (continued) |
|
|
|
|
|
Electrical
Equipment |
$ — |
$ 7,874,766 |
$ — |
$ 7,874,766 |
|
Electronic
Equipment, Instruments & Components |
64,547,360 |
— |
— |
64,547,360 |
|
Entertainment |
106,857,659 |
36,012,474 |
— |
142,870,133 |
|
Financial
Services |
— |
23,788,664 |
— |
23,788,664 |
|
Health
Care Technology |
— |
8,365,651 |
— |
8,365,651 |
|
Independent
Power and Renewable Electricity Producers |
13,176,242 |
— |
— |
13,176,242 |
|
Industrial
Conglomerates |
— |
29,055,611 |
— |
29,055,611 |
|
Interactive
Media & Services |
— |
— |
4,604,159 |
4,604,159 |
|
IT
Services |
72,528,388 |
15,687,420 |
— |
88,215,808 |
|
Life
Sciences Tools & Services |
9,726,131 |
— |
— |
9,726,131 |
|
Media |
9,166,461 |
— |
— |
9,166,461 |
|
Professional
Services |
26,259,734 |
— |
— |
26,259,734 |
|
Semiconductors
& Semiconductor Equipment |
258,122,529 |
132,889,366 |
— |
391,011,895 |
|
Software |
154,327,355 |
26,256,199 |
19,450,699 |
200,034,253 |
|
Technology
Hardware, Storage & Peripherals |
38,012,343 |
11,596,270 |
— |
49,608,613 |
|
Preferred
Securities |
|
|
|
|
|
Preferred
Stocks |
— |
— |
337,158,317 |
337,158,317 |
|
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
87,433,341 |
— |
— |
87,433,341 |
|
|
$950,377,517 |
$306,467,400 |
$372,820,027 |
$1,629,664,944 |
|
|
Common
Stocks |
Preferred
Stocks
|
Total
|
|
Assets |
|
|
|
|
Opening
balance, as of December 31, 2024 |
$ 48,285,769 |
$ 394,763,266 |
$ 443,049,035 |
|
Transfers
into Level 3 |
— |
— |
— |
|
Transfers
out of Level 3 |
— |
— |
— |
|
Accrued
discounts/premiums |
— |
— |
— |
|
Net
realized gain (loss) |
— |
— |
— |
|
Net
change in unrealized appreciation (depreciation)(a)(b) |
(12,624,059
) |
40,537,131 |
27,913,072 |
|
Purchases |
— |
31,324 |
31,324 |
|
Sales |
— |
(98,173,404
) |
(98,173,404
) |
|
Closing
balance, as of June 30, 2025 |
$ 35,661,710 |
$ 337,158,317 |
$ 372,820,027 |
|
Net
change in unrealized appreciation (depreciation) on investments still held
at June 30, 2025(b) |
$ (12,624,059
) |
$ (7,536,020
) |
$ (20,160,079
) |
|
(a)
|
Included
in the related net change in unrealized appreciation (depreciation) in the
Statements of Operations. |
|
(b)
|
Any
difference between net change in unrealized appreciation (depreciation)
and net change in unrealized appreciation (depreciation) on investments
still held at June 30, 2025 is
generally
due to investments no longer held or categorized as Level 3 at period
end. |
|
|
Value |
Valuation
Approach |
Unobservable
Inputs |
Range
of
Unobservable
Inputs
Utilized(a)
|
Weighted
Average
of
Unobservable
Inputs
Based
on
Fair Value
|
|
Assets |
|
||||
|
Common
Stocks |
$35,661,710 |
Market |
Revenue
Multiple |
4.75x -
13.00x |
9.34x |
|
|
|
Gross
Profit Multiple |
8.25x |
— | |
|
|
|
|
|
|
|
|
Preferred
Stocks |
337,158,317 |
Market |
Revenue
Multiple |
0.50x -
13.50x |
8.01x |
|
|
|
|
Time
to Exit |
0.5 -
5.0 years |
2.8
years |
|
|
Value |
Valuation
Approach |
Unobservable
Inputs |
Range
of
Unobservable
Inputs
Utilized(a) |
Weighted
Average
of
Unobservable
Inputs
Based
on
Fair Value
|
|
|
|
|
Volatility |
35% -
90% |
68% |
|
|
|
|
Market
Adjustment Multiple |
0.59x -
1.05x |
0.94x |
|
|
$372,820,027 |
|
|
|
|
|
(a)
|
A
significant change in unobservable input could result in a correlated or
inverse change in value. |
|
Security |
|
Shares |
Value |
|
Common
Stocks | |||
|
Air
Freight & Logistics — 0.8% |
| ||
|
DSV
A/S |
18,548 |
$ 4,448,816 | |
|
Building
Products — 9.0% |
| ||
|
Cie
de Saint-Gobain SA |
129,562 |
15,220,325 | |
|
Kingspan
Group PLC |
|
113,314 |
9,655,415 |
|
Owens
Corning |
60,266 |
8,287,780 | |
|
Trane
Technologies PLC |
|
40,629 |
17,771,531 |
|
|
|
50,935,051 | |
|
Chemicals
— 2.7% |
| ||
|
Air
Liquide SA |
26,659 |
5,497,114 | |
|
Linde
PLC |
|
20,666 |
9,696,074 |
|
|
|
15,193,188 | |
|
Commercial
Services & Supplies — 4.2% |
| ||
|
Republic
Services, Inc. |
49,729 |
12,263,669 | |
|
Waste
Management, Inc. |
|
50,451 |
11,544,198 |
|
|
|
23,807,867 | |
|
Construction
& Engineering — 4.4% |
| ||
|
Quanta
Services, Inc. |
26,538 |
10,033,487 | |
|
Vinci
SA |
|
101,356 |
14,947,008 |
|
|
|
24,980,495 | |
|
Construction
Materials — 1.1% |
| ||
|
Heidelberg
Materials AG |
26,122 |
6,151,645 | |
|
Electric
Utilities — 26.3% |
| ||
|
American
Electric Power Co., Inc.(a) |
121,078 |
12,563,053 | |
|
Constellation
Energy Corp.(b) |
|
52,718 |
17,015,262 |
|
Duke
Energy Corp.(a) |
97,190 |
11,468,420 | |
|
Elia
Group SA/NV |
|
82,881 |
9,572,289 |
|
Enel
SpA |
2,078,337 |
19,724,890 | |
|
Entergy
Corp. |
|
116,940 |
9,720,053 |
|
NextEra
Energy, Inc.(a)(b) |
396,738 |
27,541,552 | |
|
PG&E
Corp. |
|
642,650 |
8,958,541 |
|
Southern
Co. |
137,158 |
12,595,219 | |
|
SSE
PLC |
|
791,034 |
19,918,326 |
|
|
|
149,077,605 | |
|
Electrical
Equipment — 15.3% |
| ||
|
GE
Vernova, Inc.(a) |
34,154 |
18,072,589 | |
|
Hubbell,
Inc. |
|
17,492 |
7,143,908 |
|
Nexans
SA |
70,566 |
9,234,207 | |
|
NEXTracker,
Inc., Class A(c) |
|
143,560 |
7,805,357 |
|
Prysmian
SpA |
161,397 |
11,426,777 | |
|
Schneider
Electric SE |
|
32,611 |
8,755,562 |
|
Siemens
Energy AG(c) |
107,806 |
12,600,467 | |
|
Vertiv
Holdings Co., Class A |
|
25,548 |
3,280,619 |
|
Vestas
Wind Systems A/S |
566,715 |
8,512,600 | |
|
|
|
|
86,832,086 |
|
Electronic
Equipment, Instruments & Components — 0.7% |
| ||
|
Hexagon
AB, B shares |
|
415,384 |
4,186,902 |
|
Ground
Transportation — 1.8% |
| ||
|
Canadian
Pacific Kansas City Ltd. |
|
126,296 |
10,033,194 |
|
Security |
|
Shares |
Value |
|
Independent
Power and Renewable Electricity Producers — 6.0% |
| ||
|
Boralex,
Inc., Class A |
|
243,828 |
$ 5,665,297 |
|
EDP
Renovaveis SA |
1,204,133 |
13,473,899 | |
|
Orron
Energy AB(c) |
|
3,401,100 |
1,684,961 |
|
Vistra
Corp. |
69,133 |
13,398,667 | |
|
|
|
|
34,222,824 |
|
Multi-Utilities
— 14.9% |
| ||
|
CenterPoint
Energy, Inc. |
|
273,436 |
10,046,039 |
|
CMS
Energy Corp.(a) |
136,248 |
9,439,262 | |
|
Dominion
Energy, Inc. |
|
206,300 |
11,660,076 |
|
National
Grid PLC |
1,216,098 |
17,850,687 | |
|
NiSource,
Inc. |
|
240,500 |
9,701,770 |
|
Public
Service Enterprise Group, Inc.(b) |
131,874 |
11,101,153 | |
|
Sempra(b) |
|
191,134 |
14,482,223 |
|
|
|
84,281,210 | |
|
Oil,
Gas & Consumable Fuels — 10.1% |
| ||
|
Cheniere
Energy, Inc.(b) |
65,832 |
16,031,409 | |
|
Hess
Midstream LP, Class A |
|
103,250 |
3,976,157 |
|
Pembina
Pipeline Corp. |
182,548 |
6,854,180 | |
|
Targa
Resources Corp. |
|
69,138 |
12,035,543 |
|
Williams
Cos., Inc.(b) |
297,331 |
18,675,360 | |
|
|
|
|
57,572,649 |
|
Semiconductors
& Semiconductor Equipment — 1.5% |
| ||
|
First
Solar, Inc.(b)(c) |
|
51,714 |
8,560,736 |
|
Total
Long-Term Investments — 98.8%
(Cost:
$353,728,923) |
560,284,268 | ||
|
Short-Term
Securities | |||
|
Money
Market Funds — 2.2% |
| ||
|
BlackRock
Liquidity Funds, T-Fund, Institutional Shares,
4.20%(d)(e) |
|
12,298,539 |
12,298,539 |
|
Total
Short-Term Securities — 2.2%
(Cost:
$12,298,539) |
12,298,539 | ||
|
Total
Investments Before Options Written — 101.0%
(Cost:
$366,027,462) |
572,582,807 | ||
|
Options
Written — (1.0)%
(Premiums
Received: $(4,970,499)) |
(5,817,506
) | ||
|
Total
Investments, Net of Options Written — 100.0%
(Cost:
$361,056,963) |
566,765,301 | ||
|
Other
Assets Less Liabilities — 0.0% |
68,247 | ||
|
Net
Assets — 100.0% |
$ 566,833,548 | ||
|
(a)
|
All
or a portion of the security has been pledged and/or segregated as
collateral in
connection
with outstanding exchange-traded options written. |
|
(b)
|
All
or a portion of the security has been pledged as collateral in connection
with
outstanding
OTC derivatives. |
|
(c)
|
Non-income
producing security. |
|
(d)
|
Affiliate
of the Trust. |
|
(e)
|
Annualized
7-day yield as of period
end. |
|
Affiliated
Issuer |
Value
at
12/31/24 |
Purchases
at
Cost |
Proceeds
from
Sales |
Net
Realized
Gain
(Loss) |
Change
in
Unrealized
Appreciation
(Depreciation) |
Value
at
06/30/25 |
Shares
Held
at
06/30/25 |
Income |
Capital
Gain
Distributions
from
Underlying
Funds |
|
BlackRock
Cash Funds: Institutional, SL Agency
Shares(a) |
$ — |
$ 489
(b) |
$ — |
$ (489
) |
$ — |
$ — |
— |
$ 540
(c) |
$ — |
|
BlackRock
Liquidity Funds, T-Fund, Institutional
Shares |
13,062,505 |
— |
(763,966
)(b) |
— |
— |
12,298,539 |
12,298,539 |
245,509 |
— |
|
|
|
|
|
$ (489
) |
$ — |
$ 12,298,539 |
|
$ 246,049 |
$ — |
|
(a)
|
As
of period end, the entity is no longer held. |
|
(b)
|
Represents
net amount purchased (sold). |
|
(c)
|
All
or a portion represents securities lending income earned from the
reinvestment of cash collateral from loaned securities, net
of collateral investment fees, and other payments to and
from
borrowers of securities. |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
Cheniere
Energy, Inc. |
82 |
07/09/25 |
USD |
245.00 |
USD |
1,997 |
$ (28,900
) |
|
Constellation
Energy Corp. |
92 |
07/11/25 |
USD |
320.00 |
USD |
2,969 |
(93,380
) |
|
NextEra
Energy, Inc. |
432 |
07/11/25 |
USD |
75.00 |
USD |
2,999 |
(5,184
) |
|
American
Electric Power Co., Inc. |
156 |
07/18/25 |
USD |
105.00 |
USD |
1,619 |
(16,380
) |
|
Boralex,
Inc., Class A |
540 |
07/18/25 |
CAD |
31.00 |
CAD |
1,709 |
(43,620
) |
|
Canadian
Pacific Kansas City Ltd. |
192 |
07/18/25 |
CAD |
114.00 |
CAD |
2,077 |
(3,525
) |
|
CenterPoint
Energy, Inc. |
459 |
07/18/25 |
USD |
38.01 |
USD |
1,686 |
(9,877
) |
|
CMS
Energy Corp. |
273 |
07/18/25 |
USD |
70.00 |
USD |
1,891 |
(17,745
) |
|
Dominion
Energy, Inc. |
536 |
07/18/25 |
USD |
55.00 |
USD |
3,029 |
(112,560
) |
|
Duke
Energy Corp. |
170 |
07/18/25 |
USD |
115.00 |
USD |
2,006 |
(62,900
) |
|
Entergy
Corp. |
204 |
07/18/25 |
USD |
85.00 |
USD |
1,696 |
(16,320
) |
|
GE
Vernova, Inc. |
10 |
07/18/25 |
USD |
520.00 |
USD |
529 |
(23,600
) |
|
Hess
Midstream LP, Class A |
180 |
07/18/25 |
USD |
38.01 |
USD |
693 |
(19,744
) |
|
Hubbell,
Inc. |
38 |
07/18/25 |
USD |
400.00 |
USD |
1,552 |
(57,760
) |
|
Linde
PLC |
44 |
07/18/25 |
USD |
460.00 |
USD |
2,064 |
(60,940
) |
|
NextEra
Energy, Inc. |
631 |
07/18/25 |
USD |
75.00 |
USD |
4,380 |
(14,829
) |
|
NiSource,
Inc. |
387 |
07/18/25 |
USD |
40.00 |
USD |
1,561 |
(31,927
) |
|
Owens
Corning |
105 |
07/18/25 |
USD |
140.00 |
USD |
1,444 |
(34,387
) |
|
Quanta
Services, Inc. |
62 |
07/18/25 |
USD |
360.00 |
USD |
2,344 |
(137,950
) |
|
Republic
Services, Inc., Class A |
79 |
07/18/25 |
USD |
250.00 |
USD |
1,948 |
(15,603
) |
|
Sempra |
334 |
07/18/25 |
USD |
75.00 |
USD |
2,531 |
(67,635
) |
|
Southern
Co. |
220 |
07/18/25 |
USD |
90.00 |
USD |
2,020 |
(60,500
) |
|
Targa
Resources Corp. |
145 |
07/18/25 |
USD |
185.00 |
USD |
2,524 |
(13,050
) |
|
Trane
Technologies PLC |
70 |
07/18/25 |
USD |
430.00 |
USD |
3,062 |
(93,450
) |
|
Trane
Technologies PLC |
77 |
07/18/25 |
USD |
440.00 |
USD |
3,368 |
(59,675
) |
|
Vertiv
Holdings Co. |
20 |
07/18/25 |
USD |
95.00 |
USD |
257 |
(67,350
) |
|
Vertiv
Holdings Co. |
49 |
07/18/25 |
USD |
110.00 |
USD |
629 |
(94,202
) |
|
Vertiv
Holdings Co. |
20 |
07/18/25 |
USD |
120.00 |
USD |
257 |
(21,450
) |
|
Vista
Energy Corp. |
140 |
07/18/25 |
USD |
170.00 |
USD |
2,713 |
(361,200
) |
|
Waste
Management, Inc. |
176 |
07/18/25 |
USD |
240.00 |
USD |
4,027 |
(5,720
) |
|
Williams
Cos., Inc. |
216 |
07/18/25 |
USD |
60.00 |
USD |
1,357 |
(71,280
) |
|
Cheniere
Energy, Inc. |
78 |
07/25/25 |
USD |
245.00 |
USD |
1,899 |
(49,530
) |
|
Constellation
Energy Corp. |
92 |
07/25/25 |
USD |
335.00 |
USD |
2,969 |
(99,820
) |
|
NextEra
Energy, Inc. |
325 |
07/25/25 |
USD |
75.00 |
USD |
2,256 |
(17,063
) |
|
Vista
Energy Corp. |
101 |
07/25/25 |
USD |
185.00 |
USD |
1,957 |
(165,892
) |
|
Hubbell,
Inc. |
28 |
07/29/25 |
USD |
397.14 |
USD |
1,144 |
(56,118
) |
|
Williams
Cos., Inc. |
216 |
08/01/25 |
USD |
60.00 |
USD |
1,357 |
(81,000
) |
|
American
Electric Power Co., Inc. |
267 |
08/15/25 |
USD |
107.00 |
USD |
2,770 |
(35,680
) |
|
Description |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
Boralex,
Inc., Class A |
313 |
08/15/25 |
CAD |
33.00 |
CAD |
990 |
$ (15,055
) |
|
Canadian
Pacific Kansas City Ltd. |
250 |
08/15/25 |
CAD |
114.00 |
CAD |
2,705 |
(16,523
) |
|
CenterPoint
Energy, Inc. |
498 |
08/15/25 |
USD |
37.00 |
USD |
1,830 |
(51,045
) |
|
CMS
Energy Corp. |
203 |
08/15/25 |
USD |
70.00 |
USD |
1,406 |
(27,405
) |
|
Dominion
Energy, Inc. |
186 |
08/15/25 |
USD |
55.00 |
USD |
1,051 |
(51,615
) |
|
Entergy
Corp. |
204 |
08/15/25 |
USD |
85.00 |
USD |
1,696 |
(41,310
) |
|
GE
Vernova, Inc. |
110 |
08/15/25 |
USD |
490.00 |
USD |
5,821 |
(677,600
) |
|
Hess
Midstream LP, Class A |
181 |
08/15/25 |
USD |
40.00 |
USD |
697 |
(9,955
) |
|
Linde
PLC |
28 |
08/15/25 |
USD |
470.00 |
USD |
1,314 |
(39,340
) |
|
NiSource,
Inc. |
454 |
08/15/25 |
USD |
40.31 |
USD |
1,831 |
(50,650
) |
|
Owens
Corning |
105 |
08/15/25 |
USD |
140.00 |
USD |
1,444 |
(74,550
) |
|
PG&E
Corp. |
621 |
08/15/25 |
USD |
15.00 |
USD |
866 |
(22,666
) |
|
Public
Service Enterprise Group, Inc. |
461 |
08/15/25 |
USD |
82.50 |
USD |
3,881 |
(182,095
) |
|
Quanta
Services, Inc. |
30 |
08/15/25 |
USD |
370.00 |
USD |
1,134 |
(72,600
) |
|
Republic
Services, Inc., Class A |
96 |
08/15/25 |
USD |
250.00 |
USD |
2,367 |
(57,120
) |
|
Sempra |
334 |
08/15/25 |
USD |
80.00 |
USD |
2,531 |
(27,555
) |
|
Southern
Co. |
260 |
08/15/25 |
USD |
92.50 |
USD |
2,388 |
(60,450
) |
|
Targa
Resources Corp. |
96 |
08/15/25 |
USD |
185.00 |
USD |
1,671 |
(36,960
) |
|
Williams
Cos., Inc. |
608 |
08/15/25 |
USD |
65.00 |
USD |
3,819 |
(83,600
) |
|
Duke
Energy Corp. |
170 |
09/19/25 |
USD |
125.00 |
USD |
2,006 |
(24,650
) |
|
|
|
|
|
|
|
|
$ (3,850,490
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call |
|
|
|
|
|
|
|
|
|
SSE
PLC |
UBS
AG |
84,900 |
07/02/25 |
GBP |
17.51 |
GBP |
1,557 |
$ (94,102
) |
|
Vestas
Wind Systems A/S |
Citibank
N.A. |
76,000 |
07/02/25 |
DKK |
118.98 |
DKK |
7,231 |
— |
|
Cheniere
Energy, Inc. |
UBS
AG |
7,000 |
07/07/25 |
USD |
234.00 |
USD |
1,705 |
(72,830
) |
|
EDP
Renovaveis SA |
Bank
of America N.A. |
125,000 |
07/08/25 |
EUR |
10.26 |
EUR |
1,187 |
(9
) |
|
PG&E
Corp. |
Morgan
Stanley & Co. International PLC |
15,400 |
07/08/25 |
USD |
17.46 |
USD |
866 |
— |
|
SSE
PLC |
Goldman
Sachs International |
85,000 |
07/08/25 |
GBP |
17.51 |
GBP |
1,559 |
(101,080
) |
|
Pembina
Pipeline Corp. |
Citibank
N.A. |
31,900 |
07/09/25 |
CAD |
53.05 |
CAD |
1,631 |
(4,514
) |
|
Compagnie
de Saint-Gobain S.A. |
Morgan
Stanley & Co. International PLC |
23,000 |
07/10/25 |
EUR |
103.21 |
EUR |
2,294 |
(11,843
) |
|
DSV
A/S |
Goldman
Sachs International |
3,400 |
07/10/25 |
DKK |
1,665.30 |
DKK |
5,165 |
(129
) |
|
Nexans
S.A. |
Citibank
N.A. |
6,200 |
07/10/25 |
EUR |
101.82 |
EUR |
689 |
(68,766
) |
|
PG&E
Corp. |
Barclays
Bank PLC |
15,400 |
07/10/25 |
USD |
17.85 |
USD |
215 |
— |
|
Prysmian
SpA |
Citibank
N.A. |
19,200 |
07/10/25 |
EUR |
56.88 |
EUR |
1,154 |
(81,407
) |
|
Siemens
Energy AG |
Morgan
Stanley & Co. International PLC |
18,200 |
07/10/25 |
EUR |
81.28 |
EUR |
1,806 |
(363,400
) |
|
SSE
PLC |
Morgan
Stanley & Co. International PLC |
50,900 |
07/15/25 |
GBP |
17.77 |
GBP |
934 |
(52,120
) |
|
PG&E
Corp. |
Barclays
Bank PLC |
15,400 |
07/16/25 |
USD |
17.89 |
USD |
215 |
(12
) |
|
Nexans
S.A. |
Goldman
Sachs International |
6,200 |
07/17/25 |
EUR |
102.71 |
EUR |
689 |
(66,285
) |
|
Siemens
Energy AG |
BNP
Paribas SA |
19,600 |
07/17/25 |
EUR |
97.81 |
EUR |
1,945 |
(77,916
) |
|
Vestas
Wind Systems A/S |
Goldman
Sachs International |
25,000 |
07/17/25 |
DKK |
110.00 |
DKK |
2,378 |
(2,167
) |
|
Pembina
Pipeline Corp. |
Morgan
Stanley & Co. International PLC |
31,900 |
07/22/25 |
CAD |
52.05 |
CAD |
1,631 |
(14,351
) |
|
Air
Liquide SA |
Barclays
Bank PLC |
8,400 |
07/23/25 |
EUR |
187.88 |
EUR |
1,470 |
(2,221
) |
|
Elia
Group SA/NV |
UBS
AG |
25,000 |
07/23/25 |
EUR |
95.68 |
EUR |
2,451 |
(129,206
) |
|
Enel
SpA |
Barclays
Bank PLC |
595,400 |
07/23/25 |
EUR |
8.19 |
EUR |
4,797 |
(6,509
) |
|
Hexagon
AB, B Shares |
Barclays
Bank PLC |
53,400 |
07/23/25 |
SEK |
98.99 |
SEK |
5,092 |
(4,575
) |
|
National
Grid PLC |
Barclays
Bank PLC |
198,400 |
07/23/25 |
GBP |
10.74 |
GBP |
2,122 |
(35,836
) |
|
Schneider
Electric SE |
UBS
AG |
6,000 |
07/23/25 |
EUR |
223.92 |
EUR |
1,368 |
(52,492
) |
|
SSE
PLC |
UBS
AG |
56,000 |
07/23/25 |
GBP |
18.53 |
GBP |
1,027 |
(30,195
) |
|
EDP
Renovaveis SA |
Bank
of America N.A. |
160,000 |
07/24/25 |
EUR |
9.61 |
EUR |
1,520 |
(28,282
) |
|
Air
Liquide SA |
JPMorgan
Chase Bank N.A. |
1,000 |
07/29/25 |
EUR |
189.85 |
EUR |
175 |
(296
) |
|
Compagnie
de Saint-Gobain S.A. |
JPMorgan
Chase Bank N.A. |
19,800 |
07/29/25 |
EUR |
103.82 |
EUR |
1,975 |
(30,470
) |
|
Elia
Group SA/NV |
UBS
AG |
4,100 |
07/29/25 |
EUR |
95.02 |
EUR |
402 |
(25,427
) |
|
Kingspan
Group PLC |
JPMorgan
Chase Bank N.A. |
23,000 |
07/29/25 |
EUR |
79.35 |
EUR |
1,664 |
(7,193
) |
|
Prysmian
SpA |
Goldman
Sachs International |
37,200 |
07/29/25 |
EUR |
61.19 |
EUR |
2,236 |
(80,072
) |
|
Vinci
SA |
JPMorgan
Chase Bank N.A. |
35,500 |
07/29/25 |
EUR |
130.71 |
EUR |
4,444 |
(38,043
) |
|
Hexagon
AB, B Shares |
Barclays
Bank PLC |
25,000 |
07/30/25 |
SEK |
97.33 |
SEK |
2,384 |
(4,750
) |
|
Description |
Counterparty |
Number
of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount
(000) |
Value | ||
|
Call (continued) |
|
|
|
|
|
|
|
|
|
Kingspan
Group PLC |
Barclays
Bank PLC |
14,600 |
07/30/25 |
EUR |
76.19 |
EUR |
1,056 |
$ (12,212
) |
|
National
Grid PLC |
Morgan
Stanley & Co. International PLC |
158,200 |
07/30/25 |
GBP |
10.71 |
GBP |
1,692 |
(36,347
) |
|
Vestas
Wind Systems A/S |
Bank
of America N.A. |
82,100 |
07/30/25 |
DKK |
110.16 |
DKK |
7,811 |
(19,713
) |
|
Enel
SpA |
Barclays
Bank PLC |
101,700 |
08/05/25 |
EUR |
8.04 |
EUR |
819 |
(6,981
) |
|
Hexagon
AB, B Shares |
Barclays
Bank PLC |
67,000 |
08/05/25 |
SEK |
97.43 |
SEK |
6,389 |
(15,281
) |
|
National
Grid PLC |
JPMorgan
Chase Bank N.A. |
69,100 |
08/05/25 |
GBP |
10.99 |
GBP |
739 |
(8,524
) |
|
DSV
A/S |
Barclays
Bank PLC |
3,100 |
08/06/25 |
DKK |
1,560.52 |
DKK |
4,709 |
(17,987
) |
|
Heidelberg
Materials AG |
Bank
of America N.A. |
9,200 |
08/06/25 |
EUR |
197.07 |
EUR |
1,839 |
(100,727
) |
|
Nexans
S.A. |
Citibank
N.A. |
12,200 |
08/08/25 |
EUR |
104.76 |
EUR |
1,355 |
(133,285
) |
|
PG&E
Corp. |
Barclays
Bank PLC |
116,600 |
08/08/25 |
USD |
14.16 |
USD |
1,625 |
(74,105
) |
|
Schneider
Electric SE |
Citibank
N.A. |
5,400 |
08/08/25 |
EUR |
228.43 |
EUR |
1,231 |
(49,037
) |
|
EDP
Renovaveis SA |
Bank
of America N.A. |
136,400 |
08/12/25 |
EUR |
10.40 |
EUR |
1,296 |
(6,319
) |
|
|
|
|
|
|
|
|
|
$ (1,967,016
) |
|
Description |
Premiums Paid |
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value |
Options
Written |
$ N/A |
$ (4,970,499
) |
$ 1,144,669 |
$ (1,991,676
) |
$ (5,817,506
) |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
|
Liabilities
— Derivative Financial Instruments |
|
|
|
|
|
|
|
|
Options
written
Options
written at value |
$ — |
$ — |
$ 5,817,506 |
$ — |
$ — |
$ — |
$ 5,817,506 |
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency
Exchange
Contracts |
Interest
Rate
Contracts |
Other
Contracts |
Total |
Net
Realized Gain (Loss) from: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (4,648,368
) |
$ — |
$ — |
$ — |
$ (4,648,368
) |
Net
Change in Unrealized Appreciation (Depreciation) on: |
|
|
|
|
|
|
|
|
Options
written |
$ — |
$ — |
$ (3,015,949
) |
$ — |
$ — |
$ — |
$ (3,015,949
) |
|
Options: |
|
|
Average
value of option contracts written |
$4,949,620 |
|
|
Assets |
Liabilities |
|
Derivative
Financial Instruments |
|
|
|
Options |
$ — |
$ 5,817,506 |
|
Total
derivative assets and liabilities in the Statements of Assets and
Liabilities |
— |
5,817,506 |
|
Derivatives
not subject to a Master Netting Agreement or similar agreement
(“MNA”) |
— |
(3,850,490
) |
|
Total
derivative assets and liabilities subject to an MNA |
$ — |
$ 1,967,016 |
|
Counterparty |
Derivative
Liabilities
Subject
to
an
MNA by
Counterparty |
Derivatives
Available
for
Offset |
Non-Cash
Collateral
Pledged(a) |
Cash
Collateral
Pledged(a) |
Net
Amount
of
Derivative
Liabilities(b) |
|
Bank
of America N.A. |
$ 155,050 |
$ — |
$ (155,050
) |
$ — |
$ — |
|
Barclays
Bank PLC |
180,469 |
— |
(180,469
) |
— |
— |
|
BNP
Paribas SA |
77,916 |
— |
(77,916
) |
— |
— |
|
Citibank
N.A. |
337,009 |
— |
(337,009
) |
— |
— |
|
Goldman
Sachs International |
249,733 |
— |
(249,733
) |
— |
— |
|
JPMorgan
Chase Bank N.A. |
84,526 |
— |
— |
— |
84,526 |
|
Morgan
Stanley & Co. International PLC |
478,061 |
— |
(478,061
) |
— |
— |
|
UBS
AG |
404,252 |
— |
(404,252
) |
— |
— |
|
|
$ 1,967,016 |
$ — |
$ (1,882,490
) |
$ — |
$ 84,526 |
|
(a)
|
Excess
of collateral received/pledged, if any, from the individual counterparty
is not shown for financial reporting purposes. |
|
(b)
|
Net
amount represents the net amount payable due to the counterparty in the
event of default. Net amount may be offset further by the options written
receivable/payable on the
Statements
of Assets and Liabilities. |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
Assets |
|
|
|
|
|
Investments |
|
|
|
|
Long-Term
Investments |
|
|
|
|
|
Common
Stocks |
|
|
|
|
Air
Freight & Logistics |
$ — |
$ 4,448,816 |
$ — |
$ 4,448,816 |
|
Building
Products |
26,059,311 |
24,875,740 |
— |
50,935,051 |
Chemicals |
9,696,074 |
5,497,114 |
— |
15,193,188 |
|
Commercial
Services & Supplies |
23,807,867 |
— |
— |
23,807,867 |
Construction
& Engineering |
10,033,487 |
14,947,008 |
— |
24,980,495 |
|
Construction
Materials |
— |
6,151,645 |
— |
6,151,645 |
Electric
Utilities |
99,862,100 |
49,215,505 |
— |
149,077,605 |
|
Electrical
Equipment |
36,302,473 |
50,529,613 |
— |
86,832,086 |
Electronic
Equipment, Instruments & Components |
— |
4,186,902 |
— |
4,186,902 |
|
Ground
Transportation |
10,033,194 |
— |
— |
10,033,194 |
Independent
Power and Renewable Electricity Producers |
19,063,964 |
15,158,860 |
— |
34,222,824 |
|
Multi-Utilities |
66,430,523 |
17,850,687 |
— |
84,281,210 |
Oil,
Gas & Consumable Fuels |
57,572,649 |
— |
— |
57,572,649 |
|
Semiconductors
& Semiconductor Equipment |
8,560,736 |
— |
— |
8,560,736 |
Short-Term
Securities |
|
|
|
|
|
Money
Market Funds |
12,298,539 |
— |
— |
12,298,539 |
|
$379,720,917 |
$192,861,890 |
$— |
$572,582,807 |
|
|
Level
1 |
Level
2 |
Level
3 |
Total |
Derivative
Financial Instruments(a)
|
|
|
|
|
|
Liabilities |
|
|
|
|
Equity
Contracts |
$ (3,649,521
) |
$ (2,167,985
) |
$ — |
$ (5,817,506
) |
|
(a)
|
Derivative
financial instruments are options written. Options written are shown at
value. |
|
|
BGR |
BDJ(a)
|
BOE |
BGY |
|
ASSETS |
|
|
|
|
|
Investments,
at value — unaffiliated(b)(c) |
$ 350,096,921 |
$ 1,641,704,620 |
$ 688,931,583 |
$ 567,486,284 |
|
Investments,
at value — affiliated(d) |
2,979,548 |
55,223,666 |
9,754,911 |
2,898,908 |
|
Cash |
— |
285,228 |
120,644 |
1,963,656 |
|
Cash
pledged as collateral for OTC derivatives |
— |
100,000 |
— |
1,306,794 |
|
Foreign
currency, at value(e) |
108,152 |
479,487 |
80,333 |
176,438 |
|
Receivables: |
|
|
|
|
|
Investments
sold |
1,896,144 |
41,579,240 |
— |
— |
|
Options
written |
— |
452,150 |
86,119 |
210,395 |
|
Securities
lending income — affiliated |
— |
731 |
— |
— |
|
Dividends
— unaffiliated |
779,678 |
2,536,420 |
1,528,634 |
1,532,918 |
|
Dividends
— affiliated |
16,588 |
160,614 |
22,401 |
10,888 |
|
Deferred
offering costs |
— |
210,889 |
— |
— |
|
Prepaid
expenses |
— |
26,676 |
2,470 |
8,570 |
|
Total
assets |
355,877,031 |
1,742,759,721 |
700,527,095 |
575,594,851 |
|
LIABILITIES |
|
|
|
|
|
Collateral
on securities loaned |
— |
7,493,797 |
— |
— |
|
Options
written, at value(f) |
2,132,083 |
28,938,002 |
8,112,955 |
3,825,190 |
|
Payables: |
|
|
|
|
|
Investments
purchased |
— |
41,972,981 |
— |
— |
|
Accounting
services fees |
25,505 |
54,467 |
34,203 |
28,383 |
|
Custodian
fees |
16,209 |
47,745 |
40,973 |
69,395 |
|
Deferred
foreign capital gain tax |
— |
— |
— |
143,518 |
|
Income
dividend distributions |
145,361 |
258,625 |
167,212 |
191,347 |
|
Investment
advisory fees |
288,548 |
1,069,396 |
460,373 |
464,229 |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
30,473 |
1,704,802 |
|
Trustees’
and Officer’s
fees |
339,130 |
948,885 |
603,861 |
492,539 |
|
Options
written |
— |
953,080 |
194,812 |
— |
|
Other
accrued expenses |
7,306 |
32,106 |
5,780 |
6,125 |
|
Professional
fees |
98,828 |
90,931 |
44,995 |
76,699 |
|
Transfer
agent fees |
3,463 |
91,963 |
3,370 |
4,587 |
|
Total
liabilities |
3,056,433 |
81,951,978 |
9,699,007 |
7,006,814 |
|
Commitments
and contingent liabilities |
|
|
|
|
|
NET
ASSETS |
$ 352,820,598 |
$ 1,660,807,743 |
$ 690,828,088 |
$ 568,588,037 |
|
NET
ASSETS CONSIST OF |
|
|
|
|
|
Paid-in
capital(g)(h)(i) |
$ 464,770,139 |
$ 1,226,341,998 |
$ 542,965,361 |
$ 481,199,934 |
|
Accumulated
earnings (loss) |
(111,949,541) |
434,465,745 |
147,862,727 |
87,388,103 |
|
NET
ASSETS |
$ 352,820,598 |
$ 1,660,807,743 |
$ 690,828,088 |
$ 568,588,037 |
|
Net
asset value |
$ 13.86 |
$ 9.39 |
$ 12.42 |
$ 6.27 |
|
(a)
Consolidated
Statement of Assets and Liabilities. | ||||
|
(b)
Investments,
at cost—unaffiliated |
$247,990,744 |
$1,278,972,192 |
$500,612,329 |
$445,604,277 |
|
(c)
Securities
loaned, at value |
$— |
$7,344,759 |
$— |
$— |
|
(d)
Investments,
at cost—affiliated |
$2,979,548 |
$55,223,666 |
$9,754,911 |
$2,898,908 |
|
(e)
Foreign
currency, at cost |
$107,509 |
$479,883 |
$79,920 |
$175,634 |
|
(f)
Premiums
received |
$2,561,374 |
$21,353,369 |
$7,221,732 |
$5,309,740 |
|
(g)
Shares
outstanding |
25,456,171 |
|
55,600,125 |
90,614,455 |
|
(h)
Shares
authorized |
Unlimited |
Unlimited |
Unlimited |
Unlimited |
|
(i)
Par
value |
$0.001 |
$0.001 |
$0.001 |
$0.001 |
|
|
CII |
BMEZ |
BME |
BCX |
|
ASSETS |
|
|
|
|
|
Investments,
at value — unaffiliated(a)(b) |
$ 950,115,443 |
$ 960,552,682 |
$ 504,361,297 |
$ 763,636,720 |
|
Investments,
at value — affiliated(c) |
5,646,470 |
14,416,221 |
22,508,070 |
28,271,348 |
|
Foreign
currency, at value(d) |
676 |
808 |
39,397 |
397,353 |
|
Receivables: |
|
|
|
|
|
Investments
sold |
— |
393,444 |
1,287,016 |
3,075,280 |
|
Options
written |
1,165,174 |
200,137 |
19,408 |
— |
|
Securities
lending income — affiliated |
— |
4,167 |
1,002 |
5,424 |
|
Dividends
— unaffiliated |
237,914 |
1,021,149 |
335,847 |
771,065 |
|
Dividends
— affiliated |
31,432 |
97,325 |
73,780 |
47,715 |
|
Interest
— unaffiliated |
— |
12,809 |
— |
157,500 |
|
Prepaid
expenses |
2,525 |
13,733 |
— |
— |
|
Total
assets |
957,199,634 |
976,712,475 |
528,625,817 |
796,362,405 |
|
LIABILITIES |
|
|
|
|
|
Bank
overdraft |
— |
— |
— |
2,517 |
|
Collateral
on securities loaned |
— |
2,641,056 |
1,409,957 |
5,996,511 |
|
Options
written, at value(e) |
26,761,464 |
12,526,383 |
4,276,183 |
6,383,331 |
|
Payables: |
|
|
|
|
|
Investments
purchased |
— |
— |
14,089,911 |
— |
|
Accounting
services fees |
28,383 |
134,167 |
16,804 |
34,190 |
|
Custodian
fees |
6,021 |
95,643 |
29,042 |
35,334 |
|
Income
dividend distributions |
341,862 |
1,573,414 |
207,016 |
249,336 |
|
Investment
advisory fees |
626,851 |
977,419 |
412,248 |
637,172 |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
— |
861,588 |
|
Trustees’
and Officer’s
fees |
276,863 |
306,296 |
28,330 |
239,273 |
|
Options
written |
2,442,384 |
125,816 |
2,844 |
— |
|
Other
accrued expenses |
8,429 |
100,422 |
15,115 |
31,791 |
|
Professional
fees |
37,810 |
113,538 |
36,535 |
135,311 |
|
Proxy
fees |
— |
95,387 |
— |
— |
|
Transfer
agent fees |
380 |
5,550 |
4,022 |
9,891 |
|
Total
liabilities |
30,530,447 |
18,695,091 |
20,528,007 |
14,616,245 |
|
Commitments
and contingent liabilities |
|
|
|
|
|
NET
ASSETS |
$ 926,669,187 |
$ 958,017,384 |
$ 508,097,810 |
$ 781,746,160 |
|
NET
ASSETS CONSIST OF |
|
|
|
|
|
Paid-in
capital(f)(g)(h) |
$ 493,943,118 |
$ 1,134,604,967 |
$ 367,155,641 |
$ 903,484,615 |
|
Accumulated
earnings (loss) |
432,726,069 |
(176,587,583) |
140,942,169 |
(121,738,455) |
|
NET
ASSETS |
$ 926,669,187 |
$ 958,017,384 |
$ 508,097,810 |
$ 781,746,160 |
|
Net
asset value |
$ 22.65 |
$ 15.33 |
$ 39.31 |
$ 10.25 |
|
(a)
Investments,
at cost—unaffiliated |
$626,430,005 |
$939,766,633 |
$346,697,523 |
$673,637,689 |
|
(b)
Securities
loaned, at value |
$— |
$2,569,099 |
$1,290,512 |
$5,857,497 |
|
(c)
Investments,
at cost—affiliated |
$5,646,470 |
$14,416,221 |
$22,508,070 |
$28,271,348 |
|
(d)
Foreign
currency, at cost |
$620 |
$777 |
$38,669 |
$390,487 |
|
(e)
Premiums
received |
$16,830,615 |
$9,308,544 |
$4,582,810 |
$6,518,042 |
|
(f)
Shares
outstanding |
40,917,987 |
62,501,404 |
12,924,103 |
76,238,090 |
|
(g)
Shares
authorized |
200 million |
Unlimited |
Unlimited |
Unlimited |
|
(h)
Par
value |
$0.10 |
$0.001 |
$0.001 |
$0.001 |
|
|
BSTZ(a)
|
BST(a)
|
BTX |
BUI |
|
ASSETS |
|
|
|
|
|
Investments,
at value — unaffiliated(b)(c) |
$ 1,537,935,831 |
$ 1,422,768,779 |
$ 1,542,231,603 |
$ 560,284,268 |
|
Investments,
at value — affiliated(d) |
50,993,885 |
1,029,031 |
87,433,341 |
12,298,539 |
|
Cash |
30,600 |
52,127 |
— |
11,121 |
|
Cash
pledged as collateral for OTC derivatives |
380,000 |
— |
— |
— |
|
Foreign
currency, at value(e) |
69,775 |
15,579 |
236,677 |
80,902 |
|
Receivables: |
|
|
|
|
|
Investments
sold |
5,589,208 |
14,551,082 |
9,367,828 |
1,023 |
|
Options
written |
— |
248,766 |
— |
42,321 |
|
Securities
lending income — affiliated |
26,204 |
80 |
18,199 |
282 |
|
Dividends
— unaffiliated |
185,320 |
311,433 |
183,758 |
822,657 |
|
Dividends
— affiliated |
43,512 |
15,578 |
184,537 |
45,349 |
|
Deferred
offering costs |
— |
— |
— |
116,155 |
|
Prepaid
expenses |
112,406 |
604 |
36,128 |
— |
|
Total
assets |
1,595,366,741 |
1,438,993,059 |
1,639,692,071 |
573,702,617 |
|
LIABILITIES |
|
|
|
|
|
Collateral
on securities loaned |
27,923,257 |
— |
11,973,416 |
— |
|
Options
written, at value(f) |
10,877,948 |
12,241,210 |
— |
5,817,506 |
|
Payables: |
|
|
|
|
|
Investments
purchased |
15,588,095 |
12,206,787 |
12,659,967 |
1,191 |
|
Accounting
services fees |
121,592 |
28,386 |
133,736 |
28,386 |
|
Custodian
fees |
91,537 |
23,989 |
57,543 |
26,249 |
|
Deferred
capital gain tax |
3,506,360 |
393,920 |
— |
— |
|
Income
dividend distributions |
2,036,346 |
420,384 |
1,604,510 |
— |
|
Investment
advisory fees |
1,519,648 |
1,118,152 |
1,611,512 |
455,637 |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
— |
87,335 |
|
Offering
costs |
— |
— |
— |
116,155 |
|
Trustees’
and Officer’s
fees |
281,248 |
58,805 |
275,164 |
— |
|
Options
written |
— |
373,389 |
— |
196,388 |
|
Other
accrued expenses |
65,589 |
68,385 |
11,640 |
47,850 |
|
Professional
fees |
99,197 |
85,926 |
104,623 |
54,628 |
|
Proxy
fees |
— |
— |
83,223 |
— |
|
Transfer
agent fees |
128 |
19,135 |
72,927 |
37,744 |
|
Total
liabilities |
62,110,945 |
27,038,468 |
28,588,261 |
6,869,069 |
|
Commitments
and contingent liabilities |
|
|
|
|
|
NET
ASSETS |
$ 1,533,255,796 |
$ 1,411,954,591 |
$ 1,611,103,810 |
$ 566,833,548 |
|
NET
ASSETS CONSIST OF |
|
|
|
|
|
Paid-in
capital(g)(h)(i) |
$ 954,804,595 |
$ 729,562,726 |
$ 3,723,540,676 |
$ 374,599,337 |
|
Accumulated
earnings (loss) |
578,451,201 |
682,391,865 |
(2,112,436,866) |
192,234,211 |
|
NET
ASSETS |
$ 1,533,255,796 |
$ 1,411,954,591 |
$ 1,611,103,810 |
$ 566,833,548 |
|
Net
asset value |
$ 22.30 |
$ 40.67 |
$ 7.55 |
$ 24.95 |
|
(a)
Consolidated
Statement of Assets and Liabilities. | ||||
|
(b)
Investments,
at cost—unaffiliated |
$923,995,805 |
$720,407,409 |
$1,709,330,604 |
$353,728,923 |
|
(c)
Securities
loaned, at value |
$26,849,180 |
$— |
$11,266,527 |
$— |
|
(d)
Investments,
at cost—affiliated |
$50,993,340 |
$1,029,031 |
$87,432,677 |
$12,298,539 |
|
(e)
Foreign
currency, at cost |
$69,292 |
$15,617 |
$236,484 |
$80,420 |
|
(f)
Premiums
received |
$6,127,064 |
$6,646,248 |
$— |
$4,970,499 |
|
(g)
Shares
outstanding |
68,744,150 |
34,720,019 |
213,338,148 |
22,714,729 |
|
(h)
Shares
authorized |
Unlimited |
Unlimited |
Unlimited |
Unlimited |
|
(i)
Par
value |
$0.001 |
$0.001 |
$0.001 |
$0.001 |
|
|
BGR |
BDJ(a)
|
BOE |
BGY |
INVESTMENT
INCOME |
|
|
|
|
|
Dividends
— unaffiliated |
$6,503,762 |
$21,772,431 |
$8,624,872 |
$9,523,975 |
Dividends
— affiliated |
148,975 |
828,079 |
155,491 |
157,270 |
|
Securities
lending income — affiliated — net |
— |
890 |
— |
1,260 |
Other
income — unaffiliated |
33,581 |
5,431 |
2,349 |
54,434 |
|
Foreign
taxes withheld |
(245,279
) |
(235,009
) |
(394,841
) |
(769,157
) |
Foreign
withholding tax claims |
686,134 |
375,011 |
58,807 |
855,585 |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
(30,473
) |
(54,670
) |
Total
investment income |
7,127,173 |
22,746,833 |
8,416,205 |
9,768,697 |
|
EXPENSES |
|
|
|
|
Investment
advisory |
1,751,860 |
6,382,047 |
3,410,876 |
2,806,439 |
|
Professional |
105,735 |
122,181 |
69,646 |
113,690 |
Transfer
agent |
93,419 |
84,910 |
205,349 |
176,466 |
|
Trustees
and Officer |
34,685 |
109,103 |
63,473 |
49,131 |
Accounting
services |
21,847 |
46,641 |
29,274 |
24,305 |
|
Custodian |
16,791 |
43,619 |
32,217 |
57,504 |
Printing
and postage |
12,707 |
26,022 |
13,149 |
15,139 |
|
Registration |
4,686 |
31,762 |
10,499 |
17,109 |
Miscellaneous |
24,803 |
100,404 |
54,930 |
76,156 |
|
Total
expenses excluding interest expense |
2,066,533 |
6,946,689 |
3,889,413 |
3,335,939 |
Interest
expense — unaffiliated |
576 |
1,505 |
895 |
2,066 |
|
Total
expenses |
2,067,109 |
6,948,194 |
3,890,308 |
3,338,005 |
Less: |
|
|
|
|
|
Fees
waived and/or reimbursed by the Manager |
(2,661
) |
(14,729
) |
(599,661
) |
(2,797
) |
Total
expenses after fees waived and/or reimbursed |
2,064,448 |
6,933,465 |
3,290,647 |
3,335,208 |
|
Net
investment income |
5,062,725 |
15,813,368 |
5,125,558 |
6,433,489 |
REALIZED
AND UNREALIZED GAIN (LOSS) |
|
|
|
|
|
Net
realized gain (loss) from: |
|
|
|
|
Investments
— unaffiliated |
20,239,228 |
66,514,551 |
17,063,430 |
3,078,716 |
|
Investments
— affiliated |
— |
(208
) |
— |
(354
) |
Foreign
currency transactions |
(67,733
) |
99,943 |
158,237 |
(90,121
) |
|
Options
written |
2,906,505 |
(10,227,303
) |
(6,230,812
) |
(2,365,048
) |
|
23,078,000 |
56,386,983 |
10,990,855 |
623,193 | |
|
Net
change in unrealized appreciation (depreciation) on: |
|
|
|
|
Investments
— unaffiliated |
(10,389,052
) |
74,922,741 |
37,474,908 |
51,022,479
(b) |
|
Foreign
currency translations |
9,564 |
12,710 |
113,447 |
104,979 |
Options
written |
(489,976
) |
(17,219,246
) |
(4,463,875
) |
(100,224
) |
|
|
(10,869,464
) |
57,716,205 |
33,124,480 |
51,027,234 |
Net
realized and unrealized gain |
12,208,536 |
114,103,188 |
44,115,335 |
51,650,427 |
|
NET
INCREASE IN NET ASSETS RESULTING FROM OPERATIONS |
$17,271,261 |
$129,916,556 |
$49,240,893 |
$58,083,916 |
|
(a)
Consolidated
Statement of Operations. | ||||
|
(b)
Net
of increase in deferred foreign capital gain tax of |
$— |
$— |
$— |
$(133,748
) |
|
|
CII |
BMEZ |
BME |
BCX |
|
INVESTMENT
INCOME |
|
|
|
|
|
Dividends
— unaffiliated |
$3,276,368 |
$3,300,641 |
$3,492,308 |
$13,612,010 |
|
Dividends
— affiliated |
272,879 |
1,627,665 |
468,619 |
466,512 |
|
Securities
lending income — affiliated — net |
559 |
29,460 |
2,753 |
18,110 |
|
Other
income — unaffiliated |
— |
— |
— |
51,092 |
|
Foreign
taxes withheld |
(60,094
) |
(271,761
) |
(44,084
) |
(760,609
) |
|
Foreign
withholding tax claims |
— |
— |
37,749 |
1,180,600 |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
— |
(861,588
) |
|
Total
investment income |
3,489,712 |
4,686,005 |
3,957,345 |
13,706,127 |
|
EXPENSES |
|
|
|
|
|
Investment
advisory |
3,666,689 |
8,456,910 |
2,633,784 |
3,850,838 |
|
Transfer
agent |
107,283 |
115,047 |
103,442 |
279,847 |
|
Professional |
73,137 |
97,592 |
64,441 |
155,997 |
|
Trustees
and Officer |
45,304 |
68,860 |
18,993 |
40,512 |
|
Printing
and postage |
39,096 |
43,415 |
14,817 |
14,276 |
|
Accounting
services |
24,305 |
100,108 |
14,374 |
29,283 |
|
Custodian |
14,008 |
23,134 |
24,449 |
31,713 |
|
Registration |
7,537 |
18,168 |
4,255 |
14,394 |
|
Offering |
— |
— |
84,599 |
— |
|
Miscellaneous |
28,309 |
287,386 |
33,951 |
65,392 |
|
Total
expenses excluding interest expense |
4,005,668 |
9,210,620 |
2,997,105 |
4,482,252 |
|
Interest
expense — unaffiliated |
1,041 |
189 |
87 |
3,595 |
|
Total
expenses |
4,006,709 |
9,210,809 |
2,997,192 |
4,485,847 |
|
Less: |
|
|
|
|
|
Fees
waived and/or reimbursed by the Manager |
(4,858
) |
(29,042
) |
(8,358
) |
(8,310
) |
|
Total
expenses after fees waived and/or reimbursed |
4,001,851 |
9,181,767 |
2,988,834 |
4,477,537 |
|
Net
investment income (loss) |
(512,139
) |
(4,495,762
) |
968,511 |
9,228,590 |
|
REALIZED
AND UNREALIZED GAIN (LOSS) |
|
|
|
|
|
Net
realized gain (loss) from: |
|
|
|
|
|
Investments
— unaffiliated |
92,430,066 |
(59,243,354
) |
5,716,886 |
29,657,219 |
|
Investments
— affiliated |
(305
) |
(364
) |
(366
) |
(2,474
) |
|
Foreign
currency transactions |
8,938 |
7,627 |
8,443 |
341,737 |
|
Options
written |
(11,793,743
) |
15,292,220 |
3,732,625 |
7,236,452 |
|
|
80,644,956 |
(43,943,871
) |
9,457,588 |
37,232,934 |
|
Net
change in unrealized appreciation (depreciation) on: |
|
|
|
|
|
Investments
— unaffiliated |
17,221,699 |
(5,477,154
) |
(11,778,296
) |
41,026,967 |
|
Investments
— affiliated |
41 |
779 |
(16
) |
140 |
|
Foreign
currency translations |
(409
) |
82,266 |
7,757 |
29,536 |
|
Options
written |
(13,083,917
) |
(8,668,458
) |
(2,217,202
) |
(2,882,828
) |
|
|
4,137,414 |
(14,062,567
) |
(13,987,757
) |
38,173,815 |
|
Net
realized and unrealized gain (loss) |
84,782,370 |
(58,006,438
) |
(4,530,169
) |
75,406,749 |
|
NET
INCREASE (DECREASE) IN NET ASSETS RESULTING FROM
OPERATIONS |
$84,270,231 |
$(62,502,200
) |
$(3,561,658
) |
$84,635,339 |
|
|
BSTZ(a)
|
BST(a)
|
BTX |
BUI |
INVESTMENT
INCOME |
|
|
|
|
|
Dividends
— unaffiliated |
$1,270,220 |
$2,611,854 |
$5,435,812 |
$6,117,170 |
Dividends
— affiliated |
396,525 |
203,619 |
965,180 |
245,509 |
|
Securities
lending income — affiliated — net |
94,504 |
4,134 |
67,660 |
540 |
Foreign
taxes withheld |
(138,588
) |
(72,668
) |
(140,691
) |
(168,951
) |
|
Foreign
withholding tax claims |
— |
— |
— |
138,225 |
IRS
compliance fee for foreign withholding tax claims |
— |
— |
— |
(87,335
) |
|
Total
investment income |
1,622,661 |
2,746,939 |
6,327,961 |
6,245,158 |
EXPENSES |
|
|
|
|
|
Investment
advisory |
9,316,821 |
6,465,385 |
9,837,230 |
2,609,034 |
Professional |
116,829 |
343,717 |
454,348 |
54,904 |
|
Transfer
agent |
97,774 |
137,516 |
58,495 |
31,982 |
Accounting
services |
86,717 |
24,303 |
98,666 |
24,303 |
|
Trustees
and Officer |
64,973 |
43,588 |
65,289 |
16,107 |
Custodian |
54,356 |
18,958 |
44,348 |
20,810 |
|
Printing
and postage |
14,510 |
6,039 |
15,876 |
5,758 |
Registration |
12,980 |
6,752 |
38,285 |
4,237 |
|
Offering |
— |
71,340 |
— |
124,006 |
Miscellaneous |
142,618 |
157,111 |
379,192 |
52,822 |
|
Total
expenses excluding interest expense |
9,907,578 |
7,274,709 |
10,991,729 |
2,943,963 |
Interest
expense — unaffiliated |
194 |
525 |
884 |
579 |
|
Total
expenses |
9,907,772 |
7,275,234 |
10,992,613 |
2,944,542 |
Less: |
|
|
|
|
|
Fees
waived and/or reimbursed by the Manager |
(7,006
) |
(3,625
) |
(17,044
) |
(4,369
) |
Total
expenses after fees waived and/or reimbursed |
9,900,766 |
7,271,609 |
10,975,569 |
2,940,173 |
|
Net
investment income (loss) |
(8,278,105
) |
(4,524,670
) |
(4,647,608
) |
3,304,985 |
REALIZED
AND UNREALIZED GAIN (LOSS) |
|
|
|
|
|
Net
realized gain (loss) from: |
|
|
|
|
Investments
— unaffiliated |
121,040,119 |
66,529,287 |
27,275,686 |
20,867,872 |
|
Investments
— affiliated |
(3,497
) |
(53
) |
(3,114
) |
(489
) |
Foreign
currency transactions |
16,138 |
103,776 |
(224,396
) |
(33,385
) |
|
Options
written |
2,731,607 |
(1,364,329
) |
4,924,967 |
(4,648,368
) |
|
123,784,367 |
65,268,681 |
31,973,143 |
16,185,630 | |
|
Net
change in unrealized appreciation (depreciation) on: |
|
|
|
|
Investments
— unaffiliated |
(80,001,692
)(b) |
38,378,221
(b) |
(88,827,134
) |
54,235,053 |
|
Investments
— affiliated |
(893
) |
— |
227 |
— |
Foreign
currency translations |
132 |
4,050 |
1,699 |
27,571 |
|
Options
written |
(7,662,996
) |
(9,968,022
) |
(4,189,091
) |
(3,015,949
) |
|
(87,665,449
) |
28,414,249 |
(93,014,299
) |
51,246,675 | |
|
Net
realized and unrealized gain (loss) |
36,118,918 |
93,682,930 |
(61,041,156
) |
67,432,305 |
NET
INCREASE (DECREASE) IN NET ASSETS RESULTING FROM
OPERATIONS |
$27,840,813 |
$89,158,260 |
$(65,688,764
) |
$70,737,290 |
|
(a)
Consolidated
Statement of Operations. | ||||
(b)
Net
of reduction in deferred capital gain tax of |
$52,239 |
$27,859 |
$— |
$— |
|
|
BGR |
BDJ(a)
| ||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
|
INCREASE
(DECREASE) IN NET ASSETS |
|
|
|
|
|
OPERATIONS |
|
|
|
|
|
Net
investment income |
$5,062,725 |
$8,902,650 |
$15,813,368 |
$31,964,398 |
|
Net
realized gain |
23,078,000 |
17,018,043 |
56,386,983 |
71,556,715 |
|
Net
change in unrealized appreciation (depreciation) |
(10,869,464
) |
(11,777,785
) |
57,716,205 |
61,248,610 |
|
Net
increase in net assets resulting from operations |
17,271,261 |
14,142,908 |
129,916,556 |
164,769,723 |
|
DISTRIBUTIONS
TO SHAREHOLDERS(b)
|
|
|
|
|
|
From
net investment income |
(14,988,332
)(c) |
(8,876,987
) |
(65,717,258
)(c) |
(125,237,041
) |
|
Return
of capital |
— |
(13,896,512
) |
— |
— |
|
Decrease
in net assets resulting from distributions to
shareholders |
(14,988,332
) |
(22,773,499
) |
(65,717,258
) |
(125,237,041
) |
|
CAPITAL
SHARE TRANSACTIONS |
|
|
|
|
|
Redemption
of shares resulting from share repurchase program (including transaction
costs) |
(9,032,106
) |
(19,781,491
) |
— |
(84,525,360
) |
|
NET
ASSETS |
|
|
|
|
|
Total
increase (decrease) in net assets |
(6,749,177
) |
(28,412,082
) |
64,199,298 |
(44,992,678
) |
|
Beginning
of period |
359,569,775 |
387,981,857 |
1,596,608,445 |
1,641,601,123 |
|
End
of period |
$352,820,598 |
$359,569,775 |
$1,660,807,743 |
$1,596,608,445 |
|
(a)
|
Consolidated
Statements of Changes in Net Assets. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
|
BOE |
BGY | ||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
|
INCREASE
(DECREASE) IN NET ASSETS |
|
|
|
|
|
OPERATIONS |
|
|
|
|
|
Net
investment income |
$5,125,558 |
$10,995,449 |
$6,433,489 |
$8,892,803 |
|
Net
realized gain |
10,990,855 |
20,894,699 |
623,193 |
34,431,931 |
|
Net
change in unrealized appreciation (depreciation) |
33,124,480 |
30,507,659 |
51,027,234 |
(31,544,308
) |
|
Net
increase in net assets resulting from operations |
49,240,893 |
62,397,807 |
58,083,916 |
11,780,426 |
|
DISTRIBUTIONS
TO SHAREHOLDERS(a)
|
|
|
|
|
|
From
net investment income |
(28,420,133
)(b) |
(10,955,631
) |
(23,858,982
)(b) |
(41,087,555
) |
|
Return
of capital |
— |
(36,227,997
) |
— |
— |
|
Decrease
in net assets resulting from distributions to
shareholders |
(28,420,133
) |
(47,183,628
) |
(23,858,982
) |
(41,087,555
) |
|
CAPITAL
SHARE TRANSACTIONS |
|
|
|
|
|
Redemption
of shares resulting from share repurchase program (including transaction
costs) |
(34,701,871
) |
(36,994,167
) |
(28,595,928
) |
(30,215,690
) |
|
NET
ASSETS |
|
|
|
|
|
Total
increase (decrease) in net assets |
(13,881,111
) |
(21,779,988
) |
5,629,006 |
(59,522,819
) |
|
Beginning
of period |
704,709,199 |
726,489,187 |
562,959,031 |
622,481,850 |
|
End
of period |
$690,828,088 |
$704,709,199 |
$568,588,037 |
$562,959,031 |
|
(a)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(b)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
|
CII |
BMEZ | ||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
|
INCREASE
(DECREASE) IN NET ASSETS |
|
|
|
|
|
OPERATIONS |
|
|
|
|
|
Net
investment income (loss) |
$(512,139
) |
$1,804,768 |
$(4,495,762
) |
$3,882,343 |
|
Net
realized gain (loss) |
80,644,956 |
131,087,223 |
(43,943,871
) |
17,150,385 |
|
Net
change in unrealized appreciation (depreciation) |
4,137,414 |
(8,234,771
) |
(14,062,567
) |
2,716,794 |
|
Net
increase (decrease) in net assets resulting from
operations |
84,270,231 |
124,657,220 |
(62,502,200
) |
23,749,522 |
|
DISTRIBUTIONS
TO SHAREHOLDERS(a)
|
|
|
|
|
|
From
net investment income and net realized gain |
(34,912,485
)(b) |
(53,906,727
) |
(92,726,664
)(b) |
— |
|
Return
of capital |
— |
— |
— |
(177,775,924
) |
|
Decrease
in net assets resulting from distributions to
shareholders |
(34,912,485
) |
(53,906,727
) |
(92,726,664
) |
(177,775,924
) |
|
CAPITAL
SHARE TRANSACTIONS |
|
|
|
|
|
Redemption
of shares resulting from share repurchase program (including transaction
costs) |
(22,239,867
) |
(45,649,966
) |
(550,636,007
) |
(89,462,275
) |
|
NET
ASSETS |
|
|
|
|
|
Total
increase (decrease) in net assets |
27,117,879 |
25,100,527 |
(705,864,871
) |
(243,488,677
) |
|
Beginning
of period |
899,551,308 |
874,450,781 |
1,663,882,255 |
1,907,370,932 |
|
End
of period |
$926,669,187 |
$899,551,308 |
$958,017,384 |
$1,663,882,255 |
|
(a)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(b)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
|
BME |
BCX | ||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
|
INCREASE
(DECREASE) IN NET ASSETS |
|
|
|
|
|
OPERATIONS |
|
|
|
|
|
Net
investment income |
$968,511 |
$927,098 |
$9,228,590 |
$18,418,123 |
|
Net
realized gain |
9,457,588 |
28,763,776 |
37,232,934 |
22,404,202 |
|
Net
change in unrealized appreciation (depreciation) |
(13,987,757
) |
(6,236,087
) |
38,173,815 |
(67,679,275
) |
|
Net
increase (decrease) in net assets resulting from
operations |
(3,561,658
) |
23,454,787 |
84,635,339 |
(26,856,950
) |
|
DISTRIBUTIONS
TO SHAREHOLDERS(a)
|
|
|
|
|
|
From
net investment income and net realized gain |
(20,498,157
)(b) |
(28,577,659
) |
(32,843,514
)(b) |
(20,754,349
) |
|
Return
of capital |
— |
(7,344,579
) |
— |
(32,577,896
) |
|
Decrease
in net assets resulting from distributions to
shareholders |
(20,498,157
) |
(35,922,238
) |
(32,843,514
) |
(53,332,245
) |
|
CAPITAL
SHARE TRANSACTIONS |
|
|
|
|
|
Redemption
of shares resulting from share repurchase program (including transaction
costs) |
(13,977,639
) |
(29,532,715
) |
(38,612,680
) |
(42,582,282
) |
|
NET
ASSETS |
|
|
|
|
|
Total
increase (decrease) in net assets |
(38,037,454
) |
(42,000,166
) |
13,179,145 |
(122,771,477
) |
|
Beginning
of period |
546,135,264 |
588,135,430 |
768,567,015 |
891,338,492 |
|
End
of period |
$508,097,810 |
$546,135,264 |
$781,746,160 |
$768,567,015 |
|
(a)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(b)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
|
BSTZ(a)
|
BST(a)
| ||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
|
INCREASE
(DECREASE) IN NET ASSETS |
|
|
|
|
OPERATIONS |
|
|
|
|
|
Net
investment loss |
$(8,278,105
) |
$(20,600,953
) |
$(4,524,670
) |
$(9,647,335
) |
Net
realized gain |
123,784,367 |
127,452,088 |
65,268,681 |
49,084,701 |
|
Net
change in unrealized appreciation (depreciation) |
(87,665,449
) |
170,688,787 |
28,414,249 |
232,842,089 |
Net
increase in net assets resulting from operations |
27,840,813 |
277,539,922 |
89,158,260 |
272,279,455 |
|
DISTRIBUTIONS
TO SHAREHOLDERS(b)
|
|
|
|
|
From
net investment income and net realized gain |
(93,729,677
)(c) |
(76,763,205
) |
(52,080,029
)(c) |
(54,438,359
) |
|
Return
of capital |
— |
(74,781,695
) |
— |
(49,592,586
) |
Decrease
in net assets resulting from distributions to
shareholders |
(93,729,677
) |
(151,544,900
) |
(52,080,029
) |
(104,030,945
) |
|
CAPITAL
SHARE TRANSACTIONS |
|
|
|
|
Net
proceeds from the issuance of shares |
— |
— |
— |
8,635,484 |
|
Reinvestment
of distributions |
— |
— |
— |
1,567,740 |
Redemption
of shares resulting from a repurchase offer |
(74,446,790
) |
(82,227,801
) |
— |
— |
|
Net
increase (decrease) in net assets derived from capital share
transactions |
(74,446,790
) |
(82,227,801
) |
— |
10,203,224 |
NET
ASSETS |
|
|
|
|
|
Total
increase (decrease) in net assets |
(140,335,654
) |
43,767,221 |
37,078,231 |
178,451,734 |
Beginning
of period |
1,673,591,450 |
1,629,824,229 |
1,374,876,360 |
1,196,424,626 |
|
End
of period |
$1,533,255,796 |
$1,673,591,450 |
$1,411,954,591 |
$1,374,876,360 |
|
(a)
|
Consolidated
Statements of Changes in Net Assets. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
|
BTX |
BUI | ||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
|
INCREASE
(DECREASE) IN NET ASSETS |
|
|
|
|
|
OPERATIONS |
|
|
|
|
|
Net
investment income (loss) |
$(4,647,608
) |
$(23,510,738
) |
$3,304,985 |
$6,477,896 |
|
Net
realized gain |
31,973,143 |
50,880,406 |
16,185,630 |
25,208,486 |
|
Net
change in unrealized appreciation (depreciation) |
(93,014,299
) |
8,335,555 |
51,246,675 |
3,928,824 |
|
Net
increase (decrease) in net assets resulting from
operations |
(65,688,764
) |
35,705,223 |
70,737,290 |
35,615,206 |
|
DISTRIBUTIONS
TO SHAREHOLDERS |
|
|
|
|
|
From
net investment income |
(108,168,841
)(a) |
— |
(18,491,348
)(a) |
(25,151,530
) |
|
Return
of capital |
— |
(184,726,032
) |
— |
(7,834,340
) |
|
Decrease
in net assets resulting from distributions to
shareholders |
(108,168,841
) |
(184,726,032
) |
(18,491,348
) |
(32,985,870
) |
|
CAPITAL
SHARE TRANSACTIONS |
|
|
|
|
|
Net
proceeds from the issuance of shares |
— |
— |
2,964,536 |
1,263,628 |
|
Reinvestment
of distributions |
— |
— |
769,096 |
499,080 |
|
Redemption
of shares resulting from share repurchase program (including transaction
costs) |
— |
(92,487,614
) |
— |
— |
|
Net
increase (decrease) in net assets derived from capital share
transactions |
— |
(92,487,614
) |
3,733,632 |
1,762,708 |
|
NET
ASSETS |
|
|
|
|
|
Total
increase (decrease) in net assets |
(173,857,605
) |
(241,508,423
) |
55,979,574 |
4,392,044 |
|
Beginning
of period |
1,784,961,415 |
2,026,469,838 |
510,853,974 |
506,461,930 |
|
End
of period |
$1,611,103,810 |
$1,784,961,415 |
$566,833,548 |
$510,853,974 |
|
(a)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
|
BGR |
BDJ(a)
|
BOE |
BGY |
|
CASH
PROVIDED BY (USED FOR) OPERATING ACTIVITIES |
|
|
|
|
|
Net
increase in net assets resulting from operations |
$17,271,261 |
$129,916,556 |
$49,240,893 |
$58,083,916 |
|
Adjustments
to reconcile net increase in net assets resulting from operations to net
cash provided by operating
activities: |
|
|
|
|
|
Proceeds
from sales of long-term investments and principal
paydowns/payups |
163,053,383 |
470,263,557 |
184,949,119 |
195,621,235 |
|
Purchases
of long-term investments |
(151,573,331
) |
(410,165,690
) |
(118,112,433
) |
(143,896,264
) |
|
Net
proceeds from sales (purchases) of short-term
securities |
4,604,448 |
(8,626,145
) |
(2,721,633
) |
843,075 |
|
Premiums
paid on closing options written |
(8,145,591
) |
(90,386,038
) |
(35,811,326
) |
(25,103,434
) |
|
Premiums
received from options written |
11,061,542 |
81,913,244 |
29,253,986 |
21,921,846 |
|
Net
realized gain on investments and options written |
(22,946,478
) |
(55,812,168
) |
(10,663,064
) |
(713,265
) |
|
Net
unrealized (appreciation) depreciation on investments, options written and
foreign currency translations |
10,878,033 |
(57,703,250
) |
(33,012,038
) |
(51,056,746
) |
|
(Increase)
Decrease in Assets |
|
|
|
|
|
Receivables |
|
|
|
|
|
Dividends
— affiliated |
14,341 |
(51,958
) |
853 |
6,218 |
|
Dividends
— unaffiliated |
(453,743
) |
(636,572
) |
(121,698
) |
(156,748
) |
|
Securities
lending income — affiliated |
— |
(731
) |
— |
— |
|
Prepaid
expenses |
— |
(19,236
) |
(2,470
) |
(8,570
) |
|
Increase
(Decrease) in Liabilities |
|
|
|
|
|
Collateral
on securities loaned |
— |
7,493,797 |
— |
— |
|
Payables |
|
|
|
|
|
Accounting
services fees |
7,171 |
15,299 |
9,599 |
7,963 |
|
Custodian
fees |
7,751 |
13,878 |
9,264 |
18,941 |
|
Deferred
foreign capital gain tax |
— |
— |
— |
133,748 |
|
Investment
advisory fees |
(20,233
) |
(38,827
) |
(44,288
) |
(24,802
) |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
30,473 |
54,670 |
|
Trustees’
and Officer’s
fees |
(18,905
) |
6,134 |
(13,910
) |
(23,105
) |
|
Other
accrued expenses |
(7,828
) |
2,514 |
(9,813
) |
(11,983
) |
|
Professional
fees |
30,574 |
34,220 |
(75,181
) |
(67,003
) |
|
Transfer
agent fees |
(8,992
) |
57,061 |
(13,893
) |
(10,307
) |
|
Net
cash provided by operating activities |
23,753,403 |
66,275,645 |
62,892,440 |
55,619,385 |
|
CASH
PROVIDED BY (USED FOR) FINANCING ACTIVITIES |
|
|
|
|
|
Cash
dividends paid to shareholders |
(14,842,971
) |
(65,458,633
) |
(28,252,921
) |
(23,667,635
) |
|
Net
payments on redemption of capital shares |
(9,032,106
) |
— |
(34,701,871
) |
(28,595,928
) |
|
Net
cash used for financing activities |
(23,875,077
) |
(65,458,633
) |
(62,954,792
) |
(52,263,563
) |
|
CASH
IMPACT FROM FOREIGN EXCHANGE FLUCTUATIONS |
|
|
|
|
|
Cash
impact from foreign exchange fluctuations |
994 |
(245
) |
1,004 |
743 |
|
CASH
AND FOREIGN CURRENCY |
|
|
|
|
|
Net
increase (decrease) in restricted and unrestricted cash and foreign
currency |
(120,680
) |
816,767 |
(61,348
) |
3,356,565 |
|
Restricted
and unrestricted cash and foreign currency at beginning of
period |
228,832 |
47,948 |
262,325 |
90,323 |
|
Restricted
and unrestricted cash and foreign currency at end of period
|
$108,152 |
$864,715 |
$200,977 |
$3,446,888 |
|
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION |
|
|
|
|
|
Cash
paid during the period for interest expense |
$576 |
$1,505 |
$895 |
$2,066 |
|
RECONCILIATION
OF RESTRICTED AND UNRESTRICTED CASH AND FOREIGN CURRENCY
AT THE
END OF PERIOD
TO THE STATEMENTS OF ASSETS AND LIABILITIES |
|
|
|
|
|
Cash |
$— |
$285,228 |
$120,644 |
$1,963,656 |
|
Cash
pledged |
|
|
|
|
|
Collateral
— OTC derivatives |
— |
100,000 |
— |
1,306,794 |
|
Foreign
currency at value |
108,152 |
479,487 |
80,333 |
176,438 |
|
|
$108,152 |
$864,715 |
$200,977 |
$3,446,888 |
|
(a)
|
Consolidated
Statement of Cash Flows. |
|
|
CII |
BMEZ |
BME |
BCX |
|
CASH
PROVIDED BY (USED FOR) OPERATING ACTIVITIES |
|
|
|
|
|
Net
increase (decrease) in net assets resulting from
operations |
$84,270,231 |
$(62,502,200
) |
$(3,561,658
) |
$84,635,339 |
|
Adjustments
to reconcile net increase (decrease) in net assets resulting from
operations to net cash provided by
operating
activities: |
|
|
|
|
|
Proceeds
from sales of long-term investments and principal
paydowns/payups |
472,203,125 |
1,113,333,852 |
164,683,672 |
566,464,305 |
|
Purchases
of long-term investments |
(407,288,772
) |
(514,860,399
) |
(139,521,495
) |
(524,190,450
) |
|
Net
proceeds from sales of short-term securities |
1,109,188 |
46,933,877 |
4,044,301 |
2,492,133 |
|
Premiums
paid on closing options written |
(70,826,907
) |
(32,920,630
) |
(16,881,770
) |
(19,863,243
) |
|
Premiums
received from options written |
62,539,581 |
41,885,742 |
19,837,635 |
27,753,369 |
|
Net
realized (gain) loss on investments and options
written |
(80,361,762
) |
44,286,198 |
(9,397,834
) |
(32,706,167
) |
|
Net
unrealized (appreciation) depreciation on investments, options written and
foreign currency translations |
(4,137,414
) |
14,144,771 |
13,994,782 |
(38,151,431
) |
|
(Increase)
Decrease in Assets |
|
|
|
|
|
Receivables |
|
|
|
|
|
Dividends
— affiliated |
8,000 |
128,957 |
27,026 |
26,612 |
|
Dividends
— unaffiliated |
(23,000
) |
(248,032
) |
(36,270
) |
190,333 |
|
Interest
— unaffiliated |
— |
9,251 |
2,168 |
1,750 |
|
Securities
lending income — affiliated |
456 |
3,640 |
(844
) |
(4,919
) |
|
Prepaid
expenses |
(1,822
) |
(5,081
) |
— |
— |
|
Deferred
offering costs. |
— |
— |
84,599 |
— |
|
Increase
(Decrease) in Liabilities |
|
|
|
|
|
Collateral
on securities loaned |
(435,165
) |
(7,587,276
) |
1,131,899 |
4,149,011 |
|
Payables |
|
|
|
|
|
Accounting
services fees |
7,964 |
49,836 |
4,698 |
9,608 |
|
Custodian
fees |
(6,259
) |
(2,668
) |
7,927 |
12,378 |
|
Investment
advisory fees |
(32,586
) |
(849,518
) |
(61,324
) |
(33,746
) |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
— |
861,588 |
|
Trustees’
and Officer’s
fees |
11,781 |
40,882 |
2,600 |
(2,615
) |
|
Other
accrued expenses |
1,145 |
(21,222
) |
(624
) |
(4,274
) |
|
Professional
fees |
(29,204
) |
(29,950
) |
(47,119
) |
49,282 |
|
Proxy
fees |
— |
(71,887
) |
— |
— |
|
Transfer
agent fees |
(16,766
) |
(56,287
) |
(10,972
) |
(13,590
) |
|
Net
cash provided by operating activities |
56,991,814 |
641,661,856 |
34,301,397 |
71,675,273 |
|
CASH
PROVIDED BY (USED FOR) FINANCING ACTIVITIES |
|
|
|
|
|
Cash
dividends paid to shareholders |
(34,570,623
) |
(91,153,250
) |
(20,291,141
) |
(32,594,178
) |
|
Net
payments on redemption of capital shares |
(22,239,867
) |
(550,636,007
) |
(13,977,639
) |
(38,612,680
) |
|
Decrease
in bank overdraft |
(181,324
) |
— |
— |
(149,544
) |
|
Net
cash used for financing activities |
(56,991,814
) |
(641,789,257
) |
(34,268,780
) |
(71,356,402
) |
|
CASH
IMPACT FROM FOREIGN EXCHANGE FLUCTUATIONS |
|
|
|
|
|
Cash
impact from foreign exchange fluctuations |
59 |
62 |
732 |
7,143 |
|
CASH
AND FOREIGN CURRENCY |
|
|
|
|
|
Net
increase (decrease) in restricted and unrestricted cash and foreign
currency |
59 |
(127,339
) |
33,349 |
326,014 |
|
Restricted
and unrestricted cash and foreign currency at beginning of
period |
617 |
128,147 |
6,048 |
71,339 |
|
Restricted
and unrestricted cash and foreign currency at end of period
|
$676 |
$808 |
$39,397 |
$397,353 |
|
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION |
|
|
|
|
|
Cash
paid during the period for interest expense |
$1,041 |
$189 |
$87 |
$3,595 |
|
RECONCILIATION
OF RESTRICTED AND UNRESTRICTED CASH AND FOREIGN CURRENCY
AT THE
END OF PERIOD
TO THE STATEMENTS OF ASSETS AND LIABILITIES |
|
|
|
|
|
Foreign
currency at value |
676 |
808 |
39,397 |
397,353 |
|
|
$676 |
$808 |
$39,397 |
$397,353 |
|
|
BSTZ(a)
|
BST(a)
|
BTX |
BUI |
|
CASH
PROVIDED BY (USED FOR) OPERATING ACTIVITIES |
|
|
|
|
|
Net
increase (decrease) in net assets resulting from
operations |
$27,840,813 |
$89,158,260 |
$(65,688,764
) |
$70,737,290 |
|
Adjustments
to reconcile net increase (decrease) in net assets resulting from
operations to net cash provided by
operating
activities: |
|
|
|
|
|
Proceeds
from sales of long-term investments |
676,848,435 |
311,349,975 |
1,719,180,030 |
152,423,127 |
|
Purchases
of long-term investments |
(475,144,583
) |
(245,885,969
) |
(1,527,694,748
) |
(138,846,206
) |
|
Net
proceeds from sales (purchases) of short-term
securities |
(41,496,574
) |
1,181,179 |
(71,165,412
) |
763,477 |
|
Premiums
paid on closing options written |
(40,034,170
) |
(44,730,478
) |
(12,508,001
) |
(22,930,312
) |
|
Premiums
received from options written |
34,510,276 |
34,835,716 |
7,260,812 |
18,867,014 |
|
Net
realized gain on investments and options written |
(123,768,638
) |
(65,146,169
) |
(32,194,861
) |
(15,808,541
) |
|
Net
unrealized (appreciation) depreciation on investments, options written and
foreign currency translations |
87,718,063 |
(28,380,934
) |
93,014,299 |
(51,246,675
) |
|
(Increase)
Decrease in Assets |
|
|
|
|
|
Receivables |
|
|
|
|
|
Dividends
— affiliated |
(36
) |
(1,103
) |
(170,359
) |
(10,138
) |
|
Dividends
— unaffiliated |
(110,437
) |
(169,181
) |
(134,089
) |
(141,522
) |
|
Securities
lending income — affiliated |
(11,072
) |
693 |
(15,357
) |
115 |
|
Prepaid
expenses |
(105,940
) |
3,518 |
(27,386
) |
— |
|
Deferred
offering costs. |
— |
71,340 |
— |
(10,090
) |
|
Increase
(Decrease) in Liabilities |
|
|
|
|
|
Collateral
on securities loaned |
20,437,427 |
(565,400
) |
(2,287,241
) |
— |
|
Payables |
|
|
|
|
|
Accounting
services fees |
41,659 |
7,961 |
49,252 |
7,961 |
|
Custodian
fees |
24,468 |
6,446 |
23,475 |
7,514 |
|
Deferred
capital gain tax |
(52,239
) |
(27,859
) |
— |
— |
|
Investment
advisory fees |
(294,903
) |
(65,556
) |
(362,467
) |
11,192 |
|
IRS
compliance fee for foreign withholding tax claims |
— |
— |
— |
87,335 |
|
Trustees’
and Officer’s
fees |
34,456 |
22,802 |
37,935 |
(246
) |
|
Other
accrued expenses |
(41,747
) |
(15,973
) |
(544,018
) |
11,021 |
|
Professional
fees |
(74,180
) |
(47,582
) |
(77,730
) |
(12,426
) |
|
Proxy
fees |
— |
— |
83,223 |
— |
|
Transfer
agent fees |
(93,831
) |
(10,903
) |
22,222 |
23,630 |
|
Net
cash provided by operating activities |
166,227,247 |
51,590,783 |
106,800,815 |
13,933,520 |
|
CASH
PROVIDED BY (USED FOR) FINANCING ACTIVITIES |
|
|
|
|
|
Cash
dividends paid to shareholders |
(91,693,331
) |
(51,659,645
) |
(106,564,331
) |
(17,722,252
) |
|
Payments
for offering costs |
— |
— |
— |
116,155 |
|
Net
payments on redemption of capital shares |
(74,446,790
) |
— |
— |
— |
|
Proceeds
from issuance of capital shares |
— |
— |
— |
3,538,836 |
|
Net
cash used for financing activities |
(166,140,121
) |
(51,659,645
) |
(106,564,331
) |
(14,067,261
) |
|
CASH
IMPACT FROM FOREIGN EXCHANGE FLUCTUATIONS |
|
|
|
|
|
Cash
impact from foreign exchange fluctuations |
507 |
175 |
193 |
589 |
|
CASH
AND FOREIGN CURRENCY |
|
|
|
|
|
Net
increase (decrease) in restricted and unrestricted cash and foreign
currency |
87,633 |
(68,687
) |
236,677 |
(133,152
) |
|
Restricted
and unrestricted cash and foreign currency at beginning of
period |
392,742 |
136,393 |
— |
225,175 |
|
Restricted
and unrestricted cash and foreign currency at end of period
|
$480,375 |
$67,706 |
$236,677 |
$92,023 |
|
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION |
|
|
|
|
|
Cash
paid during the period for interest expense |
$194 |
$525 |
$884 |
$579 |
|
NON-CASH
FINANCING ACTIVITIES |
|
|
|
|
|
Reinvestment
of distributions |
$— |
$— |
$— |
$769,096 |
|
|
BSTZ(a) |
BST(a) |
BTX |
BUI |
|
RECONCILIATION
OF RESTRICTED AND UNRESTRICTED CASH AND FOREIGN CURRENCY
AT THE
END OF PERIOD
TO THE CONSOLIDATED STATEMENTS OF ASSETS AND
LIABILITIES |
|
|
|
|
|
Cash |
$30,600 |
$52,127 |
$— |
$11,121 |
|
Cash
pledged |
|
|
|
|
|
Collateral
— OTC derivatives |
380,000 |
— |
— |
— |
|
Foreign
currency at value |
69,775 |
15,579 |
236,677 |
80,902 |
|
|
$480,375 |
$67,706 |
$236,677 |
$92,023 |
|
(a)
|
Consolidated
Statement of Cash Flows. |
|
|
BGR | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$13.77 |
$14.13 |
$14.21 |
$10.77 |
$8.17 |
$12.57 |
|
Net
investment income(a) |
0.20 |
0.33 |
0.37 |
0.42 |
0.28 |
0.32 |
|
Net
realized and unrealized gain (loss) |
0.47 |
0.15 |
0.32 |
3.60 |
2.77 |
(4.06
) |
|
Net
increase (decrease) from investment operations |
0.67 |
0.48 |
0.69 |
4.02 |
3.05 |
(3.74
) |
|
Distributions(b)
|
||||||
|
From
net investment income |
(0.58
)(c) |
(0.33
) |
(0.37
) |
(0.42
) |
(0.28
) |
(0.32
) |
|
Return
of capital |
— |
(0.51
) |
(0.40
) |
(0.16
) |
(0.17
) |
(0.34
) |
|
Total
distributions |
(0.58
) |
(0.84
) |
(0.77
) |
(0.58
) |
(0.45
) |
(0.66
) |
|
Net
asset value, end of period |
$13.86 |
$13.77 |
$14.13 |
$14.21 |
$10.77 |
$8.17 |
|
Market
price, end of period |
$13.26 |
$12.61 |
$12.45 |
$12.53 |
$9.48 |
$7.10 |
|
Total
Return(d)
|
|
|
|
|
|
|
|
Based
on net asset value |
5.21
%(e) |
3.93
%(f) |
5.75
% |
38.51
% |
38.36
%(f) |
(29.03
)% |
|
Based
on market price |
9.91
%(e) |
8.02
% |
5.66
% |
38.76
% |
40.14
% |
(34.74
)% |
|
Ratios
to Average Net Assets(g)
|
|
|
|
|
|
|
|
Total
expenses |
1.16
%(h) |
1.23
% |
1.29
% |
1.26
% |
1.33
% |
1.37
% |
|
Total
expenses after fees waived and/or reimbursed |
1.16
%(h) |
1.12
% |
1.07
% |
1.04
% |
1.11
% |
1.15
% |
|
Total
expenses after fees waived and/or reimbursed and excluding
professional fees for
foreign
withholding taxes |
1.14
%(h) |
1.12
% |
1.07
% |
1.04
% |
1.11
% |
1.15
% |
|
Net
investment income |
2.89
%(h) |
2.25
% |
2.66
% |
3.21
% |
2.88
% |
3.77
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$352,821 |
$359,570 |
$387,982 |
$398,493 |
$313,503 |
$237,868 |
|
Portfolio
turnover rate |
43
% |
42
% |
38
% |
76
% |
61
% |
62
% |
|
(a)
|
Based
on average shares outstanding. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(d)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(e)
|
Not
annualized. |
|
(f)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(g)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(h)
|
Annualized. |
|
|
BDJ | |||||
|
|
Six
Months Ended
06/30/25
(unaudited)(a)
|
Year
Ended
12/31/24(a)
|
Year
Ended
12/31/23(a)
|
Year
Ended
12/31/22(a)
|
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$9.02 |
$8.82 |
$8.74 |
$10.23 |
$9.35 |
$10.03 |
|
Net
investment income(b) |
0.09 |
0.17 |
0.18 |
0.16 |
0.15 |
0.18 |
|
Net
realized and unrealized gain (loss) |
0.65 |
0.71 |
0.63 |
(0.56
) |
1.60 |
(0.26
) |
|
Net
increase (decrease) from investment operations |
0.74 |
0.88 |
0.81 |
(0.40
) |
1.75 |
(0.08
) |
|
Distributions(c)
|
||||||
|
From
net investment income |
(0.37
)(d) |
(0.20
) |
(0.13
) |
(0.04
) |
(0.28
) |
(0.15
) |
|
From
net realized gain |
— |
(0.48
) |
(0.60
) |
(1.05
) |
(0.59
) |
(0.45
) |
|
Total
distributions |
(0.37
) |
(0.68
) |
(0.73
) |
(1.09
) |
(0.87
) |
(0.60
) |
|
Net
asset value, end of period |
$9.39 |
$9.02 |
$8.82 |
$8.74 |
$10.23 |
$9.35 |
|
Market
price, end of period |
$8.89 |
$8.28 |
$7.69 |
$9.01 |
$10.08 |
$8.47 |
|
Total
Return(e)
|
|
|
|
|
|
|
|
Based
on net asset value |
8.63
%(f) |
10.89
%(g) |
10.37
% |
(3.71
)%(g) |
19.33
% |
0.77
% |
|
Based
on market price |
12.04
%(f) |
16.76
% |
(6.65
)% |
0.74
% |
29.80
% |
(7.70
)% |
|
Ratios
to Average Net Assets(h)
|
|
|
|
|
|
|
|
Total
expenses |
0.87
%(i) |
0.88
% |
0.86
% |
0.84
% |
0.85
% |
0.86
% |
|
Total
expenses after fees waived and/or reimbursed |
0.87
%(i) |
0.88
% |
0.86
% |
0.84
% |
0.85
% |
0.86
% |
|
Total
expenses after fees waived and/or reimbursed and excluding
professional
fees for foreign withholding taxes |
0.86
%(i) |
0.88
% |
0.85
% |
0.84
% |
0.85
% |
0.86
% |
|
Net
investment income |
1.98
%(i) |
1.89
% |
2.12
% |
1.69
% |
1.44
% |
2.15
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$1,660,808 |
$1,596,608 |
$1,641,601 |
$1,629,642 |
$1,902,838 |
$1,739,122 |
|
Portfolio
turnover rate |
28
% |
50
% |
43
% |
81
% |
40
% |
48
% |
|
(a)
|
Consolidated
Financial Highlights. |
|
(b)
|
Based
on average shares outstanding. |
|
(c)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(d)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(e)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(f)
|
Not
annualized. |
|
(g)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(h)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(i)
|
Annualized. |
|
|
BOE | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$12.05 |
$11.81 |
$10.97 |
$13.40 |
$12.28 |
$12.32 |
|
Net
investment income(a) |
0.09 |
0.18 |
0.22 |
0.20 |
0.19 |
0.26 |
|
Net
realized and unrealized gain (loss) |
0.78 |
0.84 |
1.38 |
(1.87
) |
1.69 |
0.46 |
|
Net
increase (decrease) from investment operations |
0.87 |
1.02 |
1.60 |
(1.67
) |
1.88 |
0.72 |
|
Distributions(b)
|
||||||
|
From
net investment income |
(0.50
)(c) |
(0.18
) |
(0.22
) |
(0.19
) |
(0.19
) |
(0.26
) |
|
From
net realized gain |
— |
— |
— |
(0.41
) |
(0.57
) |
— |
|
Return
of capital |
— |
(0.60
) |
(0.54
) |
(0.16
) |
— |
(0.50
) |
|
Total
distributions |
(0.50
) |
(0.78
) |
(0.76
) |
(0.76
) |
(0.76
) |
(0.76
) |
|
Net
asset value, end of period |
$12.42 |
$12.05 |
$11.81 |
$10.97 |
$13.40 |
$12.28 |
|
Market
price, end of period |
$11.35 |
$10.77 |
$9.92 |
$9.56 |
$12.18 |
$10.91 |
|
Total
Return(d)
|
|
|
|
|
|
|
|
Based
on net asset value |
7.75
%(e) |
9.67
% |
16.16
% |
(11.87
)% |
16.21
% |
7.65
% |
|
Based
on market price |
10.17
%(e) |
16.70
% |
11.95
% |
(15.51
)% |
18.89
% |
7.22
% |
|
Ratios
to Average Net Assets(f)
|
|
|
|
|
|
|
|
Total
expenses |
1.14
%(g) |
1.11
% |
1.09
% |
1.06
% |
1.07
% |
1.09
% |
|
Total
expenses after fees waived and/or reimbursed |
0.96
%(g) |
0.93
% |
0.91
% |
0.89
% |
0.90
% |
0.92
% |
|
Total
expenses after fees waived and/or reimbursed and excluding
professional fees for
foreign
withholding taxes |
0.96
%(g) |
0.93
% |
0.91
% |
0.88
% |
0.90
% |
0.92
% |
|
Net
investment income |
1.50
%(g) |
1.48
% |
1.93
% |
1.72
% |
1.46
% |
2.33
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$690,828 |
$704,709 |
$726,489 |
$688,464 |
$857,721 |
$786,230 |
|
Portfolio
turnover rate |
17
% |
51
% |
46
% |
44
% |
65
% |
61
% |
|
(a)
|
Based
on average shares outstanding. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(d)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(e)
|
Not
annualized. |
|
(f)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(g)
|
Annualized. |
|
|
BGY | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$5.91 |
$6.21 |
$5.78 |
$6.81 |
$6.49 |
$6.47 |
|
Net
investment income(a) |
0.07 |
0.09 |
0.09 |
0.10 |
0.09 |
0.12 |
|
Net
realized and unrealized gain (loss) |
0.55 |
0.02 |
0.75 |
(0.72
) |
0.64 |
0.31 |
|
Net
increase (decrease) from investment operations |
0.62 |
0.11 |
0.84 |
(0.62
) |
0.73 |
0.43 |
|
Distributions(b)
|
||||||
|
From
net investment income |
(0.26
)(c) |
(0.08
) |
(0.08
) |
(0.10
) |
(0.14
) |
(0.13
) |
|
From
net realized gain |
— |
(0.33
) |
(0.09
) |
(0.10
) |
(0.15
) |
— |
|
Return
of capital |
— |
— |
(0.24
) |
(0.21
) |
(0.12
) |
(0.28
) |
|
Total
distributions |
(0.26
) |
(0.41
) |
(0.41
) |
(0.41
) |
(0.41
) |
(0.41
) |
|
Net
asset value, end of period |
$6.27 |
$5.91 |
$6.21 |
$5.78 |
$6.81 |
$6.49 |
|
Market
price, end of period |
$5.79 |
$5.31 |
$5.27 |
$5.02 |
$6.28 |
$5.87 |
|
Total
Return(d)
|
|
|
|
|
|
|
|
Based
on net asset value |
10.95
%(e) |
2.55
% |
15.94
% |
(8.33
)% |
11.92
% |
8.18
% |
|
Based
on market price |
14.04
%(e) |
8.58
% |
13.29
% |
(13.67
)% |
14.11
% |
7.49
% |
|
Ratios
to Average Net Assets(f)
|
|
|
|
|
|
|
|
Total
expenses |
1.18
%(g) |
1.19
% |
1.10
% |
1.08
% |
1.09
% |
1.10
% |
|
Total
expenses after fees waived and/or reimbursed |
1.18
%(g) |
1.19
% |
1.10
% |
1.03
% |
0.99
% |
1.00
% |
|
Total
expenses after fees waived and/or reimbursed and excluding
professional fees for
foreign
withholding taxes |
1.16
%(g) |
1.13
% |
1.10
% |
1.02
% |
0.99
% |
1.00
% |
|
Net
investment income |
2.29
%(g) |
1.44
% |
1.40
% |
1.71
% |
1.34
% |
1.99
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$568,588 |
$562,959 |
$622,482 |
$593,471 |
$709,510 |
$676,949 |
|
Portfolio
turnover rate |
25
% |
46
% |
55
% |
41
% |
71
% |
60
% |
|
(a)
|
Based
on average shares outstanding. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(d)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(e)
|
Not
annualized. |
|
(f)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(g)
|
Annualized. |
|
|
CII | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$21.43 |
$19.81 |
$17.55 |
$22.10 |
$19.12 |
$17.96 |
|
Net
investment income (loss)(a) |
(0.01
) |
0.04 |
0.07 |
0.06 |
0.04 |
0.13 |
|
Net
realized and unrealized gain (loss) |
2.08 |
2.82 |
3.38 |
(2.51
) |
4.04 |
2.08 |
|
Net
increase (decrease) from investment operations |
2.07 |
2.86 |
3.45 |
(2.45
) |
4.08 |
2.21 |
|
Distributions(b)
|
||||||
|
From
net investment income |
(0.85
)(c) |
(0.03
) |
(0.07
) |
(0.04
) |
(0.04
) |
(0.13
) |
|
From
net realized gain |
— |
(1.21
) |
(1.12
) |
(2.06
) |
(1.06
) |
(0.92
) |
|
Total
distributions |
(0.85
) |
(1.24
) |
(1.19
) |
(2.10
) |
(1.10
) |
(1.05
) |
|
Net
asset value, end of period |
$22.65 |
$21.43 |
$19.81 |
$17.55 |
$22.10 |
$19.12 |
|
Market
price, end of period |
$21.35 |
$20.10 |
$19.00 |
$17.12 |
$22.12 |
$17.40 |
|
Total
Return(d)
|
|
|
|
|
|
|
|
Based
on net asset value |
10.26
%(e) |
15.21
% |
20.45
% |
(10.95
)% |
21.97
% |
13.94
% |
|
Based
on market price |
10.80
%(e) |
12.66
% |
18.43
% |
(13.21
)% |
34.15
% |
7.97
% |
|
Ratios
to Average Net Assets(f)
|
|
|
|
|
|
|
|
Total
expenses |
0.93
%(g) |
0.93
% |
0.89
% |
0.89
% |
0.90
% |
0.91
% |
|
Total
expenses after fees waived and/or reimbursed |
0.93
%(g) |
0.93
% |
0.89
% |
0.89
% |
0.90
% |
0.91
% |
|
Net
investment income (loss) |
(0.12
)%(g) |
0.20
% |
0.35
% |
0.31
% |
0.21
% |
0.78
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$926,669 |
$899,551 |
$874,451 |
$774,667 |
$975,479 |
$843,673 |
|
Portfolio
turnover rate |
46
% |
63
% |
28
% |
32
% |
27
% |
46
% |
|
(a)
|
Based
on average shares outstanding. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(d)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(e)
|
Not
annualized. |
|
(f)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(g)
|
Annualized. |
|
|
BMEZ | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Period
from
01/30/20(a)
to
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$16.43 |
$17.91 |
$18.76 |
$26.47 |
$30.73 |
$20.00 |
|
Net
investment income (loss)(b) |
(0.05
) |
0.04 |
(0.12
) |
(0.18
) |
(0.32
) |
(0.22
) |
|
Net
realized and unrealized gain (loss) |
0.00
(c) |
0.17 |
0.85 |
(5.79
) |
(2.23
) |
11.85 |
|
Net
increase (decrease) from investment operations |
(0.05
) |
0.21 |
0.73 |
(5.97
) |
(2.55
) |
11.63 |
|
Distributions(d)
|
||||||
|
From
net investment income |
(1.05
)(e) |
— |
— |
— |
— |
— |
|
From
net realized gain |
— |
— |
— |
(1.63
) |
(1.71
) |
(0.90
) |
|
Return
of capital |
— |
(1.69
) |
(1.58
) |
(0.11
) |
— |
— |
|
Total
distributions |
(1.05
) |
(1.69
) |
(1.58
) |
(1.74
) |
(1.71
) |
(0.90
) |
|
Net
asset value, end of period |
$15.33 |
$16.43 |
$17.91 |
$18.76 |
$26.47 |
$30.73 |
|
Market
price, end of period |
$14.26 |
$14.40 |
$14.65 |
$15.43 |
$25.36 |
$28.65 |
|
Total
Return(f)
|
|
|
|
|
|
|
|
Based
on net asset value |
(0.06
)%(g) |
2.11
% |
5.60
% |
(21.66
)% |
(8.31
)% |
59.62
%(g)(h) |
|
Based
on market price |
6.07
%(g) |
9.40
% |
5.02
% |
(32.75
)% |
(5.76
)% |
48.82
%(g) |
|
Ratios
to Average Net Assets(i)
|
|
|
|
|
|
|
|
Total
expenses |
1.36
%(j) |
1.44
%(k) |
1.33
%(l) |
1.32
% |
1.30
% |
1.29
%(j) |
|
Total
expenses after fees waived and/or reimbursed |
1.36
%(j) |
1.44
%(k) |
1.32
%(l) |
1.32
% |
1.30
% |
1.28
%(j) |
|
Net
investment income (loss) |
(0.66
)%(j) |
0.21
% |
(0.65
)% |
(0.91
)% |
(1.10
)% |
(1.00
)%(j) |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$958,017 |
$1,663,882 |
$1,907,371 |
$2,056,419 |
$2,981,886 |
$3,462,638 |
|
Portfolio
turnover rate |
40
% |
43
% |
63
% |
63
% |
44
% |
43
% |
|
(a)
|
Commencement
of operations. |
|
(b)
|
Based
on average shares outstanding. |
|
(c)
|
Amount
is less than $0.005 per share. |
|
(d)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(e)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(f)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(g)
|
Not
annualized. |
|
(h)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(i)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(j)
|
Annualized. |
|
(k)
|
Includes
non-recurring expenses of proxy costs. Without these costs, total
expenses, total expenses after fees waived and/or reimbursed would have
been 1.34% and 1.34%, respectively. |
|
(l)
|
Includes
non-recurring expenses of proxy costs. Without these costs, total
expenses, total expenses after fees waived and/or reimbursed would have
been 1.31% and 1.30%,
respectively. |
|
|
BME | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$41.20 |
$42.18 |
$43.30 |
$47.96 |
$45.66 |
$41.19 |
|
Net
investment income(a) |
0.07 |
0.07 |
0.14 |
0.11 |
— |
0.01 |
|
Net
realized and unrealized gain (loss) |
(0.39
) |
1.56 |
1.30 |
(2.21
) |
4.74 |
6.86 |
|
Net
increase (decrease) from investment operations |
(0.32
) |
1.63 |
1.44 |
(2.10
) |
4.74 |
6.87 |
|
Distributions(b)
|
||||||
|
From
net investment income |
(1.57
)(c) |
(0.07
) |
(0.17
) |
(0.12
) |
(0.00
)(d) |
(0.05
) |
|
From
net realized gain |
— |
(2.01
) |
(1.66
) |
(2.34
) |
(2.44
) |
(2.35
) |
|
Return
of capital |
— |
(0.53
) |
(0.73
) |
(0.10
) |
— |
— |
|
Total
distributions |
(1.57
) |
(2.61
) |
(2.56
) |
(2.56
) |
(2.44
) |
(2.40
) |
|
Net
asset value, end of period |
$39.31 |
$41.20 |
$42.18 |
$43.30 |
$47.96 |
$45.66 |
|
Market
price, end of period |
$36.46 |
$37.93 |
$40.46 |
$43.58 |
$48.50 |
$47.59 |
|
Total
Return(e)
|
|
|
|
|
|
|
|
Based
on net asset value |
(0.61
)%(f) |
4.09
% |
3.80
% |
(4.19
)% |
10.66
%(g) |
17.50
% |
|
Based
on market price |
0.14
%(f) |
(0.09
)% |
(1.08
)% |
(4.64
)% |
7.37
% |
18.69
% |
|
Ratios
to Average Net Assets(h)
|
|
|
|
|
|
|
|
Total
expenses |
1.12
%(i)(j)(k) |
1.10
% |
1.06
% |
1.08
% |
1.08
% |
1.10
% |
|
Total
expenses after fees waived and/or reimbursed |
1.12
%(i)(j)(k) |
1.10
% |
1.06
% |
1.07
% |
1.08
% |
1.10
% |
|
Total
expenses after fees waived and/or reimbursed and excluding amortization of
offering
costs and excluding professional fees for foreign withholding
taxes |
1.10
%(i) |
1.10
% |
1.06
% |
1.07
% |
1.08
% |
1.10
% |
|
Net
investment income |
0.37
%(i) |
0.15
% |
0.34
% |
0.27
% |
0.01
% |
0.01
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$508,098 |
$546,135 |
$588,135 |
$600,197 |
$625,775 |
$545,936 |
|
Portfolio
turnover rate |
29
% |
29
% |
43
% |
41
% |
49
% |
28
% |
|
(a)
|
Based
on average shares outstanding. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(d)
|
Amount
is greater than $(0.005) per share. |
|
(e)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(f)
|
Not
annualized. |
|
(g)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(h)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(i)
|
Annualized. |
|
(j)
|
The
Offering costs were not annualized in the calculation of the expense
ratios. If these expenses were annualized, the total expenses and total
expenses after fees waived and/or reimbursed
would
have been 1.14% and 1.13%, respectively. |
|
(k)
|
Includes
non-recurring expenses of offering costs. Without these costs, total
expenses and total expenses after fees waived and/or reimbursed would have
been 1.10% and 1.10%,
respectively. |
|
|
BCX | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$9.58 |
$10.57 |
$11.23 |
$10.21 |
$8.45 |
$9.04 |
|
Net
investment income(a) |
0.12 |
0.22 |
0.29 |
0.30 |
0.29 |
0.20 |
|
Net
realized and unrealized gain (loss) |
0.97 |
(0.57
) |
(0.33
) |
1.27 |
1.95 |
(0.26
) |
|
Net
increase (decrease) from investment operations |
1.09 |
(0.35
) |
(0.04
) |
1.57 |
2.24 |
(0.06
) |
|
Distributions(b)
|
||||||
|
From
net investment income |
(0.42
)(c) |
(0.25
) |
(0.28
) |
(0.29
) |
(0.38
) |
(0.23
) |
|
Return
of capital |
— |
(0.39
) |
(0.34
) |
(0.26
) |
(0.10
) |
(0.30
) |
|
Total
distributions |
(0.42
) |
(0.64
) |
(0.62
) |
(0.55
) |
(0.48
) |
(0.53
) |
|
Net
asset value, end of period |
$10.25 |
$9.58 |
$10.57 |
$11.23 |
$10.21 |
$8.45 |
|
Market
price, end of period |
$9.45 |
$8.54 |
$8.88 |
$9.97 |
$9.35 |
$7.41 |
|
Total
Return(d)
|
|
|
|
|
|
|
|
Based
on net asset value |
11.93
%(e) |
(2.80
)%(f) |
0.56
% |
16.31
% |
27.20
% |
1.56
% |
|
Based
on market price |
15.76
%(e) |
3.14
% |
(4.84
)% |
12.76
% |
32.83
% |
(0.23
)% |
|
Ratios
to Average Net Assets(g)
|
|
|
|
|
|
|
|
Total
expenses |
1.15
%(h)(i) |
1.10
% |
1.06
% |
1.05
% |
1.07
% |
1.09
% |
|
Total
expenses after fees waived and/or reimbursed |
1.15
%(h)(i) |
1.10
% |
1.06
% |
1.05
% |
1.07
% |
1.09
% |
|
Total
expenses after fees waived and/or reimbursed and excluding
professional fees for
foreign
withholding taxes |
1.14
%(h) |
1.10
% |
1.06
% |
1.05
% |
1.07
% |
1.09
% |
|
Net
investment income |
2.40
%(h) |
2.13
% |
2.63
% |
2.73
% |
3.05
% |
2.62
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$781,746 |
$768,567 |
$891,338 |
$983,181 |
$901,782 |
$746,615 |
|
Portfolio
turnover rate |
69
% |
67
% |
46
% |
92
% |
66
% |
78
% |
|
(a)
|
Based
on average shares outstanding. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(d)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(e)
|
Not
annualized. |
|
(f)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(g)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(h)
|
Annualized. |
|
(i)
|
Professional
costs were not annualized in the calculation of the expense ratios. If
these expenses were annualized, the total expenses and total expenses
after fees waived and/or reimbursed
would
have been 1.16% and 1.16%,
respectively. |
|
|
BSTZ | |||||
|
|
Six
Months Ended
06/30/25
(unaudited)(a)
|
Year
Ended
12/31/24(a)
|
Year
Ended
12/31/23(a)
|
Year
Ended
12/31/22(a)
|
Year
Ended
12/31/21(a)
|
Year
Ended
12/31/20(a)
|
|
| ||||||
|
Net
asset value, beginning of period |
$23.14 |
$21.43 |
$19.53 |
$38.82 |
$38.72 |
$20.95 |
|
Net
investment loss(b) |
(0.12
) |
(0.27
) |
(0.20
) |
(0.30
) |
(0.51
) |
(0.30
) |
|
Net
realized and unrealized gain (loss) |
0.60 |
4.00 |
3.92 |
(16.69
) |
3.69 |
19.32 |
|
Net
increase (decrease) from investment operations |
0.48 |
3.73 |
3.72 |
(16.99
) |
3.18 |
19.02 |
|
Distributions(c)
|
||||||
|
From
net investment income |
(1.32
)(d) |
— |
— |
— |
— |
— |
|
From
net realized gain |
— |
(1.02
) |
— |
(0.89
) |
(3.08
) |
(1.10
) |
|
Return
of capital |
— |
(1.00
) |
(1.82
) |
(1.41
) |
— |
(0.15
) |
|
Total
distributions |
(1.32
) |
(2.02
) |
(1.82
) |
(2.30
) |
(3.08
) |
(1.25
) |
|
Net
asset value, end of period |
$22.30 |
$23.14 |
$21.43 |
$19.53 |
$38.82 |
$38.72 |
|
Market
price, end of period |
$20.75 |
$20.71 |
$16.71 |
$15.64 |
$38.94 |
$36.38 |
|
Total
Return(e)
|
|
|
|
|
|
|
|
Based
on net asset value |
3.08
%(f) |
19.60
% |
21.74
%(g) |
(43.98
)% |
8.41
% |
94.60
%(h) |
|
Based
on market price |
7.17
%(f) |
37.27
% |
18.54
% |
(55.27
)% |
15.75
% |
86.85
% |
|
Ratios
to Average Net Assets(i)
|
|
|
|
|
|
|
|
Total
expenses |
1.33
%(j) |
1.48
%(k) |
1.35
% |
1.33
% |
1.31
% |
1.33
% |
|
Total
expenses after fees waived and/or reimbursed |
1.33
%(j) |
1.48
%(k) |
1.34
% |
1.33
% |
1.31
% |
1.33
% |
|
Net
investment loss |
(1.11
)%(j) |
(1.24
)% |
(0.96
)% |
(1.16
)% |
(1.25
)% |
(1.16
)% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$1,533,256 |
$1,673,591 |
$1,629,824 |
$1,524,658 |
$3,048,962 |
$3,023,744 |
|
Portfolio
turnover rate |
33
% |
37
% |
38
% |
47
% |
18
% |
45
% |
|
(a)
|
Consolidated
Financial Highlights. |
|
(b)
|
Based
on average shares outstanding. |
|
(c)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(d)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(e)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(f)
|
Not
annualized. |
|
(g)
|
Includes
payment from an affiliate, which impacted the Fund’s total return.
Excluding the payment from an affiliate, the Fund’s total return would
have been 21.68%. |
|
(h)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(i)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(j)
|
Annualized. |
|
(k)
|
Includes
non-recurring expenses of proxy costs. Without these costs, total
expenses, total expenses after fees waived and/or reimbursed would have
been 1.34% and 1.34%,
respectively. |
|
|
BST | |||||
|
|
Six
Months Ended
06/30/25
(unaudited)(a)
|
Year
Ended
12/31/24(a)
|
Year
Ended
12/31/23(a)
|
Year
Ended
12/31/22(a)
|
Year
Ended
12/31/21(a)
|
Year
Ended
12/31/20(a)
|
|
| ||||||
|
Net
asset value, beginning of period |
$39.60 |
$34.74 |
$29.11 |
$52.40 |
$51.94 |
$32.45 |
|
Net
investment loss(b) |
(0.13
) |
(0.28
) |
(0.23
) |
(0.29
) |
(0.43
) |
(0.28
) |
|
Net
realized and unrealized gain (loss) |
2.70 |
8.14 |
8.86 |
(20.00
) |
5.84 |
21.82 |
|
Net
increase (decrease) from investment operations |
2.57 |
7.86 |
8.63 |
(20.29
) |
5.41 |
21.54 |
|
Distributions(c)
|
||||||
|
From
net investment income |
(1.50
)(d) |
— |
— |
— |
— |
— |
|
From
net realized gain |
— |
(1.57
) |
(1.48
) |
(2.16
) |
(4.27
) |
(2.05
) |
|
Return
of capital |
— |
(1.43
) |
(1.52
) |
(0.84
) |
— |
— |
|
Total
distributions |
(1.50
) |
(3.00
) |
(3.00
) |
(3.00
) |
(4.27
) |
(2.05
) |
|
Dilutive
effect of rights offer (Note
10) |
— |
— |
— |
— |
(0.68
) |
— |
|
Net
asset value, end of period |
$40.67 |
$39.60 |
$34.74 |
$29.11 |
$52.40 |
$51.94 |
|
Market
price, end of period |
$38.17 |
$36.56 |
$33.66 |
$28.37 |
$49.97 |
$53.30 |
|
Total
Return(e)
|
|
|
|
|
|
|
|
Based
on net asset value |
7.06
%(f) |
23.84
% |
30.78
% |
(39.56
)%(g) |
9.44
% |
68.76
%(h) |
|
Based
on market price |
8.83
%(f) |
18.01
% |
30.03
% |
(38.23
)% |
1.70
% |
68.92
% |
|
Ratios
to Average Net Assets(i)
|
|
|
|
|
|
|
|
Total
expenses |
1.12
%(j)(k)(l) |
1.07
% |
1.09
% |
1.11
% |
1.05
% |
1.09
% |
|
Total
expenses after fees waived and/or reimbursed |
1.12
%(j)(k)(l) |
1.07
% |
1.09
% |
1.11
% |
1.00
% |
0.99
% |
|
Total
expenses after fees waived and/or reimbursed and excluding offering cost
and
dividend expense |
1.11
%(j) |
1.07
% |
1.09
% |
1.10
% |
1.00
% |
0.99
% |
|
Net
investment loss |
(0.70
)%(j) |
(0.75
)% |
(0.70
)% |
(0.77
)% |
(0.78
)% |
(0.73
)% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$1,411,955 |
$1,374,876 |
$1,196,425 |
$960,703 |
$1,681,166 |
$1,297,344 |
|
Portfolio
turnover rate |
20
% |
19
% |
32
% |
38
% |
31
% |
20
% |
|
(a)
|
Consolidated
Financial Highlights. |
|
(b)
|
Based
on average shares outstanding. |
|
(c)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(d)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(e)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(f)
|
Not
annualized. |
|
(g)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(h)
|
For
financial reporting purposes, the market value of a certain investment was
adjusted as of the report date. Accordingly, the net asset value (NAV) per
share and total return performance based
on
NAV presented herein are different than the information previously
published as of December 31, 2020. |
|
(i)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(j)
|
Annualized. |
|
(k)
|
The
Offering costs were not annualized in the calculation of the expense
ratios. If these expense was annualized, the total expenses and total
expenses after fees waived and/or reimbursed
would
have been 1.13% and 1.12%, respectively. |
|
(l)
|
Includes
non-recurring expenses of offering costs. Without these costs, total
expenses and total expenses after fees waived and/or reimbursed would have
been 1.11% and 1.11%,
respectively. |
|
|
BTX | ||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Period
from
03/29/21(a)
to
12/31/21 |
|
| |||||
|
Net
asset value, beginning of period |
$8.37 |
$9.03 |
$8.82 |
$16.72 |
$20.00 |
|
Net
investment loss(b) |
(0.02
) |
(0.11
) |
(0.11
) |
(0.13
) |
(0.15
) |
|
Net
realized and unrealized gain (loss) |
(0.29
) |
0.28 |
1.09 |
(6.78
) |
(2.43
) |
|
Net
increase (decrease) from investment operations |
(0.31
) |
0.17 |
0.98 |
(6.91
) |
(2.58
) |
|
Distributions(c)
|
|||||
|
From
net investment income |
(0.51
)(d) |
— |
— |
— |
— |
|
Return
of capital |
— |
(0.83
) |
(0.77
) |
(0.99
) |
(0.70
) |
|
Total
distributions |
(0.51
) |
(0.83
) |
(0.77
) |
(0.99
) |
(0.70
) |
|
Net
asset value, end of period |
$7.55 |
$8.37 |
$9.03 |
$8.82 |
$16.72 |
|
Market
price, end of period |
$7.34 |
$7.44 |
$7.33 |
$6.81 |
$14.54 |
|
Total
Return(e)
|
|
|
|
|
|
|
Based
on net asset value |
(3.08
)%(f) |
3.39
% |
13.28
% |
(41.14
)%(g) |
(13.03
)%(f) |
|
Based
on market price |
6.00
%(f) |
13.22
% |
19.09
% |
(47.74
)% |
(24.37
)%(f) |
|
Ratios
to Average Net Assets(h)
|
|
|
|
|
|
|
Total
expenses |
1.40
%(i) |
1.51
%(j) |
1.44
%(k) |
1.36
% |
1.29
%(i) |
|
Total
expenses after fees waived and/or reimbursed |
1.39
%(i) |
1.51
%(j) |
1.44
%(k) |
1.36
% |
1.28
%(i) |
|
Net
investment loss |
(0.59
)%(i) |
(1.22
)% |
(1.22
)% |
(1.22
)% |
(1.02
)%(i) |
|
Supplemental
Data |
|
|
|
|
|
|
Net
assets, end of period (000) |
$1,611,104 |
$1,784,961 |
$2,026,470 |
$2,026,488 |
$3,981,653 |
|
Portfolio
turnover rate |
99
% |
39
% |
37
% |
41
% |
55
% |
|
(a)
|
Commencement
of operations. |
|
(b)
|
Based
on average shares outstanding. |
|
(c)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(d)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(e)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(f)
|
Not
annualized. |
|
(g)
|
Includes
payment from an affiliate, which had no impact on the Trust’s
total return. |
|
(h)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(i)
|
Annualized. |
|
(j)
|
Includes
non-recurring expenses of proxy costs. Without these costs, total
expenses, total expenses after fees waived and/or reimbursed would have
been 1.37% and 1.37%, respectively. |
|
(k)
|
Includes
non-recurring expenses of proxy costs. Without these costs, total
expenses, total expenses after fees waived and/or reimbursed would have
been 1.33% and 1.33%,
respectively. |
|
|
BUI | |||||
|
|
Six
Months Ended
06/30/25
(unaudited) |
Year
Ended
12/31/24 |
Year
Ended
12/31/23 |
Year
Ended
12/31/22 |
Year
Ended
12/31/21 |
Year
Ended
12/31/20 |
|
| ||||||
|
Net
asset value, beginning of period |
$22.65 |
$22.53 |
$22.37 |
$25.86 |
$23.80 |
$22.02 |
|
Net
investment income(a) |
0.15 |
0.29 |
0.35 |
0.33 |
0.24 |
0.33 |
|
Net
realized and unrealized gain (loss) |
2.97 |
1.30 |
1.26 |
(2.37
) |
3.27 |
2.90 |
|
Net
increase (decrease) from investment operations |
3.12 |
1.59 |
1.61 |
(2.04
) |
3.51 |
3.23 |
|
Distributions(b)
|
||||||
|
From
net investment income |
(0.82
)(c) |
(0.25
) |
(0.37
) |
(0.30
) |
(0.24
) |
(0.20
) |
|
From
net realized gain |
— |
(0.87
) |
(0.59
) |
(0.56
) |
(0.76
) |
(1.08
) |
|
Return
of capital |
— |
(0.35
) |
(0.49
) |
(0.59
) |
(0.45
) |
(0.17
) |
|
Total
distributions |
(0.82
) |
(1.47
) |
(1.45
) |
(1.45
) |
(1.45
) |
(1.45
) |
|
Net
asset value, end of period |
$24.95 |
$22.65 |
$22.53 |
$22.37 |
$25.86 |
$23.80 |
|
Market
price, end of period |
$25.75 |
$23.43 |
$21.82 |
$20.77 |
$26.62 |
$25.04 |
|
Total
Return(d)
|
|
|
|
|
|
|
|
Based
on net asset value |
14.05
%(e) |
7.28
% |
7.66
% |
(7.73
)% |
15.13
% |
15.87
% |
|
Based
on market price |
13.79
%(e) |
14.58
% |
12.30
% |
(16.78
)% |
12.65
% |
20.32
% |
|
Ratios
to Average Net Assets(f)
|
|
|
|
|
|
|
|
Total
expenses |
1.11
%(g)(h)(i) |
1.08
% |
1.08
% |
1.08
% |
1.08
% |
1.13
% |
|
Total
expenses after fees waived and/or reimbursed |
1.11
%(g)(h)(i) |
1.08
% |
1.08
% |
1.08
% |
1.07
% |
1.10
% |
|
Total
expenses after fees waived and/or reimbursed and excluding amortization of
offering
costs and excluding professional fees for foreign withholding
taxes |
1.07
%(g) |
1.08
% |
1.08
% |
1.08
% |
1.07
% |
—
% |
|
Net
investment income |
1.25
%(g) |
1.26
% |
1.58
% |
1.44
% |
0.97
% |
1.58
% |
|
Supplemental
Data |
|
|
|
|
|
|
|
Net
assets, end of period (000) |
$566,834 |
$510,854 |
$506,462 |
$498,393 |
$559,805 |
$444,526 |
|
Portfolio
turnover rate |
27
% |
36
% |
31
% |
36
% |
20
% |
39
% |
|
(a)
|
Based
on average shares outstanding. |
|
(b)
|
Distributions
for annual periods determined in accordance with U.S. federal income tax
regulations. |
|
(c)
|
A
portion of the distributions from net investment income may be deemed a
return of capital or net realized gain at fiscal
year-end. |
|
(d)
|
Total
returns based on market price, which can be significantly greater or less
than the net asset value, may result in substantially different returns.
Where applicable, excludes the effects of any
sales
charges and assumes the reinvestment of distributions at actual
reinvestment prices. |
|
(e)
|
Not
annualized. |
|
(f)
|
Excludes
fees and expenses incurred indirectly as a result of investments in
underlying funds. |
|
(g)
|
Annualized. |
|
(h)
|
The
Offering costs were not annualized in the calculation of the expense
ratios. If these expense was annualized, the total expenses and total
expenses after fees waived and/or reimbursed
would
have been 1.13% and 1.13%, respectively. |
|
(i)
|
Includes
non-recurring expenses of offering costs. Without these costs, total
expenses and total expenses after fees waived and/or reimbursed would have
been 1.12% and 1.12%,
respectively. |
|
Trust
Name
|
Herein
Referred To As
|
Organized
|
Diversification
Classification
|
|
BlackRock
Energy and Resources Trust |
BGR |
Delaware |
Non-diversified |
|
BlackRock
Enhanced Equity Dividend Trust |
BDJ |
Delaware |
Diversified |
|
BlackRock
Enhanced Global Dividend Trust |
BOE |
Delaware |
Diversified |
|
BlackRock
Enhanced International Dividend Trust |
BGY |
Delaware |
Diversified |
|
BlackRock
Enhanced Large Cap Core Fund, Inc. |
CII |
Maryland |
Diversified |
|
BlackRock
Health Sciences Term Trust |
BMEZ |
Maryland |
Diversified |
|
BlackRock
Health Sciences Trust |
BME |
Delaware |
Diversified |
|
BlackRock
Resources & Commodities Strategy Trust |
BCX |
Delaware |
Non-diversified |
|
BlackRock
Science and Technology Term Trust |
BSTZ |
Delaware |
Diversified |
|
BlackRock
Science and Technology Trust |
BST |
Delaware |
Diversified |
|
BlackRock
Technology and Private Equity Term Trust |
BTX |
Maryland |
Non-diversified* |
|
BlackRock
Utilities, Infrastructure & Power Opportunities
Trust |
BUI |
Delaware |
Diversified |
|
*
|
The
Trust’s
classification changed from diversified to non- diversified during the
reporting period. |
|
Trust
Name/Counterparty |
Securities
Loaned
at Value |
Cash
Collateral
Received(a)
|
Non-Cash
Collateral
Received,
at Fair Value(a)
|
Net
Amount(b)
|
|
BMEZ |
|
|
|
|
|
Barclays
Capital, Inc. |
$ 405,882 |
$ (405,882
) |
$ — |
$ — |
|
BofA
Securities, Inc. |
231,861 |
(231,861
) |
— |
— |
|
Citigroup
Global Markets, Inc. |
516,244 |
(516,244
) |
— |
— |
|
Jefferies
LLC |
1,212,676 |
(1,212,676
) |
— |
— |
|
Morgan
Stanley |
42,731 |
(42,731
) |
— |
— |
|
Toronto-Dominion
Bank |
159,705 |
(159,705
) |
— |
— |
|
|
$ 2,569,099 |
$ (2,569,099
) |
$ — |
$ — |
|
BME |
|
|
|
|
|
BofA
Securities, Inc. |
$ 146,619 |
$ (146,337
) |
$ — |
$ 282 |
|
Citigroup
Global Markets, Inc. |
955,896 |
(955,896
) |
— |
— |
|
J.P.
Morgan Securities LLC |
155,340 |
(155,340
) |
— |
— |
|
Morgan
Stanley |
32,657 |
(32,657
) |
— |
— |
|
|
$ 1,290,512 |
$ (1,290,230
) |
$ — |
$ 282 |
|
BCX |
|
|
|
|
|
Citigroup
Global Markets, Inc. |
$ 5,699,597 |
$ (5,699,597
) |
$ — |
$ — |
|
SG
Americas Securities LLC |
157,900 |
(157,900
) |
— |
— |
|
|
$ 5,857,497 |
$ (5,857,497
) |
$ — |
$ — |
|
BSTZ |
|
|
|
|
|
Barclays
Capital, Inc. |
$ 702,027 |
$ (702,027
) |
$ — |
$ — |
|
BNP
Paribas SA |
1,716,487 |
(1,716,487
) |
— |
— |
|
BofA
Securities, Inc. |
143,537 |
(143,537
) |
— |
— |
|
Goldman
Sachs & Co. LLC |
15,998,065 |
(15,998,065
) |
— |
— |
|
J.P.
Morgan Securities LLC |
1,859,715 |
(1,859,715
) |
— |
— |
|
Jefferies
LLC |
3,861,681 |
(3,861,681
) |
— |
— |
|
Morgan
Stanley |
2,493,310 |
(2,493,310
) |
— |
— |
|
National
Financial Services LLC |
74,358 |
(74,358
) |
— |
— |
|
|
$ 26,849,180 |
$ (26,849,180
) |
$ — |
$ — |
|
BTX |
|
|
|
|
|
BNP
Paribas SA |
$ 4,505,940 |
$ (4,505,940
) |
$ — |
$ — |
|
Trust
Name/Counterparty |
Securities
Loaned
at Value |
Cash
Collateral
Received(a) |
Non-Cash
Collateral
Received,
at Fair Value(a) |
Net
Amount(b) |
|
BTX
(continued) |
|
|
|
|
|
J.P.
Morgan Securities LLC |
$ 2,936,217 |
$ (2,936,217
) |
$ — |
$ — |
|
Jefferies
LLC |
43,740 |
(43,740
) |
— |
— |
|
Morgan
Stanley |
3,780,630 |
(3,780,630
) |
— |
— |
|
|
$ 11,266,527 |
$ (11,266,527
) |
$ — |
$ — |
|
(a)
|
Collateral
received, if any, in excess of the market value of securities on loan is
not presented in this table. The total cash collateral received by each
Trust is disclosed in the Trust’s
Statements
of Assets and Liabilities. |
|
(b)
|
The
market value of the loaned securities is determined as of June 30, 2025.
Additional collateral is delivered to each Trust on the next business day
in accordance with the MSLA. The
net
amount would be subject to the borrower default indemnity in the event of
default by the counterparty. |
|
|
BGR |
BDJ |
BOE |
BME |
|
Investment
advisory fees |
1.00
% |
0.80
% |
1.00
% |
1.00
% |
|
|
CII |
|
Investment
advisory fees |
0.85
% |
|
|
BGY |
BUI |
Investment
advisory fees |
1.00
% |
1.00
% |
|
|
BMEZ |
BSTZ |
BST |
BTX |
|
Investment
advisory fees |
1.25
% |
1.25
% |
1.00
% |
1.25
% |
|
|
BOE |
|
|
0.175
% |
|
Trust
Name |
Fees
Waived and/or Reimbursed
by
the Manager |
|
BOE |
$ 596,903 |
|
Trust
Name |
Fees
Waived and/or Reimbursed
by
the Manager |
|
BGR |
$ 2,661 |
|
BDJ |
14,729 |
|
BOE |
2,758 |
|
BGY |
2,797 |
|
CII |
4,858 |
|
BMEZ |
29,042 |
|
BME |
8,358 |
|
BCX |
8,310 |
|
BSTZ |
7,006 |
|
BST |
3,625 |
|
BTX |
17,044 |
|
BUI |
4,369 |
|
Trust
Name
|
Amounts |
|
BDJ |
$ 177 |
|
BGY |
277 |
|
CII |
129 |
|
BMEZ |
6,569 |
|
BME |
623 |
|
BCX |
3,634 |
|
BSTZ |
22,031 |
|
BST |
779 |
|
BTX |
15,726 |
|
BUI |
94 |
|
Trust
Name |
Purchases |
Sales |
Net
Realized
Gain
(Loss) |
|
BGY |
$ 2,820,003 |
$ 5,776,078 |
$ 160,391 |
|
Trust
Name
|
Purchases |
Sales |
|
BGR |
$ 151,573,331 |
$ 164,949,527 |
|
BDJ |
448,577,895 |
511,627,173 |
|
BOE |
118,112,433 |
184,949,119 |
|
BGY |
143,896,264 |
195,621,235 |
|
CII |
407,288,772 |
472,072,979 |
|
BMEZ |
514,856,533 |
1,113,710,191 |
|
BME |
153,115,996 |
165,968,975 |
|
BCX |
524,190,450 |
569,539,585 |
|
BSTZ |
490,732,678 |
682,437,643 |
|
BST |
258,092,756 |
324,703,237 |
|
BTX |
1,540,354,715 |
1,723,578,395 |
|
BUI |
138,847,397 |
152,423,443 |
|
Trust
Name |
Non-Expiring
Capital
Loss
Carryforwards |
Qualified
Late-Year
Ordinary
Losses |
|
BGR |
$ (203,787,893
) |
$ — |
|
BOE |
(5,383,743
) |
(23,287
) |
|
BMEZ |
(26,094,837
) |
— |
|
BME |
— |
(9,210
) |
|
BCX |
(210,243,025
) |
— |
|
BST |
— |
(6,188
) |
|
BTX |
(1,849,884,782
) |
— |
|
BUI |
— |
(43,667
) |
|
Trust
Name |
Tax
Cost |
Gross
Unrealized
Appreciation |
Gross
Unrealized
Depreciation |
Net
Unrealized
Appreciation
(Depreciation) |
|
BGR |
$ 266,095,629 |
$ 109,101,323 |
$ (21,691,192
) |
$ 87,410,131 |
|
BDJ |
1,333,396,601 |
420,804,739 |
(64,857,687
) |
355,947,052 |
|
BOE |
510,890,138 |
196,210,876 |
(9,305,743
) |
186,905,133 |
|
BGY |
448,503,185 |
139,343,547 |
(15,976,990
) |
123,366,557 |
|
CII |
634,269,244 |
328,972,878 |
(17,411,058
) |
311,561,820 |
|
BMEZ |
976,352,077 |
180,353,011 |
(184,954,024
) |
(4,601,013
) |
|
BME |
370,857,261 |
181,698,936 |
(25,380,203
) |
156,318,733 |
|
BCX |
712,346,180 |
146,939,002 |
(67,242,403
) |
79,696,599 |
|
BSTZ |
1,002,329,196 |
737,605,600 |
(155,755,964
) |
581,849,636 |
|
BST |
723,223,200 |
822,604,446 |
(127,624,798
) |
694,979,648 |
|
BTX |
1,808,010,698 |
232,647,895 |
(410,993,649
) |
(178,345,754
) |
|
BUI |
362,420,982 |
213,028,372 |
(3,713,554
) |
209,314,818 |
|
Sectors |
Trust
Name |
|
Energy |
BGR,
BCX |
|
Financials |
BDJ |
|
Health
Care |
BMEZ,
BME |
|
Information
Technology |
CII,
BSTZ, BST |
|
Materials |
BCX |
|
Utilities |
BUI |
|
|
Six
Months Ended |
Year
Ended |
|
Trust
Name |
06/30/25 |
12/31/24 |
|
BST |
— |
236,917 |
BUI |
130,020 |
55,243 |
|
|
Six
Months Ended |
Year
Ended |
|
Trust
Name |
06/30/25 |
12/31/24 |
|
BST |
— |
43,442 |
BUI |
32,859 |
21,581 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
01/22/25 |
02/22/25 |
3,894,759 |
14.9
% |
652,722 |
2.5
% |
$13.8376 |
$9,032,106 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
01/23/25 |
02/25/25 |
13,246,807 |
22.7
% |
1,462,199 |
2.5
% |
$12.1520 |
$17,768,642 |
|
04/16/25 |
05/20/25 |
12,288,978 |
21.6 |
1,425,644 |
2.5 |
11.8776 |
16,933,229 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
01/23/25 |
02/25/25 |
31,046,841 |
32.6
% |
2,383,023 |
2.5
% |
$6.0662 |
$14,455,894 |
|
04/16/25 |
05/20/25 |
22,873,636 |
24.6 |
2,323,447 |
2.5 |
6.0858 |
14,140,034 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
01/22/25 |
02/22/25 |
4,275,883 |
10.2
% |
1,049,179 |
2.5
% |
$21.1974 |
$22,239,867 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
01/22/25 |
02/22/25 |
1,188,063 |
9.0
% |
331,387 |
2.5
% |
$42.1792 |
$13,977,639 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
01/23/25 |
02/25/25 |
17,748,385 |
22.1
% |
2,004,946 |
2.5
% |
$9.7706 |
$19,589,525 |
|
04/16/25 |
05/20/25 |
14,138,859 |
18.1 |
1,954,822 |
2.5 |
9.7314 |
19,023,155 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
01/23/25 |
02/25/25 |
16,170,310 |
22.4
% |
1,807,867 |
2.5
% |
$21.6776 |
$39,190,218 |
|
04/16/25 |
05/20/25 |
12,715,932 |
18.0 |
1,762,670 |
2.5 |
20.0018 |
35,256,573 |
|
(a)
|
Date
the tender offer period
began. |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/17/24 |
08/19/24 |
7,466,508 |
27.2
% |
686,624 |
2.5
% |
$14.5824 |
$10,012,626 |
|
10/15/24 |
11/18/24 |
6,002,507 |
22.4 |
669,458 |
2.5 |
14.5922 |
9,768,865 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/17/24 |
08/19/24 |
22,908,137 |
12.3
% |
4,653,377 |
2.5
% |
$9.1826 |
$42,730,100 |
|
10/15/24 |
11/18/24 |
18,268,902 |
10.1 |
4,537,043 |
2.5 |
9.2120 |
41,795,240 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/19/24 |
08/21/24 |
14,942,512 |
24.3
% |
1,538,145 |
2.5
% |
$12.2794 |
$18,887,498 |
|
10/17/24 |
11/20/24 |
14,941,364 |
24.9 |
1,499,691 |
2.5 |
12.0736 |
18,106,669 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/18/24 |
08/20/24 |
33,752,225 |
33.7
% |
2,506,796 |
2.5
% |
$6.3014 |
$15,796,324 |
|
10/16/24 |
11/19/24 |
33,315,326 |
34.1 |
2,444,126 |
2.5 |
5.8996 |
14,419,366 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/17/24 |
08/19/24 |
5,850,437 |
13.3
% |
1,103,672 |
2.5
% |
$20.9524 |
$23,124,577 |
|
10/15/24 |
11/18/24 |
5,713,692 |
13.3 |
1,076,081 |
2.5 |
20.9328 |
22,525,388 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/18/24 |
08/20/24 |
24,040,558 |
22.6
% |
2,662,856 |
2.5
% |
$17.6204 |
$46,920,588 |
|
10/16/24 |
11/19/24 |
21,043,412 |
20.3 |
2,596,285 |
2.5 |
16.3856 |
42,541,687 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/18/24 |
08/20/24 |
1,279,599 |
9.2
% |
348,599 |
2.5
% |
$44.4822 |
$15,506,450 |
|
Commencement
Date
of Tender
Offer
Period(a) |
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
10/16/24 |
11/19/24 |
1,360,222 |
10.0
% |
339,884 |
2.5
% |
41.2678 |
14,026,265 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/19/24 |
08/21/24 |
22,521,822 |
26.7
% |
2,109,082 |
2.5
% |
$10.3292 |
$21,785,130 |
|
10/17/24 |
11/20/24 |
20,587,371 |
25.0 |
2,056,355 |
2.5 |
10.1136 |
20,797,152 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/19/24 |
08/21/24 |
23,251,771 |
30.6
% |
1,901,766 |
2.5
% |
$21.4522 |
$40,797,065 |
|
10/17/24 |
11/20/24 |
19,714,994 |
26.6 |
1,854,222 |
2.5 |
22.3440 |
41,430,736 |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
07/22/24 |
08/22/24 |
42,424,300 |
18.9
% |
5,610,470 |
2.5
% |
$8.1242 |
$45,580,580 |
|
10/18/24 |
11/21/24 |
35,904,019 |
16.4 |
5,470,208 |
2.5 |
8.5750 |
46,907,034 |
|
(a)
|
Date
the tender offer period
began. |
|
Commencement
Date
of Tender
Offer
Period(a)
|
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
Purchased |
Tendered
Shares
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
03/21/25 |
04/18/25 |
38,753,713 |
38.3
% |
38,753,713 |
38.3
% |
$14.2086 |
$550,636,007 |
|
Trust
Name |
Declaration
Date |
Record
Date |
Payable/
Paid
Date |
|
Dividend
Per
Common
Share |
|
BGR |
07/01/25 |
07/15/25 |
07/31/25 |
|
$ 0.097300 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.097300 |
|
BDJ |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.061900 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.061900 |
|
BOE |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.082700 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.082700 |
|
BGY |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.042600 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.042600 |
|
CII |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.141000 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.141000 |
|
BMEZ |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.167200 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.164960 |
|
BME |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.262100 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.262100 |
|
BCX |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.069700 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.069700 |
|
BSTZ |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.216840 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.216470 |
|
BST |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.250000 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.250000 |
|
BTX |
07/01/25 |
07/17/25 |
07/31/25 |
|
0.079680 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.078840 |
|
BUI |
07/01/25 |
07/15/25 |
07/31/25 |
|
0.136000 |
|
|
08/01/25 |
08/15/25 |
08/29/25 |
|
0.136000 |
|
Commencement
Date
of Tender
Offer
Period |
Valuation
Date |
Number
of Shares
Tendered |
Tendered
Shares
as
a Percentage of
Outstanding
Shares |
Number
of Tendered
Shares
to be
Purchased |
Tendered
Shares to be
Purchased
as
a Percentage of
Outstanding
Shares |
Purchase
Price |
Total
Amount of
Purchases |
|
06/09/25 |
07/09/25 |
96,627,850 |
45.3
% |
96,627,850 |
45.3
% |
$7.4924 |
$723,974,503 |
|
|
Votes
For |
Votes
Against |
Votes
Abstain |
|
BTX |
103,516,399 |
2,795,926 |
732,630 |
|
|
Votes
For |
Votes
Against |
Votes
Abstain |
|
BTX |
103,045,937 |
3,140,232 |
858,786 |
|
Currency
Abbreviation | |
|
AUD |
Australian
Dollar |
|
CAD |
Canadian
Dollar |
|
CHF |
Swiss
Franc |
|
DKK |
Danish
Krone |
|
EUR |
Euro |
|
GBP |
British
Pound |
|
HKD |
Hong
Kong Dollar |
|
JPY |
Japanese
Yen |
|
KRW |
South
Korean Won |
|
NOK |
Norwegian
Krone |
|
SEK |
Swedish
Krona |
|
SGD |
Singapore
Dollar |
|
TWD |
New
Taiwan Dollar |
|
USD |
United
States Dollar |
|
Portfolio
Abbreviation | |
|
ADR |
American
Depositary Receipt |
|
CVR |
Contingent
Value Right |
|
GDR |
Global
Depositary Receipt |
|
LP |
Limited
Partnership
|
|
PJSC |
Public
Joint Stock Company |
|
REIT |
Real
Estate Investment Trust |
|
S&P |
Standard
& Poor’s |
|
SAP |
Subject
to Appropriations |